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Abstract 
 
Next-generation sequencing technologies are revolutionising our ability to characterise and 
investigate infectious diseases. Utilising the power of high throughput sequencing, this study 
reports, the development of a sensitive, non-PCR based, unbiased amplification method. Which 
allows the rapid and accurate sequencing of multiple microbial pathogens directly from clinical 
samples.  
The method employs ɸ29 DNA polymerase, a highly efficient enzyme able to produce strand 
displacement during the polymerisation process with high fidelity. Problems with DNA secondary 
structure were overcome and the method optimised to produce sufficient DNA to sequence from 
a single bacterial cell in two hours. Evidence was also found that the enzyme requires at least six 
bases of single stranded DNA to initiate replication, and is not capable of amplification from nicks.  
ɸ29 multiple displacement amplification was shown to be suitable for a range of GC contents and 
bacterial cell wall types as well as for viral pathogens. The method was shown to be able to 
provide relative quantification of mixed cells, and a method for quantification of viruses using a 
known standard was developed.  
To complement the novel molecular biology workflow, a data analysis pipeline was developed 
to allow pathogen identification and characterisation without prior knowledge of input. The use 
of de novo assemblies for annotation was shown to be equivalent to the use of polished reference 
genomes. Single cell φ29 MDA samples had better assembly and annotation than non -
amplification controls, a novel finding which, when combined with the very long DNA fragments 
produced, has interesting implications for a variety of analytical procedures. 
 A sampling process was developed to allow isolation and amplification of pathogens directly 
from clinical samples, with good concordance shown between this method and traditional testing. 
The process was tested on a variety of modelled and real clinical samples showing good 
application to sterile site infections, particularly bacteraemia models. Within these samples 
multiple bacterial, viral and parasitic pathogens were identified, showing good application across 
multiple infection types. Emerging pathogens were identified including Onchocerca volvulus 
within a CSF sample, and Sneathia sanguinegens within an STI sample. 
Use of ɸ29 MDA allows rapid and accurate amplification of whole pathogen genomes. When 
this is coupled with the sample processing developed here it is possible to detect the presence of 
pathogens in sterile sites with a sensitivity of a single genome copy.    
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1. Introduction  
Infectious diseases are still a major cause of morbidity and mortality, even in developed 
countries. According to the CDC (Centre for Disease Control and Prevention) in the US in 2010 
infectious diseases accounted for 23.6 million visits to primary physicians. With global travel 
becoming increasingly popular and affordable the epidemiology of infections is changing, as 
demonstrated by the 2009 H1N1 influenza outbreak which rapidly spread across the globe. 
Additionally, the emergence of drug resistance such as New Delhi Metallo-beta-lactamase-1 
(NDM-1) carrying Enterobacteriaceae, meticillin resistant Staphylococcus aureus (MRSA) and drug 
resistant HIV are becoming more common.  Diagnosis and surveillance of pathogens is 
increasingly important as human populations grow and people live in increasingly densely 
populated areas. Increasing medical interventions, such as the use of chemotherapy and care in 
intensive care units is leading to a higher burden of resistant pathogens. Opportunistic infections 
are becoming more of a concern, often being serious and sometimes fatal. In the face of rapidly 
changing global epidemiology, improved diagnostics and understanding of infectious diseases will 
become increasingly important for global mortality, morbidity and health economics.  
Much of the processes in modern microbiology diagnostics can be traced back to 1890 when 
Koch established a causative relationship between specific pathogens and disease. The formation 
of Koch’s postulates informed much of the basis of culture based diagnostics. As understanding of 
infectious disease increased, multiple exceptions to the postulates were observed, such as 
asymptomatic carriage and differing host susceptibilities to infectious agents. Despite this 
evidence based culture methods continued to be the main tools used for bacterial infection 
diagnosis. Automation of culture based methods have allowed increased accuracy and 
throughput, allowing better diagnosis of bacterial infections. Use of nucleic acid for detection and 
identification of infectious diseases allowed a shift in the diagnostic process. The development of 
PCR in 1983 has allowed increasingly rapid identification of infectious agents without the need for 
culture. This development had significant impact on diagnosis of pathogens which are slow 
growing, difficult to culture, or with no known culture method. Diagnosis by led to further 
development of Koch’s postulates by Fredrick and Relman in 1996 to augment interpretation of 
microbial detection using more modern techniques and understanding of infections. However, 
these still centred around demonstrating reproducible and evidence based results associated with 
infectious diseases. Combining PCR with fluorescence allowed simultaneous amplification and 
detection of products in the form of real-time PCR, which increased the speed and ease of PCR. 
Additionally, the use of different reporting fluoroforms allowed multiplexing of assays made it 
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possible to simultaneously detect multiple targets in a single test. The invention of Sanger 
sequencing in 1977 allowed the genetic code of pathogens to be used both for identification and 
characterisation. In parallel to the advancing of PCR, sequencing technologies became increasingly 
cost effective thereby increasing the use of sequencing in diagnostic and research microbiology.  
Another major milestone for diagnosis of infectious disease was the introduction of the MALDI -
TOF into microbiology, which allowed rapid identification of many pathogenic bacteria changing 
the management of infectious disease.  
For reliable identification and characterisation of infections, several biological problems need 
to be addressed.  The number of pathogens within clinical samples such as cerebrospinal fluid 
(CSF), blood and tissue is often low, especially in comparison to human cells . In none sterile site 
infections pathogens may have low numbers compared to regional flora. Whilst it is sometimes 
possible to visualise bacteria in samples using staining techniques, this often has low sensitivity 
and only informs about the morphology of the bacteria. Therefore, most diagnostics rely on 
increasing either the number of cells, or the number of copies of a specific gene.  Traditionally 
selective media and tissue cultures have been used to increase the number of cells to a level that 
is detectible. Selective culture will allow pathogens of interest to be preferentially grown, allowing 
separation from flora.  Biochemical test such as carbohydrate metabolism and the presence of 
enzymes such as oxidase and catalase are used in identification of bacteria, but often involve 
overnight incubation. Introduction of the MALDI-TOF (Matrix-assisted laser desorption/ionization 
Time of Flight) mass spectrometers to diagnostic laboratories has allowed rapid identification of 
bacteria from cultured samples. Identification using MALDI-TOF is achieved by comparing a mass-
charge ratio spectrum produced from protein ionisation against a reference database.  
Advances in molecular techniques, in particular application of polymerase chain reaction 
(PCR), has allowed targeted amplification of pathogen signals to quickly detect pathogens with a 
high sensitivity. Further advances have allowed multiplexing, allowing multiple targets to be 
detected in a single reaction.  Characterisation of pathogens has mainly centred on resistance 
testing, toxin production and the relatedness of pathogens to each other. Most resistance testing 
for bacteria is currently phenotypic, such as serial dilutions, disc and E-test. Viral resistance testing 
is achieved by detecting mutations in drug targets, giving a genotypic prediction of the expected 
phenotypic reaction to anti-virals. Toxins are either detected directly using ELISA (enzyme-linked 
immunosorbent assay) or the genes encoding the toxins are detected using polymerase chain 
reaction (PCR). Serotyping uses antigens presented on the surface of bacterial cells and viral 
particles to provide further information about the infectious agent. This may be used to predict 
disease severity, potential treatment options or for epidemiological tracking. Serotyping, phage 
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typing and an organism’s antibiogram have traditionally been use to establish relatedness of 
infections. Molecular tests allow the use of amplicon detection, single nucleotide polymorphisms 
(SNP) detection and targeted sequencing, increasing discrimination in a more rapid and 
reproducible manor. During sample processing for pathogen detection and characterisation there 
are biases towards known and common aetiologies of infections. There are  also frequent cases 
where, although there is a strong clinical suspicion of infection all tests are negative. Many 
contributing factors have been reported, such as previous antibiotic treatment, poor sample 
processing and novel or unknown aetiologies. Furthermore, pathogens are often investigated in 
isolation with no consideration to interaction with flora or host response, with little explanation 
about how low virulence pathogens can potentially cause serious disease. Workflows are often 
multi-factorial and time consuming with several different tests being used to identify and 
characterise pathogens. Whilst improvements have been made, each technique used is subject to 
inherent biases, which may contribute to the number of infections which are clinically suspected 
but the primary pathogen never identified. This is particularly apparent in central nervous system 
(CNS) infections, one study identified the aetiology in  only 28% of cases in 334 patients with  
encephalitis1. 
Ultimately there are three key challenges to be faced for improving the diagnosis of infectious 
diseases: 
 Low pathogen numbers and signals amongst host and flora,  
 Accurate characterisation of pathogens allowing suitable treatment and effective 
epidemiology  
 Diagnosis of infections due to unknown pathogens and pathogens with novel 
characteristics   
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1.1 Analysis of Low Level Pathogens 
Detection of low level pathogens is essential, particularly where bacteria or viral pathogens 
cause acute or invasive human illness. For the identification of such pathogens signals must be 
recognised above both the background host and flora. There are two primary methods to achieve 
this, increasing the cell number of pathogens (e.g. culture) or detection of increased pathogen 
signals using molecular methods (e.g. PCR). 
Most diagnostics in bacteriology are based on the abil ity to culture viable organisms, which is 
achieved through a combination of selective and none selective media. For some samples, such as 
those collected from sterile sites where there is no regional bacterial flora, non-selective media 
and enrichment broths are often used to capture all bacteria present in the sample. However, 
some samples, such as stool samples, have high levels of regional flora. For these cases selective 
media is used to enrich for predefined pathogenic bacteria over the normal flora. In some cases, 
only a single bacterial species with specific characteristics is isolated, such as MRSA screens which 
provides rapid identification of MRSA amongst flora including non- resistant S. aureus. Separation 
of flora and pathogen is more difficult in some samples types, especially when a single species can 
be classed as both normal flora and a pathogen. For example Streptococcus pneumoniae is a 
major cause of pneumonia, but is also present as a carriage organism in 4% of adults and 53% of 
children2. Semi-quantitative culture methods are used to differentiate infection from carriage, 
these are open to individual interpretation. Culturing of bacteria is highly labour intensive, but 
automation, such as blood cultures, within the laboratory has lowered the hands on time required 
for pathogen detection. Bacteraemia has a very high associated mortality rate, up to 34% 3, but 
can have very low bacterial load, and no specific clinical symptoms. Automated liquid culture 
methods such as the Bactec (Becton-Dickinson), allows constant monitoring of growth using CO2 
sensors, which means only positive cultures are processed by hand. However these systems only 
provide a positive result with no identification, the need to subculture these samples delays the 
identification by up to 72 hours 4. Time to positivity of more fastidious organism, particularly 
those belonging to the HACEK (Haemophilus, Aggregatibacter (previously Actinobacillus), 
Cardiobacterium, Eikenella corrodens, Kingella) group associated with endocarditis, can take up to 
21 days using culture techniques5.  
After isolation, the bacteria of interest need to be identified and characterised. Traditional 
identification techniques such as biochemistry and serology require high numbers of bacterial 
cells, with automated biochemical methods such as the Phoenix needing over 1 x 109 bacterial 
cells6.  Biochemical methods rely on detection of reactions with a number of substrates, such as 
fermentation of sugars, production of by products such as indole or H2S, or presence of enzymes 
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such as oxidase. Most biochemical panels need to be incubated overnight before results can be 
interpreted. With the introduction of MALDI-TOF technology into laboratories time to 
identification has been reduced from 18 hours, to minutes. Only a single colony is needed, which 
allows rapid identification of bacteria, and allows colonies on mixed plates to be identified 
without the need of purity plates. The technology has recently been used to identify isolates 
directly from positive blood cultures7, saving at least 18 hours. However high numbers of bacteria 
are needed for this, at least 107 CFU/ml 4, limiting its use for detection of pathogens directly from 
clinical specimens. In addition, pure cultures are required for sensitivity testing. MALDI -TOF also 
had difficulty resolving the Streptococcus mitis group, which is of particular importance as S. 
pneumoniae is a major cause of infections and is associated with high mortality. It is also poor at 
identifying mixed infections directly from blood cultures. 
The traditional culture based work-flow in diagnosing bacterial infections is often time 
consuming and labour intensive. Minimum time to identification is 18 hours from receipt of 
sample, and is often longer when pathogens have to be separated from flora. Identification 
depends on having a database to compare results to, such as a biochemical profile or MALDI -TOF 
spectra. For novel or unusual isolates, the database may be unreliable or insufficient. Antibiotic 
sensitivities take at least a further 24 hours after identification, with other characterisations 
taking up to three days. Overall a fundamental shortfall of the culturing methods is that it relies 
on both viable organisms, and a suitable culture medium.  Viability can be affected by antibiotic 
use, poor sample transport or sampling technique. It also selects for those organisms which grow 
quickly and with relatively simple growth requirements that can be met by basic growth media.  As 
a result, organisms which are intracellular, or grow within biofilms are often overlooked as 
pathogens. 
Some viral pathogens are diagnosed by detecting the body’s response to the infection 
through the use of serology. This can be used to detect immunity to a virus such as anti -natal 
screens and for diagnosis of a current infection. In chronic infections such as Hepatitis B Virus 
(HBV), serology can be used to distinguish between chronic and acute infections. The detection of 
antibodies from serum has allowed consolidation of sample processing, allowing high levels of 
automation. Improvement in data management systems have also allowed automated 
interpretation and reporting of results. However, serology is an indirect mechanism that relies on 
a detectable and predictable response to a known infection. This would be difficult to apply to a 
novel pathogen, and test development relies on understanding immunological response to an 
infection.  
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Viruses are obligate intracellular organisms requiring living cells to replicate in. Cell cultures 
using mammalian cells, was traditionally the main method by which viruses were diagnosed, with 
specific cell lines allowing pathogens to be detected above flora. Once samples are inoculated into 
susceptible cells lines, the samples need to checked every other day for cytopathic effects (CPE). 
Cell cultures need to be kept for up to two weeks for  CPE to be observed8 .Longer  incubation 
times are required for some viruses such as Cytomegalovirus (CMV). Some viruses such as 
Influenza don’t ordinarily induce CPE and so secondary indicators are needed, such as interaction 
with added red blood cells. For final identification, immunofluorescence, neutralization, 
haemadsorption inhibition, electron microscopy, or molecular tests are normally carried out. 
Disadvantages of cell culture include a relative lack of sensitivity for some viruses, the inability 
to culture viruses of considerable medical importance (i.e. Hepatitis B Virus (HBV) and Hepatitis C 
(HCV) Virus). Tissue culture is labour intensive with a requirement for specific tissue samples (i.e. 
foetal lung). For CPE to be observed there is often a need for very high viral numbers, this leads to 
increased potential for laboratory based infection. For these reasons, cell culture is now not used 
in most diagnostic laboratories and has been replaced by molecular technologies.  
Improvements in molecular techniques have allowed improved diagnosis of infections where 
specific pathogens can be targeted. Identification of infections through the amplification and 
detection of specific nucleic acid signals is a major diagnostic tool in virology and has been gaining 
momentum in bacteriology. The use of PCR allows the amplification and detection of pathogen 
signals from very low copy numbers, giving highly sensitive results. Real time PCR allows the 
coupling of amplification and detection, lowering turnaround times, especially when it is 
performed directly from specimens. The use of specific primers with or without a specific probe 
also allows for high specificity, selectively amplifying pathogen signals over flora and host. 
Molecular methods also negate the need for viable organism, and allow safer sample handling. 
Using specific primers along with whole nucleic acid extraction techniques applicable to all 
samples allows the consolidation of sample processing. Increases in automation has lowered both 
hands on and turnaround times. It has had particular advantages for slow growing, difficult to 
culture or un-culturable pathogens.   
Reduced turnaround times for both positive and negative results, has a major impact on 
patient treatment. This is particularly important for prevention of transmission and appropriate 
therapy prescription. One example where the introduction of molecular techniques has improved 
diagnosis and treatment indication is Mycobacterium tuberculosis (M. tuberculosis), which is the 
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causative agent of tuberculosis.  M. tuberculosis is a slow growing organism, with liquid cultures 
of smear negative sputum take around can take up to six weeks9. Treatment for TB requires a 
multi-drug regime with a minimum treatment time of six months10. Traditional diagnostics of TB 
have relied on microscopy, liquid and solid culture,  detection limits of these methods being 
10000, 10-50 and 100 CFU/ml respectively9. Multiple genes have been targeted for the detection 
of M. tuberculosis, including the rpoB gene, IS6110 and 16S rRNA genes as well as multiple 
housekeeping genes such as those involved in phosphate transport 11. Both commercial and in 
house assays have been developed, with detection levels as low as 1 fg and sensitivity varying 
from 75-100% in studies 11–13. The Xpert MTB/RIF test (Cepheid) 14, is the most widely used system 
and allows the detection of TB from samples in two hours.  The use of a second probe targeting 
the rpoB gene, where 95% of rifampicin resistance mutations occur can be used to determine 
whether an isolate is likely to be rifampicin resistant 9. This test consists of a single modular test, 
for both extraction and detection, which require little hands on time (20 minutes) or specialised 
skills. The detection limit is five copies of purified DNA or 131 CFU/ml spiked into sputum15.  
Sensitivity in smear positive respiratory samples has been demonstrated to be up to 100%, 
whereas sensitivity in smear negative respiratory samples is as low as 75%. In paediatric and extra 
pulmonary TB the sensitivity is lower, with sensitivities as low as 65% and 25% respectively 9. Use 
of this test has increased the number of patients who are appropriately treated for multi -drug 
resistant tuberculosis (MDR TB).  However, this method relies on detecting resistance using a 
single gene and is not useful for differentiating between MDR, XDR (extensively drug-resistant 
tuberculosis) and TDR TB (totally drug-resistant tuberculosis).   
CNS infections often have  a rapid onset and are still associated with high morbidity and 
mortality16.  Rapid detection of the aetiological agent of the infection allows better case 
management and will eliminate inappropriate antibiotic and antiviral treatment. Due to the 
severity of clinical presentation, broad-spectrum antibiotics may be administered prior to sample 
collection, which lowers the recovery of bacteria reducing the chance of detecting the pathogen.  
Enteroviruses are the cause of up to 90% of aseptic meningitis, where the cause is known 17. The 
use of molecular testing for Enteroviruses has been linked to better patient management, 
decreased time of stay in hospital and less use of broad spectrum antibiotics 18,19. Other known 
viral aetiologies are also commonly tested for in routine or reference laboratories. However even 
with increased virus target panels, the detection rate can be as low as 14.4% 20, in patients where 
there was strong symptomatic evidence of a CNS infection. The diagnostic gold standard for 
bacterial meningitis is still culture; however, the recovery of bacteria is greatly hampered by the 
previous administration of antibiotics.  Real-time PCR has been shown to have a sensitivity of over 
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95%, when looking for the three most common aetiologies of bacterial CNS infections, 
(Haemophilus influenzae, S. pnuemoniae and Neisseria meningitidis).16  
Detection of pathogens above regional flora is often a difficult and subjective process as 
pathogens may be present in low numbers, be slow growing or have complex growth 
requirements. The upper respiratory tract is a complex, dynamic eco-system of bacteria, and 
pneumonia is a major cause of mortality and morbidity, meaning identification of pathogens 
above this flora is very important. Atypical pneumonia is mainly differentiated from typical 
pneumonias by the presence of extra-pulmonary symptoms. Six specific aetiologies have been 
described as causing this syndrome (Chlamydophila psittaci, Francisella tularensis, Coxiella 
burnetii, Chlamydophila pneumonaei, Mycoplasma pnuemoniae and Legionella pneumonaie).  
Typical pneumonia isolates are often grown on selective media plates from sputum, and a semi-
quantitative method is used to separate carriage from infection. However, this is not a practical 
approach with the aetiologies of atypical pneumonia, as the bacteria are difficult to culture due to 
their intracellular or very fastidious nature. Differentiating the cause of pneumonia is particularly 
important, as treatment varies depending upon the aetiology. Antigen tests are often used for 
diagnosis of atypical infections; however often these need to be paired samples to demonstrate a 
change in titre or conversion to IgG and rates of obtaining   second serum sample  ( convalescent 
serum)  are as low as 10% 21. Real-time PCR test are sometimes used to support the diagnosis of 
these pathogens but  the sensitivity is often low, around 52% 21 although  when  used in addition 
to serology results for M. pneumoniae RT-PCR  increased case detection by over 20% and so a 
combination test here is recommended.  
The use of accurate real-time PCR along with standards allows the number of copies of a virus 
(viral load) to be established. This is of particular importance for chronic blood borne viruses, such 
as HIV, where it is used to monitor disease progression. By monitoring the viral load of patients, 
indications of treatment failure can be identified faster than simply relying on clinical indications.  
Diagnosis and disease monitoring in microbiology has been made faster, simpler and safer 
through the introduction of molecular techniques. Automation of extraction and reaction 
techniques has consolidated sample processing, increasing sample throughput and lowered the 
user errors which delay results. Use of specific primers has been very successful at quickly and 
accurately detecting some pathogens above flora. However, this is limited when the same species 
of bacteria may be present as commensals but also have the ability to become pathogens, such as 
S. pneumoniae and Staphylococcus aureus, which are both major causes of infections in multiple 
sites. Although the use of molecular diagnostics has reduced the turnaround time to diagnosis, 
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especially for slow growing organisms such M. tuberculosis, it has also reduced the amount of 
information that we gain about the infection. PCR techniques will amplify where primers bind, 
whether the organism is viable or not, this is an advantage in cases where previous antibiotic 
therapy hinders culture, however the method cannot be used as a test of cure, as segments of 
DNA/RNA may persist long after the pathogen has been killed. Multiplexing of PCRs has been a 
powerful tool, allowing symptomatic detection panels to be put together, so a single test can 
detect multiple known aetiologies. However, for molecular diagnostics to be successful, the 
possible aetiologies must already be known. For example amongst CNS disease whilst some 
aetiologies are known, it is generally accepted that that vast majority are unknown 20. As for all 
targeted molecular diagnostics, results are limited to the selected targets potentially missing 
cases with unusual pathogens. Specific primers need to be designed and the targets need careful  
selection to ensure binding to stable areas of the genome, preventing primer drop outs. However, 
this needs to be balanced with specificity to prevent false positives. Multiplexing of targets may 
restrict the selection of primers, as the binding temperature and amplicon length need to be 
similar. Most assays simply detect a certain genomic region, giving positive or negative results, 
limiting the information about characteristics and transmission. Viruses often have a high 
mutation rate and some have mechanisms for re-assortment of genes marking target selection 
and monitoring very important. Many emerging infectious agents are viruses, with potential to 
spread quickly around the world. With current targeted methods, novel infections would either 
be missed, or diagnosed as a routine pathogen. Targeted detection would miss gene and plasmid 
acquisition as well as gene re-assortments such as those seen in Influenza. Ultimately the short 
fall of current targeted molecular test is the need for knowledge of the targets. For molecular 
techniques to offer insight into novel pathogens more information needs to gained, in a way that 
is less targeting than current techniques. 
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1.2 Accurate Characterisation of Pathogens Allowing Suitable 
Treatment and Effective Epidemiology  
After identification of a pathogen further characterisation might be needed to identify the 
best patient management, including the best treatment options. Additionally, characterisation 
may inform patient isolation, epidemiological or public health studies.  
Traditionally phenotypic methods have been used to look at antimicrobial resistances. This 
can include dilution broths, discs or E-tests. Automation with machines such as the Phoenix (BD) 
or Vitek (bioMérieux) systems have allowed higher throughput and more accurate interpretation 
of minimum inhibitory concentrations (MICs), as well as automated interpretation based on the 
isolate being tested. However, for highly resistant organisms more manual methods are needed 
such as E-tests, which provide a more accurate MIC. As for all phenotypic tests large numbers of 
pure bacteria are required.  Whilst a phenotypic test gives valuable information for treatment 
guidance it gives no indication of mechanisms, and is not discriminatory enough to provide in 
depth epidemiological insight.  
A valuable use of molecular tests their potential to provide treatment guidelines in a rapid 
manner, such as resistance indicators, or pre-clinical indications of treatment failures. Among 
Enterobacteriaceae there is increasing concern about drug resistance, particularly to beta-lactam 
antibiotics. Extended spectrum beta lactamases (ESBLs) are particularly concerning as they limit 
the number of possible therapies for treating infection, they are also highly mobile and able to 
spread between multiple species. ESBL prevalence has been increasing with 1% of all clinically 
isolated Enterobacteriaceae carried an ESBL22. Traditional phenotypic methods often take 48 
hours after isolation to confirm the presence of an ESBL, which potentially leads to inappropriate 
treatment.  Use of PCR for the detection of these genes allows quicker detection of ESBLs and 
improves patient treatment. There are several types of ESBLs, with the most common being TEM, 
OXO, SHV and CTX22, due to the high number of types and subtypes, multiplex PCRs are often 
required to detect their presence. PCR results have been shown to be concordant with phenotypic 
methods, as well as decreasing time to detection and potentially being a cheaper method 23.  
Although most laboratories use in-house tests, commercial tests are available which have been 
shown to have a sensitivity of nearly 99% and a specificity of 100% 24.There is also potential that 
PCR could be used for direct detection of bacterial resistance genes directly from clinical samples, 
reducing turnaround times. However, targeted resistance detection is not able to replace 
phenotypic tests due to the complex nature of resistance acquisition especially within Gram 
negative organisms. For example, when looking at detection of resistance due to ESBLS, new or 
unusual ESBL genes will not be detected, as they won’t be included in the targets. Some resistant 
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bacteria employ multifactorial mechanisms, such as over expression of genes and efflux pumps 
leading to increases in MICs. PCR genotype and phenotype do not always correlate and false 
negatives may arise from novel mechanism or mutations in primer sites. Additionally, false 
positives may occur from gene drop-outs, or disruptions where the primer sites are still intact. 
Use of targeted assays does not give information about these more complex resistance 
mechanisms. 
Sequencing is used for detection of drug resistant mutations in chronic viral infections such as 
HIV, Hepatitis C and B. Current guidelines for HIV drug testing in Europe recommend testing 
patients when they are first infected and when there is suspicion of treatment failure (usually a 
rise in viral load) 25. Retro viruses have high mutation rates, with some genes being as high as 10-3 
26, this leads to high variations in the population of HIV even within a single person. Drug targets 
are under particular pressure to mutate, and accumulation of mutations in drug targets can lead 
to drug failure. It has been estimated that every possible single point mutation occurs between 
104 and 105 times per day in an untreated HIV-1-infected individual 27 . Because of the high 
variation in the HIV genome, several sets of primers, including redundant bases may have to be 
used to gain successful amplification. It is often a complex test which requires special  training and 
large amounts of hands-on time. Because of the presence of quasi species Sanger sequences are 
often interpreted by hand, before the consensus sequence can be loaded into prediction 
databases. The ability to reliably call quasi species is limited to those that make up at least 20% 
28of the total viral population. The interpretation of the resistant mutations is complicated and 
often relies on public resources which have to be updated often 29 25 to reflect discovery of new 
clinically important mutations.  
It is often important to be able to differentiate between an outbreak and sporadic cases of 
infectious diseases. Identification of outbreaks allows infection control and public health 
measures to be implemented to prevent the further spread of infection in the community. 
Techniques need to discriminate between isolates of the same species, whilst targeting stable 
elements present in all isolates. Typing schemes should be rapid, reproducible, comparable and 
have high resolution. At present there are several different schemes to type bacteria including 
phenotypic tests, such as serotyping, biotyping and phage typing. However, these often have low 
sensitivity and are only useful to rule out pathogen links.  Molecular typing tests are now 
commonly used in reference laboratories to identify potential epidemiological links and several 
different methods are used. Current typing schemes are often species specific, labour intensive 
and highly specialist. Choosing a typing scheme currently depends on the pathogen, the 
epidemiological context and the level of discrimination required.  
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The most commonly used method is Pulsed-field gel electrophoresis (PFGE)30, and is used for 
many bacterial species, including Escherichia coli 31, Streptococcus agalactiae32 and Pseudomonas 
aurginosa 33. The method briefly consists of using a rare cutting restriction enzyme to digest the 
genome of the bacteria. The product is then separated on a gel and the banding patterns used to 
type the bacteria. The method takes into account whole genomes, and will show any large 
insertion or deletion events. There are protocols that have tried to establish schemes that can be 
compared between laboratories, such as Pulsenet 34. This allows emerging clones to be identified 
in multiple sites and countries. However, this technique is labour intensive, time consuming and 
has limited resolution. The technique also requires the bacterial to be cultured to high numbers.  
Alternative typing methods take advantage of repetitive elements in bacterial genomes, in the 
form of variable number tandem repeat (VNTR) typing or Repetitive-element PCR typing. Both of 
these methods involve amplifying the DNA from the repetitive elements and using a gel to 
distinguish between the strains. These methods are often cheaper and quicker than PFGE and 
don’t require such high amounts of starting material. However, inter-laboratory reproducibility 
can be poor due to the low –resolution of agarose gels and overall reproducibility is still 
questionable 35.Although lower starting material is required, a minimum of 25 ng is recommended 
for the Repetitive-element PCR 35which still equates to around 5.5x108 copies of the bacterial 
genome. The typing schemes are also tailored to each pathogen, with different primers and 
grading schemes used.  
To overcome some of the problems with reproducibility using fragment size analysis, 
sequencing typing methods are widely used, either based on a single or multiple loci on the 
genome. The main advantage being robust standardised international databases for many 
pathogens, with their own the nomenclatures allowing multiple sites to compare strains,  which 
allows clones to be identified across multiple countries 36. Hence although the method lacks some 
of the discrimination of VNTR analysis, its standardisation has allowed it to be used across 
multiple sites and monitoring of clones over a time period. For other bacteria, such as N. 
meningitidis, multiple genes targets are selected, usually 7 housekeeping genes 37. For each gene 
a number is assigned to each unique sequence, giving a 7-digit code that is the multi-locus 
sequence type (MLST) for that isolate. These can then be compared to other isolates.  
The use of DNA microarrays allows greater number of loci to be examined by attaching 
complementary probes to a solid surface38.  The results are recorded using an automated scanner, 
removing human based interpretation errors. The technology has been used to look for SNPs, and 
plasmids which are often ignored by other typing methods. This has allowed for the identification 
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of multiple virulence gene variants 39. It has been particularly successful in identifying virulence 
targets in E. coli40, which is known for its high genetic diversity, allowing novel combinations of 
virulence genes to be detected. The use of microarrays allows a large number of targets to be 
used, increasing flexibility and discrimination. However, a prior knowledge of gene targets is 
required, making them inappropriate for totally novel outbreaks or large scale gene shuffling.  
They also require specialist equipment and training and will also only detect presence or absence 
or genes or mutations present on the chip.  
Determining how closely related isolates are is important for determining the epidemiology of 
infections.  Effective methods can be used to trace infections globally, and be used to inform 
infection control practices. However most of the current methods used are complex, time 
consuming and expensive. The typing schemes are often highly focused to a single organism, are 
often difficult to compare across sites, and have limited discrimination. Current schemes offer 
limited flexibility to adapt to outbreaks in novel organism or genotypes.  Clonal typing is also 
important in reconstructing evolutionary changes in pathogens and acquisition of genes such as 
pathogenicity islands and targeted typing techniques may provide limited data on this.  
1.3 Diagnosis of Infections of Unknown Pathogens and 
Pathogens with Novel Characteristics   
Determining the nucleic acid sequence of a segment of a genome can be used to identify, 
characterise or find novel properties of infectious agents. A major application of sequencing has 
been to use the technology to detect bacteria in samples which were culture negative, or from 
colonies which were difficult to identify by traditional methods. Prior use of antibiotics, poor 
sampling or fastidious organisms can lead to cultures being negative despite a strong suspicion of 
an infection. With increasing medical intervention and immunosuppression, opportunistic 
pathogens are increasingly being isolated, which may be more difficult to identify.  
A major tool for identifying bacteria is the use of the variable region of the ribosomal  gene, 
known as 16S rRNA. This target has been extensively used due to the presence of highly variable 
regions, and highly conserved region which can serve as primer targets. This has been used for 
both single isolate identifications within clinical laboratories and for identifying bacterial mixes in 
bacterial community profiling studies. Diagnosis using 16S rRNA has been used for a variety of 
clinical samples including  tissue and fluid samples from patients with endocarditis, CNS and bone 
and joint infections 41. It has often been shown to increase the sensitivity, and decrease the time 
to identification. This gain is particularly notable in cases of fastidious organisms, especially in the 
case of endocarditis. One study42   identified a pathogen in 42.9% of culture negative samples, 
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with the process being particularly good when previous antibiotic therapy had been administered. 
The sequence of the 16S rRNA gene is used to identify bacteria that are not commonly 
encountered, such as fastidious Gram negative rods where traditional methods, such as 
biochemical assays, give little or no insight into the bacteria identity. In one study 80% of 
identification of fastidious Gram negative rods was improved using 16s sequencing43. Other major 
reports have shown the use of 16S rRNA sequencing improves identification in cases where 
cultures are negative, but there is high suspicion of bacterial infection42.  Previous antibiotic 
therapy is stated as a major reason for culture negative results, the use of 16S rRNA sequencing 
has been shown to allow detection of bacteria even under these circumstances 42. 16S rRNA 
sequencing  has also proved useful in identifying novel pathogens in groups of patients which are 
immune-compromised such as the detection of Mycobacterium genavense 44. Complex 
communities can also be studied using the 16S gene; such as studying the oral bacteria 
community. Culturing these bacteria often proves difficult, with bias towards the faster growing 
less fastidious bacteria, often the communities exist due to interactions between bacteria, which 
is difficult to mimic in vitro. A study looking at bacteria associated with periodontal disease 45 
identified 596 bacterial species, over half of the species identified were associated with 
periodontal disease and were previously uncultivated. Several studies have been performed to try 
and ascertain the core microbiome of humans 46,47,48 showing variation over time, disease state 
and with the use of antibiotics. However, the information given by use of the 16S gene is limited 
to identification of the genus or species of bacteria, and often relies on public databases which 
often have sequencing errors. The technique is limited to those organisms that have a binding site 
for the selected primers, leading to bias in the identification technique.  
Whilst 16s rRNA sequencing has had significant impact on detection of uncultured bacteria in 
both clinical and metagenomic studies, it lacks resolution to distinguish between some bacterial 
groups, particularly the Enterobacteriaceae. Alternative gene targets have been investigated, such 
as the rpoB gene, which has both highly conserved and highly variable regions, so with careful 
selection of primers it can be used to identify bacterial species. A 512 base pair region was used to 
identify 14 Enterobacteriaceae strains, within this group the rpoB gene differed from 2-22%49. It 
was particularly good at distinguishing between Escherichia species which all have identical 16s 
rRNA sequences. It is also only found in a single copy in genomes, unlike 16s rRNA, which may 
have several copies complicating the interpretation of sequence.  
Targeted amplification using housekeeping genes allows for detection and sequencing of 
bacterial species and has been used for both diagnosis of infection as well as for metagenomic 
studies49–51. However, the quality of results depends on the selection of primers. No primer set is 
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without some bias, even a ‘universal’ primer such as those targeting the 16s rRNA gene, studies 
have shown different primers  give differences in taxonomic compositions  from various bacterial 
communities 52. Using a bacterial target will ignore any viral or eukaryotes within the sample, the 
high variability of viruses means there are no universal markers for viral detection. For 
identification of truly unknown viruses, either random priming or none amplification techniques 
need to be used.  Random priming has been used to look at the virome of the respiratory tract 
and has identified more than 39 species including a novel Rhinovirus which would have been 
missed with specific primers used in diagnositics53. Using none amplification techniques has also 
proved a strong method for viral discovery, samples from the oropharyngeal were sequenced and 
homologues to an algae infecting virus were found 54. This showed a rare cross-kingdom infecting 
virus. Further studies showed infection with this virus was associated with impaired cognitive 
function. Demonstrating the potential power of diagnostics using none specific priming methods.  
Recent advances in sequencing technologies have allowed dramatically increased sequence 
data output, for decreasing costs. In 1977 dideoxy chain termination sequencing was inveted55, 
which led to the first completed bacterial genome to be published in 199756 . In 2005 one of the 
first commercialised high through put sequencers, the Roche 454 Gs20 was released. Two years 
later the Solexa system (now Illumina) was launched. These new technologies gave massive 
improvements in data output, which permitted a study of more than  3000 S. pneumoniae 
genomes to be conducted in 201457. Analysis of genomes in such high numbers allows 
comparative analysis between isolates, but also allows bacterial genomes not just to be seen in 
isolation but also as an interacting community.   There are three systems currently used in 
microbiology laboratories the Roche 454 system, the Ion Torrent system from Life Technologies 
and Illumina platforms. Each of the sequencing systems has both bench top and large scale 
versions of their systems. These next generation sequencing (NGS) platforms have three key 
stages for sequencing, which vary in mechanisms depending upon the platform.  
The first stage is the preparation of a sequencing library. This includes the extraction, 
(possible amplification), fragmentation and tagging of the DNA to be sequenced. The input 
amount required varies, between platforms and library preparation method, from 1 ng total DNA 
to 500 ng total DNA. Fragmenting the library can be achieved through numerous methods, 
including physical sheering followed by end repairing, or enzymatic shearing. The first is often 
quicker and cheaper, but requires higher DNA input and may result in more loss of material. The 
later allows less input and fragment size can be controlled by varying the incubation time but is 
more likely to produce insertion and deletions 58–60. Adaptors are then added, varying by 
sequencing technology.  
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The second stage for sequencing is the amplification of the template molecules. This is 
achieved through attaching the molecules to a solid surface. In the case of Ion torrent and the 
Roche 454 system beads are used, these are then enclosed in an aqueous phase micro reaction 
(emulsion PCR). Initially a single DNA molecule is added to each bead and then amplified, so many 
copies of each molecule is present. The beads are then concentrated and cleaned before being 
loaded onto the sequencing chips and sequenced. For the Illumina systems a flow cell is used, the 
amplification is automated and performed on the sequencing instrument itself59.  
The sequencing chemistries are the main variation between the platforms. The 454 and ion 
torrent systems flow a single base across the cell at a time, if the base in complementary and 
added a phosphate and a hydrogen ion are released. On the 454 system the released phosphate 
group is detected through the reaction with luciferin to create osylucuferin, producing visible 
light. The intensity and order of the light is recorded and converted into a DNA sequence. The ion 
torrent system uses a similar method, but the release of hydrogen ions is detected directly 
through pH change. Both of these methods are prone to errors in homopolymer stretches. The 
read length of the 454 system is around 1000 bp on the FLX system and 500 bp on the Junior 
system. Ion torrent read lengths are around 200 bp. The Illumina system uses reversible 
termination nucleotides, which are fluorescently labelled. Upon incorporation of a base an image 
is taken and then the signal is quenched and the terminator removed allowing further base 
additions. Read lengths are around 250 base pairs, using paired end (2x250) 59,60.  The output of 
these sequencers vary from 100,000 reads (454 junior) to 3 billion reads (Mi Seq on high output 
mode). Sequencing run times vary from 3 hours (ion Personal Genome Machine (PGM)) to 11 days 
(Hi seq high output mode). Selection of platforms is dependent on the required outcome, 
including turnaround time, number of reads required and sample through put.   
Although short read technologies are the most used techniques for producing bacterial 
sequencing, difficulty in placing repetitive elements and fully mapping chromosomes means that 
it is not always possible to fully identify novel resistance and virulent islands in pathogens. Long 
read technologies such as the MinION nanopore have been used to fully characterise these gene 
structures 61. An alternative long read technology for closing gaps in bacterial genomes is the 
PacBio sequencer 62. The PacBio system from Pacific Bioscience allows read lengths of up to 
15,000 base pairs to be achieved by direct detection of base incorporation in single copies of the 
DNA. As labelled bases are incorporated the light is detected and recorded, in contrast to other 
platforms, no amplification of the library is required as the incorporation on a single molecule can 
be detected. 
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Next generation sequencers have already been used within microbiology for many studies, 
including epidemiological, resistance detection and pathogen discovery. The additional data 
produced using these technologies have allowed the whole genome of bacteria to be studied, 
increasing the resolution of typing and allowing novel pathogenic mechanism to be classified.  
Next generation sequencing technologies have been used to track outbreaks between countries, 
such as the 2010 outbreak of Vibrio cholera in Haiti, which allowed its origin to be determined as 
Nepal 63, other studies into the lineage of V. cholera have tracked its global spread using 154 
whole genome isolates from varying temporal  and global points 64. This study supported the 
theory that the outbreak had multiple waves of spread, rather than a single point outbreak.   
Beginning in May 2011 there was a large outbreak of E. coli, which caused a high number of 
haemolytic uremic syndrome (HUS) cases (over 900) 65. It was highly virulent, antibiotic resistant 
and was sorbitol fermenting, meaning it was not easily identified in routine laboratories, (where 
selection for non-sorbitol fermenting 0157 is usually performed). Multiple sites used next 
generation sequencing to allow identification of the pathogen. One study used a metagenomic 
approach to identify the pathogen66. DNA was extracted directly from stools, fragmented and 
sequenced using the Illumina HiSeq platform. Sequences present in in a least 20 outbreak stools, 
but not present in healthy controls, were selected as gene tags to indicate infection. These were 
then used to identify and isolate signals in the infected patients. A draft genome was produced 
using the sequence data gathered, which could then be used to improve isolation of pathogens 
signals from host background. Using this culture independent method, other pathogens could also 
be identified, such as Campylobacter jejuni, which allowed these samples to be removed from the 
study. The sensitivity was 67% in this study, showing the potential for non-culture based methods 
to detect novel pathogens. Next generation sequencing technologies were also used to identify 
the lineage of the outbreak, 65,67,68. Using isolates and varying sequencing technologies including 
Illumina and Ion Torrent, the progenitor was identified and gene acquisition mapped. One of the 
studies sped up the analyses by allowing the data to be open source 67,demonstrating the power 
of data sharing allowing simultaneous multi-site analysis.  
Whole genome sequencing (WGS) has been used to predict the antibiograms for a variety of 
organisms including, S. aureus 69, M. tuberculosis 70 and E. coli 6. The advantage of WGS is that 
additional information such as phylogeny is also available as well as the prediction of methods of 
acquisition of new resistance genes 69. Enterobacteriaceae spp. pose a serious threat due to their 
ability to cause infections in multiple sites, and for the ability to spread and acquire new 
resistance mechanisms. Therefore, the ability to rapidly identify the best treatment for infections 
would be advantageous. However resistant pathogens often have multiple resistance mechanism 
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spread across their genome and plasmids. A study comparing phenotypic and genotypic results 
for susceptibility to seven antibiotics showed good concordance for E. coli and K. pneumoniae6. 
The advantage of the genotypic method was the mechanisms of resistance were also identified. A 
reference data base was required for the study, and the results will only be as good as the 
reference database allows. Online databases are being developed that allow the prediction of 
antibiotic resistances such as ResFinder 71. Online databases have the advantage of being 
accessible to anybody, but can only be updated by specific people allowing quality to be 
maintained. In a study of 200 isolates using the Resfinder server high concordance (99.74%) with 
phenotypic results was found, with 6 out of 7 disagreements being for a single drug in a single 
bacterial species (spectinomycin in E. coli) 72. Whole genome sequencing can also be used to 
determine the methods of resistance that are not just associated with the presence or absence of 
a gene. For example a study of Acinetobacter baumannii, identified factors such as a SNP in a 
signal transduction histidine kinase, which is implicated in the up regulation of an ef flux system73. 
This was associated with an increase MIC to tigeclyine.  Another study, of the whole genome S. 
pneumioniae 74 showed mutations upstream of a ATP-binding cassette transporters (ABC) 
transporter gene was associated with resistance to linezolid. They also found mutations in a 
hypothetical protein was also associated with resistance to linezliod and a further study showed 
that the mutations were in a region predicted to contain an RNA methyltransferease. An ortholog 
of this gene was found to also be mutated in a resistant S. aureus isolate.   
While NGS technologies have improved our ability to investigate infectious diseases, the 
identification of these pathogens remains restricted by the need for initial culture and use  of 
selective methods. This has biased the use of NGS to infectious agents to those that can be readily 
cultured and harvested from the media.  To truly take advantage of the technologies available, 
methods for detection and sequencing of pathogens direct from clinical samples need to be 
developed. Many clinical samples have a low number of the infecting bacterial cells and so 
amplification of the target organism’s DNA will be required before sequencing will be possible. 
Most molecular techniques used in clinical laboratories currently involve amplification of specific 
targets, to either identify known targets, or amplifying conserved regions within highly diverse 
genes to allow identification through sequencing (e.g. 16S rRNA). To be able to diagnose clinical 
infections the amplification method would need to be able to amplify without prior knowledge of 
the bacteria being looked for. 
One of the major challenges of using next generation sequence technologies is reconstructing 
a consensus sequence for the produced short reads  
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Initial stages focus on the raw data produced by the sequencer, which in most cases is in fastq 
format, however when using the 454 technology the raw data is written into a SFF (standard 
flowgram format). Preliminary investigation focusses around the quality of data produced by the 
sequencer, including investigating the read length and read quality. The quality of a base call 
within a read is measured using a Phred score. The Phred score (often shown as a Q score), 
indicates the probability that the base was called incorrectly. For example, if a base had a Phred 
score of Q20 there would be a 1:100 chance that the base was incorrect, giving it a base call 
accuracy of 99%. The first stages of an analysis pipeline is often to remove poor quality bases, 
either by removing whole reads of poor quality, or trimming regions of reads with poor quality 
bases.  
The majority of data analysis when using next generation sequencing data for identification is 
focused around piecing the short reads together, known as assembly. Assembly can be based 
around a known reference genome, or can only use the read information itself. De novo 
assemblers try to piece together these segments without a reference to guide them, which can be 
computationally challenging. Several different algorithms have been developed and applied to 
meet this challenge ,107. One of the earliest assemblers applied to next generation sequence data 
was SSAKE (Short Sequence Assembly by progressive K-mer search and 3′ read Extension)110 
the algorithm used by SSAKE  is known as the greedy graph algorithm. Firstly, the reads are 
entered into a hash table with each read given a unique keyed sequence. A prefix tree is then 
built using the first 11 bases of the 5’ end of the reads. Each unassembled read is used in turn and 
the highest scoring overlap is used to make the next join.   
Newbler assembler was released by Roche, which is an overlap layout consensus 
assembler109. Initially seeds of the reads are produced in the form of 16mers, each seed being 12 
bases from the previous seed. If two reads have identical seeds the programmed tries to overlap 
them, with a minimum overlap of 40 base pairs and a minimum stringency of 90%. This then form 
a consensus known as a unitig, which is a preliminary highly confident contig or mini -assembly. 
These unitigs are then joined by pairwise over laps to form a larger consensus.  
Many recently developed assemblers apply the de Bruijn graph approach to assemble 
genomes. Each read is decomposed into substrings of a given length (k) known as a kmer, each of 
these kmers overlaps the previous Kmer by k-1. Each kmer then becomes a node in the graph, 
with overlapping kmers connection nodes at their edges. Bubbles may form in the graph due to 
errors, repeats or genome variations. The graph is then compacted by reducing linear chains to 
single nodes. Paths are then mapped across the graph, with the interpretation of the graph being 
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dependant on the specific algorithm used by each assembler. Mostly a Eularian approach is 
adopted, which is the route across the graph which crosses all nodes without re -visiting any. 
Abyss111 is an example of an assembler that used this method.  Spades112  is also uses the de Bruijn 
graph approach as its core algorithm, but has further adaptations for resolving bubbles in the 
graphs, using a multi-sized de Bruijn graph approach and distance histograms, which improves 
consensus accuracy. Ray113 uses a two stage approach that initially uses kmers to construct the 
graph and then uses the full read information to improve the accuracy of the assembler.   
Mira-4114 initially establishes the relationship between reads using a bitmap algorithm, which 
states whither a given string contains a substring which is approximately equal to a given pattern. 
All the potential overlaps are then evaluated based on the length and quality of the overlap and 
given an alignment weight. This information is then used to form a weighted graph. A pathfinder 
algorithm is then used to form contigs, it starts at the node edge which has the highest weighting, 
and moves through the graph using the highest weighted route.  
When assembly is completed there are many ways in which to judge its quality, and usually a 
combination of factors is used. The proportion of the genome covered is a good indication of 
sequencing success, however coverage will be impacted by the closeness of the reference to the 
strain actually sequenced. The Lander-Waterman theory assumes that reads map randomly across 
the genome and coverage is dependant on the read length, number of reads and the size of the 
genome itself. Another major consideration is the depth of coverage, which is how many reads 
are assembled the same point in the genome. As depth at a single point increases the accuracy of 
the consensus also increases, when looking for SNPs compared to a reference, depth of coverage 
is particularly important to provide evidence of a true SNP. Additionally, when comparing mixed 
populations increased depth is needed to separate variants from sequencing errors. Other factors 
when assessing the quality of the assembly includes the number of contigs the genome was 
assembled into, a contig refers to over lapping sequencing that have been assembled with no 
gaps. When there is high genome coverage fewer contigs indicates a better genome assembly. 
Another metric that can be measured is the accuracy of the assembly, especially when using de 
novo techniques, this is achieved by mapping the assembly back to a reference and isolating areas 
when a misassembly has occurred, again this metric depends upon how related the strain is to the 
reference.  
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1.4 Unbiased Sample Preparation for Next Generation 
Sequencing 
To be able to effectively use whole genome sequencing for diagnosis of infections a rapid, 
robust and unbiased sample preparation for NGS is needed. Current applications of next 
generation sequencing are usually organism specific, using either cultured bacteria or amplicons. 
To sequence a genome, at least 1ng is needed, which is the equivalent of over a 200,000 copies of 
the E. coli K12 genome. Mostly this is achieved by culturing the organism and then extracting the 
DNA, however this is labour intensive and culturing is not always possible. Mixed infections are 
also a problem for many current protocols, which rely on isolation of pathogens before 
sequencing. This may mean pathogens present in lower numbers, which are slow growing, or 
which are not targeted by the culture conditions are not enriched and therefore not sequenced. It 
is not possible to isolate all infectious agents and so detection and sequencing of nucleic acid is a 
key diagnostic. There is a need for the development of a rapid, highly sensitive and accurate 
unbiased method for detection of infectious agents directly from clinical specimens.   
The need for rapid and accurate amplification is of particular importance when using the 454 
technologies as there is a requirement for a high concentration of DNA to be input into the library 
preparation, (500ng DNA total). Most current methods for bacterial sequencing involve isolating 
the bacteria and culturing the bacteria to a high enough number to provide DNA without need for 
amplification. Where amplification is performed before next generation sequencing it is targeted, 
amplifying only specific genome regions. By using a strand displacement enzyme to produce 
genomic DNA for sequencing, the need for culture and targeted amplification can be removed. 
This will allow production of sequencing that represents the DNA in the sample rather than just 
the organisms that can be cultured or targeted.  
 
To achieve this goal, the use of novel enzymes will be investigated, as well as novel 
applications of previously used enzymes. An important application for unbiased whole genome 
sequencing will be for emerging infectious diseases. Of the many emerging infections detected 
over the past 20 years most have been viral and one third have been RNA viruses 75. The most 
common method for viral detection, for both DNA and RNA, is the use of PCR with specific 
targets. However, detection of RNA viruses requires additional processing, often relying on 
random conversion of RNA to DNA using a reverse transcription (RT) enzyme, followed by specific 
target detection using PCR. RNA conversion is often a limiting step for detection, in terms of both 
the sensitivity of the assay and the additional time needed for cDNA production. A key  
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requirement for enzymatic RT is thermostabilty enabling for better transcription through 
secondary structures, which may cause conversion issues. One of the most commonly used 
reverse transcription enzymes is SuperScript III (Thermo Fisher Scientific) whi ch produces longer 
transcripts than other RT enzymes. The sensitivity is also higher, which is quoted as 0.1 pg of 
RNA76, this is equivalent to  25654 copies of the HIV virus. Low viral load is around 40 copies/ml, 
depending on the detection limit of tests used, which equates to 0.000156 pg.  Superscript IV 
(Thermo Fisher Scientific), a modified version of Superscript III, is a more rapid reverse 
transcriptase, which is less susceptible to sample inhibitors. SuperScript IV (SSIV) is quoted as 
having better sensitivity than SSIII, yet the company only quotes lower Ct values at 1 pg RNA input 
compared to SSIII, to better determine their sensitivity and suitability for WGS both of these 
enzymes will be investigated for detection of targets at very low RNA input.  
A study in Yellow Stone National Park77, identified a thermostable polymerase, which 
functions as both a reverse transcriptase and DNA polymerase. The enzyme known as PyroPhage 
3137 has a processivity score (number of bases added in a single binding reaction) of 47nt 78, 
which is high in comparison to Taq (9), although much lower than ɸ29 (>70,000). The enzyme 
fidelity of 8x104 is comparable to Taq (1.4x104), and in addition to its one step conversion of RNA 
to DNA and amplification of DNA the enzyme has strand displacement ability, along with the 
capability to extend from Nicks in the DNA.  A study performed by Moser et al 78, indicated that 
the performance of PyroPhage 3137 was comparable to the two-enzyme system of SuperScript III, 
with the advantage of a single enzyme protocol. Two versions of the enzyme are commercially 
available, the wild type, and an exonuclease knock-out version, which is more amenable to 
reverse transcription, but has a slightly reduced fidelity at 0.9x104. Both versions of the enzyme 
will be compared for sensitivity and suitability alongside the SuperScript III and IV enzymes.  
Several distinct groups of DNA polymerases have been identified (Family A, B, C, D, X and Y), 
often having a similar structure, whilst having little or no sequence homology, showing 
convergent evolution and demonstrating their importance in the maintenance and replication of 
DNA79. Different polymerase families have been associated with different functions possessing 
different enzymatic attributes. Family A polymerases are mostly single unit with highly functional 
exonucleases involved in DNA repair and Okazaki fragment maturation80. Whereas Family B 
polymerases often consist of multiple subunits and perform the bulk of DNA replication, they also 
contain exonucleases and have the highest fidelity and processivity81. They have also been found 
to be the main replication enzymes within bacteriophages. Group C and D are less characterised 
than other DNA polymerase families, but have been shown to be replicative in prokaryotic and 
eukaryotic cells respectively.  Group X polymerases  have gap filling properties 82, and family Y are 
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responsible for replication of damaged and degraded DNA, and lack features such as exonuclease 
activity83. 
Recent advancements in molecular techniques has allowed modification of polymerase 
enzymes, to produce more desirable characteristics and increased production, allowing greater 
commercial availability for a variety of polymerases. Characteristics that have been particularly 
important for use in diagnostics include fidelity, processivity and thermostabilty that allow cycling  
with specific primers to be used. Due to its thermostabilty Taq polymerase has been the most 
commonly used DNA polymerase in molecular microbiology, however it has a relatively low 
processivity, incorporating 9 nucleotides per binding event,  and high error rate 5x104 78, which for 
simple detection of short targets has little impact on result quality. However, for amplification and 
sequencing of whole genomes other enzymes which have lower fidelity and higher processivity 
need to be investigated.  
Strand displacement enzymes have the potential to decrease our reliance on primers and 
increase the lengths of DNA produced through amplification. Multiple displacement amplification 
(MDA) is an alternative method to PCR for the production of DNA in high enough amounts for 
sequencing. This method has the advantage of being able to produce large lengths of DNA with 
lower errors than conventional PCR. MDA has been applied to samples with very low starting DNA 
amounts from single cells  (both prokaryotic and eukaryotic) and provided DNA in levels high 
enough to perform sequencing 84.   
MDA utilises a DNA polymerase initially isolated from a bacteriophage in Bacillus subtilis, ɸ29 
DNA polymerase has two catalytic regions an exonuclease region at the N-terminal region and the 
polymerase in the C-terminal domain85. ɸ29 DNA polymerase is a highly efficient enzyme able to 
produce strand displacement during polymerisation process without the need for accessory 
proteins86. The DNA is copied repeatedly in a branching mechanism, with the ɸ29 DNA 
polymerase extending from random hexamer primers. The polymerase also displaces previously 
made copies of the genome, producing branching DNA84. The enzyme is very stable and can 
continue to work for over 12hours at 30oC. The ɸ29 DNA polymerase possesses a high 
processivity 3’-5’ exonuclease which removes incorrect nucleotide incorporation. The high fidelity 
and 3’–5' proofreading activity reduces the amplification error rate to 1 in 106−107 bases 
compared to conventional Taq polymerase with a reported error rate of 1 in 90,000 87. A single 
binding reaction can incorporate over 70kb 86, meaning that this method is not limited by the 
length of the initial target like conventional PCR. The use of exonuclease resistant hexamer 
primers increases the amount of amplified product produced by 20x, giving 10,000-fold 
32 
 
amplification of circular ssDNA88]. It has been demonstrated that this method is suitable for use 
with single bacterial cells89.  By using the high processivity combined with the low error rate of ɸ 
29 very low copy numbers can be amplified quickly to produce enough DNA to sequence.  
Other strand displacement enzymes will also be investigated such as Bst which is used for 
whole genome amplifications90 as well as loop mediated isothermal amplification (LAMP), which 
has been used to increase speed of target amplification91,92 . Other engineered enzymes such as 
Vent exo- and Klenow fragment, will be investigated, however often the strand displacement 
properties have been engineered by removing exonuclease portions increasing enzyme error 
rates. A recently discovered polymerase PyroPhage 3173, that has both DNA polymerase and 
reverse transcription activity 78 will also be studied. It has been shown to have DNA polymerase 
fidelity of 8x104, which is comparable to Taq polymerase. It is a thermostable reverse 
transcription enzyme, with its most efficient working temperature being 72oC, compared to 
Superscript III (Life technologies), which has a maximum temperature of 55oC. Raising the 
temperature of the reaction with both increase the speed of the reaction and also lower the 
interference from secondary structure.  
The sensitive of the enzymes will be investigated, using amplification of a single bacterial cell 
as the target. Enzyme bias will be assessed by using a variety of pathogens, including viruses, 
bacteria with varying GC contents, and mixed samples.  
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1.5 Project Hypothesis 
Unbiased whole genome amplification and characterisation of pathogens directly from clinical 
specimens enables more in-depth analysis of pathogen or mixed pathogens infecting sterile 
samples than traditional methods.   
1.6 Project Aims  
Inherent biases in sample processing may result in undiagnosed infections, especially where 
pathogens are novel or unculturable. Current diagnostic techniques are based around isolation 
techniques, which aim to simplify mixed infections, therefore it is likely low abundant co-infecting 
microorganisms may be missed. Direct pathogen sampling and partial genome sequencing from 
infected sites will transform identification, better directing therapeutics and patient care. This 
could potentially impact on the identification and characterisation of low abundance pathogens, 
with numerous possible aetiologies.  We propose to undertake unbiased amplification of 
pathogens present in low numbers and or mixed with normal flora from clinical material. A novel 
approach will be developed and evaluated, resulting in the generation of comprehensive genetic 
information about the characteristics and genetic composition of pathogens analysed.  This 
information could be used to inform clinicians of the predicted antibiogram, toxin gene presence 
and virulence determinants, to better guide the decision tree related to treatment and control. 
Using whole genome analysis enables real time infection control decisions to be made, to help 
contain outbreaks in a rapid manner. 
Objectives 
 Develop a method for amplification of very low and mixed starting material that is rapid, 
limits the introduction of amplification errors and amplifies all regions of the genome 
(chromosomal and extra-chromosomal). Different enzymes and methods will be tested to 
find the most suitable mechanism generating high quality, informative data.  
 Define the sensitivity of the assay, including single cell work, and low number cell mixes. 
 Integrate sample preparation pathways to allow a workflow for unbiased diagnosis of 
both viral and bacterial pathogens to be created 
 To examine approaches to allow pathogen signals to be amplified preferentially to host 
signals. This will allow unbiased amplification methods to be applied directly to 
environmental and clinical samples.  
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 An optimised bioinformatic pipeline will be developed, based on comparison of multiple 
quality trimmers and genome assemblers. The criteria used to identify the optimal 
pipeline will be genome assembly quality. The pipeline will aim to have an output that 
allows identification and characterisation of pathogens, including predictions for novel 
characteristics.   
 A primer free amplification technique will be developed which will prevent the loss of 
information at genome ends and will incorporate a system to allow simultaneous 
amplification of RNA and DNA in a representative manner. Methods for tagging of 
samples will be explored to allow the initial diversity of a sample to be accurately 
determined.  
 Multiple sample types will be tested including low starting number and mixed, GC content 
and pathogen genome size will be varied, in both control and clinical samples.  
The methods developed will aim for a culture independent, unbiased method to produce 
whole genome sequencing data from mixed and low cell numbers. The method will aim to achieve 
a consolidated laboratory workflow for sample processing and allow full characterisation of a 
mixed sample from a single molecular assay. The methods can be applied for the detection of 
known pathogens, characterisation of novel features and potentially pathogen discovery. 
Additionally, the method could be applied to assess co-infections and novel pathogen interactions 
as well changes in flora in health and disease. It can also be applied to large scale metagenomic 
studies to give whole genome information.   
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2. Materials and Methods  
2.1. Culture Conditions and Strain Acquisition for Pathogens 
used in this Thesis 
2.1.1. Bacteria used as Controls 
Control bacteria for initial experiments were selected from onsite PHE collections; reasons for 
selection were availability of completed reference sequences, variable GC content and different 
cell wall types. The selected bacteria were Escherichia coli (E. coli) K12 substr. MG1655, 
Actinomyces naeslundii (A. naeslundii) (NCTC 10301)) and (Pepto) Clostridium difficile 630 (C.  
difficile 630). For later experiments involving mixed cells, genome size was the main selection 
criteria, the two bacteria selected were Haemophilus influenza (H. influenzae) (NCTC 8143) and 
Enterococcus faecalis (E. faecalis) (NCTC 12201). Bacterial isolates were recovered from long term 
storage and cultured from beads stored at -80oC and grown at 37oC overnight on Columbia blood 
agar (CBA), chocolate Columbia blood agar (ChocBA) or Fastidious Anaerobe Agar (FBA), under 
aerobic, 5% CO2 or anaerobic condition. Culture details and basic genome information is listed 
below Table 2-1.  Agar plates are made and quality controlled onsite at PHE Colindale by the 
media service unit. 
Strain Agar Incubation 
atmosphere 
GC Genome size 
Escherichia coli K12 substr. MG1655 CBA O2  50% 4.6MB 
Actinomyces naeslundii (NCTC 10301) FBA An O2 69% 3.0MB 
Peptoclostridium difficile 630 FBA An O2 29% 4.2MB 
Haemophilus influenza (NCTC 8143) ChocBA 5% C O2 38% 1.8MB 
Enterococcus faecalis (NCTC 12201) CBA O2 37.5% 3.2MB 
Table 2-1 Details of the culture conditions and basic genome information of bacterial s trains used as controls in 
this  thesis 
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2.1.2. Clinical Isolate Collection and Growth 
Clinical isolates were collected from the long term storage from the microbiology department 
at the Royal Free Hospital Hampstead. These were sub-cultured from beads stored at -80oC, 
checked for purity and the identity confirmed by MALDI-TOF before fresh beads were made and 
transported. Clinical information and isolate sensitivity were gathered based on final reports 
issued by the laboratory and all patient identifiable information was removed from reports before 
use. Isolates were selected using a variety of criteria; wherever possible the source was a sterile 
site, with a focus on blood culture isolates. Firstly  the most common blood culture isolates in 
England  according the study produced by the Health Protection Agency93 were collected. 
Furthermore, isolates were selected for additional interest including antimicrobial resistance, 
difficulty in traditional identification and isolates of high clinical impact. The list of isolates with 
their culture conditions is shown in Table 2-2  
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 Isolate Hospital ID Source Other info Media Incubation 
1 Escherichia coli 15M154850 Blood Culture  ESBL CBA O2 
2 Staphylococcus 
epidermidis 
15M033693 Fluid Aspirate  CBA O2 
3 Staphylococcus 
aureus 
15M154940 Blood Culture MSSA CBA O2 
4 Staphylococcus 
aureus 
15M150748 Blood Culture MRSA CBA O2 
5 Enterococcus 
faecium 
15M032581 Bone (Hip) VanA CBA O2 
6 Klebsiella 
pneumoniae  
14M181010 Blood Culture ESBL CBA O2 
7 Streptococcus 
pneumoniae 
14M180245 Blood Culture  ChocB
A 
5% C O2 
8 Pseudomonas 
aurginosa 
15M154350 Blood Culture  CBA O2 
9 Pseudomonas 
aurginosa 
13M155577 Blood Culture Resistant to 
Carbapenems 
CBA O2 
10 Proteus vulgaris 15M017752 Tissue (Foot)  CLED O2 
11 Enterobacter 
cloacae 
15M154841 Blood Culture Inducible 
AmpC 
CBA O2 
12 Streptococcus 
agalactiae 
15M036872 High Vaginal 
Swab 
 CBA 5% C O2 
13 Bacteroides 
vulgatus 
14M180862 Blood Culture  FBA An O2 
14 Streptococcus 
oralis 
15M150586 Blood Culture  CBA 5% C O2 
15 Streptococcus 
mitis 
15M150586 Blood Culture  CBA 5% C O2 
16 Streptococcus 
anginosus 
15M152569 Blood Culture  CBA 5% C O2 
17 Haemophilus 
influenzae 
15M154514 Blood Culture   ChocB
A 
5% C O2 
18 Streptococcus 
pyogenes 
15M153838 Blood Culture  CBA O2 
19 Salmonella sp. 14M180208 Blood Culture WGS available CBA O2 
20 Serratia 
marcescens 
14M154557 Blood Culture  Inducible 
AmpC 
CBA O2 
21 Fusobacterium 
necrophorum 
14M163444 Blood Culture  FBA An O2 
22 Listeria 
monocytogenes 
15M152571 Blood Culture  CBA O2 
23 Actinomyces 
naeslundii 
14M346820 Bone (Femur)  FBA An O2 
24 Proprionibacteriu
m acens  
14M37379 Tissue 
(Shoulder) 
 FBA An O2 
25 Paenibacillus 
anaericanus 
14M366429 Tissue 
(Shoulder) 
ID by 16S 
sequencing 
FBA An O2 
26 Clostridium 
butyricum 
14M180616 Fluid (hip)  FBA An O2 
27 Shigella  sonnei 15M005139 Faeces  CBA O2 
Table 2-2 Details of clinical isolates collected from the Microbiology Department at the Royal Free Hospital 
Hampstead, including growth conditions and original infection s ite.  
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2.1.3. Tissue Culture of Viral Strains 
2.1.3.1. Culture of Adenovirus 
Adenovirus was selected as an initial test virus because of its DNA genome, the relative ease 
of culture and it’s none enveloped capsid which allowed testing of the extraction method.  
Frozen Human Embryonic Kidney 293 cells were retrieved from storage in liquid nitrogen, and 
gently warmed to defrost.  9 ml of Minimum Essential Media (Life technologies) supplemented 
with 10% foetal bovine serum (Sigma-Aldrich) and 1% penicillin/streptomycin (Gibco) was added 
to 1 ml of frozen cell stock. Cells were gently mixed and then centrifuged at 1000 rpm for 5 
minutes. The supernatant was removed and 10ml of warmed media was added to a T25 corning 
flask (Sigma-Aldrich) and washed cells were added. The cells were checked for healthy 
morphology before the flask was incubated at 370C at 5% CO2 using vented caps. After 24 hours 
the cells were 80% confluent and were passaged into T75 flasks. Briefly the Hank’s balanced salt 
solution (HBSS) (Thermo Fisher Scientific) and trypsin 0.25% (Invitrogen) were added and the cells 
and incubated at room temperature for 2 minutes before removal of the liquid.  The flasks were 
then incubated for 5 minutes at 37oC, before 5ml of warmed media was added. 10ml of warmed 
media was added to the new T75 flask before addition of the washed cells. Cells were checked 
daily and once at 80% confluence, were split into fresh flasks for infection. The flasks were 
incubated for 72 hours as previously. After cells had reached 90% confluence they w ere infected 
with 5 ml supernatant containing Adenovirus 40, Adenovirus 41 or 5ml media for negative 
control. Samples were checked daily for signs of Cytopathic effect (CPE) and compared to the 
negative control. Once 100% CPE was observed the flask was frozen at -80oC and thawed three 
times and the flask content was transferred to a falcon tube (Thermo Fisher Scientific). The 
sample was then centrifuged at 5000 rpm, 10 minutes, to pellet the cell debris; aliquots of 1 ml of 
the virus supernatant were then made and stored at -80oC.  
2.1.3.2. HIV Culture  
HIV was used for initial work to investigate application of methods to RNA genomes, strain 
selection was based availability of a well characterised category two tissue culture model. 
Additionally, as its an enveloped virus, the sample processing pipeline could be tested on a more 
fragile virus. 
8E5/LAV94 cells, which are  a sub clone of A3.01, a CD4+ CEM derived human T-cell line (HIV-1 
subtype B, NIBSC repository reference ARP110),were defrosted by gently warming. The cell line, 
containing a single defective copy of HIV-1 proviral DNA, was grown in 90% RPMI 1640 (life 
technologies) and 10% foetal bovine serum (Life Technologies). Initially the cells were grown in 
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T25 flasks at 5% CO2 until 80% confluence was achieved. After which the cells were transferred in 
to T75 flasks under the same conditions.  Once 90% confluence was achieved supernatant from 
the flask was poured into a 50ml falcon tube, and cells pelleted at 6000xg for 20 minutes. The 
supernatant was then aliquoted into 1ml aliquots. The virus particle number was quantified using 
The TC20 automated cell counter (Bio Rad).  
2.1.4. Viral Pathogens Externally Acquired 
Control materials of a variety of viral strains were ordered from the National Institute of 
Biological Control (NIBSC) collection of Nucleic acid reference materials.    The viruses selected 
were representative of different genome types, nucleic acid organisation and particle sizes.  The 
list and details supplied by NIBSC is shown in Table 2-3. These strains were stored at -80oC until 
use.  
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NIBSC 
product 
number  
Virus Additional information  
08/310 Varicella Zoster 
virus (type B) 
This  preparation contains both infectious Varicella Zoster vi rus which 
has  NOT been inactivated and Foetal ca lf serum. The control consists of 
a  whole vi rus preparation of Varicella Zoster vi rus 
Type B di luted in a buffer comprising 10 mM Tris -HCl pH7.4 and 2% 
foetal ca lf serum. 
Ct 30 
11/182 HBV DNA 
working reagent 
The preparation contains a dilution of freeze-dried human plasma 
known to be positive for HBV DNA. The diluent is made from human 
plasma tested negative for anti-HCV, anti-HIV, and HBsAg. 
The reagent contains a genotype A i solate diluted in HBV negative 
plasma.  
1140 IFU/ml 
11/208: Parvovirus B19 
DNA working 
reagent 
The preparation contains a dilution of parvovirus B19 in normal human 
plasma tested and found negative for anti-HBsAg, anti-HCV and anti-HIV 
1.  
the control consists of a dilution of Parvovirus B 19 genotype 1 diluted in 
normal human plasma 
unitage of 800 IFU/ml (range 569-1039)  
07/294: Norovirus 
(genogroup GII)  
This  preparation contains both infectious Norovirus genogroup (G) I I 
which has NOT been inactivated and foetal calf serum. 
The control consists of a diluted faecal sample containing Human 
Norovirus genogroup II diluted in a  buffer comprising 10mM Tris-Cl 
pH7.4 and 2% foetal calf serum. 
Ct 30 
13/102:  HAV RNA 
working reagent 
The preparation contains a dilution of Hepatitis A vi rus in normal human 
plasma tested and found negative for anti HBsAg, anti-HCV and anti-
HIV1.  
The control consists of a dilution of Hepatitis A vi rus genotype 1B 
di luted in normal human plasma 
Unitage 588 IFU/ml (range 507–680 IFU/ml). 
13/168  Measles 
(MVi/Moscow.R
US/0.88) 
This  preparation contains both Measles vi rus which has been inactivated 
and foetal Calf serum 
The control consists of a whole vi rus preparation of Measles Virus  
MVi/Moscow.RUS/0.88virus diluted in a buffer comprising 10 mM Tris -
HCl  pH7.4 and 2% foetal calf serum 
Ct 30  
07/298 Influenza A 
H3N2 
(A/Wyoming/3/
2003) 
This  preparation contains both infectious Influenza vi rus which has NOT 
been inactivated and foetal calf serum.  
The control consists of a whole vi rus preparation of Influenza vi rus 
(A/Wyoming/3/2003, H3N2) diluted in a  buffer comprising 10 mM Tris -
HCl  pH7.4 and 2% foetal calf serum. 
Ct 30 
02/264: HCV RNA 
working reagent 
The preparation contains material of human origin, and either the final 
product or the source materials, from which i t is derived, have been 
tested and found negative for HBsAg, anti-HIV and HAV RNA 
The reagent contains a genotype 3 i solate diluted in HCV RNA negative 
plasma. Each vial of the reagent contains 0.5 ml  of liquid 
assigned a value 1438 IFU/ml 
08/314 
 
human 
cytomegalovirus 
(HCMV) 
This  preparation contains infectious human cytomegalovirus which has 
NOT been inactivated and foetal calf serum.  
The reagent consists of a whole vi rus preparation of HCMV strain AD169 
di luted in a  buffer comprising 10mM Tris-HCI pH 7.4 and 2% foetal ca lf 
serum. 
Ct 30 
Table 2-3 Details of vi ral control media supplied by NIBSC, including vi ral strain, product number, details given by 
NISBC regarding the preparation of the control media and any quantification data supplied.  
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2.2. Evaluation of Potential Whole Genomes Using None PCR 
Amplification Techniques  
Initial experiments focused on finding a suitable alternative to PCR that allowed rapid and 
accurate amplification of whole genomes without targeting specific genes. ɸ29 was the 
preliminary focus, due to its ability to accurately amplify DNA into long transcripts.  Further work 
was carried out to attempt to remove the need for primers, as there are inherent biases even in 
random primers. Experiments were carried out to assess the compatibility of reverse transcription 
enzymes with DNA amplifying enzymes to allow methods to be applied to RNA pathogens. An 
additional enzyme was investigated, which is able to both convert RNA and amplify DNA, 
potentially allowing a one-step process for all pathogen types.  
Initial bacterial work was performed using Escherichia coli K12 substr. MG1655 which is well 
characterised strain, with a GC content of 50%. There is also a fully constructed reference genome 
available for this strain. To give a quick evaluation of genome coverage after amplification, a PCR 
was designed with ten gene targets spread evenly across the genome. Primers for this were 
selected using the NCBI primer designing tool. When looking at RNA conversion, RNA extracted 
from tissue culture grown HIV was used (describe in 2.1.3.2). To investigate the length of 
transcripts created by the reverse transcription enzymes, a PCR was designed with varying lengths 
of amplified targets. 
2.2.1. Use of ɸ29 MDA for Whole Genome Amplification Using 
Random Primers   
2.2.1.1. Preparation of None Amplification Controls  
The material from two overnight agar culture plates was suspended in 1 ml of sterile PBS, 
spun at 6000xG for 5 minutes, the supernatant removed and the pellet resuspended in 400 µl 
sterile PBS.  The DNA was then extracted using the Qiagen QIAamp DNA Mini Kit, using the 
protocol for extraction from blood, with reactions scaled up from 200 µl to the 400 µl input. 
Briefly 40 µl of proteinase K and 400 µl buffer AL was added to the suspended bacteria and the 
mixture vortexed. This was incubated for 10 minutes at 56oC before the addition of 400 µl 100% 
ethanol. 1240 µl of the product was then added to the spin column and centrifuged at 6000 x g 
for 1 min and the filtrate discarded; this was repeated for the remaining product. The column was 
then washed using 500 µl buffer AW1 and centrifuged at 6000 x g for 1 min, with the filtrate being 
discarded. The column was washed again by adding 500 µl buffer AW2, before an additional 
centrifugation at 20,000 x g for 3 minutes. The DNA was then eluted by addition of 50 µl of DNase 
43 
 
free water, incubation at room temperature for 2 minutes and eluted into a clean tube by 
centrifuging the column at   6000 x g for 1 min.  
2.2.1.2. Extraction for ɸ29 MDA amplification 
Bacterial cells or viral particles were suspended in PBS, and 4 µl was used in the amplification 
reaction. Extraction was performed using alkaline method; briefly cell suspensions were added to 
200 mM potassium hydroxide (Qiagen) and 50mM dithiothreitol (Qiagen) and incubated at 65oC 
for 10 minutes. The reaction was then neutralised using neutralisation buffer (Qiagen). The 
sample was then briefly vortex and placed on ice. 
2.2.1.3. Amplification reaction for ɸ29 MDA 
The ɸ29 MDA was performed using the Repli-g Single Cell Kit (Qiagen). A master mix was 
prepared in a total volume of 40 µl, with 29 µl reaction buffer, containing endonuclease resistant 
hexamer primers and 2 µl (40 U) of ɸ29polymerase (Qiagen, REPLI-g Single Cell Kit). The 
denatured DNA was then added to the master mix and the sample was placed on the 
thermocycler which ran on the following parameters, 300C for 16 hours, 650C for 3 minutes and 
then a 40C hold.     
2.2.1.4. Quantification of Product  
The ɸ29 MDA product was quantified using the Qubit broad range assay (Thermo Fisher 
Scientific). Briefly a working solution was made by preparing a 1:200 dilution of the Qubit reagent. 
Two standards were then made by adding 10 µl of standard to 190 µl working solution, and 
samples were prepared by adding 2 µl of sample to 198 µl working solution. The samples were 
vortexed and incubated at room temperature for 2 minutes. The tubes were then read using the 
Qubit 2.0 Fluorometer. The same tube was read three times for each sample (in accordance to the 
manufacturer’s instructions) and an average taken as the DNA concentration.  
2.2.1.5. Visualisation of Amplification Product 
5 µg of product was visualised using a 0.8% agarose gel stained with SYBR safe, this was ran 
for up to four hours at 50v to visualise the large product. The product was run alongside a 1kb 
plus DNA ladder (Life technologies). 
2.2.1.6. Assessment of K-12 Genome Coverage 
 The PCR was performed using GeneAmp PCR System 9700 (Applied Bioscience). The reaction 
was performed using AmpliTaq Gold (Thermo Fisher Scientific) in a total volume of 25 µl. The 
reaction consisted of 2.5 µl PCR 10x gold buffer, 2 µl 25mM MgCl2, 0.5 µl DNTP mix (10nM), 0.125 
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µl DNA polymerase (1.25 Units) and 1.25 µl of 20 µM forward and reverses primer. To this master 
mix 5 µl of a 1:1000 dilution of ɸ29 MDA product was added. The cycling condition were as 
follows, 95oC 10 minutes, and 30 cycles 94oC 30 seconds, 59oC 30 seconds, 72oC 30 seconds, hold 
at 72oC 10 minutes, and a final hold at 4oC. The products were visualised using a 1.5% agarose gel 
stained with SYBR safe or the Bioanalyser (Agilent) 1000 DNA kit. Details of the primers can be 
found in Table 2-4 
Gene Position F primer  R primer 
yafD 231122 TACCACCTGGGGAACCGTTA TCACTGACGTTCAGACCACG 
nagC 699597 CGGCAGATTAGTGCGAAACG CGGACAGCGGCAAAATTCAT 
fabG 1149893 AGTTATTGGCACTGCGACCA CGCCGTTCACATGCAAAGTT  
abgB 1399834 GGGGGCGCGGATAAGATAAA TTACCCGCAACGTAGGCAAT 
hisG 2088216 ACTTTACCCTGCGTCGTCTG GAATTGAACTGGCACCCAGC 
eutB 2555340 TTGAGGTTCTGGTCAGCGTC GACGACGTGCAAAGTATCGC 
speB 3080899 AAAGCAGGATCCAGGCAGTC ACTGGGTGATTACTGGCGTG 
kefB 3476824 CTTCATGGTGTCTTCCGGCT CCTCGGGGTGCTTTATACCC 
mnmG 3921767 GCAGATCTTCACCACTGGCT CCGAACGGTATCTCCACCAG 
treR 4464322 ACGATCTCCGGATGGAGGAA ACCCGTCTGGATTCGTTGTC 
Table 2-4 Details of PCR targets used in initial assessment of amplification of the E. coli K12 genome, including gene 
name, gene position and primer sequences 
 
2.2.2. Assessment RNA Conversion Enzymes   
2.2.2.1. Concentration of HIV Using PEG-High Volume  
100 ml of tissue culture supernatant from 8E5/LAV94 cells  was divided into four 25 ml 
aliquots, and centrifuged at 6000xg to remove host cells. The supernatant was then added to 25 
ml of Polyethylene glycol (PEG) 20,000 (Sigma-Aldrich) in 0.9% NaCl to a total of 20% (w/v) PEG, 
vortexed and incubated overnight at 4oC. The sample was centrifuged at 17860xg for 20 minutes. 
The pellet was resuspended in 5 ml sterile PBS, vortexed and combined into a single tube and 
incubated overnight at 4oC. The sample was once again centrifuged at 17860xg for 20 minutes. 
The sample was resuspended in 1ml sterile PBS. The 1ml was then concentrated as before and 
resuspended in 20 µl.  
2.2.2.2. RNA Extraction  
The concentrated virus was then extracted using either alkali extraction or column based 
extraction. For the alkali extraction the protocol described in 2.2.1.2 was followed but with the 
volume scaled up to a total reaction volume of 50 µl. Alternatively the concentrated virus was 
extracted using PureLink® Viral RNA/DNA Kit (Invitrogen), as described in the manual, with the 
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substitution of the carrier RNA with Linear Acrylamide (LPA) (Invitrogen). Briefly 25 µl Proteinase 
K, 200 µl lysis buffer and 5 µl LPA was added to the sample, gently vortexed and then incubated at 
56oC for 15 minutes. After the addition of 250 µl 100% ethanol the sample was incubated for a 
further 5 minutes at room temperature. The sample was then added to the viral spin column and 
centrifuged for 1 minute at 6800xg, and the flow through was discarded. The sample was then 
washed twice with wash buffer before being eluted in 50 µl RNase free water. The RNA from both 
extractions was then quantified using Qubit RNA HS Assay Kit or Qubit RNA BR Assay Kit.  
After quantification dilutions were prepared to contain 1000, 10, 0.1, 0.01, 0.001 and 0.0001 
pg/µl concentrations using RNAse free water containing 2 U/µl RNaseOUT™ Recombinant 
Ribonuclease Inhibitor (Thermo Fisher Scientific).  These dilutions were then used for investigating 
the sensitivity of reverse transcription enzymes.  
2.2.2.3. Addition of RNase and DNase  
After viral concentration with PEG, and suspension in 50 µl of sterile PBS 10ng of RNase A 
(Thermo Fisher Scientific) along with 5 units of DNase I, (Thermo Fisher Scientific) was added. The 
sample was then briefly vortexed and incubated at 37oC for 20 minutes. After incubation 100 U 
RiboLock (Thermo Fisher Scientific) was added to the sample and 5µl 0.5M EDTA.  
 
2.2.2.4. RNA Conversion using Superscript III 
1 µl of RNA was added to 50 ng of random primers (Thermo Fisher Scientific) and 1 µl 10mM 
dNTPS mix (Thermo Fisher Scientific) and made up to 13 µl with sterile water. This was then 
incubated at 65oC for 5 minutes and put on ice for 2 minutes. To this 4 µl 5x first-strand buffer, 1 
µl 0.1M DTT, 1 µl RNaseOUT and 1 µl SuperScript III (Thermo Fisher Scientific) was added. The 
sample was then incubated at 55oC for 60 minutes before inactivation at 70oC 15 minutes 
2.2.2.5. RNA Conversion using Superscript IV 
1 µl of RNA was added to the following reaction to 50 ng of random primers and 1 µl 10mM 
dNTP mix and made up to 13 µl with sterile water.  This was then incubated at 65oC for 5 minutes 
before the addition of 4 µl 5 x SSIV buffer, 1 µl 0.1M DTT, 1 µl RNaseOUT and 1 µl SuperScript IV 
reverse transcriptase (Life technologies). The reaction was then for 10 minutes at 55oC and 10 
minutes at 80oC.  
2.2.2.6. PCR for Amplification of HIV Transcripts                                                                     
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Using envelope targeting primers95 one forward primer and five reverse primers in the 
envelope gene were selected, listed in  Table 2-5. PCRs were performed for each primer 
combination in the following mixture 5μl 10X PCR Buffer, 1.5 µl 50 mM MgCl, 1 µl 10mM dNTP 
mix, 1 µl 20 µM forward and reverse primers, 0.4 µl Taq (5U/ µl), 5 µl first strand cDNA, water to 
50 µl total volume. The following cycling conditions were used 94oC 2 minutes, 30 cycles 94oC 30 
seconds, 53oC 30 seconds, 72oC 30 seconds, hold at 72oC 10 minutes, and a final hold at 4oC 
 
 Primer Location Product 
length  
Sequence(5’–3’)   
Forward E70 335  GGGATCAAAGCCTAAAGCCATGTGTAA 
     
Reverse  E03 +218 2283 TAAGTCATTGGTCTTAAAGGTACCTG 
 E45 2113 1778 CCTGCCTAACTCTATTCAC 
 E65 1568 1233 AGTGCTTCCTGCTGCTCC 
 E125 1091 756 CAATTTCTGGGTCCCCTCCTGAGG 
 E145 757 422 CAGCAGTTGAGTTGATACTACTGG 
Table 2-5 Details of primer name, amplicon size and genome position of primers used to amplify HIV  
2.2.2.7. PyroPhage 
PyroPhage 3173 (Lucigen) is designed to have a one-step reaction for reverse transcription 
and PCR amplification. Two forms of the enzyme are available, a wild-type and an exonuclease 
knock out (exo-); both enzymes were tested using the specific primer combinations described in 
Table 2-5. 
Initially the enzyme was used to amplify the cDNA produced by SuperScript IV in 2.2.2.5 using 
the following reaction using either the wild type or exo- versions of the enzyme. 200 ng cDNA was 
added to 25 µl PyroPhage 3173 2X PCR Buffer, 1 µl 10mM dNTP mix, 1 µl 10 µM forward and 
reverse primer, 0.5 µl PyroPhage 3173 and water to a total of 50 µl. The cycling conditions were 
the same as used in the PCR in 2.2.2.6  
The utility of the enzyme to perform both RNA conversion and DNA amplification in a single 
step was then investigated. The reaction was set up as follows 1 µg RNA, 25 µl PyroPhage 3173 2X 
PCR Buffer, 1 µl 10mM dNTP mix, 1 µl 10 µM forward and reverse primer, 0.5 µl PyroPhage 3173 
and water to a total of 50 µl.  
The following cycling conditions were used 94oC 2 minutes, 30 cycles 94oC 30 seconds, 53oC 
30 seconds, 72oC 30 seconds, hold at 72oC 10 minutes, and a final hold at 4oC. 
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2.2.2.8. Reverse Transcription and MDA 
The cDNA library produced using SuperScript III and IV in 2.2.2.4 and 2.2.2.5 were amplified 
using   ɸ29 MDA. Briefly 10 µl of cDNA was added to 40 µl mastermix and amplified for 8 hours. 
After amplification, the  ɸ29 MDA product was quantified and then diluted 1:1000 before 
addition to the PCR reactions using primers described in 2.2.2.6.   
2.2.3. Whole Genome Amplification Using Nick Extension 
Amplification   
Experiments were undertaken to assess the possibility of producing whole genome 
amplification by initiating the DNA replication at nicks in DNA. Nt. BstNBI (New England Biolabs) is 
an endonuclease that cleaves one strand of DNA at a specific site downstream of a 5 base 
recognition site. The enzyme has previously been used for isothermal  amplification from nicking 
by Moser et 78 using the amplification enzyme PyroPhage 3174 77.  
2.2.3.1. Nicking Reaction with Nt. BstNBI 
Initially bioinformatic predictions of the number of nicking events in the three bacteria were 
performed on the reference genome of, Escherichia coli K12 substr. MG1655, Actinomyces 
naeslundii (NCTC 10301) and C. difficile. This was performed by searching the reference sequence 
for the recognition sites on both strands of DNA. Using the following command 
 
Command 2-1 bioinformatic search for nicking enzyme recognition site 
Firstly 100 ng of control DNA (as described in 2.2.1.1) extracted from E. coli K12, C. difficile or 
A.naeslundii were incubated with Nt.BstNBI in the following reaction scaled down from a generic 
restriction enzyme protocol. Input DNA 100 ng, 1 µl 10x buffer (NEB), 1U Nt. BstNBI enzyme (NEB) 
and water to a total volume of 10 µl. 
The reaction was incubated at 55oC for 1 hour. The enzyme was then de activated at 80oC for 
20 minutes. The DNA was cleaned up using isopropanol precipitation.  Briefly 5 µl 7.5M NH4OAc 
(Sigma-Aldrich) and 30 µl 100% isopropanol (Sigma-Aldrich) was added to the samples and 
incubated at room temperature for 10 minutes. This was then centrifuged at 4oC for 10 minutes at 
21000xg. The pellet was then washed with 70% ethanol and centrifuged as before. The ethanol 
was removed and the sample allowed to air-dry for 15 minutes before being resuspended in 15 µl 
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of molecular grade water. The sample was then quantified using the Qubit dsDNA HS Assay Kit 
(Thermo Fisher Scientific) and stored at -20oC.  
 
2.2.3.2. MDA Reaction with Nicked DNA 
DNA was nicked and cleaned up as described in 2.2.3.1 then four ɸ29 MDA reactions were set 
up for each isolate,  
1. Non-nicked with primer control  
2. Non-nicked without primer 
3. Nicked DNA with primer  
4. Nicked DNA no primers.  
The ɸ29 enzyme for all nicking work was supplied by NEB, with specific 10x ɸ 29 DNA 
polymerase reaction buffer. Samples which included primers were denatured prior to addition to 
the reaction mix below. 0.5 ng of DNA was added to the reactions.  5 µl of ɸ29 10x buffer, BSA to 
0.2 µg/ µl, 200 µM dNTPs, 10U ɸ 29, 250ng Endonuclease resistant random hexamers (where 
needed) and water to a total volume of 50 µl 
The reactions were then incubated at 30oC for 6 hours and DNA was quantified at 1, 2, 3, 4, 5 
and 6 hours, and inactivated at 65oC for 10 minutes.  
2.2.3.3. Co-nicking and MDA Amplification  
The nicking and amplification reactions were combined without a clean-up stage. 0.5 ng of 
DNA was added to the above nicking reaction (2.2.3.1) and incubated for 30 minutes at 55oC, then 
ramped down 30oC before addition of the MDA reaction mix (2.2.3.2). The same four 
combinations of reactions were used as previously, with the samples including pri mers denatured 
before addition to ɸ29 MDA mix.  
2.2.3.4. Use of T4 Gene 32 Protein for Amplification Stabilisation 
T4 Gene 32 Protein (NEB) is a single stranded binding protein (SSBP), which stabilises single 
stranded DNA, preventing re-annealing. This was  previously reported96 to increase DNA yields 
during amplification at a level of 2.5  µg/100 µl. The T4 Gene 32 Protein was supplied at a 
concentration of 10 mg/ml, in 50 µl reactions 1.5 µg was added (1.5 µl 1:10 dilution).  
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2.2.4. Combining Displacement Enzymes 
Other polymerases with strong stand displacement activity were combined with ɸ29 to 
investigate the impact on extension from nicks. For assessment of the potential use of enzyme 
combinations with ɸ29, E. coli K12 cultured control DNA was extracted as described in 2.2.1.1 and 
nicked as described in 2.2.3.1. 
 
2.2.4.1. Klenow Fragment (3′→5′ exo-) 
 Klenow fragment  has been previously used to produced DNA from nicks 97 and so was 
investigated in isolation and in combination with ɸ29. The following reaction mix combinations 
were trialled 
1. Klenow Fragment with nicked DNA and random primers 
2. Klenow Fragment with nicked DNA 
3. Klenow Fragment with nicked DNA and SSBP 
4. Klenow Fragment and ɸ29 with nicked DNA and random primers 
5. Klenow Fragment and ɸ29 with nicked DNA 
6. Klenow Fragment and ɸ29 with nicked DNA and SSBP 
 
Klenow Fragment (NEB) was supplied with 10 x NEB buffer 2 (NEB).  2.5 µl was added to the 
reaction along with 2.5 µl 10 x ɸ29 DNA Polymerase Reaction Buffer (NEB) to create a 
combination reaction buffer. To this buffer mix 0.2 µg/ µl of Bovine Serum Albumin (BSA), 200 µM 
dNTPs and 10 U of Klenow fragment were added along with the required combination of the 
following components: 
 250ng Endonuclease resistant random hexamers  
 1.5 µg T4 Gene 32 Protein (NEB)  
 10U of ɸ29 
 10 ng nicked DNA was added and reactions made up to a total volume of 50 µl with water. If 
samples had primers added DNA was denatured by heating to 95oC for 2 minutes and held on ice 
for one minute before addition to the reaction mix.  All reactions were then incubated at 30oC for 
six hours. 
2.2.4.2. Deep VentR™ DNA Polymerase 
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Deep VentR has known strand displacement activity, but is normally used for thermo cycling 
production of DNA, where there are high levels of secondary structure. Initially a thermocycling 
reaction was set up using the E. coli K12 primers described in 2.2.1.6 
A 50 μl reaction was set up, using Deep VentR DNA Polymerase (NEB). The mix consisted of 5 
μl ThermoPol Reaction Buffer (10X), 1 μl dNTP mix, 1.25 µl 20µM forward and reverse primer, 10 
ng denatured DNA, 0.5 μl Deep Vent DNA Polymerase and water to 50 µl. The cycling condition 
were as follows, 95oC 5 minutes, and 30 cycles 94oC 30 seconds, 59oC 30 seconds, 72oC 30 
seconds, hold at 72oC 10 minutes, and a final hold at 4oC. 
To assess the potential for isothermal amplification the same reaction mix was used, with 250 
ng endonuclease resistant random hexamers used in place of the specific primers. 10 ng 
denatured DNA was added to the reaction which was held at 30oC for 1 minute, and either held at 
30oC for six hours or the temperature was ramped up to 40oC, 50oC, 60oC, 70oC or 80oC for six 
hours.  
To test for ability to extend from nicks, 10 ng of nicked DNA was added to the reaction mix 
without primers, with or without the addition of 1.5 µg T4 Gene 32 Protein. This was then 
incubated at 70oC or 80oC for six hours.  
2.2.4.3. Bst DNA Polymerase, Large Fragment 
50 µl reactions using Bst DNA Polymerase, Large Fragment and 10X ThermoPol Reaction 
Buffer (NEB).  ).  5 μl ThermoPol Reaction Buffer (10X), 3 µl MgSO4 (100 mM), 2 μl dNTP mix, 10 
ng nicked DNA, 10 U Bst DNA polymerase and water to 50 µl.  Where necessary 1.5 µg of T4 Gene 
32 Protein (NEB) was added. The sample was then held for six hours at 30oC, 40oC, 50oC, 60oC, or 
70oC.   
When combined with ɸ29 2.5 µl ThermoPol Reaction Buffer (10X) and 2.5 µl 10 x ɸ29 DNA 
Polymerase Reaction Buffer was used in the above reaction mix.  For the primer control 250 ng 
endonuclease resistant random hexamers were added. Before addition of the ɸ29 to the mixture 
(including Bst) was held at 50oC, 60oC, or 70oC for one hour before cooling to 30oC and the ɸ29 
(10U) added.  
2.2.5. Amplification of DNA using DNA tagging  
 
Addition of nucleic acid tags to the 3’ end of nucleic acids has the potential to stabilise the 
nucleic acid and produce more full length transcripts by allowing replication to initiate upstream 
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of the start of the target DNA. By limiting the start of replication to a single sight amplification 
bias and over amplification of regions will be limited. Addition of tags also give s the potential to 
add barcodes, allowing initial abundance in samples to be calculated.  
Tag Design  
Tags were designed using the basic hairpin structure used by Ding et al 98, with additional 
bases added to increase the melting temperature, and to include the recognition site for the 
restriction enzyme BamHI (NEB). Over hangs were added to act as priming sites, of either five, ten 
or fifteen bases, the secondary structure was predicted using http://eu.idtdna.com/calc/analyzer. 
Sequences of the tag designs are detailed bellow 
Basic hairpin 
5’ GGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
5 base 5’ overhang  
5’ TCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
10 base 5’ overhang 
5’AAGTATCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
15 base 5’ overhang 
5’AGTTCAAGTATCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
 
2.2.5.1. Tagging with RNA Segments 
RNA bases were added along the length of the stem and loop to allow better degradation of 
the stem loop using RNAses. The positions of the RNA bases are highlighted below.   
5’ GGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
2.2.5.2. Formation of Stem-loop  
The stem loop designs were ordered from Eurogentec, in dried formation after being purified 
by Polyacrylamide Gel Electrophoresis. The DNA tags were reconstituted in sterile water to a 
concentration of 200 µM. The DNA was phosphorylated using T4 Polynucleotide Kinase (3' 
phosphatase minus) (NEB) using the following reaction mix, 10 ng tag DNA, 1 µl 10x buffer, 1 µl 10 
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mM ATP, and water to 10 µl. This was incubated at 37oC for 30 minutes and heat deactivated at 
65oC for 20 minutes. The DNA tag was then incubated at 95oC for one minute before being placed 
on ice for 2 minutes and then placed at room temperature for 20 minutes to aid hairpin 
formation. The stem loops with RNA segments were placed on ice for two minutes after enzyme 
inactivation. The stem loops were then ran on a 2% agarose gel to assess size of products 
produced and check for double stranded DNA formation. 
 
2.2.5.3. Attachment of Stem-loop using t4 RNA Ligase  
T4 RNA Ligase 1 (NEB) catalyses the ligation of a 5´ phosphoryl -terminated nucleic acid donor 
to a 3´ hydroxyl-terminated nucleic acceptor, through the formation of a 3´ → 5´ phosphodiester 
bond. To prevent self-ligation, the DNA was dephosphorylated using Alkaline Phosphatase, Calf 
Intestinal (CIP) (NEB). Variable DNA and RNA input amounts were dephosphorylated by addition 
of 1U CIP for every 1µg of nucleic acid and incubated at 37oC for 30 minutes.   
Stem-loops were attached in 20 µl reactions by addition of 10 U TD RNA ligase 1 along with 
1mM ATP, and incubated at 37oC overnight. 
2.2.5.4. DNA Amplification with Tagged DNA  
10 ng of tagged DNA was incubated in a 50 µl reaction with 10U ɸ29, 200 µM dNTPs and 5 µl 
10x ɸ29 buffer. The sample was then incubated for four or six hours at 30oC. 
2.2.5.5. RNA Conversion with Tagged RNA  
10 ng of RNA with tag attached was added 1µl 10mM dNTP mix, 4 µl 5 x SSIV buffer, 1 µl 0.1M 
DTT, 1 µl RNaseOUT and 1 µl SuperScript IV reverse transcriptase (Life technologies) and water to 
a total volume of 20 µl. The reaction was then incubated for 15 minutes at 55oC and 10minutes at 
80oC.  
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2.3. Development of ɸ29 MDA for Rapid and Sensitive Whole 
Genome Amplification of Bacterial Isolates 
The second study of the thesis evaluated the suitability of the enzyme ɸ29 for detection and 
characterisation of low abundant microbial genomes production, for the application of whole 
genome sequencing.  The first question addressed was whether ɸ29 could produce DNA that was 
suitable for library preparation for next generation sequencing, and how this compared to the 
DNA produced by current culture based methods. Additionally, the sensitivity of the method was 
evaluated and the processivity investigated. The quality of the sequencing data produced was 
assessed and compared to that produced by culture based methods. To establish these properties 
Escherichia coli K12 substr. MG1655 was used as the test organism. The impact of GC content and 
cell wall type was also investigated, along with the ability to detect and analyse extra 
chromosomal elements using Actinomyces naeslundii (NCTC 10301) and Peptoclostridium difficile 
630. To further test the enzyme a mixed bacterial sample was amplified to look for amplification 
bias, using Haemophilus influenza (NCTC 8143) and Enterococcus faecalis (NCTC 12201). 
Additionally, DNA viral genomes from Adenovirus 40 and 41 were amplified to investigate the 
application to smaller genomes and the extraction of none enveloped viruses.  Finally, negative 
samples were sequenced to monitor contamination, randomly produced DNA and sequencing 
artefacts.  
2.3.1. Development of ɸ29 MDA for whole genome Sequencing 
2.3.1.1. Preparation of None Amplification Controls  
Overnight cultures of bacteria were extracted using Qiagen QIAamp DNA mini kit as described 
in 2.2.1.1.  The DNA was quantified using Qubit BR kit and 500 ng of DNA taken forward to 
sequencing. 
2.3.2. Fragmenting DNA for sequencing  
The recommended method for fragmenting DNA for sequencing on the 454 Junior was 
physical shearing for 1 minute using nebulisation. However due to the long lengths and presence 
of secondary structure in DNA produced by ɸ29 MDA alternative methods were investigated.  
DNA extracted from cultured bacteria was fragmented using the recommended parameters 30psi 
for 60 seconds. Three biological replicates of the culture based control were  sequenced  
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2.3.2.1. Using Nebulisation  
500ng of DNA was made up to a final volume of 100 µl with TE buffer. The mixture was added 
to an assembled nebulisation cup (Roche) to which 500 µl of nebulisation buffer was added 
(Roche). The sample was then nebulised at 30 psi (pounds per square inch) for 60, 120 or 180 
seconds.  
2.3.2.2. De-branching of Product 
3 µg of ɸ29 MDA DNA was de-branched using S1 nuclease in a 90 µl reaction as follows, 3 µl 
10x buffer, 3 µl 0.5M NaCl, 10 µl S1 nuclease (1U/ µl) with water to make the volume to 90µl. The 
digestion reaction was left at room temperature for 30 minutes and the enzyme deactivated by 
incubating at 70oC with 6 µl 0.5M EDTA. This was then nebulised at 30psi for 60, 120 or 180 
seconds. 
2.3.2.3. Using Fragmentase 
NEBNext® dsDNA Fragmentase (NEB) generates dsDNA breaks in a time-dependent manner to 
yield 50–1,000 bp DNA fragments. 1 µg of ɸ29 MDA was added to the following reaction mix, 2µl 
10x Fragmentase buffer, 2 µl 10x BSA, and made up to a total volume of 18 µl using the supplied 
sterile water. The reaction was then incubated on ice for 5 minutes, before the addition of 2 µl 
dsDNA Fragmentase. After which the reaction was vortexed and incubated at 37oC 10, 15 or 20 
minutes. After incubation 5 µl 0.5M EDTA was added to stop the reaction.  
2.3.2.4. Combination of S1 Nuclease and Fragmentase 
5 µg of DNA was added to the following reaction mix, 10 µl Fragmentase 10x buffer, 10 µl 10x 
BSA, 24 µl water. This was then incubated on ice for 5 minutes before the addition of the 
following, 10 µl dsDNA Fragmentase, 10 µl S1 10x buffer, 10 µl 0.5M NaCl, 30 µl S1 nuclease 
(1U/ml). Followed by 30-minute incubation at 37oC, after which 2.5 µl 5M EDTA was added to 
stop the reaction.  
2.3.2.5. Sample Purification 
The sample was purified using the Qiagen MinElute PCR purification kit, as described in the 
Roche Rapid Library Preparation method. Briefly, 2.5ml of PB buffer was added to the sample and 
mixed.  750 µl of this mixture was added to the spin column and centrifuged for 15 seconds and 
the through flow discarded. This was repeated until the entire sample had been added. The 
sample was then washed with 750 µl PE buffer and eluted in 20 µl of TE buffer. After which the 
DNA was quantified using Qubit broad range kit as previously described in 2.2.1.4, 500ng of DNA 
in a total volume of 16µl in TE buffer was added then taken forward for sequencing.  
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2.3.3. Sample sequencing  
For sequencing the following Roche 454 Junior protocols were followed: 
2.3.3.1. Rapid Library Preparation Method Manual-Match 2012  
Briefly, 500ng of fragmented DNA was end repaired and adapters added, the DNA was then 
size selected using AMPure beads. Library quality was assessed using the Agilent Bioanalyser 
where successful library preparation consisted of the average read length being between 600 and 
900bp. The library was quantified using the QuantiFluor ST Fluorometer (Promega) fluorescence 
was measured against the standards provided in the library preparation kit. Samples were then 
diluted to working stocks of 1x107 molecules/ μl, in TE Buffer.  
2.3.3.2. EmPCR Amplification Method Manual -Lib-L-March 212 
Firstly, an emulsion PCR was set up, aiming at four or two copies per bead. The emulsion was 
then dived into 100 μl aliquots in a PCR plate. The emulsion PCR used the following parameters in 
a thermocycler with heated lid turned on. A hold at 94°C for 4 minutes, 50 cycles of 30 seconds at 
94°C, 4.5 minutes at 58°C, 30 seconds at 68°C, with a final hold at 10°C. The beads were then 
harvested and the emulsion broken using isopropanol and ethanol. The beads were then washed 
using a provided buffer and concentrated into 1 ml. Enrichment primers were then annealed to 
the libraries and the beads enriched to keep only beads with attached DNA. The recovered beads 
were then visually quantified before a sequencing primer was attached to the libraries.  
2.3.3.3. Sequencing Method Manual – January 2013  
Firstly, all frozen sequencing reagents were defrosted in the dark by submersion in water.  
Then the instruments were primed using the provided pre-wash buffer. Four bead layers were 
prepared as instructed and added to the Pico Titer Plate (PTP) in the order shown in Table 2-6. 
The PTP was then loaded onto the sequencer and sequenced usng 200 cycles and full processing 
for shotgun libraries. Run time was 9 hours and 20 minutes.  
Bead layer Bead type 
Layer 1 Enzyme beads pre-layer 
Layer 2 DNA and packing beads 
Layer 3 Enzyme beads post-layer 
Layer 4 PPiase beads 
Table 2-6 details of bead layers in the PTP for DNA sequencing on the Junior 454 
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2.3.4. Determining Sensitivity and Processivity of Technique in the 
Context of Bacterial Genomes 
2.3.4.1. Lowering Reaction Volumes 
Reaction volumes were scaled down to total volumes of 25 µl and 12.5 µl with two sets of 
biological replicates being sequenced for each reaction volume.   
2.3.4.2. Preparation of Single Cells for Sequencing  
Single colonies from overnight cultures were suspended in 1ml phosphate -buffered saline 
(PBS) to produce a 10-3 dilution, serial 1:10 dilutions were then prepared until 10-10 was achieved. 
A blood agar plate was divided into four and 10 µl of the 10-7 – 10-10; dilutions were plated four 
times on each plate. These were then incubated overnight and a colony count performed. This 
was then used to calculate the average number of cells in the PBS and the required volume of 
diluted cells was added to the extraction for ɸ29 MDA amplification.  Three biological replicates 
of estimated single cells were sequenced. 
2.3.4.3. Reducing Incubation Time  
Incubation times of eight, four, two and one hours were investigated using single cell extracts 
in 50 µl reactions.  Bacteria were extracted as described in 2.2.1.2 , and amplified in the reaction 
as described in 2.2.1.3 before incubation for the required time at 30oC and inactivation at 65oC for 
10 minutes.  Two biological replicates were performed per incubation time.  
2.3.5. Basic Analysis of Sequencing Data Produced 
 
After 454 junior sequencing run completion run statistics were viewed using the Roche 
‘runviewer’ programme, where information on raw reads, reads filter passed and read length 
were obtained. According to Roche sequencing guidelines, a successful run follows the following 
characteristics,  
 Raw reads above 200,000 reads 
 Passed filter wells >100,000 (>50%) 
 Average read length 400-500 base pairs 
After sequencing if these minimum parameters were achieved the sequencing was considered 
successful and further analysis performed.  
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2.3.5.1. Reference Assembly  
Initially the SFF files (Standard flowgram format) were mapped against the appropriate 
reference as listed in Table 2-7. Reference sequences were downloaded in fasta format from the 
National Centre for Biotechnology Information (NCBI) or Integrated Microbial Genome (IMG) 
database.  The sequencing files were assembled using the standard parameters in Newbler GS 
Reference Mapper (Roche Diagnostics). This was used for initial run assessment to determine 
genome coverage and number of mapped reads. The software allows both SFF and FASTQ files to 
be input and assembled, using Command 2-2. From the output file ‘NewblerMetrics.txt’, 
reference assembly information was extracted, including the number of reads which mapped to 
the reference, the number and size of contigs and the percentage of the reference which was 
covered. Once the reference assembly was completed, the resulting bam file was sorted and 
indexed using Sam tools 99. The assembly was then viewed against the reference in Artemis 
15.0.0100.  
 
Command 2-2 reference assembly of SFF using Newbler 
Reference name  Identification  
Enterococcus faecalis V583 
chromosome, complete genome 
NCBI Reference Sequence: NC_004668.1 
Haemophilus influenzae 10810, 
complete genome 
NCBI Reference Sequence: NC_016809.1 
Escherichia coli str. K-12 substr. 
MG1655 strain K-12 cont1.1, whole 
genome shotgun sequence 
NCBI Reference Sequence: NZ_AYEK01000001.1 
Actinomyces naeslundii MG1 IMG reference 2502171150  
Peptoclostridium difficile 630 GenBank: AM180355.1 
Human adenovirus 41 isolate Tak, 
complete genome 
GenBank: DQ315364.2 
Human adenovirus F, complete 
genome (human adeno virus 
serotype 40) 
NCBI Reference Sequence: NC_001454.1 
Escherichia coli K-12 plasmid F DNA, 
complete sequence 
GenBank: AP001918.1 
Peptoclostridium difficile 630 
plasmid pCD630 
NCBI Reference Sequence: NC_008226.1 
Table 2-7 details of reference files used in initial assessment of the of ɸ29 MDA to amplify whole genomes 
including extra chromosomal elements. 
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2.3.5.2.  De Novo Assembly 
Initial de novo assemblies were performed using Newbler GS De novo Assembler (Roche 
Diagnostics) using default parameters, inputting either SFF files or FASTQ files as detailed below in 
Command 2-3. The de novo assembly output was then assessed using  QUAST: Quality 
Assessment Tool for Genome Assemblies 101, Command 2-4, along with the relevant reference 
sequence from Table 2-7. From the output file quast_results.tsv, information on contig size, 
reference coverage and misassemblies were extracted.  
  
Command 2-3 de novo assembly of SFF file using Newbler 
 
Command 2-4 assessment of de novo assembly quality using QUAST 
2.3.5.3. Statistical Analysis of Run Data  
Statistical tests were performed using the inbuilt functions in Microsoft Excel (2010). Two-
tailed T-tests were used to determine if two sets of data were significantly different from each 
other. Firstly, an F test was performed to assess whether the distribution of data was equal. After 
this a two tailed t test was performed in excel using the output of the F test, either equal or 
unequal distribution. A cut off of 0.05 was used to interpret the information.    
2.3.5.4. Extra Chromosomal Elements 
For known and expected extra chromosomal elements, reference mapping was used as 
described in 2.3.5.1 using the appropriate reference file from Table 2-7.    
2.3.5.5. Extraction of Unmapped Reads  
A custom python script was written and named ‘unmapped.py’ to identify the sequencing 
reads that were unmapped during reference assembly (2.3.5.1), the read identifications were 
then written to a text file Command 2-5. The list of read headings was then used to extract those 
reads from the original SFF using sfffile tool, (GS junior suite) as detailed in Command 2-6 
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Command 2-5 Custom python script for identifying reads which were unmapped after a  reference assembly using 
Newbler 
 
Command 2-6 use of s fffile to create a new SFF file with unmapped reads removed, using the text output file from 
Command 2-5 
 
2.3.5.6. Conversion of SFF file  
SFF files were converted to fastq format using sff2fastq (The Genome Institute at Washington 
University, St. Louis, MO), Command 2-7, which allows the extraction of read information from 
SFF files and output of quality scores and sequences into a FASTQ format.  
 
Command 2-7 convers ion of SFF file to a fastq using sff2fastq  
2.3.5.7. Identification of Read Taxonomy  
To identify the taxonomy of the reads a Blastn (Basic Local Alignment Search Tool, nucleotide) 
search was used against the non-redundant nucleotide NCBI database.  Firstly fastq files were 
converted to fasta format using seqtk version 1.0-r82, and then a local Blastn search was 
performed Command 2-8.  
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Command 2-8 convers ion of fastq to fasta using seqtk, use of Blastn to identify reads  
2.3.5.8. Lowest Common Ancestor Analysis 
MEGAN5 - MEtaGenome ANalyzer102, was used to visualise the results of the Blastn output, 
using the following Lowest common ancestor (LCA) parameters.   
 The Min_Score of 150 (minimum threshold for the bit score of hits (indication of 
alignment quality)). 
 The Max_Expected of 0.01 (maximum threshold for the expected value of hits, E-value)  
 The Min_Support_Percentage of 0.01 (minimum percentage of reads a hit needs)  
The corresponding fasta was also loaded into MEGAN, allowing reads to be extracted and 
written to a new fasta file. After the reads had been extracted in to fasta file, the read IDs were 
extracted into a text file, and this list was used to create a fastq file with extracted read and 
quality data Command 2-9.  
 
Command 2-9 extraction of read headings from the fasta file output by MEGAN using Perl script and the creation 
of a  fastq of the corresponding reads from the original fastq 
2.3.6. Impact of GC content on sequencing production  
48 hour cultures of Peptoclostridium difficile 630 and Actinomyces naeslundii (NCTC 10301) 
were extracted as described in 2.2.1.1 and 500 ng of DNA was sequenced using the 454 Junior and 
manufacturers recommended method (2.3.3), with two replicates for each bacteria.  
Single cells for C. difficile and A. naeslundii were prepared as described in 2.3.4.2 with the 
exception of cultures being incubated for 48 hours. For ɸ29 MDA reactions single cells were 
extracted using the alkali method described in 2.2.1.2 and amplified in 50 µl for two hours. These 
were then prepared for sequencing by use of S1 nuclease and 2 minutes nebulisation. Before 
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sequencing on the 454 Junior using manufacturers recommended method (2.3.3). Three 
biological replicates of each bacterium were performed 
2.3.7. Application to low level mixed bacteria  
Serial dilutions of Haemophilus influenza (NCTC 8143) and Enterococcus faecalis (NCTC 12201) 
were prepared as described in 2.3.4.2. Mixes of the two bacteria were then set up varying the cell 
input. A single cell of E. faecalis was mixed with a single, ten, 100 or 1000 H. influenzae cells. 
These mixes were then extracted, amplified using ɸ 29 MDA for two hours and sequenced.  
2.3.8. Amplification of DNA virus 
Tissue culture grown Adenovirus 40 and 41 were defrosted and centrifuged at 4000x g for 10 
minutes to pellet any eukaryotic cells.  A one in ten dilution of the viral supernatant was prepared 
and 3 µl of this was extracted and amplified using ɸ29 MDA for two hours. Three biological 
replicates were performed for each serotype.  
A further three biological replicates of Adeno41 were performed with an additional DNase 
stage to remove tissue culture DNA. After centrifugation to pellet host cells, 2 µl of supernatant 
was added to 2 µl 10X DNase I Reaction Buffer (NEB), 1 µl DNase I (NEB) and 15 µl water.  This was 
then incubated for 10 minutes at 37oC before the addition of 1 µl 0.5M EDTA and heat inactivated 
at 75oC.  
2.3.9. Development of contamination library   
A negative library was sequenced to allow removal of reads from kit contamination. ɸ29 MDA 
reaction was set up as above using the PBS used to suspend the cells.  Negative libraries were 
sequenced periodically to monitor potential contamination.  
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2.4. Development of a data analysis pipeline for processing 
data produced using ɸ29 MDA 
 
2.4.1. Quality control  
The methods adopted in the project aimed to be a balance of the laboratory and 
bioinformatic techniques to produce the highest quality output possible.  
2.4.1.1. Removal of Human Contamination 
Large amounts of human signal in the sequencing run increases the sequencing cost by 
wasting data with none pathogen reads. Human reads may interfere with the assembly of 
pathogens and may even lead to erroneous gene identification. However harsh laboratory 
methods for removal of host contamination may cause degradation of the pathogen signals. 
Removing the reads at an early stage of data processing will lower the size of the file, increasing 
the speed of downstream application.  
Using Newbler GS Reference Mapper (Roche Diagnostics), SFF files were reference mapped to 
the human genome reference, a concatenated file of all chromosomes listed in Table 2-8. The 
reads not mapped to the human genome were then extracted and written to a new SFF as 
described in 2.3.5.5.  
 
 
Type  Name  RefSeq   Type  Name  RefSeq  
Chr 1 NC_000001.11  Chr 13 NC_000013.11 
Chr 2 NC_000002.12  Chr 14 NC_000014.9 
Chr 3 NC_000003.12  Chr 15 NC_000015.10 
Chr 4 NC_000004.12  Chr 16 NC_000016.10 
Chr 5 NC_000005.10  Chr 17 NC_000017.11 
Chr 6 NC_000006.12  Chr 18 NC_000018.10 
Chr 7 NC_000007.14  Chr 19 NC_000019.10 
Chr 8 NC_000008.11  Chr 20 NC_000020.11 
Chr 9 NC_000009.12  Chr 21 NC_000021.9 
Chr 10 NC_000010.11  Chr 22 NC_000022.11 
Chr 11 NC_000011.10  Chr X NC_000023.11 
Chr 12 NC_000012.12  Chr Y NC_000024.10 
Table 2-8  l i s t of accessions for human genome chromosome reference files from NCBI, which were concatenated 
to create the reference file to remove human signals  
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2.4.1.2. Removal of Kit Contamination 
 The problem of environmental and kit contamination was recently highlighted in the 
literature 103, when looking at high sensitivity assays, especially in the context of cross laboratory 
studies. Multiple negative libraries produced over time allowed temporal monitoring of the 
environment, kit lot numbers and changing laboratory practices. A negative library database was 
developed and used to remove known nonsense reads from the sequencing library.  
Reads in the negative libraries were first checked for identifiable reads using Blastn as 
described in 2.3.5.7  and the results visualised using MEGAN. Any reads that didn’t match to 
known bacteria were concatenated into a single fasta file, to create the negative library. 
Sequenced reads were then mapped against this database, and any sequence matches were 
removed using an adapted version of the python script for identification of unmapped reads 
(Command 2-5) shown in Command 2-10 and a new SFF file was created with reads that didn’t 
have hits in the negative library. 
 
Command 2-10 Python script for identifying reads which fully mapped to the reference after reference assembly 
us ing Newbler  
 
2.4.2. Error Trimming 
As suggested by Fabbro et al 104the best trimming algorithm and software is highly dependent 
on the data set, downstream analysis and user defined trade-offs. The associated Phred, or Q 
score with each read dictates the confidence in the base calling at that point. Poor quality bases 
add potentially unreliable sequences into the data, possibly causing false interpretations during 
downstream analysis. Erroneous bases can cause particular problems for kmer based assemblers 
by producing false kmers, increasing the complexity of the assembly and leading to false 
assembly. By removing erroneous bases, the overall amount of data is decreased but the 
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reliability is increased, speeding up analysis and allowing more confidence in the results. Different 
methods for read error trimming were investigated to find the most suitable for the data 
produced.  
 
2.4.2.1. Prinseq 
PRINSEQ  (PReprocessing and INformation of SEQuences) 105 is a window based trimming tool 
with a variety of trimming options, four of these were investigated. The first was the removal of 
known index sequences at the start of the reads, for this the -trim_left function was used with the 
value 4. This command was used in all further algorithms. The input and output sequence file was 
a fastq file (out_put 3); a log file for each parameter was also created. 
The programme has two trimming parameters which were tested with different quality cut 
offs. The first parameter tested was filtering reads based on an average Q score using the -
min_qual_mean <integer> function. The quality scores tested were Q35, Q30, Q25 and Q20. The 
second parameter tested was an end trimming command, removing poor quality bases from the 
5’ and 3’ end of the read. Using the commands, -trim_qual_left <integer> and -trim_qual_right 
<integer> functions with values Q35, Q30, Q25 and Q20, using the same value to trim both ends. 
The final parameter to be investigated was the removal of reads that had a length shorter than 
99, using -min_len <integer> function. 
Finally, combinations of filtering and trimming functions used above were investigated. The -
min_qual_mean <integer> was fixed at the Q20 parameter and the end trimming ( -trim_qual_left 
<integer> and -trim_qual_right <integer> functions) were varied using the values Q30, Q28, Q25 
and Q20, with a fixed minimum read length of 99 base pairs Command 2-11 
 
Command 2-11 Prinseq command for error trimming of a  fastq file 
2.4.2.2. Cutadapt  
 Cutadapt106 is a running sum error trimmer.  Firstly, the known tag sequence was removed 
using –u command, which removes a fixed number of bases from the beginning of reads. Low 
quality ends were removed to Q35, Q30, Q25 or Q20, using the –q command. Minimum reads 
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length was set at 99 using the –m function.  The input and output format for this trimmer was 
fastq Command 2-12 
 
Command 2-12 Cutadapt command for error trimming of a fastq file  
The produced FASTQ files were then assembled using both Newbler GS Reference Mapper 
and Newbler GS De novo Assembler as described above. De novo assemblies were assessed using 
QUAST (Quality Assessment Tool for Genome Assemblies)101.   
2.4.3. Abundance Filtering 
2.4.3.1. Depth Analysis  
Samtools depth in combination with awk was used to assess the depth of the reference 
assembly Command 2-13.  
 
Command 2-13 depth analysis commands using Samtools and awk for identification of the number of points in the 
reference assembly with no coverage, coverage depth less than five, average depth of coverage and peak depth of 
coverage  
 
 
2.4.3.2. Khmer 
Data was digitally normalised to reduce the dynamic range of the coverage depth, using 
Khmer107. The aim of digital normalisation was to decrease the data size by di scarding redundant 
reads, whist maintaining the information within the file.  This software also has the additional 
benefit of removing those reads that appear at very low numbers, which are most likely due to 
random sequencing errors.  
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The programme uses a reference free algorithm to estimate the genome coverage of the data 
by looking at the abundance distribution of kmers on the assumption that kmers tend to have 
similar abundances within a read. (The more times a piece of DNA is copied the higher the kme r 
abundance will be in that region). In the absence of errors, the average kmer number can be used 
to estimate the depth of coverage. Additionally, any kmers that overlap errors will have low 
abundance, which is the basis for the additional error trimming.   
Reads were normalized using The khmer software package 107 known as  “digital 
normalization”. Firstly, the fastq files were normalised by median, to a depth of 60, using the 
normalize-by-median.py function of the programme, K values were variable (20, 50, 80, 110 and 
150), C represents the depth cut off, x informs the amount of memory to use , saving the hash 
table speeds up downstream work. After digital normalisation to 60, abundance trimming was 
performed using abundance-dist.py with the depth cut off at 2 which will trim at k-mers below 
this abundance. The V command was used to indicate variable coverage, meaning the programme 
will only trim low-abundance k-mers from sequences that have high coverage. The digital 
normalisation was then repeated with the depth cut off of 50.  Details of the commands used are 
below in Command 2-14.  
 
 
Command 2-14 Khmer commands for a  three pass digital normalisation with low abundance error trimming aiming 
at a  final coverage depth output of 50 
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2.4.4. De novo Assembly  
Several different algorithms were trialled to find the best de novo algorithm for this set of 
data to find the most suitable one. Four data sets were selected to compare the de novo 
assemblers, single cell amplifications from E. coli k12, C. difficile 630 and A. naeslundii, along with 
adenovirus post DNAse treatment, were assembled using each software. Firstly the SFF files were 
converted to fastqs before abundance and error trimmed as described 2.4.2 and 2.4.3.2.  
2.4.5. Assembly with SSAKE  
The version of SSAKE110 used was V3-8-3, SSAKE requires the input to be in fasta format so the 
resulting trimmed fastq files were converted as described previously.  The files were then 
assembled using the shell script in Command 2-15. With –f indicating the input file, -w being the 
lowest depth of overlap allowed and –b indicating the name of the output files.  
 
Command 2-15 Shell script for assembling reads using the de novo assembler SSAKE of four selected genomes  
 
2.4.6. Assembly using Abyss 
The version of Abyss111 used to assemble the data was 1.9.0.Firstly the kmer length used in 
the assembly used needed to be optimised, the maximum possible kmer length was 96, and the 
length suggested as a start point in the manual was 20 and so the script in Command 2-16  (A) 
was used to assess the best possible kmer size for this data set, using the E. coli k12 dataset. The 
files were then assembled using the best K value found using the shell script in Command 2-16 
(B). With k representing the kmer length and -o being the output  name. abyss-fac produces basic 
information on the assembly quiality. A shell script was then used to run through the assembly 
files usign a kmer value of 96.  
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Command 2-16 ABYss de novo assembly, A) k-mer optimisation script B) shell script for assembly of four selected 
genomes  
2.4.7. Assembly with Spades 
The version of SPades112 used was 3.5.0, the shell script in Command 2-17 was used to asseble 
inout reads. With –o specifying the output directory to be created, -s indicates the reads are 
unpaired.   
 
Command 2-17 shell script for de novo assembly of four selected genomes with SPades 
2.4.8. Asembly using Ray 
The version of Ray113 used was 2.3.1, firstly the optimal kmer size was investigated using the 
script shown in Command 2-18 (A). The maximum kmer size is 149, a range of kmer values from 
69 to 149 were trialled against the E. coli k12 reads to assess the best Kmer value for this 
assembler. The reads were then assembled using the optimsed kmer size using the shell script in 
in Command 2-18 (B).  Where -n is the number of machines available for Ray to use,  -o names 
the output directory to be made and –s is the sequecne input file. A kmer size of 149 was selected 
A 
B 
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for the files to be assembled with. 
 
Command 2-18 de novo assembly with Ray (A) kmer optimisation script (B) assembly shell script  
 
 
2.4.9. Assembly with Mira 
The version of Mira used was 4.0.2, before assembly with Mira a mainfest file was prepared 
for each set of reads, shown in Figure 2-1. Within this file the following  parameters were 
specified, project is the name of the files that will be produced. Job describes what  the input data 
is, and what processes are required. In this case the type of data is genome data, the asssembly is 
de novo  and an accurate assembly is required. The manifest also specifies that the reads were 
produced on the 454 platform. And data gives the location of the file that neds to be assembled. 
The assembly is then performed by identify the manifest file that contains the information.  
 
Figure 2-1 manifest file for Mira 
 
A 
B 
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2.4.10. Genome Annotation  
Prokka115 was used to annotate the de novo assembly of both the none amplification control 
and the ɸ29 MDA single cell of E. coli, A. naeslundii and C. difficile. It was also used to annotate 
the Adenovirus ɸ29 MDA sample which had had a DNAse treatment prior to sequencing.  
Alongside the sequencing files, the reference for each genome was annotated.  
Sequence files were prepared by abundance filtering as described in section 2.4.3 using a 
kmer size of 140, normalized to a depth of 50. The resulting sequences were then error trimmed 
using Prinseq as described in section 2.4.2.1 using end trimming cut off of Q20 and average 
quality of Q20 and the minimum read length of 99. The files were then assembled using Spades as 
described in section 2.4.7. The version of Prokka used was 1.9. The full commands used are 
detailed in Command 2-19. The name of the created output directory is specified using --outdir, 
and the prefix of the files within this folder is defined using --prefix. The command to add gene 
annotations is –addgenes. By default, Prokka assumes the input file is a bacterial assembly, in the 
case of the viral annotations – kingdom command is used to specify viral input. If known the input 
genus and species can be specified, which is only used in headers in the report. The final 
command is to specify the location and name of the input fasta file, in this case the output from 
the Spades assembly. 
 
Command 2-19 Prokka commands for genome annotations of bacteria and vi ruses 
2.4.10.1. Gene Extraction  
The total number of genes was extracted from the GenBank file created by Prokka, by 
searching for the phrase “product=”. The results were input into a text file, and the number of 
genes predicted was then calculated by counting the number of lines. The  number of hypothetical 
proteins was then calculated by searching for “hypothetical proteins” in the resulting text file, 
which was output into another text file and again the number of lines were counted. The  
extracted lists of genes were then entered into jvenn116 which filters the lists for repetition and 
draws a Venn diagram to allow the identification of  common items on each list. The information 
contained in each section of the Venn diagram was then downloaded in csv format and analysed 
for patterns.  
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Command 2-20 gene extraction and counting from Prokka output 
 
2.4.11. Virulence Factor Detection  
Rapidly detecting virulence factors such as toxins using genome data will allow prediction of 
disease states caused by the pathogen 
2.4.11.1. Virulence Factor Data Base (VFDB)  
The virulence factor database117–119 was downloaded and a local blast library was produced. 
The results of the de novo assembly were then investigated using Blastn and this database.  
2.4.11.2. Virulence Factors from Prokka Annotation  
The product list extracted from Prokka as described in 2.4.10.1 was searched for the following 
phrases phage, plasmid, toxin, pathogen, virulence, adhesion, transposon and conjugative. The 
results were output into a text file and investigated.  
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2.4.12. Resistance Prediction  
The use of genomic data to predict resistance in bacteria is an on-going challenge; matching 
genotype to phenotype is a major development, with many species specific studies being 
performed with the aim to address this challenge. In this study generic methods were 
investigated in order to provide a single pipeline for all species identified using this method.  
 Resistance 
 Drug 
 Efflux 
 Beta-lac 
 Antibiotic 
 Cillian 
 Mycin 
 Cef 
 Penem 
 Oxacin 
 Bactam 
 Cyclin 
 Etheprim 
 Kacin 
 Lothin 
 Lisitn 
 Furatoin 
 Icin 
 Fusaric 
 
2.4.12.1. Using ardbAnno.pl 
A test file was created detailing the fasta files that were products of the de novo assembly, 
then the ardbAnno.pl 120script was ran (Perl ardbAnno.pl). This produced genomeList.tab which 
was viewed using excel to assess resistance factors.    
2.4.12.2. Using ResFinder  
The online version of ResFinder 2.1 71 was used, the fasta file produced by the de novo  
assembly was uploaded to the site.  
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2.4.13. Final pipeline 
The final pipeline uses all the best parameters identified in this chapter to allow automation 
in the genome assessment. The final pipeline is split into two segments, each automated by 
simply changing the input file. The break in the automation allows visualisation of the sample, and 
allows mixed cells to be separated and analysed separately in the second half of the pipeline.  
 
2.4.14. Part 1 
The first part of the data analysis pipeline, has the raw reads as the input file, removes host 
signals as well as any reads that map to the negative library. The pipeline then abundance and 
error trims the data before it is de novo assembled. The taxonomy of the reads is then identified 
using blast and the resulting file is opened in Megan viewer. This is then visually investigated 
before the second part of the pipeline was implemented.  
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Command 2-21 Pipeline part 1- for automated preparation of reads by removal of host and environmental 
contaminations, followed by error and abundance trimming. Reads are then identified using Blastn before being 
visualised using LCA analysis on MEGAN. 
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2.4.15. Part 2 
 The second half of the pipeline runs using the extracted reads from megan which are in fasta 
format. It extracts the reads from the trimmed fastq file to give a fastq of the extracted reads. The 
reads are then assembled, and the resulting file annoatated and information extracted.  
 
Command 2-22 Second part of the automated pipeline, which extracts reads identified by LCA analysis on MEGAN 
into a  fastq file. This fastq i s then de novo assembled and annotated. 
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2.5. Further Application of ɸ29 MDA to viral pathogens  
2.5.1. Sequencing of DNA and RNA extracted from viral tissue culture. 
Methods for amplification of pathogens need to be applicable to both RNA and DNA, ideally 
with a single sample processing pathway capable of detecting both nucleic acid types. This will 
need to combine both reverse transcription and DNA amplification. Along with a compatible 
concentration and extraction technique, with added stages for removing any host genetic 
material. The aim is to have a very sensitive method for pathogen detection, this section will 
concentrate on the ability to characterise a variety of viral pathogens with a single work-flow. 
Initial work focused on the compatibility of the process for both RNA and DNA virus, with both an 
enveloped and none enveloped virus being used (HIV and Adenovirus 41). After this a more 
complex viral mixture was set up, with viruses representing multiple genome types, viral parcel 
size and particle type.  
2.5.1.1. Concentration of Tissue Culture Material for HIV and 
Adenovirus  
The supernatant from tissue culture of 8E5/LAV and Adenovirus 41 were defrosted at 37oC 
before being placed on ice. The aliquots were then centrifuged at 6000xg to pellet host cells,  
before 500 µl  of the supernatants were concentrated using PEG as described by Kohno et al 121. 
PEG 20,000 was dissolved in 0.9% NaCl to give a PEG total of 20% (w/v).  A 1:1 volume ratio of 
sample and PEG was used, and the samples were then incubated at 4oC for 16 hours or one hour 
or on ice for 1 hour. The samples were then centrifuged at 17860xg for 20 minutes, the 
supernatant removed and the pellet resuspended in 50µl PBS.  
 
2.5.1.2. Addition of RNase and DNase  
After concentration with PEG, and suspension in 50µl of sterile PBS 10 units of RNase A 
(Thermo Fisher Scientific) along with 5 units of DNase I, (Thermo Fisher Scientific) was added. The 
sample was then briefly vortexed and incubated at 37oC for 20 minutes. After incubation 100U 
RiboLock (Thermo Fisher Scientific) was added to the sample and 5µl 0.5M EDTA.  
2.5.1.3. Extraction of RNA and DNA using Column Extraction Method 
The RNA and DNA were then extracted using the alkali method described in 2.4.1 or by using 
PureLink® Viral RNA/DNA Mini Kit (Thermo Fisher Scientific), as described in the manual .  Carrier 
RNA was substituted with Linear Acrylamide (LPA) (Invitrogen). Briefly 25µl Proteinase K, 200 µl 
lysis buffer and 5 µl LPA was added to the sample, gently vortexed and then incubated at 56oC for 
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15 minutes. After the addition of 250 µl 100% ethanol the sample was incubated for a further 5 
minutes at room temperature. The sample was then added to the viral spin column and 
centrifuged for 1 minute at 6800xg, and the flow through was discarded. The sample was then 
washed twice with wash buffer before being eluted in 25 µl RNase free water.  
Any nucleic acids not immediately used were stored at -80oC.  The RNA was quantified using 
the Qubit High sensitivity RNA assay. The DNA was quantified using Qubit High sensitivity DNA 
assay. 
 
2.5.1.4. Dilution of RNA and DNA 
After quantification the RNA and DNA was diluted to a level that would represent 25 viral per 
µl for each virus. Calculations of viral particles based on nucleic acid quantification was performed 
using End Memo online tool for copy number calculator. Calculations were performed based on 
HIV having two copies of the ssRNA genome per Virion and Adenovirus having a single copy of a 
dsDNA genome. Dilutions were made using RNAse free water containing 2 U/µl RNaseOUT™ 
Recombinant Ribonuclease Inhibitor. The DNA extracted from the adenovirus tissue culture was 
diluted to 0.001 pg/µl. This was added to the equivalent of 25 virions of HIV (0.0002 pg/ µl).  
2.5.1.5. Reverse Transcription, ɸ29 Amplification and Sequencing  
The mixture of the extracted RNA and DNA was added to the reverse transcription reaction 
with SuperScript IV in a half volume reaction. 1 µl of each viral extract dilution was added to 0.5 µl 
50 µM random hexamers (Life Technologies), 0.5 µl 10mM dNTP mix (Life Technologies), and 3.5 
µl nuclease-free water. This mix was vortexed and centrifuged before incubation at 65oC for 10 
minutes and then on ice for 2 minutes. Whilst the reaction was on ice the following components 
were added, 2 µl SSIV busser (Life Technologies), 0.5 µl 100mM DTT, 0.5 µl RNASE OUT, and 0.5 µl 
SSIV. This was then gently vortexed, centrifuged and incubated at 23oC for 10 minutes, 55oC for 10 
minutes.  After completion of the reverse transcription reaction the product was then heated to 
95oC for two minutes and then held on ice for two minutes. The resulting DNA was then amplified 
using ɸ29 MDA for two hours. The product was then fragmented using S1 nuclease treatment and 
nebulisation for two minutes before library preparation as described by Roche protocols and 
sequenced on the 454 Junior.  
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2.5.2. Adenovirus and HIV-Viral Particles 
Dilutions of the supernatant of HIV and Adenovirus tissue cultures were made so as to contain 
an estimated 25 viral particles. These were pooled and then the total volume made up to 10 ml  
using PBS. This was then concentrated with PEG 20,000 incubated overnight at 4oC as described in 
2.5.1.1 , host nucleic acid removed 2.5.1.2 and the sample was extracted using column extraction 
2.5.1.3.  The resulting eluted nucleic acid was then added to a reaction with SuperScript IV using 
random primers 2.5.1.5 before being heated to 95oC for two minutes followed by 2 minutes on 
ice. This was then amplified in a two hour ɸ29 MDA reaction. The resulting DNA was quantified, 
fragmented and sequenced on the 454 junior as previously described.  
2.5.3. Amplification of Mixed Viruses   
 
Viruses detailed in Table 2-3 were obtained from NIBSC and stored at -80oC until use. These 
were selected to represent a wide range of viruses, including different viral morphology, size and 
particle type. A review of concentration methods was undertaken, with most focusing on a 
concentration method optimised for a single virus group. Details of the results of this review are 
shown in Table 2-9. After consideration of all the concentration protocols, it was decided to use 
the highest molecular weight PEG, which should allow concentration of even the smallest viruses, 
and has previously been used for even delicate enveloped viruses. As this method is focusing on 
finding a rapid method of pathogen detection, it was decided to incubate the samples on ice for 
an hour. Centrifuge speed was selected as the highest available on common bench top centrifuges 
17860xg.   
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Family Virion Size Enveloped? Shape PEG Incubation  Spin Ref 
Herpesviridae  
 
150- 
200nm 
yes spherical to 
pleomorphic 
20% PEG 
8000 
Ice 
30 min 
11,000xg  
20 min  
4
o
C 
122,123
 
Adenoviridae 
 
90nm no Icosahedral  7% PEG 
8000 
2 hours 
4
o
C 
10, 000 x 
g  
30 
minutes 
124
 
Parvoviridae  
 
18-26nm no Icosahedral 7.5% PEG 
8000 
16 hours  
4
o
C 
15,000xg  
45 min  
4
o
C 
125
 
Hepadnaviridae 
 
42nm yes spherical  10% 
8000 PEG 
4
o
C  
I hour 
925 xg  
20 min 
126,127
 
Retroviridae 80-
100nm 
Yes  spherical to 
pleomorphic 
20% PEG 
20,000 
4
o
C 
16 hours 
17, 860x 
g 
20 min 
121
 
Paramyxoviridae  
 
150nm yes  10% PEG 
8000 
4
o
C  
2 hours 
10,000x g  
1 hour 
128
 
Orthomyxoviridae  
 
80-120 yes Usually 
rounded but 
can be 
fi lamentous 
50% PEG 
6000 
4
o
C  
2 hours 
10,000 x 
g  
30 
minutes 
129
 
Picornaviridae 30nm no spherical  8% PEG 
8000 
4
o
C  
overnight 
10,000x g 
1 hour 
130,131
 
Caliciviridae 
 
27-40nm no icosahedral 8% PEG 
8000 
2 hours  
4
o
C 
10,000xg  
20 mins 
132
 
Flaviviridae  
 
50nm yes spherical  6% PEG 
6000 
 7500 x g 
 30 min 
133
 
Table 2-9 Details of previously used concentration methods for the viruses to be s tudied, including details of the 
vi rus  s ize and particle type.  
 
2.5.3.1. Creating Mixed Viral media 
To test the concentration and amplification methods a low input viral mix was created using 
the viruses obtained from NIBSC. Where the standards were assigned a value in terms of 
infectious units per millilitre (IFU/ml) the volume was calculated which would contain 
approximately 25 viral particles, which were 22 µl HBV, 31 µl Parvovirus 19, 43 µl HAV and 17 µl 
HCV. For samples where a Ct value was given 20 µl of sample was added. These were pooled, 
along with the addition of the equivalent of 25 virions of HIV and Adenovirus from tissue culture.  
Before pooling of viral samples all tubes were centrifuged at 6000xg to pellet host cells.  
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NIBSC 
product 
number  
Virus Quantification information   µl required for 
estimated 25 IFU 
08/310 Varicella Zoster 
virus  
Ct 30 20 
11/182 HBV  1140 IFU/ml 22 
11/208: Parvovirus B19  unitage of 800 IFU/ml (range 569-1039)  31 
07/294: Norovirus  Ct 30 20 
13/102:  HAV  Unitage 588 IFU/ml (range 507–680 
IFU/ml). 
43 
13/168  Measles  Ct 30  20 
07/298 Influenza  Ct 30 20 
02/264: HCV  assigned a value 1438 IFU/ml 17 
Table 2-10 details of quantification measurements for vi ruses used in the mixed vi ral media along with volume 
input of each vi rus into the initial vi ral mix 
2.5.4. Preparation of DNA for sequencing from mixed viral media  
Pooled virus media was made up to a total volume of 10ml in HBSS. 10 ml of 20% (w/v) PEG 
20,000 in 0.9% NaCl was added to the viral mix. This was then gently shaken at room temperature 
for 5 minutes before incubation on ice for 1 hour. The sample was then centrifuged at 17860xg 
for 20 minutes, the supernatant removed and the pellet resuspended in 50µl HBSS by vigorous 
vortexing.  
The sample was then treated with DNAse and RNAse as described in 2.5.1.2 before being 
extracted using column extraction as described in 2.5.1.3. After extraction the nucleic acid was 
reverse transcribed and amplified using a 2 hour ɸ29 MDA reaction as described in 2.5.1.5. Once 
amplified the sample was quantified and sequence using the 454 Junior.   
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2.5.4.1. Improvements in Mixed Viral Media  
After reviewing of initial sequencing results, the input amounts of each viral pathogen were 
adjusted to create a more even mixture. The VZV reference material was diluted 1:100 in HBSS 
and 20 µl added. The amount of the HBV reference material added was lowered to 6 µl and the 
Parvovirus was diluted   1:10 and 30 µl added. The Norovirus was diluted 1:100 and 12.5 µl added. 
The amount of HAV virus added was increased to 65 µl, the amount of HCV added was lowered to 
3.5 µl. the amount of measles reference material added was increased to 200 µl. a 1:100 dilution 
of influenza was prepared and 17 µl of this was added to the viral mix. The amount of HIV and 
Adenovirus remained the same. The mixed media was made up to a total volume of 10ml and 
prepared for sequencing as described in 2.5.4.  
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2.6. Development of a Bacteraemia Model to Simulate Highly 
Sensitive WGS of Pathogens from Sterile Clinical Specimens  
2.6.1. Survival of Bacterial in Horse Blood and 2% Saponin De Novo 
Assembly  
Freshly grown plates from all of the clinical isolates in Table 2-2 were suspended in 1 ml PBS 
and diluted in a 1:10 series and 10μl of each dilution plated out in triplicate. After 24 or 48 hours 
incubation the number of cells was counted and an average calculated. 500 cells were then added 
to 1ml PBS, 1ml defibrinated horse blood (TCS Bioscience) or 1ml 2% saponin (Sigma) and 
vortexed, before being incubated for 2 hours at room temperature. The samples were then 
vortexed again and two aliquots of 100μl from each sample were plated on appropriate media 
and incubated in appropriate conditions for 24 or 48 hours. Colonies were then counted and 
survival rates calculated.  
2.6.2. Bacterial Isolation Using Density Gradients  
Percoll (Sigma) density gradients were set up using 1.5M NaCl at the following densities, 1.13 
g/ml (E. coli), 1.09 (erythrocytes) and 1.1 for a small layer in between to catch un-separated cells. 
The volume calculation shown in Equation 1 was used and the layers prepared as shown in Figure 
2-2 to form a discontinuous gradient. Briefly the highest density gradient was added first using a 
wide bore pipette, then subsequent layers were added by slowly pipetting the layer with the tip 
against the edge of the tube. To this a 2ml mixture of blood and PBS (50:50) spiked with 50 cells 
of wither S. aureus or E. coli was added gently to the top of the tube.  The sample was then 
centrifuged at 800xg for 25 minutes. The different segments were then plated out as follows, the 
top layer was split into 3x1ml and the layer with the red blood cells was plated in the following 
order 2x500 μl, 200 μl and 100 μl and the final 500μl clear zone was also plated out. A control of 
the 2ml horse blood and PBS spiked with S. aureus or E. coli was also plated out to assess the 
bacterial input.  
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Equation 1 Percol l volume equation to calculate formation of required 
density gradient  
 
 
 
2.6.3. Erythrocyte Depletion Using HetaSep® 
2.6.3.1. Centrifugation vs. Gravity. 
There are two options for use of HetaSep® (Stemcell technologies), either separation through 
centrifugation or by gravity, both were investigated.  Samples were set up using 2ml 50:50 horse 
blood and PBS spiked with either E. coli or S. aureus, or with 1ml horse blood spiked with bacteria. 
To this 400μl HetaSep® was added to the PBS and horse blood mix, or 200μl HetaSep® was added 
to the horse blood sample. Samples were then either incubated at 37oC for 20 minutes or 
centrifuged at 90xg for1 minute and then left at room temperature for 10 minutes. The top and 
bottom fractions were then plated on blood agar and incubated overnight. A control was also 
plated which was spiked blood or blood PBS mixed incubated at 37oC for 20 minutes and then the 
whole sample was plated out.  
2.6.3.2. Single vs. Double Incubation 
Samples were set up using 2ml PBS and horse blood (50:50) spiked with either E. coli or S. 
aureus with the addition of 500μl HetaSep®. Set A was the incubated for 20 minutes at 37oC as 
previous. Three segments were then plated the top segment, the segment at the interphase of 
the red blood cells and supernatant, and the pellet containing the red blood cells.  Set B was 
incubated at 37oC for 10 minutes and the top layer removed, an additional 500μl HetaSep® was 
Figure 2-2 prepared 
Percol l layers including 
volume and density of each 
layer 
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added and the sample incubated for a further 10 minutes. The same segments were plated as 
above with the addition of the pellet from the first HetaSep® incubation.  
2.6.3.3. Different HetaSep® Ratios and Shortened Incubation Time 
Different ratios of blood to HetaSep® were investigated, along with the impact of PBS dilution 
with a shorter incubation time. The following ratios of blood to HetaSep® were set up, 1:0.2 
(recommended), 1:.4, 1:0.6, 1:0.8, 1:1. The same ratios were also set up with the  blood and PBS 
mix.  The samples were then incubated at 37oC for 10 minutes. The top and bottom segments for 
each were plated, along with a control that had no HetaSep® added. 
2.6.4. Bacterial isolation and sequencing from Horse blood  
Blood models were set up with the addition of 10 bacterial cells (S. aureus and E. coli) to 1ml 
horse blood. The following workflow was then applied, with samples being cultured at each stage 
to assess bacterial survival.  200 μl HetaSep® was added and the sample vortexed and incubated 
at 37oC for 10 minutes. 500 μl supernatant was removed and 200μl 5% was added to a final 2% 
solution, and incubated at room temperature for 5 minutes. 700μl sterile water was added for a 
water shock and incubated at room temperature for 3 minutes before salt restoration with the 
addition of 21μl 5M NaCl. The sample was then centrifuged for 5 minutes at 3000xg and the 
supernatant removed and discarded. The pellet was then washed in lowering volumes of PBS, 
initially 200μl then 100μl followed by 20μl with each stage being span at 6000xg fir three minutes, 
and the final pellet being resuspended in 4μl PBS Figure 2-3-A.   
2.6.4.1. Bacterial Isolation from Horse Blood-Improvements  
The work flow from above was repeated with the following points of improvements, the 
volume of supernatant removed from the HetaSep® incubation was increased from 500μl to 
550μl. After this the volumes of Saponin and water and salt restoration were increased in ratio 
with the increased volume. The water shock was also reduced to 30 seconds. The initial 
centrifugation after salt restoration was increased from 3000xg to 4000xg. The final centrifugation 
during the wash stages was increased from 3 minutes to 5 minutes Figure 2-3-B.  
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Figure 2-3 Work flow for isolation of bacterial cells from whole blood including removal of RBCs using HetaSep, 
selective eukaryotic  lysis using saponin and water shock followed by salt restoration and washes with PBS  (A) original 
workflow (B) workflow after improvements to include shorter water shock and DNAse treatment. 
 
 
 
A
 B
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2.6.4.2. Sequencing from Horse Blood 
The E. coli and S. aureus isolated using the method in 2.6.4.1 were amplified and then 
sequenced.  
2.6.4.3. Addition of DNAse Stage 
A DNase treatment was added after the first spin at 4000xg for 5 minutes. 5 μl of 10xbuffer 
and 2μl turbo DNase 1 (Ambion) was added to the pellet and the sample was vortexed and 
incubated at 37oC for 15 minutes. EDTA was then added to a final concentration of 15nM and the 
sample was then either heated to 75oC before entering the washing phase, or was taken straight 
in to the washing phase. To assess the inactivation of the DNase1 after washing 1μg of DNA was 
added to the pellet and incubated at 37oC for 30 minutes and then the DNA was quantified.  
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2.6.5. Process for Isolation, Amplification and Sequencing of 
Pathogens in Clinical Specimens  
 
Figure 2-4  final sample processing pipeline for whole genome sequencing from sterile site infections  with two 
processing pathways  for bacteria and vi ruses. Processing includes, isolation concentration, extraction and amplification 
of pathogen s ignals  
SAMPLE 
 Add 1/5th volume HetaSep 
 10 minutes, 37oC 
 Keep supernatant  
 Spin 8000xg    
  5 minutes   Supernatant  
Pel let 
 Resuspend pellet in 250µl PBS 
 Add 100µl5% Saponin 
 3 mins, room temperature  
 Add 350 µl water 
 Add 10.5 µl 5M NaCl 
 
 Add 1:1 Volume 20% PEG 20000 
 Incubate on Ice for one hour 
 Spin 21,000x g 20 minutes 40C 
 Remove supernatant 
 Add 200 µl PBS 
 
 Add 5 µl 10X TURBO DNase Buffer 
 2 µl Turbo DNase 
 43µl PBS 
 15 minutes 37oC   
 
 Add 1/8th Volume Proteinase K, equal volume Lysis buffer 
and 1/40th volume LPA and vortex 
 Incubate 56oC 15 minutes 
 Add 1 volume 100% ethanol 
 Incubate at room temperature 5 minutes 
 Add to spin column and spin 1 minute 68000xg 
 Wash twice with wash buffer 
 Add 7µl RNAse free water incubate 2 minutes  
 Elute into clean tube 
 
 Add 250µl PBS spin 6000xg 3 min 
 Discard supernatant 
 Add 100µl  PBS spin 6000xg 3 min 
 Discard supernatant  
 Add 50µl  PBS spin 6000xg 3 min 
 Discard supernatant 
 
 Add 0.5 µl random primers, and 0.5 µl dNTP 
 Incubate 65oC 5 minutes, ice 2 minutes 
 Add 2 µl SSIV buffer, 0.5 µl DTT  and 0.5 µl SSIV 
reverse transcriptase 
 Incubate 23oC 10minutes, 55oC 10 minutes 
 95oC 2 min, ice 2 minutes 
   
 Add 5 µl PBS and vortex 
 Transfer to 0.2ml PCR tube 
 Add 3 µl D2 
 Incubate 65oC 10 min  
 Add 3 µl stop solution  
 29 µl  Reaction buffer, 2 µl 
Phi29 
 30oC 2 hours 
Volume 
>500µl  
 
Volume 
<500µl  
 
 Add 0.1 total volume turbo DNase buffer and 3ul turbo DNAse 
and 1 µl RNase 
 Incubate at 37oC 30minutes 
 (Add 3 µl turbo DNase and incubate) 
 Add 1.5ul RiboLock and 0.2 volumes DNase inactivation 
 Incubate 5 min room temp (25oC) 
 Centrifuge 10,000xg 1.5 min and keep supernatant 
 
 Spin 4000xg5 mins, room temperature 
 Remove supernatant 
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2.7. Sequencing using Illumina Technology 
The MDA products were treated with S1 nuclease as described in section 2.3.2.2, nebulised 
for 15 seconds before being purified using the MinElute PCR Purification Kit (Qiagen). The sample 
was then diluted to 0.2ng/µl and 5µl was taken forward to the library preparation.  
2.7.1. Library Preparation 
Nextera XT DNA library preparation Kit (Illumina) was used to prepare the libraries for 
sequencing. The first stage involves simultaneous fragmentation and tagging of the DNA 
(Tagmentation), using an engineered transposon.  Briefly, buffer TD, the DNA and the enzymes 
were mixed in a 20µl reaction and incubated at 55oC for 5 minutes, before being neutralised.  
Indexes were then added to the samples before PCR amplification, using the following 
parameters: 72oC hold 3 minutes, and 95oC hold 30 seconds, 12 cycles of 95oC 10 seconds, 55oC 30 
seconds, 72oC 30 seconds. There is a further hold at 72oC followed by cooling and holding at 10oC. 
The PCR products are then cleaned up using AMPure XP beads, aiming for a pool size of 300-
500bp in length. 1 μl of undiluted library was then QC tested on the Bioanalyser (Agilent) using a 
High Sensitivity DNA chip. After library normalisation the samples were pooled.  
2.7.2. Sequencing  
When sequencing on the MiSeq, V2 300 cycle kits were used, when sequencing on the HiSeq, 
V1 200 cycle kits were used.  
2.7.3. Data analysis Adaptations for Illumina data 
The pipeline was adapted for use with the shorter paired-end reads produced by illumina 
platforms. The first alteration was the use of ‘seqtk subseq’ command (line 35 Command 2-23) to 
remove reads which mapped to the host or contmaination, in place of the custom script and 
sfffile command previously used for 454 junior produced data. The value of K used in the digital 
normalisation stage was reduced to 32 (line 48  Command 2-23) to reflect the shorter reads 
produced on the ilumina platform. Orphan reads were removed ( line 58 Command 2-23) to 
mainitain pair-end reads. During the error trimming stage the  mimimun read length was reduced 
to 25 (line 65 Command 2-23). When converting the fastq produced to a fasta file for use in Blastn 
analysis the comman ‘Seqtk seq –A’ was used, reflecting an updated version of the Seqtk software 
(release 1.2).  
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Command 2-23 pipeline part one adapted for Illumina sequencing, including adaptations for shorter reads in the 
abundance and error trimming and removal of orphaned reads  
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2.8. Application of Methods Developed to Real and Modelled 
Clinical Samples  
Several sample types, including real clinical samples and infection models were prepared for 
sequencing in parallel.  This allowed the sample processing developed in 2.6.4 to be tested for 
utility on several sample types simultaneously. All samples were sequenced in a single sequencing 
run on the HiSeq.  A summary of all samples can be found in Table 2-12 
2.8.1. Negative Samples 
An extraction negative control was set up by starting with 1ml of PBS in place of sample and 
the entire sample processing including reverse transcription and ɸ29 MDA was performed, and 
the products sequenced.   The second negative control was water which was used in a reverse 
transcription and ɸ29 MDA reaction.  
2.8.2. Further Blood Models 
Four further bacteraemia models were created to model more challenging diagnosis. The f irst 
was a mixture of S. Pyogenes (clinical isolate 15M153838) and Influenza virus (NIBSC control 
media Influenza A H3N2 07/298) to model cases of secondary bacteraemia following viral 
infection.  The second model was a Shigella, which many methods (including MALDI-TOF) cannot 
differentiate from E. coli. A model using non Typhi invasive Salmonella was used, as whole 
genome sequencing was available from the Salmonella Reference Unit at PHE Colindale, and this 
provided an opportunity to compare straight from sample methods to culture based sequence 
library preparation.  The final model was a P. aeruginosa, which was highly resistant, including to 
carbapenems.   
Dilutions of bacteria were prepared as described in 2.3.4.2   and single cells of S.Pyogenes, 
Salmonella sp and P. aeruginosa were inoculated into 1 ml horse blood. Ten cells of S. sonnei 
were inoculated into 1 ml horse blood, due to poor survival rates shown in 2.6.1.  For the 
Influenza in the mixed model, 20 µl of a 1:100 dilutions of the control material was used, to aim at 
25 viral copies, as described in 2.5.4.1.  
2.8.3. Tissue Model 
Post mortem none human primate tissue (rhesus macaque) was obtained from PHE Porton 
Down. Roughly 1cm3 tissue samples were collected and were stored in RNAlater (Sigma) until use. 
The first tissue model was to simulate endocarditis, by inoculating heart tissue with H. influenzae  
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(clinical isolate 15M154514) dilutions of an overnight culture were prepared as described in 
2.3.4.2 and five cells were inoculated into the tissue. The second model was to simulate viral 
hepatitis, using Hepatitis A virus control media, the aim was to inoculate 25 viral particles, and so 
65 µl of the control media was added (as in 2.5.4.1) to the tissue.  The third tissue was a model of 
a mixed infection using Bacteroides vulgatus (14M180862), Streptococcus oralis (15M150586), 
Streptococcus mitis (15M150586) and Streptococcus anginosus (15M152569). Five cells of each 
bacterium were mixed into a total volume of 50 µl and inoculated into the brain tissue. The final 
model was a viral kidney infection, for this CMV was used, 20 µl of 1:100 control media was 
inoculated into the tissue, this value was aiming at ~25 viral particles based on previous work 
using VZV virus in 2.5.4.1 
 
Samples were inoculated using, extra-long 10 µl pipette tips (VWR®) and incubated at 37oC for 
one hour. The tissue samples were first ground using Dounce tissue grinder set (Sigma-Aldrich), 
with the addition of 500 µl sterile PBS. 50 U of collagenase (Sigma) was added and the sample was 
incubated on a shaker at 37oC. 250 µl of 2% 2-mercaptoethanol (Sigma) was then added and the 
sample incubated a further hour at room temperature on a shaker. The sample was then 
centrifuge at 6000 xg for 5 minutes and the supernatant discarded. The sample was then washed 
three times using 3 ml PBS and centrifuged at 6000 xg. The final pellet was resuspended in 5ml of 
PBS. This was then vacuum filtered using a 100µm filter (Millipore). The filter was discarded and 
the filtered sample was used as the input for the previously developed sample process.  
2.8.4. Urines  
Urine samples were sent from Addenbrookes hospital for deep sequencing analysis as part of 
an on-going project looking at genotyping BK virus directly from samples. Samples from 
symptomatic patients were included in the project and four of these urines were randomly 
chosen and 50 µl used for processing in this thesis.  
2.8.5. CSF  
CSF samples with unknown aetiology from symptomatic patients were collected as part of a 
PHE historic study. 20 µl of four of these CSF were processed, however due to the uncertain age 
and handling of these samples some adaptations of the sample processing was made. DNAse and 
RNAse stages weren’t carried out, to be certain of the recovery of pathogen DNA which may have 
been degraded.  
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2.8.6. STI swabs  
Four blinded samples were used from sexually transmitted bacteria reference unit (STBRU) at 
PHE Colindale full sample details are in Table 2-11. These were samples which had been referred 
to the reference laboratory for diagnostic confirmation. The samples consisted of swabs which 
had been placed in buffer and vortexed to deposit material into liquid.  After completion of STBRU 
processing 40 µl of sample was processed as shown in Figure 2-4 
 
 Swab type  Buffer 
type 
Reference lab results 
1 RECTAL  BD VIPER C. trachomatis + (Ct@23.02) 
LGV + (Ct@23.41/23.63) 
2 VAGINAL 
 
BD VIPER C. trachomatis + (CT@23.56) 
LGV - 
3 VAGINAL COBAS N. gonorrhoeae  + (Ct @29.14/29.14) 
4 VAGINAL COBAS N. gonorrhoeae  +  (Ct @32.64/30.36) 
Table 2-11 Details of STBRU samples processed in this thesis, including swab site, buffer and STBRU results  LGV= 
Lymphogranuloma venereum 
 
2.8.7. Treponema pallidum Samples 
In collaboration with St Marys Hospital six samples with presumed T. pallidum infections were 
tested, two sets of matched samples from patients positive for Treponema pallidum (whole blood 
and ulcer samples) and two further blood samples from an additional two patients.  Samples were 
retried from the Imperial College London Communicable Disease Research Tissue Bank. Ulcer 
samples were shipped in RNA later solution (Sigma). 
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Sample 
number  
Sample type Input  Input amount 
1 Control Negative extract  1 ml PBS 
2 Control Negative amplification 10 µl water 
3 Bacteraemia model   Streptococcus Pyogenes 
(15M153838) 
 Influenza A H3N2 
(07/298) 
Single cell  
20 µl 1:100 dilution of 
control media (~25 VP) 
4 Bacteraemia model Shigella   sonnei 
(15M005139) 
Ten cells  
5 Bacteraemia model Salmonella Sp. 
(14M180208)  
Single cell  
 
6 Bacteraemia model Pseudomonas aurginosa 
(13M155577)  
Single cell  
7 Endocarditis model Haemophilus influenzae 
(15M154514)  
Five cells  
8 Viral Hepatitis HAV RNA  (13/102) 65 µl control media 
 (~25 VP) 
9 Mixed brain abscess   Bacteroides vulgatus 
(14M180862) 
 Streptococcus oralis 
(15M150586) 
 Streptococcus mitis 
(15M150586) 
 Streptococcus anginosus 
(15M152569) 
Five cells of each 
10 Viral kidney infection  human cytomegalovirus 
(HCMV) (08/314) 
20 µl 1:100 dilution of 
control media (~25 VP) 
11 Clinical Urine   50 µl clinical sample  
12 Clinical Urine  50 µl clinical sample 
13 Clinical Urine  50 µl clinical sample 
14 Clinical Urine  50 µl clinical sample 
15 Clinical CSF   20 µl clinical sample 
16 Clinical CSF  20 µl clinical sample 
17 Clinical CSF  20 µl clinical sample 
18 Clinical CSF  20 µl clinical sample 
19 STI swab  40 µl buffer 
20 STI swab  40 µl buffer 
21 STI swab  40 µl buffer 
22 STI swab  40 µl buffer 
23 T. Pallidum blood   1ml blood  
24 T. Pallidum blood  1ml blood 
25 T. Pallidum blood  1ml blood 
26 T. Pallidum blood  1ml blood 
27 T. Pallidum ulcer  1ml of buffer containing 
swab 
28 T. Pallidum ulcer  1ml of buffer containing 
swab  
Table 2-12  Summary of real and modelled samples processed using developed sample extraction and amplified by 
ɸ29 MDA 
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3. Results: Development of Non-PCR Amplification 
Techniques for Rapid and Sensitive Whole Genome 
Amplification of Pathogens 
 
Current diagnostic approaches are based on either the ability to culture pathogens, or the 
detection of a specific amplified gene target. These approaches instil a diagnostic bias toward 
known causes of infection, potentially missing a large variety of unculturable and/or novel 
pathogens. Use of an unbiased amplification method to amplify the whole genome of a pathogen 
without prior knowledge of the pathogens, both bacterial and viral (DNA and RNA), could be a 
powerful tool for infectious disease diagnosis.  The potential of ɸ29 DNA for pathogen 
amplification was investigated to assess its suitability as a highly sensitive, accurate and rapid 
method for whole genome sequencing production.  
Current reverse transcription and DNA amplification techniques rely heavily on the use of 
primers to initiate replication. Primers introduce bias into whole genome amplification, which can 
be a particular problem in extreme GC contents. Reaction conditions need to be optimised to 
allow primer binding, including reaction temperature and salt concentration of the reaction mix. 
Additionally, amplification will only occur downstream of where the primer binds, which can be 
an issue with short or degraded nucleic acids. This is often a particular problem in RNA viruses, 
with the 3’ ends of viral genomes often being difficult to sequence. This is because the primer 
effect is doubled due to two rounds of reactions with primers. Two alternatives to the use of 
primers will be investigated. The first will be introduction of nicks into double stranded DNA, and 
extension from these nicks. The second will involve addition of a tag to the nucleic acid, and 
extension from this tag.  
Several previous studies have successfully copied DNA from nicking points 97,134,78,135, however 
the product lengths were often limited, with Sequenase 2.0 producing fragments of 250 bp 134, and 
3173 Pol  and Klenow producing products of a maximum of 400 bp78,135. It is hoped that by using 
ɸ29 which has very strong strand displacement activity and high productivity, larger fragments 
suitable for WGS will be produced. The nicking enzyme Bst.NBI (New England Bioscience) was 
used by Moser et al 78 to extend from nicks using PyroPhage 3137 on  pUC19 DNA. Additionally, 
Bst.NBI has a rare binding site and is not affected by DNA methylation.  This enzyme will be the 
starting point for investigating DNA extension from nicks using ɸ29.  
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Secondly, a looping extension tag will be designed and ligated on to the end of DNA to 
investigate the potential DNA production from these tags. The tag will contain a recognition site 
for a nicking enzyme, allowing its removal after extension. An alternative tag will be designed that 
also has small RNA segments which will allow degradation of the tag.  Additionally , the tag will be 
ligated onto RNA molecules to investigate its potential use for RNA conversion.  The advantage of 
this method is the additional control of where amplification begins, which is external to the region 
of interest itself.  
After establishing the most suitable way to prepare untargeted whole genome amplification 
this method will be compared to currently used methods for library preparation (culture based). 
Additionally, the sensitivity and processivity of the enzyme in the context of amplification of 
bacterial DNA for WGS will investigated.  Further analysis will be undertaken to evaluate the 
impact of genomic GC content on DNA production as well as considering the application of the 
technique to mixed bacterial samples. 
An important application for unbiased whole genome sequencing will be for emerging 
infectious diseases. Of the many emerging infections detected over the past 20 years  most have 
been viral and one third have been RNA viruses75. Detection of viruses in clinical samples can be 
hindered by low viral loads and difficulty in concentrating viruses, which vary greatly in the ir 
morphology and particle sizes.  Viral particles show a huge variety of morphologies, size and 
surface type. In order to efficiently isolate, extract and identify viruses, concentration methods 
need to be employed. Polyethylene glycol (PEG) is a nontoxic water-soluble synthetic polymer 
which has multiple uses in biological studies. Addition of high weight PEG allows the 
concentration of viruses using centrifugation without the need for ultracentrifuges, PEG is an inert 
chemical which doesn’t interfere with viral viability. Multiple virus specific PEG concentration 
methods have been published, Table 2-9, this study will aim to identify a suitable PEG 
concentration method for multiple viruses. To achieve this, a mixture of viruses will be produced, 
representing multiple viral morphologies and varying genome types.  
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3.1 Use of ɸ29 MDA for Whole Genome Amplification using 
Random Primers   
3.1.1 Quantification and Visualisation 
A single colony of E. coli K12 MG1655 from an overnight culture was suspended in 4 µl sterile 
PBS, extracted and amplified as described in method sections 2.2.1.2 and 2.2.1.3. Three ɸ29 MDA 
replicates were performed, which produced DNA concentrations of 1.12x103 ng/µl, 998 ng/ µl 
and 1.24x103 ng/ µl.  The ɸ29 MDA products were visualised on an agarose gel, after three hours 
a smear of DNA could be seen, Figure 3-1. The smallest product was 200bp, and some DNA 
products greater than 12 kb in length failed to migrate through the gel.  
A PCR for ten loci spread across the E. coli K12 MG1655 genome was used as a rapid 
indication of the presence of the whole genome in the ɸ29 MDA product. The PCR described in 
section 2.2.1.6 was performed using 1:1000 dilutions of the ɸ29 MDA products (as recommended 
by the φ29 manufacturer).  All ten PCR products from the E. coli k12 MG1655 genome were 
detected in all three ɸ29 MDA, with all bands at the expected size.   Three negative sample were 
also amplified using ɸ29 MDA alongside the E. coli samples, producing 765 ng/ µl, 693 ng/ µl and 
936 ng/ µl of DNA. Despite this, all ten PCR amplifications to detect E. coli were negative. 
 
Figure 3-1 Gel  Image Showing the Size of the  ɸ29 MDA (MDA) Product Produced, Along Side the Ladder (L)  
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3.2 Assessment of RNA Conversion Enzymes   
3.2.1  HIV Concentration and RNA Extraction  
HIV was grown in tissue culture as described in 2.1.3.2, when the supernatant was 
investigated the number of virions per ml was determined to be 2x108. 100 ml of the supernatant 
from the HIV tissue culture was concentrated via serial centrifugation using PEG 20,000 as 
described in 2.2.2.1.  The final supernatant was removed, suspended and alkali extracted as 
described in 2.2.1.2, with the exception that the volume was scaled up to a total reaction volume 
of 50 µl. The RNA and DNA were then quantified and a final concentration of 1.62 ng/µl of RNA 
and 1.87 ng/µl of DNA was produced.  The high DNA concentration, strongly suggests the large 
presence of host contamination.  To resolve this, a DNase and RNase treatment stage was added, 
described in 2.2.2.3. Following this treatment, the final RNA concentration was 1.14 ng/µl and the 
DNA concentration was below detection (<10 pg/µL).  Based upon this, RNase and DNase 
treatment was used for all other extractions. To reduce assay time, shortened PEG incubation 
times were investigated. After incubation with PEG for one hour at 4oC the amount of RNA 
extracted was 0.76 ng/µl, and after one hour on ice the RNA extracted was 1.07 ng/µl.   
3.2.2 HIV Amplicon Amplification  
To investigate the sensitivity of three reverse transcription enzymes the HIV extract was 
diluted to 1000, 10, 0.1, 0.01, 0.001 and 0.00001 pg/µl.  Three replicates of these dilutions were 
then added to the reaction with SuperScript III (SSIII) and SuperScript IV (SSIV) with random 
primers (2.2.2.4 and 2.2.2.5), followed by amplification with specific HIV primers described in 
2.2.2.6. The dilutions were also added to reactions with PyroPhage 3137 wild-type with the same 
specific primers (Error! Reference source not found.).  
Varying lengths of PCR product were investigated to assess the ability of the enzymes to 
produce long transcripts. A single forward primer was used, alongside five different reverse 
primers to produce products of different lengths, (422, 756, 1233, 1778 and 2283 base pairs). 
 All five products were observed when using SSII and SSIV, at input amounts of 1000 pg, 10 pg 
and 0.1 pg.  SSIII was unable to amplify from less than 0.1 pg, whereas when using SSIV , two 
products were observed at 0.01 pg (1233 bp and 756 bp), no other amplification products were 
observed less than 0.1 pg.  PyroPhage 3137 enzyme no products were observed at any of the RNA 
input amounts (Table 3-1). 
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Reverse 
primer 
E03  
 (2283bp) 
III      IV   PP 
E05  
(1778bp) 
III      IV   PP 
E65 
(1233bp) 
III      IV  PP  
E125 
(756bp) 
III      IV   PP 
E145 
(422bp) 
III       IV        PP       Input 
(pg) 
1000                
10                
0.1                
0.01                
0.001                
0.0001                
Table 3-1 results of HIV specific PCR following reverse transcription with SuperScript I II, SuperScript IV  and 
PyroPhage after PEG concentration, SuperScript III= I II, SuperScript IV=IV and PyroPhage 3137= PP,  =PCR pos itive,   = 
PCR negative   
3.2.3 HIV Random Genome Amplification 
To check the compatibility of the reverse transcription enzymes with ɸ29, 10 µl of the cDNA 
produce by the SuperScript III and IV was added to the ɸ29 MDA reaction. The product was then 
diluted 1:1000 before being amplified by the specific PCR described before. When using SSIII, the 
specific PCR only detected products where the input RNA was 1000 pg. When using SSIV all 
products were detected in the 1000 pg input and in the 10 pg input the 756 bp and 422 bp 
products were detected. No other products were detected. The results are summarised in Table 
3-2 
 
Reverse 
primer 
E03 
(2283bp) 
III      IV    
E05  
(1778bp) 
III      IV    
E65 
(1233bp) 
III      IV   
E125 
(756bp) 
III      IV    
E145 
(422bp) 
III       IV    Input (pg) 
1000                
10                
0.1                
0.01                
0.001                
0.0001                
Table 3-2 Specific HIV  PCR results after PEG concentration, reverse transcription with  SSIII (III) or SSIV (IV) and 
amplification using  ɸ29 MDA.  =PCR pos itive,  = PCR negative   
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3.2.4 HIV Random Genome Amplification-After Column Extraction 
 
 After concentration using PEG, samples were DNase and RNase treated and extracted using a 
column based method as described in 2.2.2.2 with an elution volume of 50 µl. The average output 
of the extraction was 1.8 ng/µl RNA. This RNA was diluted to produce samples at 1000, 10, 0.1, 
0.01, 0.001 and 0.00001 pg/µl. These were converted to cDNA using SuperScript III or IV before 
the reaction was put into the ɸ29 MDA reaction, diluted 1:1000 and then amplified using the HIV 
specific targets.  
After the RT reaction with SSIII, the PCR was able to detect products at all sizes in the 1000, 
10, 0.1, and 0.01 pg input samples. There were also products at 2283, 1778 and 1233 bp in the 
0.001 pg input sample. No products were detected in the 0.0001 pg input.  
When RT was per formed using SSIV, the PCR was able to detect products at all sizes in the 
1000, 10, 0.1, 0.01 and 0.001 pg input samples. There were also products at 2283, 1778 and 1233 
bp in the 0.0001 pg input sample, Table 3-3 
 
Reverse 
primer 
E03  
 (2283bp) 
III      IV    
E05  
(1778bp) 
III      IV    
E65 
(1233bp) 
III      IV   
E125 
(756bp) 
III      IV    
E145 
(422bp) 
III       IV    Input (pg) 
1000                
10                
0.1                
0.01                
0.001                
0.0001                
Table 3-3 Specific HIV PCR results after PEG concentration, column extraction, RT using SSIII or SSIV and ɸ29 MDA 
amplification  =PCR positive,  = PCR negative   
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3.2.5 PyroPhage 3137 after Column Extraction  
After extraction using the column method the resulting RNA dilutions were used in reactions 
with the specific HIV primers using both PyroPhage 3137 wild type and the PyroPhage 3137 
exonuclease knock out.  No products above 422 base pairs were detected using either enzyme. 
The PCR amplification of the wild type enzyme RT was only positive in the 1000 pg input. The 
exonuclease knock-out produced 422 bp results with input levels of 1000, 10, 0.1 and 0.01 pgs. 
These results are illustrated in Table 3-4 
Reverse 
primer  
E03  
 (2283bp) 
E05  
(1778bp) 
E65 
(1233bp) 
E125 
(756bp) 
E145 
(422bp) 
Input (pg) WT Exo- WT Exo- WT Exo- WT Exo- WT Exo- 
1000           
10           
0.1           
0.01           
0.001           
0.0001           
Table 3-4 Results of specific HIV amplification using PyroPhage WT or exo- after PEG concentration and column 
extraction  =PCR positive,  = PCR negative   
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3.3 DNA Amplification for Nicks  
3.3.1 Nicking Prediction Results 
 Four genomes (three bacterial with varying GC content and a viral genome) were investigated 
for the frequency of the nicking site, both in the forward strand and in the reverse strand. E. coli 
had 1698 nicking sites in the forward and 1661 sites in the reverse strand resulting in an average 
gap between nicks of 2732 and 2793 bps.  C. difficile had 938 and 963 recognition sites in the 
forward and reverse strand leading to nicking every 45735 and 44548 bases. The  A. naeslundii had 
3232 and 3129 predicted nicking sites, with a gap between nicks of 941 and 972 bps. The 
adenovirus genome had 17 and 21 predicted nicking sites, with the average size of products being 
1666 and 2058 bases.   
3.3.2 Amplification of Nicked DNA using ɸ29  
Amplification of three bacterial genomes was investigated, E. coli, C. difficile and A. naeslundii. 
100 ng of extracted bacterial DNA (2.2.1.1) was nicked using Bst.NBI in 10 µl (2.2.3.1) reactions, 
which were incubated for one hour before the enzyme was inactivated. ɸ29 MDA reactions were 
then set up in total volumes of 50 µl, with 10 ng input. These were incubated for up to six hours, 
with the DNA being quantified after one, two, four and six hours. For each bacteria four reactions 
were used, the first with none nicked control DNA with primers (positive control), the second with 
none nicked DNA and no primers (negative control). The third reaction had nicked DNA with the 
addition of primers, and the final reaction had nicked DNA without primers. Where samples had 
primers the DNA was denatured using heat before addition to the reaction mix. A negative sample 
was also included, consisting of sterile water in place of input DNA incubated with or without 
primers.  
The positive control for E. coli produced 19.3, 100, 1000 and >1200 ng/µl after one, two, four 
and six hours. C. difficile and A. naeslundii gave similar patterns, with the C. difficile sample 
producing 15.6, 104, 922 and >1200 ng/µl, and the A. naeslundii. producing 3.72, 106, 588 and 
>1200 ng/µl. DNA production   the negative control reaction varied between 0.236 and 0.376 
ng/µl across all bacteria and negative sample.  
 The E. coli sample which had been nicked but also had primers included produced 5.56, 25.8, 
36.8 and 52.4 ng/µl after one, two, four and six hours. Similar results were obtained for the C. 
difficile and A. naeslundii (3.87, 31.2, 42.3 and 45.0 ng/µl for C. difficile and 1.81, 18.0, 21.9 and 
40.9 ng/µl for A. naeslundii). 
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The amount of DNA produced by the nicked DNA without primers ranged from 0.234 and 
0.643 ng/µl. The full DNA quantification results can be found in Table 3-5, the quantification of E. 
coli DNA across all reaction conditions are shown in Figure 3-2-A 
 
3.3.2.1 Amplification of Nicked DNA after Clean up 
 E. coli DNA was nicked and the resulting DNA cleaned up using isopropanol precipitation 
described in 2.2.3.1. 10 ng was incubated in ɸ29 MDA reactions using the same conditions as 
previously described in 3.3.2. The positive control produced 21.8, 97.9, 998 and > 1200 ng/µl after 
one, two, four and six hours. The negative control gave 0.236, 0.212, 0.258 and 0.314 ng/µl. The 
nicked DNA with the addition of a primer produced 18.8, 60.7, 154 and 490 ng/µl after one two, 
four and six hours. The nicked DNA without primers quantified as 0.356, 0.490, 0.398 and 0.411 
ng/µl. The results are illustrated in Figure 3-2-B.  
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Time  Condition E. coli 
(ng/µl) 
C. difficile 
(ng/µl) 
A. naeslundii 
(ng/µl) 
Neg  
(ng/µl) 
I hour  Not nicked 
and primers 
19.3 15.6 3.72 ND 
 Not nicked no 
primer 
0.240 0.292 0.234 ND 
 Nicked and 
primer 
5.67 3.87 1.81  
 Nicked no 
primer 
0.564 0.346 0.413  
2 hours Not nicked 
and primers 
100 104 106 36.8 
 Not nicked no 
primer 
0.272 0.236 0.336 ND 
 Nicked and 
primer 
25.8 31.2 18.0  
 Nicked no 
primer 
0.465 0.643 0.329  
4 hours  Not nicked 
and primers 
1000 922 588 276 
 Not nicked no 
primer 
0.368 0.326 0.376 ND 
 Nicked and 
primer 
36.8 42.3 21.9  
 Nicked no 
primer 
0.432 0.398 0.392  
6 hours  Not nicked 
and primers 
>1200 >1200 >1200 798 
 Not nicked no 
primer 
0.362 0.360 0.334 0.270 
 Nicked and 
primer 
52.4 45.0 40.9  
 Nicked no 
primer 
0.389 0.431 0.234  
Table 3-5 DNA quantification post ɸ29 MDA amplification of E. coli, C. difficile and   A. naeslundii  DNA using either 
whole or nicked DNA, incubated with or without primers. ND= not detected (<10 pg/µL assay detection limit)  
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Figure 3-2 DNA quantification post ɸ29 MDA amplification using either whole or nicked E. coli DNA, incubated with 
or without primers (A) before and (B) after isopropanol clean-up 
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3.3.2.2 Co-nicking and Amplification   
T4 Gene 32 Protein binds to single stranded DNA thereby stabilising single stranded DNA 
regions, (known as a single stranded binding protein, SSBP), nicked DNA was incubated with and 
without this SSBP before addition to the ɸ29 MDA reaction (described in 2.2.3.3).  
10 ng of E. coli DNA was incubated with Bst.NBI with or without T4 Gene 32 Protein in 10 µl 
reactions and incubated at 55oC for 30 minutes. The temperature was then lowered to 30oC 
before the addition of the ɸ29 MDA reaction mixture. For the primer control samples after 30 
minutes of incubation at 55oC the sample temperature was raised to 95oC before being placed on 
ice and the ɸ29 reaction mixture added along with primers. The results are summarised in Table 
3-6. The control sample produced 3.44, 19.8, 28.8 and 43.8 ng/µl after one, two, four and six 
hours without the addition of T4 Gene 32 Protein. The sample incubated with T4 Gene 32 Protein 
produced 1.89, 5.98, 10.8 and 19.7 ng/µl. The test sample with no primer had DNA concentrations 
of 0.311, 0.43, 0.299 and 0.310 ng/µl after the same time points.    
 
 
Time  Condition Bst.NBI 
(ng/µl) 
Bst.NBI and T4 Gene 32 Protein 
(ng/µl) 
I hour  Nicked and primer 3.44 1.89 
 Nicked no primer 0.311 0.289 
2 
hours 
Nicked and primer 19.8 5.98 
 Nicked no primer 0.341 0.213 
4 
hours  
Nicked and primer 28.8 10.8 
 Nicked no primer 0.299 0.313 
6 
hours  
Nicked and primer 43.8 19.7 
 Nicked no primer 0.310 0.287 
Table 3-6 DNA concentrations after co-nicking and amplification using ɸ29 of E. coli DNA with and without SSBP 
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3.3.3 Enzyme combinations with ɸ29 for Nicked DNA Amplification 
Other polymerases with strong stand displacement activity were combined with ɸ29 to 
investigate the impact on extension from nicks.  
3.3.3.1 Klenow Fragment (3′→5′ exo-) 
Klenow exo- has previously been shown to be able to replicate from nicks, 10 ng of nicked 
DNA was added to a reaction with Klenow fragment with and without the addition of ɸ29 and T4 
Gene 32 Protein. Reactions were incubated for six hours at 30oC. Controls for these incubation 
conditions were also performed using primers for Klenow and for Klenow with ɸ29.  
The positive control of Klenow fragment using primers produced 460 ng/µl.  Klenow fragment 
incubated with nicked DNA produced 56 ng/µl, and when the SSBP was added 73 ng/µl of DNA 
was produced. The positive control using Klenow and ɸ29 (with primers) produced 950 ng/µl. The 
Klenow and ɸ29 incubated with nicked DNA produced 65 ng/µl DNA and with the addition of SSBP 
78 ng/µl of DNA was produced. When the fragments produced using Klenow with nicked DNA 
were investigated using the Bioanalyser (Agilent Technologies, USA), most of the DNA produced 
was between 150 and 300 base pairs with a peak at 195 bases, with Klenow alone 72% of the DNA 
was between 150 and 300 base pairs, with 16% being 300 and 100 base pairs. When SSPB was 
added, 69% of the reads fell between 150 and 300 bases and 24% fell between 300 and 1000 
bases  
Condition DNA Produced   
Klenow fragment with primers 460 ng/µl 
Klenow fragment with nicked DNA 56 ng/µl 
Klenow fragment with nicked DNA and SSBP 73 ng/µl 
Klenow with ɸ29 and primers 950 ng/µl 
Klenow fragment and ɸ29 with nicked DNA 65 ng/µl 
Klenow fragment and ɸ29 with nicked DNA and 
SSBP 
78 ng/µl 
Table 3-7 DNA concentration after nicked E. coli DNA was incubated with Klenow fragment or Klenow fragment   
and ɸ29 with or without SSBP extension from nicks   
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3.3.3.2 Deep VentR™ DNA polymerase 
Deep VentR has strong strand displacement activity, but its usual application is in cycling PCRs 
for samples which have high GC content or stem loop structures. An initial investigation was 
undertaken to ascertain if the enzyme was capable of isothermal amplification. Initially a 
thermocycling reaction was used as a control for the reaction buffer, using K12 specific primers 
and cycling conditions from 2.2.1.6. After the positive control was cycled 30 times in 50 µl 
reactions, an average 12.3 ng/µl of DNA was produced, when the products were visualised on an 
agarose gel all products were present at expected size (around 650 base pairs) 
 The ability of the enzyme to perform isothermal amplification was then investigation by 
incubating DNA at the primer annealing temperature for 1 minute followed by 6 hours at 30oC, 
40oC, 50oC, 60oC, 70oC and 80oC.  The results of the isothermal reactions at 30oC, 40oC, 50oC, 60oC, 
70oC and 80oC after six hours were, 0.189, 0.209, 0.178, 0.452, 2.45 and 2.98 ng/µl.  
 The ability of the enzyme to extend from nicks was investigated by incubating 10 ng of nicked 
DNA with VentR at 70
oC or 80oC for 6 hours with and without the SSBP.  The amount of DNA 
produced without SSBP was 0.211 and 0.450 ng/µl at 70oC and 80oC. When incubated with SSBP 
0.231 and 0.399 ng/µl was produced at 70oC and 80oC. 
The use of VentR alongside ɸ29 was investigated by incubating the VentR with and without 
SSBP for 1 hour at 70oC or 80oC, before the reaction was ramped down to 30oC and the ɸ29 was 
added. The reactions were then incubated at 30oC for six hours. The amount of DNA produced 
without SSBP was 0.178 and 0.521 ng/µl at 70oC and 80oC. With the addition of SSBP the amount 
of DNA produced was 0.299 and 0.510 ng/µl for the 70oC and 80oC reactions.   The results of all 
incubation parameters are shown in Table 3-8.  
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INCUBATION  DNA PRODUCED   
Thermal cycling 
control 
12.3 ng/µl  
Isothermal incubations-with primers 
30oC  0.189 ng/µl  
40oC  0.209 ng/µl  
50oC  0.178 ng/µl  
60oC  0.452 ng/µl   
70oC  2.45 ng/µl  
80oC 2.98  ng/µl  
Isothermal incubations-from nicks 
 VentR VentR  with SSBP 
70oC 0.211 ng/µl 0.231 ng/µl 
80oC 0.450 ng/µl 0. 399 ng/µl 
70oC then ɸ29 at 
30oC 
0.178 ng/µl 0.299 ng/µl 
80oC then ɸ29 at 
30oC 
0.521 ng/µl 0.510 ng/µl 
Table 3-8 DNA production using VentR in the thermocycling control, isothermal incubation with primers  and for 
reactions  us ing nicked DNA with and without the addition of SSBP  
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3.3.3.3 Bst DNA polymerase, Large Fragment 
Bst has strong strand displacement and is a recommended enzyme for isothermal 
amplification. The enzyme was incubated with 10 ng of nicked E. coli DNA with and without SSBP 
at 30oC, 40oC, 50oC, 60oC and 70oC for six hours Table 3-9. After incubation the sample held at 
30oC measured 0.178 ng/µl without and 0.190 ng/µl with the addition of SSBP. The sample held at 
40oC produced 2.56 ng/µl without SSBP and 2.07 ng/µl with SSBP. When held at 50oC the Bst 
produced 5.89 ng/µl without SSBP and 6.12 ng/µl with SSBP. At 60oC 20.1 ng/µl was produced 
without SSBP and produced 22.6 ng/µl with SSBP. At 70oC the Bst produced 32.0 ng/µl without 
SSBP and 29.4 ng/µl with SSBP. When the sample held at 70oC was visualised using the 
Bioanalyser, the product was around 400 base pairs in length.  
Combination with ɸ29 was then investigated. A buffer control with ɸ29, Bst and primers was 
incubated at 30oC for six hours, this produced 750 ng/µl. The Bst was incubated with 10 ng of 
nicked E. coli DNA for 1 hour, at 50oC, 60oC or 70oC, which produced 2.61, 2.66 and 3.16 ng/µl 
respectively. Then the reaction was cooled to 30oC and the ɸ29 added, and the sample incubated 
for six hours. These reactions produced 2.56 ng/µl, 2.78 ng/µland 3.11 ng/µl respectively. The 
results of the reaction using Bst are summarised in Table 3-9  
 
 
 
 
 
 
  
Temperature Bst  
(six hours)  
ng/µl 
Bst and SSBP 
(six hours) 
ng/µl 
Bst 
(one hour) 
ng/µl 
With ɸ29 
(six hours) 
ng/µl 
30oC  0.178  0.190    
40oC  2.56  2.07    
50oC  5.89  6.12  2.61  2.56  
60oC  20.1  22.6  2.66  2.78  
70oC  32.0  29.4  3.16  3.11  
Table 3-9 DNA production from nicks in E. coli DNA using isothermal incubation with Bst with and without SSBP  
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3.4 DNA Production using DNA Tagging  
3.4.1 Tag Design  
The stem loop design was adapted from a stable looping primer from Ding et al (2012) 98, 
where it was used as part of a single molecule sequencing technique.   The basic sequence is as 
follows. 
5'-phosphorylated-GCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGC-3’ 
This was adapted by the addition of a restriction enzyme recognition site for BamHI (NEB) and 
with addition bases to increase the melt temperature thereby improving the stability of the stem 
loop.  
5’ GGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
This sequence forms the basic structure of the hair pin tag, Figure 3-3 A. Additional bases 
were then added to the 5’ end on a trial and error basis for an additional, 5, 10 or 15 bases Figure 
3-3 C. The formation of the primer was predicted using on online tool called OligoAnalyzer 3.1 
from integrated DNA technologies.   A second design was also investigated with RNA segments in 
the hairpin, to aid in the loop degradation, Figure 3-3 B.  
The final sequences are as follows 
5 bases 
5’ TCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
10 bases 
5’AAGTATCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGATCC 3’ 
15 bases 
5’AGTTCAAGTATCGTAGGATCCGCGCCTGATCGTCCACTTTTTTTTTAGTGGACGATCAGGCGCGGAT
CC 3’ 
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Figure 3-3 visualisation of predicted secondary s tructure of tag design, (A) s tem loop formation and position of 
restriction enzyme recognition s ite (B) position of RNA segments (C) additional of 5, 10 and 15 bp overhangs  
 
 
  
A 
B 
C 
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3.4.2 DNA Amplification using Tagging 
A 330 base pair PCR amplicon was used to assess the ability of ɸ29 to extend from the DNA 
tag. After attachment of the tag (as described in 2.2.5.3) the product was visualised using the 
Bioanalyser. Before attachment the peak was 330 bases, after attachment the peak had shifted to 
the right, with the peak around 360 bps Figure 3-4.  
10 ng of tagged DNA was incubated with ɸ29 for four hours in 50 µl reactions Figure 3-4. 
When quantified using the Qubit the five base tag sample had a DNA concentration of 0.189 
ng/µl, the ten base tag sample had 0.497 ng/µl and the 15 base tag sample had 0.311 ng/µl.  
When this experiment was repeated with six hours’ incubation the five base tag sample had a 
DNA concentration of 0.239 ng/µl, the ten base tag sample had 0.565 ng/µl and the 15 base tag 
sample had 0.375 ng/µl. 
 
3.4.2.1 DNA Amplification using DNA-RNA Hybrid Tag   
After the tag containing RNA was attached to the PCR products, 10 ng of tagged DNA was 
incubated with ɸ29 for four hours in 50 µl reactions. After the incubation the five base tag sample 
contained 0.176 ng/µl, the ten base tag sample had 0.398 ng/µl and the 15 base sample tag had 
0.289 ng/µl.  When this experiment was repeated with six hours incubation five  base tag sample 
had a DNA concentration of 0.211 ng/µl, the ten base tag sample had 0.489 ng/µl and the 15 base 
tag sample had 0.340 ng/µl. Figure 3-4 
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Figure 3-4 Bioanalyser trace showing the amplicon size before (A) and after (B) DNA tag addition shown a longside 
the upper and lower markers. (C) DNA produced after addition of DNA or DNA-RNA hybrid tag to 330 bp amplicon, with 
5, 10 or 15 base overhand, incubated with ɸ29 for four or s ix hours.  
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3.4.2.2 Amplification of Longer DNA Fragments 
To investigate if low DNA yields were due to short DNA fragments longer DNA fragments were 
tagged and amplified. DNA Extracts of E. coli K12 overnight cultures were nebulised for 30 
seconds, and the DNA purified as described in 2.3.2.5, when visualised on the Bioanalyser the 
product sizes peaked at 2000 bases Figure 3-5 (A). After attachment of DNA tags the fragments 
were incubated for four hours in a 50 µl ɸ29 MDA reaction. The five base tag reaction had a DNA 
concentration of 0.210 ng/µl, the 10 base tag reaction produced 0.988 ng/µl, and the 15 base tag 
sample produced 0.417 ng/µl. When the product of the ten base tag amplification was visualised, 
the peak product size had increased to 5000 bases, with some DNA being longer than the marker 
at 10800 bps Figure 3-5 (B).  
 
Figure 3-5 Bioanalyser trace of fragmented DNA size (A) before and (B) after attachment and amplification from 
tag  
3.4.3 RNA Conversion and Amplification using Tagging  
HIV tissue culture supernatant was extracted and treated with RNase and DNAse before the 
attachment of the tags. The RNA with tags attached was then added to a reverse transcription 
reaction using SuperScript IV. After this two HIV specific PCR were performed using primers E70 
and E145 (product size 422 bases), and E80 and E145 (product size 123 bases). A control RT 
reaction and PCR was performed with the same extracts using random primers in the RT reaction. 
The positive control produced products at the expected size and the PCR for all tag sizes produced 
no product.  
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3.5 Development of ɸ29 MDA for Whole Genome Sequencing 
One E. coli ɸ29 MDA product from 0 was randomly selected and taken forward for 
sequencing. The ɸ29 MDA product was used for library preparation described in 2.3.3. 500 ng of 
the product was nebulised for 60 seconds as recommended by the Roche Junior guidelines. After 
library preparation the quality of the product was assessed, the resulting fragment size was 
between 600 bp and 2500 bp. During the library preparation the library was quantified by 
detection of florescent markers present on the indexes attached to the reads. The florescence of 
the prepared library was 30.73, which equated to 4.32 x108 molecules/ µl, which was within the 
acceptable parameters. This was diluted down to 1x107 before continuing with emulsion PCR 
(EmPCR) setup in 2.3.3.2  
When the EmPCR was prepared the aim was to achieve six library copies per bead. After the 
EmPCR the beads were harvested, those with attached library were selectively isolated. When 
these beads were visualised very few beads were present, much fewer than the required 500,000 
beads needed for sequencing, and so sequencing was not undertaken.   
In an attempt to improve the EmPCR yield the same library was again prepared for EmPCR, 
but aiming for two copies per bead. Again this failed to produce sufficient beads.  
To investigate the possibility of loss of library, the ten loci PCR described in 2.2.1.6 was 
performed on the product post nebulisation and the 1x107 library. All products were detected at 
the correct size in both of these samples confirming the presence of expected DNA.  
3.5.1 Library Preparation Optimisation 
 
After the library failed to produce sufficient beads for sequencing, the use of S1 nuclease was 
investigated. S1 removes branches in DNA, lowering secondary DNA structure. This was used in 
combination with either prolonged physical fragmentation or enzymatic fragmentation.  
The ɸ29 MDA product was digested using S1 nuclease as described in  2.3.2.2. The products 
produced by the S1 nuclease, were either nebulised (60, 120 or 240 seconds) or fragmented using 
the Fragmentase enzyme (10, 15 and 20 minute incubations) and a combination of S1 and 
Fragmentase enzymes was also trialled Table 3-10. 
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After nebulisation for 60 seconds the size range of products was average between 600 bp and 
2500 bp, with the peak being around 1800 bp. The 120 second nebulisation product size ranged 
from 300 bp to 2000 bp, with the peak at 600 bp. The 240 second nebulisation had a size range of 
0 bp to 650 bp, with a peak of 350 bp.  
When the Fragmentase enzyme was used after S1 treatment, the majority of the products 
after the 10 and 15 minute incubations were larger than detectable on the Bioanalyser, over 
10380 bp. The 20-minute incubation showed a size ranging from 2000 bp to above the upper 
marker, with a peak at 10,000 bps 
When S1 nuclease and Fragmentase were combined into a single reaction the product was 
too large to be detected on the Bioanalyser and when ran on an agarose gel showed no size 
difference from the unfragmented ɸ29 MDA product. The results for the different fragmentation 
conditions are shown in Table 3-10 
 
Condition Smallest  fragment 
size (bp) 
Peak fragment (bp) Largest fragment 
size (bp) 
Nebulisation 
60 seconds 600 1,800  2,500  
120 seconds 300  600  2,000  
240 seconds 0  350  650  
Fragmentase 
10 minutes >10,380  >10,380  >10,380  
15 minutes >10,380  >10,380 >10,380  
20 minutes 2,000 10,000 >10,380  
S1 and Fragmentase single reaction 
20 minutes >10,380  >10,380  >10,380  
Table 3-10  DNA fragment sizes produced by di fferent fragmentation methods applied to ɸ29 MDA products of E. 
coli genome.  
3.5.2 Sequencing after Fragmentation Optimisation  
 
The ɸ29 MDA product was treated with S1 and then nebulised for two minutes before 
undergoing library preparation and sequencing.  When investigated on the Bioanalyser the size 
range of the library was 400 bp to 1000 bp with a peak at 600 bp.  
When preparing the EmPCR both two and four copies per bead were trialled. When four 
copies per bead was used considerably more than two million beads were produced, which is too 
high for sequencing. When two copies per bead were used just fewer than two million beads 
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were produced, allowing sequencing to be undertaken.  Sequencing on the Roche 454 Junior was 
then performed as described in 2.3.3.3 
The sequencing run was successful, allowing basic analysis of the run to be undertaken as 
described in 2.3.5. The number of reads generated in the sequencing run was 238, 827. The 
number reads that passed all filters was 180,144, totalling 79,350,696 bases, the mean length of 
reads was 439.16 bp. When assembled using Newbler against the reference (2.3.5.1), 98.44% of 
the genome was covered in 242 contigs, using 91% of the filter passed reads.  
Based on the results obtained, treatment with S1 nuclease and physical fragmentation using 
120 second nebulisation were used for further runs. 
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3.6 Comparison of ɸ29 MDA to Current Methods of Bacterial 
Sequencing   
 
3.6.1 E. coli K12 Non-Amplification Control 
Three replicates of the non-amplification control for E. coli K12 were performed as described 
in 2.3.1 briefly DNA was extracted from overnight cultures and 500 ng was used for library 
preparation. The DNA was fragmented using 1-minute nebulisation.  
After completion of the sequencing runs the average number of reads produced was 194,646 
before filter and 158,132 after filtering Figure 3-6 (A), Table 3-11.The mean read lengths 
produced were 468.52, 464.7 and 467.31 bps. After reference assembly reference coverage for 
each replicate was 98.24%, 98.14% and 94.26%. The total number of contigs in the reference 
assemblies was 310, 391 and 1281. De novo assemblies covered 94.30%, 81.19% and 79.22% of 
the genomes in 1636, 1502 and 1954 contigs (Figure 3-6 (B)) the number of de novo assembly 
errors for each replicate was 25, 27 and 29. The largest contig in each de novo assembly was 
38913, 44816 and 13251, with N50s of 7452, 3601 and 2464.  
 
  
 Control 1 Control 2 Control 3 
No: Raw reads 211,297  201,309  171,333 
No: Reads passing filter 177,442 168,106  128,849 
% reads passing filter 83.98 83.51 75.20 
Mean read length(bps) 468.52 464.7  467.31 
Reference assembly 
% ref coverage 98.24 98.14 94.26 
% reads mapped 93.76 94.87 93.31 
No: Contigs 310 391  1281 
De novo assembly 
% ref coverage 94.30 81.19  79.22% 
No: contigs 1,636 1,502  1,954 
 largest contig 38,913 44,816  13,251 
N50 7,452 3,601  2,464 
#misassemblies 25 27 29 
Table 3-11 Sequencing results of the E. coli non-amplification controls including reference and de novo assembly 
results 
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Figure 3-6  Analysis of sequencing results from non-amplification control E. coli K12, (A) Raw and Filtered Reads  
with % reads passing filter and (B) the number of contigs in the reference and de novo assemblies along  with  the 
genome coverage of each assembly. 
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3.6.2 Reproducibility of ɸ29MDA Reactions of E. coli K12 
 
In addition to the previously sequenced ɸ29 MDA E. coli K12, two further replicates were 
amplified and sequenced. The amount of DNA produced in the ɸ29 MDA reactions for the two 
additional biological replicates performed for E. coli was 998 ng/µl and 1.24x103 ng/µl producing 
235,215 and 278,531 sequencing reads (Figure 3-7(A)).  The mean read lengths produced were 
447.62 and 384.45 bases, for each run. After reference assembly the genome coverage for each 
run was 97.18% and 98%. The total number of contigs in the reference assemblies was 394 for 
both runs. De novo assemblies were performed for the three replicates covered which 94.12%, 
90.4% and 91.6% of the reference genome across 1568, 1345 and 1032 contigs (Figure 3-7 (B)). 
The number of misassemblies in the de novo assemblies was 21, 22 and 23 for each run. The 
largest de novo contigs were 32639, 38791 and 50561 bps, with the N50s for the runs being 455, 
5520 and 7897. A summary of the results obtained for the three replicates (including the original 
sequencing run) can be found in Table 3-12. 
 Replicate 1 Replicate  2 Replicate  3 
DNA produced (ng/µl) 1.12x10
3
  998  1.24x10
3
  
No: Raw reads 238, 827 235,215  278,531 
Reads passing filter 180,144 178,378  222,066 
% reads passing filter 75.43 76.03 79.72 
Mean read length (bps) 439.16 447.62  384.45 
Reference assembly 
% ref coverage 98.44 97.18 98 
% reads mapped 91% 90.16 94.06 
No: Contigs 242 394 394 
De novo assembly 
% ref coverage 94.12 90.4 91.6 
No: contigs 1568  1345  1032 
 largest contig (bps) 32,639 38,791  50,561 
N50 (bps) 455  5520  7897 
#misassemblies 21 22 23 
Table 3-12 Sequencing results of the three E. coli K12 ɸ29 MDA reaction replicates, including reference and de 
novo assembly results 
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Figure 3-7 Sequencing results of the E. coli K12 ɸ29 MDA reactions, (A) Raw and Filtered Reads including minimum 
reads required to pass run(dotted line) and (B) the number of contigs in the reference and de novo assemblies including 
the proportion of the genome covered. 
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3.6.3 Comparison of ɸ29 MDA and Culture Control in Sequencing of 
E. coli k12 
The average results of the non-amplification control and ɸ29 MDA are summarised in Table 
3-14, along with the F test results (equal or unequal variance) and the T test results, including 
interpretation with a 0.05 value. 
The average number of raw reads produced by ɸ29 MDA amplified libraries was 250,858 
compared to 194,646 produced using the non-amplification method. The difference between the 
two approaches being statistically significant when tested with a two-sample T-Test, assuming 
equal variances. However the number of pass filter reads was not significantly different between 
the two methods the average percentage of reads passing filters was 77% for ɸ29 MDA produced 
libraries and 80.9% for non-amplification libraries, again this wasn’t shown to be a significant 
difference (Figure 3-8(A)). There was no significant difference in length of sequencing reads 
produced, with the average read length being 423 bases for ɸ29 MDA produced libraries and 466 
bases for non-amplification libraries. The proportion of the reference that was covered was 
97.88% and 96.87%, for ɸ29 MDA and control libraries respectively. The number of reads used to 
construct the reference assembly was slightly higher in the non-amplification libraries (94.18%) 
compared to ɸ29 MDA libraries (91.75%) however this was not found to be significant. The 
average number of contigs produced was lower in the ɸ29 MDA library (343.33) than the non-
amplification library (660.67), but this was not found to be significant (Figure 3-8 (B)).   
The largest contig produced in the reference assembly was significantly larger (176638.33 
bases) in the ɸ29 MDA library compared to the non-amplification library (81579.00 bases), but the 
average size on the contigs was not significantly different.  The number and size of contigs 
generated by the de novo assembly was not statistically significantly different between the ɸ29 
MDA and non-amplification libraries (Figure 3-8 (C)).   The number of misassemblies in the ɸ29 
MDA libraries was significantly less (22) than the non-amplification libraries (27).   
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Figure 3-8 Comparison of ɸ29 MDA and non-amplification  preparation of sequencing of E. Coli K12, (A) number of 
raw and filter passed reads, including % reads passing filter (B)  number of contigs in the reference and de novo  
assemblies and the proportion of genome covered and (C) contig sizes produced by reference and de novo  assemblies 
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3.6.4 Extra Chromosomal Reads of E. coli  
After reference assembly of the reads against the plasmid F reference sequence, Table 3-14, 
the coverage for ɸ29 MDA amplified libraries was 99.90%, 99.89% and 99.93%, using 8.59%, 
8.54% and 5.67% of the passed filter reads.  Non-amplification libraries covered 98.49%, 97.97% 
and 94.79%, using 2.20%, 3.46% and 3.42% of reads that passed filter Figure 3-9-A. This was 
found to be significantly less than the ɸ29 MDA produced libraries.  
The number of contigs in the ɸ29 MDA reference assembly against the F plasmid was 3, 3 and 
2 with the largest contigs being 46869, 46903 and 74509 bases long, with average contig lengths 
of 33021, 33017 and 49543 bases. The non-amplification libraries were assembled into 12, 8 and 
24 contigs with the largest being 31216, 40380 and 20366 bases and the average contig size being 
8138, 13807 and 4233 bases, which was significantly shorter that the ɸ29 MDA produced 
libraries.  
For the three sets of data produced by ɸ29 MDA amplification of E. coli K12, the number of 
reads mapping to lambda phage were 143, 128 and 100, which covered 67.85%, 52.93% and 
47.94% of the lambda genome. The non-amplification libraries covered 39.69%, 40.88% and 
21.17% of the lambda genome Figure 3-9-B.  
Additionally, 374, 394 and 5 reads from the ɸ29 MDA produced library were associated with 
human genome elements, and 162, 158 and 81 were unidentified. Of the remaining reads 0, 1638 
and 414 were not mapped above the Genus level, but were mainly within the Primate Order, or 
the Rosales (order of flowing plants) order.  For the non-amplification libraries, 175, 226 and 298 
reads mapped to human, and 2802, 572 and 512 reads were unmapped. The number of reads 
classed as other was, 4140, 1968 and 2610, which fell in the Orders of either Primate or Rosales.  
 All Reads K12 
Genome 
F Plasmid Lambda Human Not 
Mapped  
Other 
MDA 
1 180144 91.04% 8.59% 0.08% 0.21% 0.09% 0.00% 
2 178378 90.16% 8.54% 0.07% 0.22% 0.09% 0.92% 
3 222066 94.06% 5.67% 0.05% 0.00% 0.04% 0.19% 
Non-amplification  
1 177442 93.76% 2.20% 0.03% 0.10% 1.58% 2.33% 
2 168106 94.87% 3.46% 0.02% 0.13% 0.34% 1.17% 
3 128849 93.91% 3.42% 0.02% 0.23% 0.40% 2.03% 
Table 3-13 proportional read identification in E. coli sequences for ɸ29 MDA and non-amplification replicates 
(reads identified as Rosales (order of flowing plants) have been grouped with reads classed as ‘other’ ) 
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Figure 3-9 comparison of E. coli K12 none chromosomal elements of ɸ29 MDA and non-amplification prepared 
sequencing.  (A) Percentage of reads mapping to plasmid F and (B) percentage coverage of Lambda phage genome and 
(C) identification of the remaining reads in the three replicates of the ɸ29 MDA and control libraries 
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  ɸ29 MDA 
amplified 
Non-amplification 
control  
F test  T test 
value 
Significant  
(0.05) 
No: Raw reads  250858 194646 equal  0.0375 Yes  
No: Pass filter 
reads 
193529 158132 unequal  0.1614 No 
% Pass filter 77.00% 80.90% equal 0.2851 No 
Mean read 
length (bp) 
423.74 466.84 equal 0.0954 No 
Median read 
length (bp) 
440 496 equal  0.0545 No 
Modal read 
length (bp) 
458 503 equal  0.1290 No 
Reference mapping 
% ref coverage 97.87% 96.88% unequal 0.5273 No 
 
% reads 
mapped  
91.75% 
 
94.18% 
 
equal  0.1200 No 
No: Contigs 343 661 unequal  0.3709 No 
Largest contig 
(bp) 
176638 81579 equal 0.0105 Yes 
Average contig 
(bp) 
15804.67 11441.67 equal  0.3888 No 
De novo assembly 
% ref coverage 92.04% 84.90% equal  0.2158 No 
No: Contigs 1315 1697 equal  0.1360 No 
Largest contig 
(bp) 
40664 32327 equal 0.4916 No 
N50 5990 4506 equal 0.4574 No 
#Misassemblies 22.00 27.00 equal 0.0179 Yes 
Plasmid F Reference Mapping 
% ref coverage 99.91% 97.09% unequal 0.1347 No 
% reads 
mapped  
7.60% 3.03% equal 0.0121 Yes 
No: contigs 2.67 14.67 unequal 0.0337 Yes 
largest contig 
(bp) 
56093.67 30654.00 equal 0.0794 No 
average contig 
(bp) 
38527.00 8726.00 equal 0.0085 Yes 
      
Table 3-14 Summary of Average Sequencing Results for E. coli K12 ɸ29 MDA and cul ture control including results of 
reference and de novo  assemblies and plasmid reference assembly, showing results F test and T test for s tatistical 
s ignificance  
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3.7 Determining Sensitivity and Processivity of ɸ29 MDA in the 
Context of Bacterial Genomes 
After establishing that ɸ29 MDA was suitable for whole genome sequencing, the method was 
optimised to provide reliable and rapid results.  For the optimisation study the E. coli K12 
previously sequenced was used. The aim was to have method that provided results are as quick as 
possible, whilst not compromising genome coverage or data quality. Initially the conditions were 
50 µl reactions incubated for 16 hours, as instructed by the manufacturer. Smaller volumes were 
investigated (25 µl and 12.5 µl), as well as reduced incubation times, scaling down from 8 hours to 
1 hour incubations. The sensitivity of the assay was also tested by reducing the input to a single 
bacterial cell.  
3.7.1 Reaction Volume Reduction  
Reaction volumes were scaled down from 50 µl to 25 µl and 12.5 µl, and two biological 
replicates of each reaction volume were sequenced, results are shown Table 3-15. 
There was a reduction in the amount of DNA produced by the 25 µl ɸ29 MDA reaction 
(average 825.5 ng/ µl) compared to the 50 µl reaction (average 1240 ng/ µl), however this was not 
significant.  The 12.5 µl reaction produced significantly less DNA (average 633.5 ng/ µl) than the 50 
µl reaction (Figure 3-10 (A)).   
There was no significant difference in the number of raw reads produced when sequencing 
the DNA produced, (average values of 250,858 in 50 µl, 219,657 in 25 µl and 277,902.5 in 12.5 µl 
ɸ29 MDA reactions.). The proportion passing filter was very similar in the 50 µl and 25 µl reactions 
(77% and 70.4%), however significantly less passed filter for the 12.5 µl reaction (47.36%) shown 
in Figure 3-10 (B)  
After reference assembly, the amount of genome coverage was significantly lower in both the 
25 µl (61.97%) and 12.5 µl (55.84%) reactions compared to the 50 µl  (97.88%) reaction Figure 
3-10 (C).  The percentage of reads used to create the reference assembly from the 50 µl (91.75%) 
and 25µl (85.45%) reactions were similar; however, was significantly lower in the 12.5 µl (42.62%) 
reaction.   
The number of contigs produced in the reference assembly was significantly  higher in both 
the 25 µl (1149) and 12.5 µl (1332.5) reactions, compared to the 50 µl reaction (343).  The largest 
contigs produced were significantly shorter (51195, 25 µl and 51204, 12.5 µl compared to 176638, 
50 µl). The average contig length were also shorter (3589, 25 µl and 3409, 12.5 µl compared to 
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15805, 50 µl). There was also significantly less of the genome covered after de novo assembly 
(45.4%, 25 µl and 41.22%, 12.5 µl compared to 92.04%, 50 µl). However, there was little 
difference in the contig number (1446 and 1843 compared to 1315) there was significantly more 
misassemblies in both the 25 µl (33) and 12 .5 µl, (44) reactions compared to the 50 µl, reaction 
(12). Results are summarised in Table 3-15 
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Figure 3-10 Results of reducing the ɸ29 MDA reaction volume of E. coli K12, (A)DNA concentration produced, (B) % 
of reads passing filter and (C) % reference coverage using reference and de novo methods  
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 50 µl vs. 25 µl Average results 50 µl vs. 12.5 µl 
 F 
test  
T test 
value 
Sig  
(0.05) 
50 µl 25 µl 12.5 µl F 
test  
T test 
value 
Sig  
(0.05) 
DNA 
produced 
(ng/µl) 
E 0.0588 No 1240 825.5 633.5 E 0.0153 Yes 
No: Raw 
reads  
UE 0.3948 No 250858 219657 277903 E 0.2294 No 
No: Pass 
filter reads 
UE 0.3521 No 193529 155928 131728 E 0.0685 No 
% Pass filter 
reads 
E 0.1590 No 77.00% 70.5% 47.36% E 0.0073 Yes 
Mean read 
length (bp) 
E 0.4002 No 424 449.07 393.95 E 0.4332 No 
Reference assembly 
% ref 
coverage 
E 0.0000 Yes 97.88% 61.97% 55.84% E 0.0009 Yes 
% reads 
mapped  
E 0.2172 No 91.75% 85.45% 42.62% E 0.0001 Yes 
No: Contigs E 0.0060 Yes 343.33 1149 1333 E 0.0111 Yes 
Largest 
contig (bp) 
UE 0.1212 No 176638 51195 51204 E 0.0264 Yes 
Average 
contig (bp) 
E 0.0232 Yes 15805 3589 3410 E 0.0222 Yes 
De novo assembly 
% ref 
coverage 
E 0.0001 Yes 92.04% 45.50% 41.22% E 0.0002 Yes 
No: Contigs E 0.7566 No 1315 1446 1843 E 0.0818 No 
Largest 
contig (bp) 
E 0.0108 Yes 40664 90015 40265 UE 0.9928 No 
N50 E 0.3250 No 5990 4423 3611.5 UE 0.1886 No 
#Misassem
blies 
E 0.0071 Yes 22 33 44 E 0.0001 Yes  
Table 3-15 Summary of comparison between 50µl, 25µl, and 12.5µl , ɸ29 MDA reactions volumes to amplify E. coli 
K12  Including s tatistical s ignificance testing of DNA production, sequencing output and assembly results.                           
F test E=Equal UE = unequal 
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3.7.2 Determining the Sensitivity of ɸ29 MDA 
 
Single cells of E. coli K12 were prepared and sequenced in triplicate as described in 2.3.4.1  
and sequenced Table 3-16.  
There was no significant different between the amount of DNA produced from a colony and 
single cell, the average being 1146 ng/µl for colony input and 1268 ng/µl for the single cell input. 
There was also no significant difference between the number of reads produced when sequenced, 
250,858 and 217,141 for the colony and single cell input respectively. The percentage of reads 
that passed filter also showed no significant difference being 77% (colony) and 78.4% (single cell). 
The length of reads showed little variation with the average read lengths being 423.75 (colony) 
and 428.77 (single cell) bases. The proportion of the genome covered with the reference assembly 
method showed little variation between the two sets of data (97.87% and 97.03%).  Slightly fewer 
reads were used to construct the assembly using the single cell library (86.49% compared to 
91.75%) but this was not found to be a significant difference.  Further analysis of the non-
chromosomally mapped reads revealed most of the colony input reads mapped to the F plasmid, 
whereas the single cell input showed a greater variety of mapping hits and a greater number that 
could not be identified. As shown below in Figure 3-11 .The number of contigs produced in the 
chromosome reference assembly was on average 343 and 316, with the average contig length 
being 15805 and 18818 bp. The de novo assembly covered 92.05% and 92.00% of the genome, in 
an average of 1315 and 1297 contigs. The N50s of the two sets of data were 5990 and 5168, 
showing no significant difference. The average number of misassemblies was 22 and 21.  The 
results are summarised in Table 3-17 
 Replicate 1 Replicate 2 Replicate 3 
DNA produced (ng/µl) 1214 ng/µl 1450 ng/µl  1140 ng/µl 
No: Raw reads 238836 224702  187886 
No: Reads passing filter 189211 171250  150240 
% reads passing filter 79.22% 76 .21% 79.96% 
Reference assembly 
% ref coverage 95.50% 96.99%  98.59% 
% reads mapped 90.84% 82.74%  85.89% 
No: Contigs 313 254  380 
De novo assembly 
% ref coverage 91.79%,  89.42%  94.78% 
No: Contigs 1036 1522  132 
N50 4276 5031  6196 
#misassemblies 22 20 21 
Table 3-16 summary table of s ingle cell E. coli K12 ɸ29 MDA reactions, performed in triplicate. Including 
sequencing output and assembly results. 
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Figure 3-11 proportional read  identity of reads not mapping to the E. coli K12 chromosome after ɸ29 MDA of 
s ingle colony or single cells 
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  Colony 
ɸ29 MDA 
amplified 
Single cellɸ29  
MDA amplified  
F test  T test 
value 
Sig  (0.05) 
DNA produced 
(ng/µl)  
1146 1268 Equal  0.3660 No 
No: Raw reads  250858 217141 Equal 0.1765 No 
No: Pass filter 
reads 
193529 170233 Equal 0.2694 No 
% Pass filter 77.00% 78.4% Equal 0.4574 No 
Mean read 
length(bp) 
423.74 428.77 Equal 0.8383 No 
Median read 
length (bp) 
440 476 Equal 0.2019 No 
Modal read 
length(bp) 
458 494 Equal 0.2459 No 
Reference mapping 
% ref coverage 97.87% 97.03% Equal 0.4223 No 
% reads mapped  91.75% 
 
86.49% Equal 0.1166 No 
No: Contigs 343 316 Equal 0.6803 No 
Largest contig 
(bp) 
176638 178657 Equal 0.9030 No 
Average contig 
(bp) 
15804.67 18817.67 Equal 0.2723 No 
De novo assembly 
% ref coverage 92.04% 91.99% Equal 0.9825 No 
No: Contigs 1315 1297 Equal 0.9347 No 
Largest contig 
(bp) 
40664 35872 Equal 0.5632 No 
N50 5990 5167 Equal 0.5103 No 
#Misassemblies 22 21 unequal 0.2879 No 
Table 3-17 Comparison of average sequencing results produced by colony and single cell input of ɸ29 MDA 
reactions of l E. coli K12, including results of s tatistical test (T test) 
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3.7.3 Incubation Time Reduction 
Single cell input ɸ29 MDA reactions were incubated at 30oC for 8, 4, 2 or 1 hour, and if 
sufficient DNA was produced, were sequenced Table 3-18. Overall the concentration of DNA 
produced from the ɸ29 MDA reactions decreased with the decreasing incubation time. The 
average amount of DNA produced being 1268, 1211.3, 1105.3, 778 and 184 ng/µl, after 16, 8, 4, 2 
and 1  hour incubations Figure 3-12 (A). The percentage of the reference genome covered was 
consistently high for the 16, 8, 4 and 2 hours’ incubation, always being above 97%. However, this 
dropped to 78.58% in the 1-hour incubation sample. A similar pattern was found with the de novo 
assemblies. The number of contigs constructed remained similar across the first four incubation 
times (316, 285, 301 and 262) but rose to 2889.5 in the 1-hour incubation sample. From the de 
novo assemblies a similar pattern was observed. With the number of contigs decreasing from 
1297, 1295, 859 and 786 from 16, 8, 4 and 2 hours, but then increasing to 1581 for the 1 hour 
incubation Figure 3-12 (B)) 
 
Figure 3-12 Impact of reducing the ɸ29 MDA incubation times for amplifying single E. coli cells , (A), DNA 
concentration production (B)number of contigs in the reference and de novo assembly a long with proportion of the 
genome covered  
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  8 hours 4 hours 2 hours 1 hour  
DNA Produced 
(ng/µl)  
1. 1,364, ng/ µl 
2. 1,125 ng/ µl 
3. 1,145 ng/ µl 
1.  1,364 ng/ µl 
2.  1,125 ng/ µl 
3.  1,145 ng/ µl 
1. 756 ng/ µl 
2. 889 ng/ µl 
3. 689 ng/ µl 
1. 345 ng/ µl 
2. 23 ng/ µl 
3. 2 ng/ µl 
Reference assembly 
% ref coverage 1. 96.63%,  
2. 83.99%  
3. 97.88%.   
1. 97.59 % 
2. 98.56%  
3. 98.52%.   
1. 98.41 % 
2. 98.46%  
3. 98.22%  
1. 71.69%  
2. 80.67% 
No: Contigs 1. 268 
2. 297  
3. 290 
1. 352 
2. 320  
3. 230  
1. 254 
2. 243  
3. 190 
1. 3567  
2. 2212 
Average contig 
size (bp) 
1. 12283 
2.  16684 
3. 17414 
1. 31051 
2. 39410  
3. 36847 
1. 31445 
2. 32395  
3.  3754 
1. 9036  
2. 9445 
Largest contig 
(bp) 
1. 190728 
2. 132053  
3. 141624 
1. 189335 
2. 289014 
3. 286883 
1. 519189  
2. 680322 
3. 408750 
1. 19102  
2. 71919 
De novo assembly 
% ref coverage 1. 91.29% 
2. 90.80%  
3. 92.6% 
1. 92.43% 
2. 91.89%  
3. 95.95% 
1. 93.4% 
2. 93.53%  
3. 94.81% 
1. 58.52 %  
2. 46.02% 
No: Contigs 1. 1343 
2. 1214  
3. 1329 
1. 948 
2. 648  
3. 982 
1. 708 
2. 809  
3. 787 
1. 1622  
2. 1540 
Largest contig 
(bp) 
1. 35379 
2. 24145  
3. 42959 
1. 31453 
2. 30713  
3. 92122 
1. 61435 
2. 89754  
3. 75063 
1. 13416  
2. 8565 
N50 1. 5178 
2.  5066  
3. 5012 
1. 5685 
2. 5690  
3. 7790 
1. 5671 
2. 7416  
3. 6347 
1. 1001  
2. 2157 
#Misassemblies 1. 20 
2. 22  
3. 23 
1. 22 
2. 22  
3. 21 
1. 21 
2. 23  
3. 24 
1. 33  
2. 38 
Table 3-18 Results of time reduction of ɸ29 MDA reactions to eight, four, two and one hour incubations. Results 
include the sequencing outputs and assembly results.  
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3.8 Assessing ɸ29 MDA for Whole Genome Amplification of 
Varying GC Contents 
To check the applicability of amplification using ɸ29 MDA to multiple pathogens two bacteria 
with extreme GC contents were investigated. The results were then compared to E. coli K12 
(50.75% GC) previously sequenced. The two bacteria were Clostridium difficile (29% GC) and 
Actinomyces naeslundii (69%GC). Additionally, these bacteria were selected as they had Gram 
positive cell walls, to ensure the extraction technique used was suitable.  
3.8.1 Clostridium difficile  
C. difficile 630 is a well characterised pathogenic strain of C. difficile, which is a Gram positive, 
spore forming anaerobic bacteria, with a GC content of 29.06% and a total genome size of 
4290252 bases. It also known to carry a plasmid, pCD630 which is also well characterised with a 
GC content of 27.9 and total length 7881 bases. The bacterium has been well studied and its 
genome was fully characterised in 2006136, the isolate has multiple drug resistances and a highly 
mobile genome.    
Two replicates were performed for non-amplification controls of C. difficile and three single 
cell ɸ29 MDA reactions were sequenced. The concentration of the three ɸ29 MDA reactions was 
1.25x103 ng/µl, 1.07x103 ng/µl and 1.02x103 ng/µl.  
When the reads from the ɸ29 MDA and culture control were mapped against the reference 
for plasmid_pCD630, no reads mapped to the reference in any file. A specific PCR targeting the 
plasmid_pCD630 was negative for the ɸ29 MDA and control. A fresh culture from an earlier sub 
cultured set of storages beads was also negative. When whole cell lysis, shown in Figure 3-13 was 
visualised on the tape station (Agilent) using genomic tapes, no products were found below 10K 
base pairs (plasmid size 7881 bases). 
The average number of reads produced by the ɸ29 MDA amplified methods was 225,451 and 
for the non-amplification control was 227,593, with the number of reads passing filter being 
174,907 and 167,093, which was 77.6% and 72.75% of the total reads. None of these variables 
were statistically significant from each other. There was no significant difference found between 
the mean read length (460 vs. 444 bases) for the ɸ29 MDA and none-amplification.  The 
proportion of the reference genome covered after reference assembly was higher in the ɸ29 MDA 
libraries 95.73% compared to 88.66% for the control libraries, however this was not found to be a 
significant difference. This is shown below in Figure 3-14 (A)   
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The average number of contigs in the reference assemblies was 430 and 850 for the ɸ29 MDA 
and control libraries respectively. The average contig size was larger in the ɸ29MDA library being 
11357 compared to 5655 bp in the control library; once again this was not found to be a 
significantly different Figure 3-14 (B).  The size of the largest contig was shown to be significantly 
bigger in the ɸ29 MDA library, 146,811 bases compared to 57823 bases in the non-amplification 
libraries. The average amount of the genome covered by the de novo assembly was 92.88% in the 
ɸ29MDA libraries and 83.16% in the non-amplification libraries, with the N50 values being very 
similar in the two assemblies (5194 and 4688 bp respectively). 
However, the number of misassemblies was significantly higher in the control libraries with 34 
misassemblies compared to 24 in the ɸ29 MDA libraries. Table 3-20 summarises the average 
results for sequencing parameters, including the T test values and interpretations.  
The reads not mapping to the C. difficile chromosome were investigated. In the non-
amplification sample, the number of reads which mapped to the human genome was 51 and 212 
for the two replicates. The number of reads mapping to the order Clostridiales was 196 and 116, 
with 32 and 11 mapping to Clostridium. The numbers of unassigned reads were 173 and 438. In 
the ɸ29 MDA libraries, the number of reads mapping to the human genome was 12, 150 and 
2098 for the three replicates. The number of reads mapping to the Order Clostridiales was 2150, 
87 and 0, with a further 292, 25 and 0 reads mapping to the Genus Clostridium. The number of 
unassigned reads was 117, 1022 and 4925. Other reads accounted for 0, 503 and 3 reads, with the 
majority being in the Primate Order. The third replicate of the ɸ29 MDA library had 4072 reads 
that were identified as Enterobacteriaceae.   
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Figure 3-13 Tape station Output for Whole Cell Lys is of C. difficile showing the absence of plasmid DNA 
 
 Culture Control ɸ29 MDA single cell reactions 
 Control 1 Control 2 Reaction 1 Reaction 2 Reaction 3 
DNA produced 
(ng/µl)   
  1.25x10
3 
ng/µl 1.07x10
3
 ng/µl  1.02x10
3
 ng/µl 
No: Raw reads 205220 249966 216897 238758  220698   
No: Reads passing 
filter 
135341 198844 179767 171830 173123 
% reads passing 
filter 
65.95% 79.55% 82.88% 71.97% 78.44% 
Mean read length 
(bp) 
452.04 436.33 452.67 470.01  457.47 
Reference assembly 
% ref coverage 93.69% 83.62% 96.25% 94.23%  96.62% 
% reads mapped 99.67% 99.29% 98.57% 98.96%  93.59% 
No: Contigs 548 1152 479.00 523.00  311.00 
Average contig 
size (bp) 
7902 3408 9440 10738  13893 
De novo assembly 
% ref coverage 89.59% 76.73% 90.63% 98.38%  89.62% 
No: contigs 654 1145 1397 1200  1108 
N50 4941 4435 4380 3839  7364 
#misassemblies 32 35 26 27  22 
Table 3-19 Raw sequencing data from C. difficile non-amplification and single cell ɸ29 MDA prepared sequencing 
including raw output and results of reference and de novo assembly   
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Figure 3-14 Comparison of single cell ɸ29 MDA and non-amplification preparation of sequencing on (A) C. difficile 
reference coverage and (B) average number of contigs rpoduced in the reference and de novo  assembllies along with 
average % genome coverage. (C) the indentification of none C. difficle DNA in non-amplification and ɸ29 MDA s amples  
 
 
0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% 90.00% 100.00%
MDA
 Control
%  C. difficle reference genome covered in refence assembly  
95.73% 
88.66% 
92.88% 
83.16% 
0
200
400
600
800
1000
1200
1400
MDA  Control
A
ve
ra
ge
 n
u
m
b
e
r 
o
f 
C
o
n
ti
gs
 
Ref assembly de novo % ref coverage % de novo coverage
2571 
1787 
11097 
447 
1412 
0
2000
4000
6000
8000
10000
12000
MDA1  MDA2  MDA 3  Control1  Control2
R
e
ad
s 
Clostridiales Clostridium Human Other
Not assigned Enterobacteriacae total
B 
A 
C 
142 
 
 
  ɸ29 MDA 
amplified 
None Amplification 
control  
F test  T test 
value 
Sig  (0.05) 
No: Raw reads  225451 227593 equal 0.9165 No 
No: Pass filter 
reads 
174907 167093 unequal  0.8465 No 
% Pass filter 77.76% 72.75% equal 0.4973 No 
Mean read 
length (bp) 
460 444 unequal 0.1717 No 
Reference mapping 
% ref coverage 95.73% 88.66% unequal 0.3905 No 
% reads mapped  97.04% 99.48% equal  0.3550 No 
No: contigs 438 850 equal  0.1843 No 
 largest contig 
(bp) 
146811 57823 equal 0.0146 Yes 
average contig 
(bp) 
11357 5655 
 
equal  0.0972 No 
De novo assembly 
% ref coverage 92.88% 83.16% equal  0.2025 No 
No: contigs 1235 900 equal  0.2142 No 
largest contig 
(bp) 
29806 30559 equal  0.8957 No 
N50 5194 4688 equal  0.7463 No 
#misassemblies 24 34 equal  0.0331 Yes 
Table 3-20 comparison of sequencing results obtained from single cell ɸ29 MDA and non-amplification for library 
preparation of C. difficile 630 including raw output and results of reference and de novo  assemblies  
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3.8.2 Actinomyces naeslundii 
Actinomyces naeslundii is a Gram positive pathogen with a GC content of 68.5% and a total 
genome size of 3,042,856 bases.  
Two sets of non-amplification control libraries were sequenced and three replicate using 
single cell ɸ29 MDA reactions were sequenced Table 3-22.  The total DNA produced by the ɸ29 
MDA reaction was 1.46x103 ng/µl, 997 ng/µl and 1.24x103 ng/µl.  
The average number of raw reads produced by the ɸ29 MDA and non-amplification libraries 
was very similar, 206578 and 201128. The percentage that passed filter being slightly higher in the 
ɸ29 MDA library, 78.14% compare to 76.87% in the non-amplification library, but this was not 
statistically significant. There was very little difference in the length of reads produced by the 
sequencing, with the average read lengths being 429 and 433 bases. The proportion of the 
reference that was covered after reference assembly was higher in the ɸ29 MDA runs 76.30% 
compared to 63.39% in the non-amplification library, but this wasn’t significant. The number of 
reads used to construct the reference mapping was 81.62% in the ɸ29 MDA and 79.43% in the 
non-amplification libraries. The number of contigs produced was similar in both sets of data 1624 
and 2018, and the largest contigs were 11,628 and 10,312 bases, with average lengths of 1116 
and 1216 bases, none of which were significant.  De novo reference coverage was 64.95% in the 
ɸ29 MDA and 60.94% in the non-amplification library, and the number of contigs was sl ightly 
higher in the ɸ29 MDA data at 1663 compared to 1583 in the control library, but again this was 
not significant. The N50 scores were also similar between the two data sets with the ɸ29 MDA 
being 3835 bp and the non-amplification being 4229 bp. The number of misassemblies was 
significantly higher in the non-amplification at 33 and only 22 in the ɸ29 MDA libraries. The 
comparison results are summarised in Table 3-23 showing the average values for each variable, 
the F test results and the T test values and interpretation. 
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 Non-amplification  ɸ29 MDA single cell reaction 
 Control 1 Control 2 Reaction 1 Reaction 2 Reaction 3 
DNA produced 
(ng/µl) 
  1.46x103 
ng/µl   
997 ng/µl  1.24x103 
ng/µl 
No: Raw reads 187569  214686 186891 242620  190222 
No: Reads passing 
filter 
149569  158825 153174 124301  95534 
% reads passing 
filter 
79.74% 79.98% 81.92% 51.23% 50.22% 
Mean read length 
(bp) 
463  430 457.25 419.49  409.23 
  Reference assembly 
% ref coverage 63.22%  63.56% 78.52% 80.49%  69.90% 
% reads mapped 81.35%  77.51%. 83.45% 81.77%  79.63% 
No: Contigs 2136  1900 1465.00 1755.00  1651.00 
Average contig 
length (bp) 
1076  1355 1198 1104  1047 
  De novo assembly 
% ref coverage 61.78%   60.09% 67.89% 65.59%  61.37% 
No: Contigs 1868  1297 1560 1760  1668 
N50 4226  4231 4132 4035  3339 
#misassemblies 33 33 22 22   23 
Table 3-21 results of sequencing single cell ɸ29 MDA and non-amplification control replicates of A. naeslundii 
including raw output and reference and de novo assembly results  
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Table 3-22 Comparison of single cell ɸ29 MDA and culture control on A.naeslundii (A) % reference coverage and 
(B) number of contigs  in the reference and de novo assemblies, including % genome coverage 
 
 
 
 
 
 
 
 
0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% 90.00% 100.00%
MDA
 Control
Percentage of A.naeslundii genome covered in the reference assembly  
76.30% 
63.39% 64.95% 
60.94% 
0
500
1000
1500
2000
2500
1 2
Ref Assembly de novo % ref coverage % de novo coverage
B 
A 
146 
 
   ɸ29 MDA 
amplified 
Non-Amplification 
control  
F test  T test 
value 
Sig  (0.05) 
No: Raw reads  206578 201128 Equal  0.8438 No 
No: Pass filter 
reads 
161003 154215 Equal 0.6944 No 
% Pass filter 
reads 
78.14% 76.87% Unequal  0.7505 No 
Mean read 
length (bp) 
429 433 Equal 0.8337 No 
Median read 
length (bp)  
489 461 Unequal 0.2091 No 
Modal read 
length (bp) 
508 496 Equal 0.2564 No 
Reference mapping 
% ref coverage 76.30% 63.39% Unequal 0.0576 No 
% reads mapped  81.62% 79.43% Unequal 0.4441 No 
No: Contigs 1624 1818 Equal 0.2190 No 
 Largest contig 
(bp) 
11628 10312 Unequal 0.4321 No 
Average contig 
(bp) 
1116 1216 Equal 0.4641 No 
De novo assembly 
% ref coverage  64.95% 60.94% Equal 0.2126 No 
No: Contigs 1663 1583 Equal 0.7457 No 
Largest contig 
(bp) 
21743 22587 Equal 0.9282 No 
N50 3835 4229 Unequal 0.2561 No 
#misassemblies 22 33 Unequal 0.0010 Yes 
Table 3-23 Comparison of sequencing results from single cell ɸ29 MDA and culture control replicates of A. 
naeslundii,  including raw output and results of reference and de novo assemblies 
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3.8.3 Analysis of the Effect of GC Content on DNA Amplification, 
Sequencing and Assembly   
 
The ɸ29 MDA single cell reactions for the three bacteria covering a wide range of GC 
contents, C. difficile (29.06%), E. coli (50.75%) and A. naeslundii (68.5%), were investigated to 
determine the impact of GC content on whole genome amplification using ɸ29 MDA. Further 
analysis was performed on sequencing results across the range of GC content, looking at 
sequencing and assembly quality. Culture control sequencing was used to control for instrument 
and programmes to allow differentiation between ɸ29 MDA bias and inherent issues in 
sequencing and analysis techniques. 
The average concentration of DNA produced by the C. difficile, E. coli and A. naeslundii ɸ29 
MDA reactions were 1113, 1268 and 1232 ng/µl the three sets of data demonstrated no 
significant difference between them. Figure 3-15  illustrates the amount of DNA produced in each 
replicate along with the average of each replicate.  
For the non-amplification control the average number of reads for the three bacteria C. 
difficile, E. coli and A. naeslundii) was 227,593, 250,858 and 201,128 and the number of reads that 
passed filter was 167,093, 193,529 and 154,215. There was no significant difference between 
bacteria.  There was also no significant difference between read lengths produced, with the 
average mean read lengths being 444, 423.74 and 433 bp.   
The average number of reads for the three bacteria C. difficile, E. coli and A. naeslundii 
amplified by ɸ29 MDA was 225,451, 217,141 and 206,578 and the number of reads that passed 
filter was 174,907, 170,233 and 161,003. There was no significant difference between bacteria.  
There was also no significant difference between read lengths produced, with the average mean 
read lengths being 460, 428.77 and 429 bases.  Table 3-24 summarises the average results and 
statistical results for sequencing data produced.  
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Figure 3-15 A Graph Showing the concentration of DNA produced by each replicate in the three bacteria studied, 
(C. difficile, E. coli and A. naeslundii), with averages concentration shown as diamonds 
 C. difficile vs. E. coli Average results A. naeslundii vs. E. coli 
Non-amplification libraries 
 F 
test  
T test 
value 
Sig  
(0.05) 
C. 
difficile 
E. coli A. 
naeslund
ii 
F 
test  
T test 
value 
Sig  
(0.05) 
No: Raw 
reads  
UE 0.3509 No 227593 250858 201128 E 0.7493 No 
No: Pass 
fi lter reads 
E 0.7880 No 167093 193529 154215 E 0.8538 No 
% Pass fi lter UE 0.4270 No 72.75% 77.00% 76.87% E 0.4146 No 
Mean read 
length (bp) 
E 0.0330 Yes 444 423.74 433 UE 0.0011 Yes 
ɸ29 MDA single cell  l ibraries  
No: Raw 
reads  
E 0.1749 No 225451 217141 206578 UE 0.1283 No 
No: Pass 
fi lter reads 
UE 0.3212 No 174907 170233 161003 E 0.1545 No 
% Pass fi lter E 0.8351 No 77.76% 78.4% 78.14% UE 0.6544 No 
Mean read 
length bp)  
E 0.1506 No 460 428.77 429 UE 0.8522 No 
Table 3-24 table summarising the average results for sequencing output of ɸ29 MDA for the three bacteria with 
di ffering GC contents (C. difficile, E. coli and A. naeslundii). Additionally, the results of a  statistical test comparing results 
of E. coli (50% GC) sequencing to the extreme GC content bacteria. (F tests E= equal UE=unequal) 
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After reference assembly the average coverage of the reference genomes for the non-
amplification controls were 88.66% for C. difficile, 96.87% for E. coli and 63.39% for A. naeslundii. 
There was no significant difference between the C. difficile and E. coli, but the reference coverage 
of the A. naeslundii was significantly lower. The percentage of reads used to create the reference 
map was significantly higher in the C. difficile (99.84%) assembly than the E. coli (94.18%), but in 
the A. naeslundii reference assembly the percentage was significant lower (79.43%). There was no 
significant difference in the number of contigs produced for the C. difficile and E. coli reference 
assembly (850 C. difficile and 661 E. coli); however, there was a significantly higher number of 
contigs produced in the A. naeslundii assembly (1216). The size of contigs didn’t significantly differ 
in the C. difficile and E. coli, the average size of the largest contigs was 57823 bp for C. difficile and 
81579 bp for E. coli. The average contig size for C. difficile was 5655 and 22,442 for E. coli.  The 
contigs produced by the A. naeslundii assembly were significantly shorter (average size 1216 
compared to 11442 bp).  
When examining the ɸ29 MDA library data the average genome coverage of the C. difficile, E. 
coli and A. naeslundii reference sequences were 95.73%, 97.03% and 76.30%, with no significant 
difference between C. difficile and E. coli, but the A. naeslundii genome coverage was significantly 
lower. The number of reads used to generate the reference assembly was significantly higher for 
the C. difficile (97.04%), assembly when compared to E. coli (86.49%) assembly. The number of 
contigs produced by the reference assembly was 438, 316 and 1624, with no significant difference 
between the C. difficile and E. coli assemblies. However, there was a significant increase in the 
number of contigs produced by the A. naeslundii assembly. The largest contig and average contig 
size of the C. difficile and E. coli assemblies showed no significant difference, but again there was 
a significant difference between the A. naeslundii and E. coli assemblies, with the A. naeslundii 
assembly producing much smaller contigs.  Figure 3-16 shows the average and largest contig size 
produced by each bacterial non-amplification control and ɸ29 MDA libraries along with the 
genome coverage and reads mapping.  
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Figure 3-16 comparison of average and longest contigs produced from reference assembly of the (A) non-
amplification control and (B) ɸ29 MDA l ibraries. Including reference coverage and % of reads used to create reference 
assembly 
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 C. difficile vs. E. coli Average results A. naeslundii vs. E. coli 
Culture control libraries 
 F 
test  
T test 
value 
Sig  
(0.05) 
C. 
difficile 
E. coli A. 
naeslundii 
F 
test  
T test 
value 
Sig  
(0.05) 
% ref 
coverage 
UE 0.3369 No 88.66% 96.87% 63.39% E 0.0003 Yes 
% reads 
mapped  
E 0.0015 Yes 99.48% 94.18% 79.43% E 0.0022 Yes 
No: 
Contigs 
E 0.7085 No 850 660.67 2018 E 0.0457 Yes 
Largest 
contig 
(bp) 
E 0.4385 No 57823 81579 10312 UE 0.0433 Yes 
Average 
contig 
(bp) 
E 0.3598 No 5655 11442 1216 UE 0.0357 Yes 
ɸ29 MDA single cells 
% ref 
coverage 
UE 0.0690 No 95.73% 97.03% 76.30% E 0.0027 Yes 
% reads 
mapped  
UE 0.0439 Yes 97.04% 86.49% 81.62% E 0.0533 No  
No: 
Contigs 
UE 0.3179 No 438 316 1624 UE 0.0006 Yes 
Largest 
contig 
(bp) 
UE 0.1216 No 146811 178657 11628 UE 0.0011 Yes 
Average 
contig 
(bp) 
E 0.1575 No 11357 1580
5 
1116 UE 0.0215 Yes 
Table 3-25 average va lues for reference assembly of non-amplification  and ɸ29 MDA sequencing for C. difficile, E. 
coli and A.naeslundii  including F and T test results comparing extreme GC content with E. coli (F test E=equal and 
UE=unequal) 
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When the non-amplification libraries of the three bacteria were de novo assembled, the 
average genome coverage was 83.16% for the C. difficile library, 84.90% for the E. coli library and 
60.94% for the A. naeslundii, with the A. naeslundii coverage being significantly lower than the E. 
coli.  The number of contigs, and contig sizes produced were similar between the three bacteria. 
The average number of contigs for C. difficile, E. coli and A. naeslundii was 900, 1697 and 1583. 
The average largest contig of the replicate assemblies was 30559, 32327 and 22587 bps for each 
bacterium.   The number of misassemblies when comparing C. difficile and E. coli showed 
significant difference (34 C. difficile vs. 27 E. coli); the number of misassemblies in the A. 
naeslundii de novo assembly was also significantly higher at 33. Further investigation of the 
QUAST analysis showed the total lengths of the  de novo assemblies for E. coli and C. difficile were 
similar to the reference sequence length. The average total assembly length for E. coli was 
4,444,129 bases (reference length 4,639,675 bp) and the average total length assembly length of 
the C. difficile was 3,908,710 bp (reference length 4,290,252 bases). However, the total length of 
the A. naeslundii assembly was only 81% of the reference length (2,464,713 bp, with a reference 
length of 3,042,856 bp). 
When inspecting the data produced from ɸ29 MDA libraries after the reads were assembled 
using a de novo approach the proportion of the genome that was covered was 92.88% for the C. 
difficile library, 92.21% for the E. coli library and 64.95% for the A. naeslundii. With the coverage 
being significantly lower in the A. naeslundii. The number of contigs produced and the contigs 
sizes showed no significant difference between the three bacterium (1235, 1230 and 1663). The 
number of misassemblies also showed no significant differences (25, 21 and 22). Further 
investigation of the QUAST analysis showed similar results to the non-amplification sample, with 
the E. coli and C. difficile assembly lengths being similar to the total reference length, and the A. 
naeslundii total reference length being shorter.  
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 C. difficile vs. E. coli Average results A. naeslundii vs. E. coli 
Non-amplification control 
 F test  T test 
value 
Sig  
(0.05) 
C. 
difficile 
E. coli A. 
naeslund
ii 
F test  T test 
value 
Sig  
(0.05) 
% ref 
coverage 
UE  0.8467 No 83.16% 84.90% 60.94% UE 0.0335 Yes 
No: 
contigs 
UE 0.1321 No 900 1697 1583 UE 0.7617 No 
 largest 
contig 
(bp) 
E 0.9029 No 30559 32327 22587 E 0.5278 No 
N50 UE 0.9317 No 4688 4506 4229 UE 0.5134 No 
#misasse
mblies 
UE 0.0398 Yes 34 27.00 33 E 0.0351 Yes 
Total assembly 
length (bp) 
  3908710 4444129 2464713    
Reference sequence 
length (bp)  
  4290252 4639675 3042856    
ɸ29 MDA single cell 
% ref 
coverage 
UE 0.7932 No 92.88% 92.21% 64.95% E 0.0003 Yes 
No: 
contigs 
E 0.6752 No 1235 1230 1663 E 0.1041 No 
 largest 
contig 
(bp) 
E 0.1256 No 29806 35872 21743 UE 0.0641 No 
N50 UE 0.6193 No 5194 5168 3835 E 0.1032 No 
#misasse
mblies 
UE 0.0677 No 25 21 22 E 0.6433 No 
Total 
assembly 
length 
(bp) 
   4,023,4
58 
4,453,1
25 
3,025,15
4 
   
Reference 
sequence 
length 
(bp)  
   4,290,2
52 
4,639,6
75 
3,042,85
6 
   
Table 3-26 average va lues for de novo assembly of culture control and ɸ29 MDA sequencing for C. difficile, E. coli 
and A.naeslundii  including F and T test results for comparison of extreme GC genomes with E. coli  
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3.9 Application to Low Level Mixed Bacteria 
To assess the utility of the approach developed in this study for the analysis of low number 
mixed infection two bacteria were mixed, amplified and sequenced. E. faecalis (3.2MB) and H. 
influenzae (1.8MB) were mixed in PBS in different ratios, E. faecalis: H. influenzae was 1:1, 1:10, 
1:100 and 1:1000 Table 3-27. 
The 1:1 ratio mix reference mapping results showed 93% coverage of the E. faecalis genome 
using 62% of the reads. The amount of the H. influenzae genome covered was 92% using 25% of 
the reads. In the 1:10 ratio, 64% of the E. faecalis genome was covered using 13% of the reads, 
and 94% of the H. influenzae using 85% of the reads. In the 1:100 ratio 15% of the E. faecalis 
genome was covered using 2% of the reads, and 94% of the H. influenzae genome was covered 
using 83% of the reads. In the 1:1000 genomes no reads mapped to E. faecalis and 93% of the H. 
influenzae genome covered was using 95% of the reads.  
 
Figure 3-17 Proportion of reads mapping to E. faecalis and H. influenzae in different ratio mixes, normalised for 
genome size 
Ratio Total 
reads 
Reads 
E. faecalis: H. 
influenzae 
% reads  
E. faecalis: 
H. 
influenzae 
% reads  
Normalised 
for genome 
size 
E. faecalis: 
H. 
influenzae 
%genome 
coverage  
E. 
faecalis 
%genome 
coverage  
H. 
influenzae 
1:1 133320 83286:33254 62:25 31:25 93% 92% 
1:10 229667 30086:195217 13:85 6.5:83 64% 94% 
1:100 148139 3169:122308 2:83 1:83 15% 94% 
1:1000 152879 0:145235  (:95) 0% 93% 
Table 3-27 Results of reference mapping to E. faecalis and H. influenzae in different ratio mixes, including 
proportion of reads before and after normalised for genome size and genome coverage.  
equal 1 in 10 1 in 100 1 in 1000
E.faecalis H.influenzae
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3.10 Amplification of Viral Genomes  
To determine whether ɸ29 MDA can be applied to viral genomes adenovirus 40 (Ad40) and 
adenovirus 41 (Ad41) were amplified and sequenced. Adenoviruses are none enveloped 
icosahedral viruses of between 90-100nm which have a double stranded DNA genome of 35-36kb. 
The group F adenoviruses were cultured as described in section 2.1.3.1  extracted and amplified 
using ɸ29 MDA as previously described. 
Three replicates of Ad40 were sequenced producing 123070, 194887 and 140934 reads, with 
73.32%, 73.79% and 79.68% of these reads passing filters. When these were assembled against 
the reference genome they formed a single contig that covered 99.98%, 99.83% and 100% of the 
genome. The percentage of reads used to form these assemblies were 20.38%, 27.21% (Figure 
3-18) and 22.95% of all the reads. The de novo assemblies formed 261, 108 and 204 contigs 
respectively covering 96.68%, 96.4% and 96.87% of the genome.  The numbers of misassemblies 
were 3, 0 and 0 for the three runs. When the reads were examined using Blastn and LCA analysis 
on average 52.8% of reads were identifies as the family Homininae, and in one sample there was a 
contamination of E. coli representing 4.7% of the reads Figure 3-18-A. The remaining reads were 
unassigned.  
Three replicates of Ad41 were sequenced. After sequencing 68225, 128802 and 147597 reads 
were produced with 64.4%, 65.05% and 76.7% of these reads passing filters. When these were 
assembled against the reference genome they formed a single contig that covered 99.69%, 
99.93% and 99.96% of the genome. The percentage of reads used to form these assemblies 
40.75%,27.17% and 22.95% of all the reads. The de novo assemblies formed 28, 102 and 41 
contigs respectively covering 98.47%, 99.71% and 98.75% of the genome.  The number of 
misassemblies was 0, 0 and 2 for the three runs. On average 24.6% of reads mapped to the family 
Homininae and the remaining reads were unassigned Figure 3-18-B.  
To lower the presence of host commination, before extraction the sample was treated with 
DNase1 to remove any host DNA that was reaming in the supernatant. After sequencing 311767, 
219881 and 168407 reads were produced with 45.79%, 74.92% and 80.36% of these reads passing 
filter. The reads were reference assembled into a single contig covering 100%, 99.96% and 99.88% 
of the reference genome. The number of reads used was 75.98%, 82.92% and 66.14%. The 
number of de novo contigs was 98, 106 and 211 covering 99.04%, 98.55% and 90.12% of the 
reference with 1, 0 and 0 misassemblies. In two out of three replicates no reads were identified as 
the family Homininae and in the final sample 3.6% of reads were assigned to the family 
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Homininae. In one sample there was a small proportion of reads (1.3%) identified as H. influenzae 
Figure 3-18-C.  
 
 
     
 
Figure 3-18 LCA analysis demonstrating proportion read identification after ɸ29 MDA and sequencing of (A) 
Adenovirus 40, (B) Adenovirus 41 and (C) post DNase treatment Adeno41  
  
B 
C 
A 
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3.10.1 Application to Mixed Adenovirus and HIV  
 
3.10.1.1 Extracted Nucleic acid 
Initially extracted nucleic acid, from a DNA (Ad41) and a RNA (HIV) virus were used to 
establish the applicability of reverse transcription and ɸ29 MDA to both RNA and DNA pathogens 
simultaneously.  
The number of particles of the adenovirus tissue culture was quantified as 2.3x108 virions per 
ml.  500 µl of adenovirus tissue culture supernatant was concentrated and extracted (including a 
DNase and RNase stage) as described in  section 2.5.1.1, the DNA was diluted to contain the 
equivalent of 25 viral copies per µl (0.001 pg/µl). This was added to the equivalent of 25 virions of 
HIV (0.0002 pg/ µl). (Using End Memo online tool for copy number calculator, based on HIV 
having two copies of the RNA genome per Virion.)   The mixture of the extracted RNA and DNA 
was added to the reverse transcription reaction with SuperScript IV as described in 2.2.2.5 . The 
resulting DNA was then amplified using ɸ29 MDA for two hours. The DNA output was 584 ng/ µl, 
which was then sequenced using the 454 Junior as previously described. In total 103115 
sequencing reads were produced, with 72143 reads passing filter, of these 6954 (9.64%) mapped 
to the human genome. 66.2% of the remaining reads were identified as Adenovirus, and 20.76% 
as HIV and 12.6 % of reads were not identified. The remaining reads were identified as 
Proteobacteria. When the reads were assembled using de novo assembly 92.3% of the adenovirus 
genome and 91.4% of the HIV genome were covered.   
 
3.10.1.2 Adenovirus and HIV-Viral Particles 
Dilutions of the supernatant of HIV and Adenovirus tissue cultures were made so as to contain 
an estimated 25 viral particles. These were pooled and then the total volume made up to 10 ml. 
This was then concentrated with PEG 20,000 incubated on ice for one hour (2.5.1.1), host nucleic 
acid removed (2.5.1.2) and the sample was extracted using column extraction (2.5.1.3). The 
resulting eluted nucleic acid was then added to a reaction with SuperScript IV using random 
primers (2.5.1.5) before being heated to 95oC for two minutes followed by 2 minutes on ice. The 
sample was then amplification in a two hour ɸ29 MDA reaction, resulting in a DNA concentration 
of 491 ng/ µl. Which was fragmented and sequenced on the 454 junior as previously described.  
After sequencing 126391 reads were produced with 91001 passing filter. When removing human 
signals, 6.8% of reads were found to be human, of the remaining reads 62.7% mapped to 
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adenovirus and 28.4% mapped to HIV, 8.8% of reads had no identity. The remaining reads were 
once again Proteobacteria.  
The adenovirus de novo assemble covered 97.1% of the genome in 392 contigs, with three 
misassemblies. The HIV de novo assembly covered 99.9% of the genome in three contigs, with 
two misassemblies. When the de novo assembly results were analysed using an automated 
genotyper, REGA version 3 (Stanford University)137  (Figure 3-19) the results were sub-type   B, 
which correlated with the input.  
 
 
 
 
Figure 3-19 HIV and DNA vi ral mix ɸ29 MDA sample (A) proportional read identification of amplification of 
extracted nucleic acid and vi ral particles of Ad41 and HIV mix. (B) HIV genotyping using de novo assembly of ɸ29 MDA 
prepared Ad41 and HIV mix using REGA version 3 (B) 
Extracted nucleic acid Particles
Other
Human
HIV
Ad41
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3.10.2 Application to Multiple Viral Pathogens  
3.10.2.1 Preparation of Initial Viral Mix  
 A viral mixture was prepared as described in 2.5.3.1, briefly; this included the same volume 
of HIV and Adenovirus tissue culture supernatant as in 3.10, which aimed at 25 virus particles. 
Additionally an estimated 25 viral particles of HBV, Parvovirus 19, HAV, and HBV were added, 
volumes were calculated using the IFU/ml given by NIBSC Table 2-3. For the VZV, Norovirus, 
Measles and Influenza A only Ct values were provided and so 20 µl of each of these were added.  
The total volume was then made up to 10 ml and the viruses were concentrated and extracted as 
previously described.  
The number of reads assigned to Ad41 was 338, which when assembled using de novo 
assembly covered 32.7% of the genome in 36 contigs. The number of reads assigned to VZV was 
1111481, which equated to 2309 viral copies, when these reads were assembled using Spades 
94.1% of the genome was covered in 39 contigs. 98 reads were assigned to HBV, which equated 
to 95 viral particles; the de novo assembly covered 42.3% of the genome in 29 contigs. Parvovirus 
19 had 255 reads assigned, equating to and input of 264 virus particles, when assembled 86.0% of 
the genome was covered in 19 contigs Table 3-28.  
Using LCA analysis 164 reads were assigned to HIV, and when assembled into 34 contigs were 
formed which covered 40.8% of the genome. Norovirus had 11136 reads assigned, which was 
calculated to represent 4117 virus particles, when these reads were assembled 97.5% of the 
genome was covered in 23 contigs. HAV had 40 reads assigned which was equated to 16 viral 
particles, when de novo assembled 21.9% of the genome was covered in 19 contigs. HCV had 451 
reads assigned; equal to 133 viral particles, when this was assembled 51.3% of the genome was 
covered in 21 contigs. No reads were assigned to Measles virus. Influenza A had 12960 reads 
assigned, with 2948 viral copies, when these reads were assembled 93.5% of the genome was 
covered in 25 contigs Figure 3-20 and Figure 3-21.  
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Virus  
Genome 
type  
Genome 
size (kb) 
GCPC  Reads  
Normalised 
Reads  
Relative 
viral 
input  
Genome 
Cov % 
Contigs 
Ad41 DS DNA 35 1 338   25 32.7 36 
VZV DS DNA 125 1 111481 9300 2309 94.1 93 
HBV 
Partial 
DS DNA 
3.2 1 98 6969 95 42.3 29 
Parvovirus 
B19 
SS DNA 5 1 255 18284 264 86 19 
HIV 
SS (+) 
RNA 
9.7 2 164   25 40.8 34 
Norovirus  
SS (+) 
RNA 
8 1 11136 13311 4117 97.5 23 
HAV 
SS (+) 
RNA 
7.5 1 40 20435 16 21.9 19 
HCV 
SS (+) 
RNA 
10 1 451 13894 133 51.3 21 
Measles 
SS (-) 
RNA 
15.5 1 0 118 0     
Influenza 
A 
SS (-) 
RNA 
13 1 12960 5956 2948 93.5 25 
Other        1575         
Total        138498         
Table 3-28 results of sequencing of mixed vi ral input using reverse transcription with SuperScript III and DNA 
amplification using ɸ29 MDA, including -reads assigned, calculated vi ral particle number and assembly 
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Figure 3-20  visualisation of proportional read identification using LCA analysis for initial mixed vi rus reaction  
amplified using ɸ29 MDA.  
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Figure 3-21 LCA analysis of initial mixed viruses amplified with ɸ29 MDA   
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3.10.2.2 Calculating Viral Input 
An equation was developed (Equation 2) to which allowed the number of viral particles 
present in a sample to be calculated by using a known quantity viral spike. This equation takes 
into account the genome size, the genome type and the number of copies of the genome the 
virus carries. The use of a known spike will allow more accurate quantification of the viral 
particles identified, as opposed to the relative abundance. In a high through put assay the values 
for the reference would be fixed. In this case the number of control particles was 25. The assigned 
reads refers to the identification given to reads using Blastn and LCA analysis using Megan, and so 
represents the number of reads identified as each virus. The reads are normali sed for genome size 
to allow for the different genome sizes, due to the assumption that, a genome that was twice the 
size would be expected to produce twice the number of reads. The strand designation value 
allows the nature of the genome to be taken into account, such that a virus with a double 
stranded genome would start off with twice the amount of reads as a virus with the same sized 
genome but a single stranded genome. Also in this case a different RNA and DNA reference spike 
was included to account for inefficiencies in RNA conversion, and any RNA degradation that may 
have occurred during processing.  
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3.10.2.3 Sequencing Output Viral Mix after Adjustment of Input 
The input volumes of the viral mix were adjusted based on the previous result to an expected 
outcome of 25 viral particles in total. The resulting number of reads for adenovirus was 5960, 
which was used as the reference for 25 viral particle input. When these reads were de novo 
assembled they covered 96.1% in 48 contigs.  The number of reads assigned to VZV was 33215, 
which equated to an input number of 39. When the VZV reads were assembled they covered 
94.2% of the genome in 115 contigs. The reads assigned to HBV totalled 531, which was 
equivalent to 29 input particles. When assembled they covered 98.7% of the genome in three 
contigs.  The number of reads assigned to Parvovirus was 1306, equating to 77 viral particles. 
When the Parvovirus19 reads were assembled 96.3% of the genome was covered in six contigs.  
   (
 (  )(
 
 )
 (  )
)   
 
 
 
V=viral number 
P=Number control particles 
A=assigned read number 
R=Spike read number 
r=Spike genome size  
a=assigned genome size 
c=genome copies per virus, assigned 
d=genome copies per virus reference 
s= spike strand designation 
t= assigned strand designation 
Strand type designations= double stranded=1, single stranded = 2,  
Partial double stranded = the number of bases double stranded divided by number of bases single 
stranded.  
 
Equation 2 (A) Equation for calculating number of vi ral particles based on a  known spike (B) worked 
example for Ad41 spike from 3.10.2 and (C) worked example for HIV spike from 3.10.2 
C 
A 
B 
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 The number of reads assigned to HIV was 3240, which was used as the reference to adjust 
the RNA virus numbers. The de novo assembly covered 99.2% of the genome in four contigs. The 
number of reads assigned to Norovirus was 5489 which equated to 103 viral particles. When the 
assigned reads were assembled 98.7% of the genome was covered in three contigs.  The number 
of reads assigned to HAV was 7900 which was the equivalent of 158 virus particles. The de novo 
assembly covered 97.9% of the genome in 9 contigs. The total number of reads assigned to HCV 
was 7162, which was comparable to 107 viral particles. The de novo assembly of the assigned 
reads consisted of 11 contigs, which covered 99.1% of the genome. The number of reads 
identified as Measles was 94, equivalent to 1 viral particle. 11.2% of the measles genome was 
covered using de novo method, in seven contigs. The number of reads assigned to influenza A was 
3991, equating to 46 copies. These reads were assembled into 32 contigs covering 88.1% of the 
genome.  
3.10.2.4 Detection of Viral Genotypes 
Using the Blastn identification and LCA analysis of the viruses’ genotypes were identified 
correctly for most of the viruses in the mixture. The adenovirus was correctly identified as Human 
adenovirus 41, the VZV was subtyped as B, the HBV was identified as genotype A (defined by S -
gene type), and also subtype adr (surface antigen typing). Using Blastn the HIV was only identified 
as HIV-1, but when an online tool was used, it was correctly identified as subtype B. The human 
parvovirus 19 was not further identified. The measles virus was also not further identified. The 
influenza was correctly identified as being H3N2, and the Norovirus was correctly  identified as 
genotype II but not further subtyped. The HCV was identified as genotype 3, and the HAV was 
identified as group 1.  
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Virus  
Genome 
type  
Genome 
size (kb) 
GCPC  Reads  
Normalised 
Reads  
Relative 
viral 
input  
Genome 
Cov % 
Contigs 
Ad41 DS DNA 35 1 5960   25 96.1 48 
VZV DS DNA 125 1 
3321
5 
9300 39 94.2 115 
HBV 
Partial 
DS DNA 
3.2 1 531 6969 29 98.7 3 
Parvoviru
s B19 
SS DNA 5 1 1306 18284 77 96.3 6 
HIV 
SS (+) 
RNA 
9.7 2 3240   25 99.2 4 
Norovirus  
SS (+) 
RNA 
8 1 5489 13311 103 98.7 3 
HAV 
SS (+) 
RNA 
7.5 1 7900 20435 158 97.9 9 
HCV 
SS (+) 
RNA 
10 1 7162 13894 107 99.1 11 
Measles 
SS (-) 
RNA 
15.5 1 94 118 1 11.2 7 
Influenza 
A 
SS (-) 
RNA 
13 1 3991 5956 46 88.1 32 
Other        1375         
Total        
7026
3 
        
Table 3-29 results of sequencing of mixed vi ral input after adjustment using reverse transcription with SuperScript 
I I I  and DNA amplification using ɸ29 MDA, including -reads assigned, calculated vi ral particle number and assembly 
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Figure 3-22 LCA Output of vi ra l mix Blastn using MEGAN after adjustment showing vi ral genotype identification 
168 
 
 
Figure 3-23 proportional read identification using LCA analysis of Blastn results of the adjusted vi ral mix after 
amplification with ɸ29 MDA  
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3.11 Chapter Discussion 
3.11.1 Assessment of RNA Conversion Enzymes 
RNA viruses are a major cause of local and global outbreaks, such as seasonal Norovirus 
outbreaks. One study suggested that two Norovirus seasons cost one hospital £1.2 million due 
lost bed days and staff absences138. Rapid and accurate whole genome sequencing will inform 
epidemiological studies, helping to interrupt transmissions.  
The first aim was to efficiently concentrate and extract viruses, which may be circulating in 
low numbers. The initial PEG concentration was based on Kohno et al’s 121 study, which used an 
overnight incubation at 4oC. This will be a major bottle neck in sample processing and so shorter 
incubation times were investigated. One-hour incubation at 4oC had a fairly poor performance 
compared to overnight (RNA concentration of 0.76 vs. 1.14 ng/µl), however by incubating the 
sample on ice for one hour, comparable results were achieved (1.07 ng/µl). Incubating viral tissue 
culture supernatant with PEG for one hour on ice recovers 94% of the viral RNA compared to 
overnight incubations at 4oC in 6.5% of the time (3.2.1). For this study, which aims at rapid 
sequencing from samples one-hour incubation on ice was seen as a better option.  
After initial concentration and nucleic acid quantification, high levels of DNA in the sample 
(1.87 ng/µl) indicated the presence of host nucleic acid, indicating some of the RNA detected 
would likely be the presence of host RNA, particularly ribosomal RNA. Whole cells should already 
have been removed by centrifuging at lower speeds without PEG, and so the source of 
contaminating nucleic acids should be free nucleic acid. The treatment with RNAse and DNAse left 
no detectable DNA and very little RNA, presumably belonging to HIV. Use of RNase and DNAse 
treatment to remove host signals is important when using non-specific amplification (3.2.1), as all 
DNA including host will be amplified.  
 
For RNA viral detection there needs to be a rapid and reliable method for producing long 
length transcripts from a variety of inputs. Initially specific amplicon targets were used to assess 
the sensitivity and compatibility of three reverse transcription enzymes. Amplicons of varying 
lengths aided in indicating the ability to produce long length transcripts. On initial testing after 
PEG concentration and alkali extraction SuperScript III and IV were both able to produce long 
transcript (2283 bases) at 0.1 pg. SuperScript III had a lower sensitivity of 0.1 pg compared to 
SuperScript IV, 0.01pg; however SuperScript IV failed to produce products ove r 1233 bases at this 
lower concentration.  SuperScript IV is known to be less affected by inhibitors which may have 
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been present in the sample explaining the slightly higher sensitivity. However, both SuperScript 
enzymes performed more poorly than expected. PyroPhage was unable to produce transcripts for 
any size amplicon at all input concentration inputs.  When the SuperScript enzymes were 
combined with ɸ29 MDA, the results were very poor, with only inputs of 1000 pg producing 
products. The source of these PCR products were most likely the original SuperScript products and 
not DNA amplified by ɸ29 MDA. Suggesting that ɸ29 was not able to produce DNA from these 
transcripts.  
The poor performance of all enzymes could be caused by inhibition of enzymes; due to  the 
presence of PEG or lack of viral extraction due to PEG interfering with the alkali extraction 
method. Also PEG allows concentration of small molecules by removing space in the solution; this 
action may prevent enzymes accessing the nucleic acids as freely. A more efficient extraction 
method which included the removal of PEG was investigated to purify the HIV extracts after PEG 
concentration. A spin column, PureLink Viral, was selected, with the substitution of carrier RNA 
with LPA, as carrier RNA would be converted and sequenced. The small filter allows elution of 
nucleic acids in small volumes, allowing additional concentration of the nucleic acids.  
After column extraction the performance of SuperScript II and IV improved, and when ɸ29 
was added, full transcripts were produced.  The sensitivity of SuperScript IV was found to be 
0.00001 pg, which was better than SuperScript III. PyroPhage 3137 was able to successfully 
amplify targets at 422 bases, the exonuclease negative enzyme had a higher sensitivity, (0.001 pg 
vs. 1000 pg) than the wild type enzyme. Although the exonuclease negative enzyme showed 
higher sensitivity, the enzyme would be less suitable for highly sensitive conversion due to the 
higher error rate. The inability of the enzyme to produce products greater than 400 bases has 
previously been reported 78, this combined with the high error rate and lower sensitivity means 
that PyroPhage 3137 is unsuitably for high sensitivity whole genome amplification.  
Overall the use of column extraction improved the performance of all enzymes, probably 
because traces of PEG were removed. SuperScript IV had the highest sensitivity, and has the 
advantage of more rapid reaction times (10 minutes, compared to 1 hour with SuperScript III)  and 
so was selected for further work. Previous work coupling ɸ29 MDA with randomly primed reverse 
transcription used SuperScript III,  and cDNA production took 100 minutes139. By using a more 
recently engineered enzyme the reaction time was reduced, allowing results to be obtained 
quicker.   
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3.11.2 Non-PCR Based Amplification of Bacterial Genomes 
Strand displacement enzymes are able to continually produce DNA, even through regions of 
double stranded DNA. This has the potential to produce reads of a long length which cover whole 
pathogen genomes without the need for specific priming.  
Escherichia coli K12 substr. MG1655 was used for initial experiments, due to its 50% GC 
content, ease of growth and fully characterised genome. Initially a PCR with targets across the 
genome of E. coli K12 was used to indicate the success of amplifying the whole genome. Although 
the ten points chosen only represent a very tiny portion of the genome, it allowed quick and 
cheap indication of the success of the ɸ29 MDA amplification.  E. coli was extracted using the 
alkali method and amplified using ɸ29 MDA producing a high concentration of DNA, which with 
repeats was shown to be reproducible. The ten-target PCR was positive in all replicates for all 
targets, indicating successful genome amplification. This demonstrated good DNA production 
across the E. coli genome.  Additionally, DNA of high concentration was produced from a negative 
sample; however, this produced negative results when tested in the E. coli PCR, ruling out 
contamination. The most likely cause is unspecific amplification due to the high processivity of 
ɸ29 which could be using the primers present to start random replication in the absence of a 
template to copy. This work combining ɸ29 MDA with targeted PCR amplification, is similar to  
earlier work, such as the amplification of the intracellular pathogen Coxiella burnetti140. The aim is 
to develop the method to rapidly produce whole genome data suitable for sequencing  
 
3.11.3 DNA Amplification from Nicks 
Potentially by removing primers from amplification reactions the introduction of primer bias 
could be prevented allowing a more even coverage of genomes. Additionally, removal of primers 
could prevent the production of non-specific DNA in low input samples. DNA has previously been 
successfully amplified from nicks 134 using other polymerase enzymes, so this section aimed to 
investigate the potential of ɸ29 MDA to produce full length amplification from nicks in DNA. 
Firstly, bioinformatic predictions of frequency of the nicking sites predicted that the number of 
nicking sites varied with the GC content of pathogen, with the high GC genomes being nicked 
more frequently. If the method was successful, an alternative enzyme or a combination of nicking 
enzymes may have been considered to even out the cutting frequency.  
After incubation of nicked DNA with ɸ29, all libraries failed to amplify DNA (3.3.2). The 
control with nicked DNA and primers also failed to produce DNA. This may be due to enzyme 
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inhibition from the nicking buffer, or enzyme competition. A clean up using isopropanol was 
trialled in an effort to remove the inhibitor.  There was still no DNA production from the nicked 
samples, however the control with nicked DNA and primers did produce DNA but at a lower level 
than the non-nicked sample with primers. Potential explanations include damage to the DNA or 
inhibition due to ethanol carry over from the clean-up. Another reason for failure could be that 
the nicking points are repaired before ɸ29 has a chance to bind. To overcome potential nick 
repairing co-nicking and amplification was investigated. The use of co-nicking and amplification 
would also have the added advantage of continually producing nick points for DNA production, 
thereby increasing amplification efficiency. The addition of a single stranded binding protein 
(SSBP) was also trialled in an effort to stabilise the nicked single stranded DNA. These reactions 
also failed to produce any DNA, potentially because ɸ29 is too large to bind in at the point of 
nicking, or ɸ29 actually starts replication upstream of the primer site. Previous investigation into 
the ability of ɸ29 to amplify from nicks also failed to produce DNA134, strengthening the argument 
that the enzyme is not capable of producing DNA in this manner. Other strand displacement 
enzymes could theoretically begin the process of amplification from nicks, increasing the size of 
the single stranded DNA section allowing ɸ29 to bind and continue amplification 
The first enzyme investigated was Klenow fragment (3.3.3.1), which has been previously used 
to produced DNA from nicks 97. When incubated with nicked DNA, Klenow did produce low levels 
of DNA, with product sizes 15-300 bases, with the sizes of the DNA fragments produced slightly 
increasing with the addition of the SSBP. Only 24% of reads produced by Klenow fragment were 
above 300 bps and none were over 2000 bp (3.3.3.1). this was an improvement on previous uses 
of Klenow Fragment135, where when it was used for TB amplification products of only 200bp were 
achieved. However, the addition of ɸ29 failed to produce any extra DNA. The control sample with 
primers was successful with ɸ 29, but at lower concentration than previous amplifications. This 
indicated that whilst the enzyme was able to produce DNA under these conditions they were not 
optimal for enzyme function.  
The next enzyme investigated was Vent, which has known strand displacement activity, 
however it is normally used for thermocycling production of DNA, where there are high levels of 
secondary structure. Firstly the ability of the enzyme to perform isothermal amplification was 
investigated (3.3.3.2). No DNA was produced below 60OC and at 60 OC only very low 
concentrations of DNA was detected. There was an increase in DNA production above 70oC, 
suggesting that the enzymes strand displacement activity is only active at high temperatures. 
Even at the higher temperature less DNA was produced, (2.98 ng/µl) compared to the 
thermocycling control (12.3 ng/µl). When investigating the extension from nicks a small amount 
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of DNA was produced above 80oC, however this is probably down to the DNA denaturing at 
nicking points.  Inclusion of SSBP had little effect on DNA production using VentR. There was a 
small increase in the concentration of DNA when the DNA was incubated with ɸ29 for six hours; 
however, this was most likely low level background amplification. Although this enzyme’s strand 
displacement ability was previously known141, this study provides  the first evidence of isothermal 
amplification with this enzyme. The increased ability to produce DNA through the stand 
displacement mechanism is in line with the findings of Kong et al 141, who described increasing 
strand displacement activity at higher temperatures.  
The final enzyme investigated was Bst, which is commonly used in stand displacement 
amplification in DNA production using Multiple Annealing and Looping Based Amplification Cycles 
(MALBAC) approach. Bst was able to produce DNA from nicks in isothermal conditions at 50oC, 
60oC, and 70oC, and to a lesser efficiency at 40oC (3.3.3.3). Combing Bst with SSBP had little impact 
on DNA input. Addition of ɸ29 to Bst reactions produced less DNA than Bst used alone, suggesting 
that the working conditions of the two enzymes are not compatible. Similarly to Klenow 
Limitations in the length of DNA produced by Bst from nicks have previously been described, with 
evidence of unspecific amplification when products of greater than 600 bp are amplified 142 
Additionally previous work suggested that amplification from nicks using Klenow and Bst was 
very sensitive to nicking enzyme concentration, success here suggests that balance of nicking 
enzyme and amplification enzymes are near optimal and limited improvements could be made134.  
 
In conclusion, ɸ29 is not able to produced DNA from nicks in DNA, even in combination with 
other strand displacement enzymes.  One explanation for the failure of ɸ29 to amplify from nicks 
is the re-sealing of nicks when the reaction is cooled to 30oC. However, the most likely 
explanation is the failure of ɸ29 at the nicking point, either as it is too large, or its initiation point 
is downstream of the primer point. Another enzyme known as Sequenase,  has been shown to 
produce product lengths of up to 5000bp134. However this enzyme is a modified T7 polymerase 
which has a higher error rate and a lower processivity than ɸ29141  and the aim of this study was 
to rapidly produce long lengths of DNA with high fidelity 
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3.11.4 DNA Production from RNA and DNA using DNA Tagging 
Addition of tags could aid in stabilisation of the 3’ ends of DNA and RNA, allowing the 
production of more full length transcripts. There is the additional potential to include unique 
identifiers in the tag to allow identification of initial mixes in samples.  
Initially small (330 base) amplicons were used to check for tag attachment (3.4.2), which 
resulted in an increase in the peak size when visualised on the Bioanalyser. When this tagged DNA 
amplicon was incubated for four hours with varying size tags attached, the tag with a five base 
pair single stranded section failed to produce DNA. The tag with a 10 base pair section produced 
DNA (0.497 ng/µl), and the 15 base pair tag produced less (0.311 ng/µl) showing there was 
successful amplification from these tags. The ten base overhang DNA tags were the most efficient 
at producing DNA, indicating ɸ29 needs between 6 and 10 bases to bind and initiate replication. 
The 15 base pair tag was less successful suggesting that the tag was less stable. There were small 
increases in the concentration of DNA in all reactions (including negative control) after six hours 
of incubation, suggesting background non-specific amplification.  When tags with RNA segments 
were used the results were similar, but with less DNA production in all cases, implying the 
secondary structure is less stable than with DNA.  
When the tags were attached to longer DNA fragments (3.4.2.2) similar results were found, 
with failure to amplify from 5 bases, and 10 base tags giving the best outcome. When the 
fragments were investigated the products were longer than the input sizes, suggesting either 
chimera formation or the secondary structure from replication caused altered DNA movement 
through the Bioanalyser chip. There was less DNA produced using tags than primers, as there is 
only a single starting point in each fragment as opposed to many random primer binding points. 
From these experiments, it is possible to infer that, for optimal initiation of replication, ɸ29 needs 
a gap greater than 5 bases and less than 15 bases. There are some similarities between this 
method and Loop mediated isothermal amplification (LAMP), which uses a stem-loop feature for 
DNA extension92. However, LAMP requires primer targets and limits the size of DNA produced, 
and so is not suitable for the rapid production of untargeted DNA.  
 When tagged RNA was incubated with reverse transcriptase it failed to produce any 
cDNA. Reasons for this include failure to attach the DNA tag to the RNA target, however T4 ligase 
has better activity to join RNA and DNA 143. Alternatively, the RNA target may not have been 
dephosphorylated, or SuperScript may have failed to initiate reverse transcription as the tag is 
made from DNA. A reverse transcription LAMP protocol exists, suggesting the possibility of 
reverse transcription from stem-loops144, however this technique is based on using MMLV reverse 
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transcribing enzyme which has a higher error rate and a lower working temperature. Additionally, 
as reverse transcription is the first stage, it mainly occurs prior to stem-loop formation.  
Overall there was no cDNA production using the tagging methods, and RNA genomes had the 
most to gain from the stabilisation of 3’ ends, which are often missing from sequencing data. The 
aim of this project was to develop a rapid method of producing sequencing data from a variety of 
inputs with a single method. The DNA production is also less efficient as there are less starting 
points, and the DNA needs to be fragmented prior to tag attachment. However, these tags could 
be used to provide accurate quantification of the starting mixes in complex samples, by adding an 
index to each original DNA fragment before a longer amplification time was used.  
Overall use of random primers was the most efficient way to produce DNA. When low starting 
material is used multiple priming points across the genome will allow rapid production of DNA 
without prior knowledge of the pathogen. However, this will also produce non-specific DNA 
without the presence of a template and so use of quantification of DNA as a measure of positivity 
would not be suitable.  
3.11.5 Development of ɸ29 MDA for Whole Genome Sequencing 
Often ɸ29 MDA is used alongside targeted techniques to increase the sensitivity of PCR140,145 
or micro-arrays146. Here the aim was to produce a library suitable for whole genome sequencing. 
The first attempt to sequence a library prepared using ɸ29 MDA (3.5) failed, producing no 
sequencing beads after enrichment. The enrichment process removes beads which have no 
amplified target bound, leaving only those beads which have successfully amplified the library 
attached. There are three potential reasons for no beads remaining after enrichment, either the 
DNA failed to attach to the beads, the library was inefficiently amplified once on the beads, or the 
library completely failed to amplify during the EmPCR stage.  In order for the DNA to attach to the 
beads it must have the correct adapters attached to the DNA fragments. During the library 
quantification it is these ligated adapters that are used to quantify the library. Any unligated 
adapters should be removed during the library size selection and clean up so only successfully 
ligated adapters would be visualised during quantification. Therefore, any unattached adapters 
will not be quantified, thus the most likely cause was problems during amplification once the DNA 
was attached to the beads. The lengths of the DNA strands after library preparation were slightly 
larger than the recommended maximum length, which could have potentially caused poor 
amplification of the product (due to a finite amount of reagents such as dNTPS and magnesium 
ions). However, there was a variety of lengths of DNA produced, with some of them being within 
the recommended length, and so this would have produced a poor yield of enrichment beads 
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rather than a total lack of enrichment beads. Therefore, the most likely reason for failure was lack 
of amplification of library once on the beads.  The amplification reaction on the be ads is 
performed using a Taq polymerase, which has no strand displacement ability. The highly complex 
DNA structure produced by the ɸ29 MDA amplification enzyme may interfere with the ability of 
the Taq polymerase to amplify the target DNA. There is a denaturation stage prior to addition of 
the DNA to beads, but this may be insufficient to overcome all of the secondary structure of the 
branched DNA.  
To attempt to overcome the issue of failure to produce libraries, two additional steps were 
incorporated into the library preparation. The first additional stage was to add an S1 nuclease 
reaction (3.5.1), which cuts DNA at points where it is single stranded; this will remove the 
branches from the DNA product and lower the overall complexity of the DNA product. Removing 
branches also makes DNA quantification using probes more accurate  because of the lowered 
complexity of the DNA structure. There have also been suggestions in the literature that use of S1 
nuclease lowers the number of chimeric reads produced147,148.   
The second step to ensure the success of sequencing runs was, to increase fragmentation of 
the DNA produced by ɸ29 MDA after S1 nuclease digestion. The reads produced using ɸ29 MDA 
amplification are very long, and so additional nebulisation was needed to reduce the DNA 
fragments to a suitable size. Two fragmentation methods were investigated, the use of the 
Fragmentase enzyme, and physical shearing via nebulisation.  
Use of the Fragmentase enzyme after S1 nuclease treatment found that both the 10 and 15 
minute incubations produced DNA that was too large to quantify on the Bioanalyser (>10380 bp) 
and even the 20-minute incubation produced most fragments above this point. When the two 
enzymes were combined in a reaction no fragmentation occurred. This inefficiency of the 
Fragmentase may be because of the very long lengths of the ɸ29 MDA, or suboptimal enzyme 
conditions due to carry over of ɸ29 MDA buffer. One possible solution would be to clean-up to 
DNA between S1 treatment and incubation with Fragmentase. However due to the large size of 
products produced during ɸ29 MDA most DNA clean-up techniques aren’t suitable, column based 
clean ups would fail to allow large DNA fragments elute through the column, and so to clean-up a 
method such as isopropanol would have to be used. The additional reaction time required for the 
enzyme fragmentation compared to the nebulisation (>30minutes compared to 2 minutes) plus 
the extra clean-up stage required, makes the physical shearing a better option. Although 
enzymatic methods are preferred for some applications, as less DNA is lost during the process, 
this is not a problem when using ɸ29 MDA as so much DNA is produced.  Nebulisation produced 
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fragments of a suitable size for sequence library preparation and also has the advantage that 
there is less bias in the points at which the DNA is fragmented as the process is random and 
enzymes have a target. This is particularly important when looking at de novo assemblies as DNA 
will be fragmented at different places.  When looking at pathogens at the extremes of GC content, 
cutting bias will be increased. In conclusion the best library preparation for ɸ29 MDA prepared 
DNA is a combination if S1 nuclease to remove braches and reduce chimers, and extended 
physical shearing.  
3.11.5.1 Reproducibility of ɸ29 MDA in Whole Genome Amplification 
After successfully sequencing libraries produced using ɸ29 MDA, the reproducibility of the 
methods was investigated in terms of the amount of DNA produced during the  ɸ29 MDA reaction, 
the amount of reads produced by the sequencing and the amount of the reference that was 
covered showed no significant difference. This confirmed that the method is robust for DNA 
amplification and sequencing and is suitable for whole genome amplification and analysis  
3.11.6 Comparison of ɸ29 MDA to Current Methods of Bacterial 
Sequencing 
The sequence data produced by the ɸ29 MDA amplification method was compared to the 
most commonly used (culture based) non-amplification method in section 3.6.1. This showed very 
similar sequencing outputs, verifying the good quality of DNA produced. There were small 
differences in the sequencing output which were most likely due to sequencer variation and 
problems with equipment overheating. This had no impact on the amount of the genome which 
was covered with both methods covering the same percentage of the reference genome, with the 
average φ29 MDA reference assembly coverage of 97.88% vs. average non-amplification 
reference coverage of 96.87% Figure 3-8. When the reads were assembled both the reference 
and de novo assembly produced fewer and longer contigs using ɸ29 MDA libraries. The number of 
misassemblies in the de novo assemblies was also lower in the ɸ29 MDA libraries. This could be 
down to better quality DNA input, as the extraction method used for the control libraries used 
columns and may have caused shearing and DNA damage. The ɸ29 MDA library included more 
reads that mapped to the plasmid than the culture control (Figure 3-9). This could either be 
caused by over amplification by the ɸ29 MDA of the plasmid DNA or poor recovery of the plasmid 
DNA during the control extraction. The results of the ɸ29 MDA assembly for the plasmid created 
fewer and longer contigs, likely due to the additional reads that were available to use.   
Detection of the lambda phage was lower in the control, most likely due to the same reasons 
as the lower plasmid representation. The amount of human contamination was similar in both 
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sets of libraries (0.14% average in ɸ29 MDA and 0.15% in the control libraries) suggesting the 
contamination was post amplification. There was a higher number of reads classified as ‘other’ or 
not mapped in the non-amplification library, which could be due to the samples being extracted in 
a none ‘PCR clean room’, low level contamination of the extraction kit, or water used during the 
extraction process, meaning residual low quality DNA was present.  
Over all ɸ29 MDA amplification was shown to be a robust method to amplify the whole 
genome of E. coli (with a GC content ~50%), the results were reproducible and comparable to the 
current method. The method was also found to be suitable for detection of extra chromosomal 
elements including phages and plasmids.  
Most uses of ɸ29 MDA have been for high sensitivity detection of un-culturable bacteria145,147, 
or used in combination with targeted techniques140149. This is the first time that the method has 
been investigated thoroughly and compared to traditional culture based techniques for the 
production of sequencing libraries.  
3.11.7 Determining the Sensitivity and Processivity of ɸ29 MDA 
amplification in the Context of Bacterial Genomes 
 
When the volume of the reaction was lowered in section 3.7.1  the amount of DNA produced 
in a ɸ29 MDA reaction was also reduced, probably due to less input reagents especially dNTPs 
causing premature termination of the reaction. However, in all cases there was still sufficient DNA 
produced to sequence the products. 
The sequencing output in terms of reads produced was similar in the reduced volumes 
compared to the full reaction volumes. However significantly fewer of the reads passed filter (47% 
in the 12.5 µl reaction compared to 77% in the 50 µl reaction), perhaps because the DNA 
produced was of poorer quality in the low volume reaction. After reference assembly significantly 
less of the reference genome was covered in both reduced volume reactions (61.97% and 47.36% 
compared to 97.88%) this could be because of incomplete ɸ29 MDA reactions, producing shorter 
DNA reads. The de novo assemblies also performed poorly with data resulting from reduced 
volumes. 
Overall the lowering of the reaction volumes produced poor results, suggesting that the 
reaction volume was already optimal. The poor amplification would also have been exaggerated 
when the starting input was lowered. Low volume pipetting is difficult and with the input volumes 
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being just 1.5 µl or 0.75 µl, this may have been a factor. When working from clinical samples it 
would be technically difficult to concentrate the input to such low volumes.  Therefore, it would 
not be appropriate to lower the volumes below the original 50 µl. 
The amount of DNA produced (3.7.2) when the input was lowered to a single cell was 
equivalent to that produced when an entire colony was input to the reaction. There were also 
very similar results after sequencing, assembly and mapping. Confirming that the ɸ29 MDA 
method is extremely sensitive and suitable for use on single bacterial cells. Application of this 
method to clinical samples has the potential to detect pathogens in samples at lower levels than 
some currently used molecular methods, in a way that doesn’t require prior knowledge of the 
target.  
In section 3.7.3 ɸ29 MDA incubation times were reduced from 16 hours to a lowest 
incubation time of 1 hour. As shown in figure 4.4.3.5 the average amount of DNA produced by the 
ɸ29 MDA reaction fell as incubation times fell, which would be expected with reduced time for 
the reaction. However, until 1-hour incubation, all reduced time incubations consistently 
produced sufficient DNA to sequence. When using the Junior 454 system high amounts of input 
DNA are required (500 ng) compared to other platforms such as Illumina where as little as 1 ng is 
required. So if this method is sufficient for Junior library preparation it will be sufficient for other, 
more sensitive platforms. 
The proportion of the reference covered was also consistently high until the 1-hour reaction 
library. When assembling the data, the number of contigs in both reference and de novo 
assemblies were lower as the incubation time decreased, until 1-hour incubation when the 
number of contigs increases significantly. This lowering of contig number could suggest that the 
assembler finds the data easier to deal with, perhaps due to lower complexity of the DNA input. 
The poor performance of the one-hour incubation could be because the reaction has had 
insufficient time to copy all of the genome.  
Overall two hours’ incubation time seems to be the optimum time to produce whole genome 
amplification using ɸ29 MDA from a bacterial input. It provided consistently high DNA 
concentrations with good coverage of the genome. This rapid time to whole genome production 
is comparable to turn around times of commonly used PCRs in the routine laboratory.  Most 
studies utilising ɸ29 MDA have incubated samples for a least ten hours 140,149,150, here the 
incubation time has been successfully reduced to allow application in a clinically relevant time.  
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When using the term single cell in this thesis, it is an estimate based upon dilutions and CFU 
counting of bacteria, and so more bacteria than a single cell may be present.  
 
3.11.8 Assessing ɸ29 MDA for Whole Genome Amplification of 
Varying GC Contents 
C. difficile has a very low GC content of 29%, and so was used an example of extreme GC 
content. Reproducibility was good across the three ɸ29 MDA replicates (3.8.1), with the amount 
of DNA and sequencing reads produced being constant. When comparing the use of ɸ29 MDA 
and non-amplification control in C. difficile no significant difference was found between the 
sequencing output, however there was slightly higher % genome coverage resulting from the ɸ29 
MDA library (95.73% compared to 88.66%), and the assemblies contained fewer and longer 
contigs than the control assemblies. Similarly, to the E. coli this could be due to better quality of 
DNA input due to DNA shearing during spin-column extraction. However, one of the control runs 
did produce significantly more contigs in the reference assembly than the other, with lower 
genome coverage after reference assembly. This may have been down to the sequencer over 
heating during the sequencing run.  
 There were significantly fewer assembly errors in the de novo assembly of the ɸ29 MDA 
library. These factors would suggest that for extremely low GC pathogens ɸ29 MDA amplification 
provides better assembly results than non-amplification methods. No extra chromosomal 
elements were detected either in the non-amplification or ɸ29 MDA libraries, with either de novo 
or reference assembly techniques. The results of whole cell lysis and specific PCR were also 
negative. These results suggest that the expected plasmid was not present in the subculture of C. 
difficile used in this study. The plasmid in this strain of C. difficile 630, has no functions assigned to 
any of its CDSs  136, and so the plasmid could have been lost during sub cultures without any 
obvious loss to functionality.  
When looking at the reads that did not map to C. difficile chromosome, there was a higher 
proportion of reads not mapping in the ɸ29 MDA samples. In two runs this only accounted for 
less than 1.5% of the reads, compared to an average of 0.52% in the control libraries, with these 
reads mainly mapping to either the genus Clostridiales (MDA1) or non-assigned reads. The third 
sample had a higher proportion of unmapped reads (6.41%). With 2.35% of these mapping to 
Enterobacteriaceae and 1.21% mapping to human, suggesting cross run contamination, most 
likely after amplification. There were also 2.84% of reads that were unmapped, suggesting 
degraded DNA contamination.   
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Overall the ɸ29 MDA approach seems appropriate for a low GC content genome, with better 
results being produced than the non-amplification control. 
Actinomyces naeslundii has a high GC content at 68.5% and was selected to represent the 
other end of the GC content scale to C. difficile.  Firstly the amount of DNA produced by the ɸ29 
MDA for the A. naeslundii reaction was the same as that produced by the other reactions (3.8.2). 
The sequencing output was also similar both between runs of A. naeslundii ɸ29 MDA and A. 
naeslundii non-MDA control libraries. The ɸ29 MDA sequencing performed better in the 
reference assembly, there was low reference coverage for both the ɸ29 MDA and the control for 
A. naeslundii. The ɸ29 MDA covered 76% of the genome and the control covering only 63.39% of 
the genome, additionally the total de novo assembly length was less than the reference sequence 
length. Both sample preparation methods performed worse than expected suggesting that the 
problem doesn’t lie with the amplification but perhaps with either the sequencing technology or 
the assembly, either due to a poor reference or the programme struggling with the high GC 
content. Poor assembly could be down to the assembly algorithm used or the repetitive nature of 
the genome or because significant differences in genome content between the strain sequenced 
in this study and the published reference genome.  
Overall the fact that both the control and ɸ29 MDA libraries both performed similarly, any 
problems that are associated with the high GC content of the pathogen lie after the amplification 
and not with the ɸ29 MDA process itself. Significant work has been carried out using ɸ29 MDA to 
investigate   organisms, and complex ecological and evolutionary questions 151.  Here, the goal was 
to determine the robustness of the method for a variety of clinical organisms. Previous work was 
expanded to determine the robustness of the method for a variety of clinical organisms  
3.11.8.1 Impact of GC on MDA and Sequencing  
When comparing the performance of reference assemblies across the range of GC studied the 
first difference to note is the percentage of reads assembled against the reference was higher in 
C. difficile than E. coli, however this was mainly accounted for when considering the extra 
chromosomal elements detected. In contrast the number of reads mapping to the reference 
sequence of A. naeslundii was lower than E. coli, in both the control and ɸ29 MDA library, again 
suggesting that this was down to post amplification problems. However overall GC content 
doesn’t appear to affect the ability of ɸ29 MDA to amplify whole genomes.  
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3.11.9  Application to Low Level Mixed Bacteria  
To further investigate the scope of ɸ29 MDA for pathogen sequencing mixed bacterial cells 
and a viral pathogen were amplified and sequenced. 
The results from the even ratio of cells show that outcome genome coverage is equal for both 
of the starting bacteria, however the percentage of reads mapping is different, with more reads 
mapping to the E. faecalis genome. When the total genome sizes of the bacteria (E. faecalis 
3.2MB, H. influenzae 1.8MB) were factored in, the number of reads indicated an equal split per 
base of input genome.  A low level mix of two bacteria were successfully amplified and 
sequenced, producing reads roughly equal to input ratios. Detection limit was found to be at 
1:1000 ratio, however this was more likely down to the sequencing platform, with higher 
sequencing depth, a lower limit of detection is expected.  Our findings indicate that ɸ29 MDA may 
be suitable for relatively simple communities, while some studies have reported that ɸ29 MDA is 
suitable for investigating complex communities like the cystic fibrosis lung152.  On the other hand, 
it has also been reported that sequencing resulting from ɸ29 MDA prepared libraries does not 
reflect the initial abundance153. This application would require further testing before it could 
approach the clinic. 
3.11.10 Amplification of Viral Genomes 
 
Good results were achieved when sequencing Adenovirus 40 and 41 (3.10), with complete 
coverage of the genome after reference assembly being achieved in a single contig even when 
using a low percentage of the reads.  Improvements in the proportion of reads used for the 
reference assembly were achieved through the use of DNAse on the sample prior to extraction.  
Adenovirus is a double stranded DNA virus, and was a starting point for the application of ɸ29 
MDA to viral genomes.  
To investigate the applicability of ɸ29 MDA as a sensitive method across multiple pathogen 
types, mixes of RNA and DNA viruses were investigated. This was used to explore the ability to 
perform reverse transcription and ɸ29 MDA on the same extract to produce good quality genome 
data. Initially viral extracts were used, with roughly the equivalent of 25 virus particle input; both 
viruses were successfully detected from this sample. The results showed that 66.2% of the reads  
were assigned to adeno virus and 20.76% assigned to HIV. When these numbers are adjusted for 
input genome size, the ratio of reads is 1:1.19 (adeno: HIV). HIV carries two copies of its genome 
in each virion, suggesting that there is inefficiency in the RNA conversion, or that some RNA 
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degrades during the process. When whole viruses were concentrated, extracted and amplified, 
the number of reads assigned to adenovirus was 62.7% and HIV had 20.76%. When this was 
normalised for genome size, the ratio was 1:1.7, which was an improvement from the extracted 
sample. However, it was still not at 1:2, suggesting there is some loss during the reverse 
transcription process, or inaccuracy in quantifying the input. Improvement may be down to low 
stability of extracted RNA, and show that extraction and RNA conversion should be performed in 
quick succession to provide highly sensitive outputs. When de novo assembled, high genome 
coverage was achieved for both viruses (97.1% and 99.90%). Annotations from both of the low 
input viruses were equivalent to the reference genome. The data produced from the HIV was of 
good enough quality to use a publically available tool (REGA version 3) to allow accurate tying of 
the virus.  
A mixed viral sample was then developed using a variety of viruses, including multiple viral 
particle types and assortment of viral genome types.  This allowed the testing of the 
concentration, extraction and amplification techniques.  An equation was developed that allows 
the use of a known copy number spike to quantify viral mixes within a sample. This equation takes 
into account the large variety of genome architecture among viruses, including the nucleic acid 
type, genome size and genome copy number. A spike for an RNA and DNA virus was used to 
account for inefficiencies in the reverse transcription stage and the more fragile nature of RNA.  
Much of the initial mixture had to be estimated, as only the Ct values were supplied which are 
not a direct quantification of the viral particles. A volume in scale with that used for other viruses 
provided was used to provide a starting point. After sequencing and reads assignment, VZV had a 
very high input estimation (2309), Norovirus and Influenza also had higher numbers all of which 
had been estimated from Ct values.  Parvovirus 19 was also in higher numbers, the provided IFU 
range for this virus was 569-1058, which is a large range, showing a possible inaccuracy of the 
initial numeration method.  
When the sample was recreated taking into account quantification results from the first 
sequencing run, all calculated viral numbers were closer to the 25 viral aim. Other than measles, 
which had a very low read assignment.  Measles was the only virus that was provided inactivated; 
the inactivation method may have damaged the virus’s viability. Alternatively, the inactivation 
method may have acted by ‘fixing’ the virus, making extraction more difficult.  After the sample 
input was adjusted, the RNA viruses were quantified at a higher level than expected (Norovirus, 
HAV, HCV). Possibly suggesting HIV is a poor spiking standard, which would account for the higher 
numbers of other RNA viruses.  
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Overall the method was successful at sequencing all viruses (other than measles). De novo 
assemblies for most viruses recovered more that 94% of the reference genome. Influenza virus de 
novo assembly performed slightly worse (88%), this is perhaps down the poor performance of the 
assembler on segmented genomes. Also 3’ ends of genomes are often missing as DNA will only b e 
produced towards the 5’ end of primer. In addition, an equation was developed to allow 
quantification of mixed viral input from a known spike. If this was used in clinical samples, a non -
human pathogen for a DNA and RNA virus should be used. 
3.11.11 Extraction using Alkali Method 
The extraction method used uses a combination of SDS (Sodium dodecyl sulphate) which as a 
detergent solubilises the cell membrane and disrupts the cellular proteins, and NaOH which 
causes dissociation of double stranded DNA allowing simultaneous extraction and denaturation of 
nucleic acids. After extraction there is a neutralisation stage, which raises the pH of the solution 
using potassium acetate, which may allow some double bonds to reform154. However as genomic 
DNA is so large it would be unlikely that the entire genomic DNA re-annealed completely allowing 
binding of the small hexamer primers. Due to the strand displacement ability of the ɸ29 enzyme 
sections of reformed double bonds would still be copied.  The selection of bacteria and viruses 
studied covered many cell wall and virion types, providing evidence that this extraction method is 
suitable for bacterial and viral pathogens.  
3.11.12 Conclusion: Development of Non-PCR Amplification 
Techniques for Rapid and Sensitive Whole Genome 
Amplification of Pathogens 
 
The use of ɸ29 MDA on bacterial and viral input is a robust and reproducible method for the 
production of whole genome amplification from as little as a single bacterial cell. Before 
sequencing can be performed the secondary structure of the amplified DNA needs to be reduced 
though the use of S1 nuclease, and extended physical fragmentation. The amplification method 
copes well with varied GC content input and in mixed cultures results in sequencing data that 
reflects the initial mix. The starting volume of 50 µl appears to be the optimum volume for 
bacterial amplification and the method is successful with only two hours of incubation at 30oC.  
However, there were some issues with the use of de novo methods to assemble genomes 
with the genome covered by all de novo assemblies in all bacteria tested being lower than the 
reference mapping method. The aim of the project is to be able to use de novo methods to 
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identify and characterise unknown infections. There was also significant problem with the 
assembly of data produced from the high GC pathogen A. naeslundii, which requires further 
investigation, but the fact that both the de novo and non-amplification control performed poorly 
would suggest that the problem is external to the amplification process.  
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4. Results: Development of an Analysis Pipeline for data 
Generated by NGS of ɸ29 MDA Prepared Libraries 
Focussing on de novo Methods 
In parallel with the development of a highly sensitive laboratory method, a robust analytical 
pipeline was developed to profile and characterise clinically relevant isolates. Analytical pipelines 
allow interpretation of NGS outputs converting data to information. Data produced by NGS 
technologies vary depending on the input genome type, library preparation techniques and the 
sequencing technologies themselves. There are multiple algorithms designed for the analysis of 
NGS data, each with different strengths. Using ɸ29 MDA to prepare libraries brings unique data 
characteristics, which need to be considered and evaluated when analysing the data, meaning 
default parameters may not be suitable. Therefore, to ensure that the best quality data outcomes 
are achieved, a specific pipeline will be tested and developed. The aim is to provide an automated 
analysis method to allow the identification and characterisation of pathogens that can be applied 
to unknown pathogens.   
The first stage developed will be data preparation including removal of host and 
environmental contaminants, followed by investigation of the best error trimming algorithms for 
this data. This will include optimisation of quality cut offs, defining the best parameters for 
maintaining data whilst removing low quality data. A comparison will be made between two 
trimming algorithms, a window based and running sum algorithm. As well as comparing the 
impact of end and average trimming techniques 
The average peak depth of ɸ29 MDA produced libraries was 129 whereas the non-
amplification peak depth of 61. Reducing the peak depth of the sequencing data will reduce the 
amount of data the assembler needs to process and so will potentially speed up the assembly. A 
process known as digital normalisation107 allows peak depth reduction without the need for a 
reference. 
Multiple de novo assembly algorithms will then be tested to find the most accurate one for 
this data set, assessment will include the impact of GC content on assembly quality and 
investigation of assembly errors. The primary focus will be on using de novo assembly techniques 
which would allow a single pipeline to be used for unknown pathogens. The data will then be 
investigated for the accuracy of characterisation of genomes in this dataset, including virulence 
determinants and resistance genes. 
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4.1 Removal of Contaminants from Sequencing Data 
Host and environmental contamination can be problematic for assembly, with the potential 
for false genome annotations, and so these were removed prior to error trimming and assembly.  
4.1.1 Host Contamination 
The adenovirus assemblies in section 3.10 had low number of reads that mapped to the 
relevant adenovirus genome (average 23.51% for Ad40).   Most of the unmapped reads belong to 
the tissue culture (393 monkey kidney) that the virus was cultured in. In one of these samples 
only 22.95% of reads mapped to the target Ad40 genome, when mapped against the host genome 
69.24% of the reads mapped. After removal of unmapped reads, 229956 reads were put into a 
new SFF file, as described in 2.3.5.5. When this new SFF was mapped against the Adenovirus 40 
reference, 100% was covered using 72.35% of the reads. The remaining unmapped reads were 
extracted and compared to the Blastn nr library. When this was investigated, the remaining reads 
were either identified as Enterobacteriaceae reads (5634), E. coli (918) or unidentified (734).  
Figure 4-1 shows the proportional mapping of reads before and after removal of host signals.  
 
Figure 4-1 proportional read assignment of ɸ29 MDA prepared Adenovirus 40 sequence data before (A) and after 
(B) removal of host reads 
  
  
A 
B 
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4.1.2 Removal of Kit Contaminants 
In addition to the expected host contamination, the lack of specificity and high sensitivity of 
the ɸ29 enzyme enables the amplification of any kit or environmental contaminants. Failure to 
acknowledge and remove these contaminants can lead to erroneous data interpretation.  
Negative libraries were frequently amplified and analysed to investigate the presence of 
contaminants.  
4.2 Negative Library   
The output files from negative runs were concatenated into a single SFF file, which was then 
converted to a fasta and a Blastn search performed using the non-redundant nucleotide database. 
The results were viewed in MEGAN5. 
The majority of reads (78.97%) had no hits to the nucleotide library.  However several 
bacterial species were identified, Figure 4-2. One major represented Genus was the 
Mycobacterium, with 13% of all reads mapping within this Genus. 
 A small number of reads mapped to significant human pathogens including Haemophilus 
influenzae (0.7%), Salmonella enterica (0.06), E. coli (0.03%), Enterococcus faecalis (0.04%), and 
Staphylococcus sp (0.24%). These reads were removed along with reads mapping to 
Mycobacterium abscessus (1.13%), other Mycobacterium sp. reads were left in the negative 
library. The resulting library was used to as a reference to remove contamination from 
subsequent sequencing runs 
 
  
Figure 4-2 Species identification within negative ɸ 29 MDA sequence data using Blastn and LCA analysis, the insert 
shows Mycobacterium species identified within this library 
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4.2.1.1 Removal of Contamination from Sequencing Run 
The negative library was tested by mapping the sequencing file produced by 16 hour ɸ29 
MDA of a single cell, as it had a high number of unidentified reads (3.34% of all reads). The SFF file 
was mapped against the negative library, 0.98% of all the reads mapped to the negative library.  
With most of these mapping to reads that had no hits or were unassigned (92%) and a small 
number mapping to the Order Actinomycetales (1%), with a subsection identified as 
Mycobacterium sp Figure 4-3.   
4.2.1.2 Improvement of Contamination Library  
All unidentified reads from previous sequencing runs were added to the negative library. 
When this improved library was used as a reference in the same sequencing file, 1.26% of reads 
mapped to the negative library.  
 
  
Figure 4-3 proportional 
identification of reads that map to the 
negative library 
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4.3 Quality Trimming of Raw Reads 
One E. coli k12 single cell sequencing run was randomly selected to investigate the impact of 
different trimming metrics using two algorithms, a window based and a running sum error 
trimming programme.   
4.3.1 Raw Data 
The number of raw reads that passed standard on-instrument filtering was 150,144 with the 
total number of bases of 79,359,696. The range of length of reads was 48 to 1200 bases with an 
average read length 529 bases.  When this was assembled against the reference 98.49% of the 
genome was covered using 91.28% of the total reads into 242 contigs. The average contig size was 
19,514 bases with the largest contig being 220,401 bases. When the reads were de novo 
assembled a total of 1692 contigs with 1239 (73.23%) of these being over 1000bp.  The largest 
contig was 32,639 bases long with an N50 value of 4554, which covered 94.12% of the genome 
with a total of 20 misassemblies.  
 
4.3.2 Tag Removal  
After tag removal there was no impact on the read number, but as expected a small decrease 
in the total number of bases (99.23% compared to the raw data)Table 4-1. The lengths of the 
shortest, longest and average reads decreased by the expected four bases, confirming removal of 
only the tag sequence. The reference assembly genome coverage dropped slightly to 98.47% and 
the contig number increased marginally to 245. Conversely the genome coverage of the de novo 
assembly slightly increased, as did the N50 whilst the number of contigs increased. There was no 
impact on the number of misassemblies in the de novo assembly. The same results were obtained 
using both trimming algorithms.  
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4.3.3 End quality Trimming  
4.3.3.1 Prinseq 
After removal of sequencing tags the 3’ and 5’ends of the reads were trimmed using Q35, 
Q30, Q25 and Q20 as cut offs, trimming outputs along with assembly information can be found in 
Table 4-1. 
Quality trimming the ends of reads had little impact on the total number of reads; however, 
there were reductions in the total number of bases remaining after trimming. The strictest 
trimming parameter (Q35) removed 38% of all bases, as the trimming parameters became less 
strict fewer bases were removed, with the Q20 data only removing 9% of the bases.  After end 
quality trimming the minimum read length was reduced to a single base pair in all conditions 
other than Q20 trimming. The longest read length was considerably reduced in the Q35 trimmed 
data, where the longest read was reduced to just 39% of the raw data read length. The impact 
was lessened as the strictness of trimming was reduced, with the Q20 trimmed data having a 
longest read length at 96% of the raw data Figure 4-4-A. This method of trimming also had an 
impact on the average read length, again with a similar pattern of Q35 end trimming reducing the 
mean read length to most (to 65% of raw) and Q20 reducing it the least (91% of raw).  
End trimming had very little impact on the genome coverage following reference assembly. 
However the contig number increased to more than twice the number following Q35 end 
trimming Figure 4-4-B. Again this affect was lessened as the strictness of trimming was reduced, 
with the Q20 actually having one fewer contig than in the data following only tag removal. Contig 
sizes reflected the changes in the contig number, with higher contig numbers leading to shorter 
contig lengths.  
Following de novo assembly the reference coverage was reduced, with the Q35 sample 
coverage falling to 90.93%. As the trimming strictness was reduced the reference coverage 
increased with the Q20 trimmed sample showing similar reference coverage to the raw sample 
(Q20 94.85% vs. raw 94.91%). Contig number was lower in all the end trimmed samples with 
fewer contigs being produced when the trimming parameters were less strict, following this as 
the contig numbers fell, the contig length increased Figure 4-4-C. There was a slight declined in 
the misassemblies in all trimmed samples.  
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 Raw tag Q35 Q30 Q25 Q20 
No: Reads  150,144 150,144 149,589 150,098 150,144 150,144 
No: Bases  79,359,696 78,750,120 49,426,937 58,191,182 65,017,487 72,283,905 
Shortest read (bps) 48  44 1 1 1 45 
Longest read (bps)  1200  1196 479 577 607 1156 
Average read length 
(bps) 
528.5 524.5 330.42 387.69 433.03 481.43 
Reference assembly 
Ref coverage (%) 98.49 98.47 97.5 98.11 98.4 98.47 
No: Contigs 242  245 584 375 264 244 
Average contig size 
(bps) 
19,514 19,345 8,464 12,802 17,959 19,427 
Largest contig size 
(bps) 
220,401 220,385 72,143 93,890 184,905 220,387 
De novo assembly 
Ref coverage (%) 94.12 94.91 90.93 93.30 94.57 94.85 
No: Contigs 1692 1600 1312 983 834 804 
N50 (bps) 4554 11356 7043 10787 12422 13863 
Largest contig (bps)  32,639 53191 41488 46088 71924 72324 
misassemblies 20 20 17 15 14 15 
Table 4-1 Output of end quality trimming using Prinseq at four different cut offs. Including basic read information 
and results of reference and de novo assemblies. tag=tag removed data, Q number refers to the quality cut off used to 
trim the ends of data 
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4.3.2.1. Cutadapt 
The sequencing tags were removed and the 3’ and 5’ ends of the reads were trimmed to Q35, 
Q30, Q25 and Q20, the samples were then reference and de novo assembled Table 4-2  
Post end trimming using Cutadapt, the number of reads remaining was reduced, with only 
88% of the raw read remaining in the Q35 data. As the trimming became less strict fewer reads 
were removed with 99.9% remaining after Q20 trimming. The number of bases was reduced to 
39% after Q35 trimming, and again as trimming strictness was reduced the proportion of bases 
remaining increase, with 78% of bases retained after Q20 trimming. The shortest read length in all 
trimmed samples was one base.  The longest read length was reduced to 479 bps (39% of raw 
length), in the Q35 trimmed sample. The longest read length increased as trimming strictness was 
reduced, with the Q20 sample’s longest read being 877 bps (73% of the raw length) Figure 4-4-A. 
A similar pattern was observed in the average read lengths with the Q35 sample showing the 
shortest average read length at 237.43 bps and the Q20 having the longest at 412.71 bps 
(compared to the raw average read length of 528.4 bps).  
Following reference assembly of the data the genome coverage was reduced, with the most 
reduction seen following the strictest trimming (94.47% genome coverage), and genome coverage 
increased as trimming decreased. Contig number increased in all samples, with the highest 
number found in the Q35 trimmed data, which had more than seven times the number of contigs 
compared to the raw data. Contig number declined as the trimming strictness decreased with the 
assembled Q20 data consisting of 307 contigs (242 contigs in raw data) Figure 4-4-B.  As expected 
the higher the number of contigs produced in an assembly the shorter the contigs lengths 
became. 
Once the reads were de novo assembled, reference coverage was lower in all samples when 
compared to the tag trimmed data. The Q35 data showed the lowest reference coverage at 
75.24% and coverage increased as trimming decreased. The Q20 data having comparable genome 
coverage (94.29%) to the tag trimmed data (94.91%). The number of contigs in the assembled 
data was highest in the samples with the strictest end trimming. The Q35 and Q30 data had more 
contigs with shorter lengths than in the raw data. However the Q25 and Q30 trimmed data had 
fewer longer contigs than the raw data Figure 4-4-C. Misassemblies were lower in all trimmed 
data with the Q25 trimmed data having the least misassemblies.  
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 Raw tag Q35 Q30 Q25 Q20 
No: Reads  150,144 150,144 132,763 143,601 148,920 150,023 
No: Bases  79,359,696 78,750,120 31,521,918 42,227,367 51,823,657 61,823,657 
Shortest read (bps) 48  44 1 1 1 1 
Longest read (bps)  1200  1196 479 563 607 877 
Average read length 
(bps) 
528.5 524.5 237.43 298.06 348 412.71 
Reference assembly 
Ref coverage (%) 98.49 98.47 94.47 96.81 97.82 98.30 
No: Contigs 242  245 1737 874 501 307 
Average contig size 
(bps) 
19,514 19,345 3137 5743 9753 15549 
Largest contig size 
(bps) 
220,401 220,385 44108 72085 89217 93807 
De novo assembly 
Ref coverage (%) 94.12 94.91 75.24 87.29 91.70 94.29 
No: Contigs 1692 1600 2671 1729 1213 896 
N50 (bps) 4554 11356 1535 3754 7212 11087 
Largest contig (bps) 32,639 53191 21254 29605 57573 71935 
misassemblies 20 20 18 16 13 17 
Table 4-2 Output of end quality trimming using Cutadapt at four different cut offs. Including basic read information 
and results of reference and de novo assemblies. tag=tag removed data, Q number refers to the quality cut off used to 
trim the ends of data 
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Figure 4-4 impact of end quality trimming at varying quality cut-offs using Prinseq and  Cutadapt on (A) read length 
(B) reference assembly (number of contigs, average and longest contig length) and (C) de novo assembly (number of 
contigs, average and longest contig length) 
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4.3.2.2. Comparison of Widow Based and Running Average Trimming 
Techniques 
Similar trends were observed in data following trimming using both algorithms, with a general 
trend showing more bases removed when a stricter cut off is used. Overall Cutadapt consistently 
removed more bases during trimming than Prinseq.  
After data was reference assembled a similar trend was again observed in both algorithms, 
with strict trimming leading to the formation of more contigs with shorter lengths on average, 
and longer fewer contigs produced as the trimming became less stringent. When comparing the 
two algorithms Prinseq consistently produced fewer longer contigs than Cutadapt. Prinseq 
trimmed data also covered a higher proportion of the reference genome, with the affect being 
amplified as trimming became stricter.  
Following de novo assembly very similar patterns were seen, with more contigs produced with 
stricter trimming. The major difference between the two algorithms was that all trimmed data 
produced fewer contigs when Prinseq was used, whereas Q35 and Q30 trimmed data using 
Cutadapt produced more contigs. Similarly, to the reference mapping a result, higher genome 
coverage was achieved when Prinseq trimmed data was used, with the affect being more obvious 
as trimming strictness increased.  
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Figure 4-5 comparison of end quality trimming at varying quality cut-offs using Prinseq and  Cutadapt on (A) 
proportion of reads remaining  compared to raw data (B) proportion of bases remaining compared to raw data number 
(C) % reference assembly genome coverage (D) de novo assembly % reference coverage  
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4.3.3. Average Read Quality Trimming-Prinseq 
Four different parameters were tested for trimming the data based on average quality of the 
reads, Q35, Q30, Q25 and Q20.  
Q35 trimming led to a large reduction in read number with only 18% of reads remaining, as 
trimming became less strict fewer reads were removed with 91% of reads remaining after Q20 
trimming. The same pattern was observed with the number of bases remaining after trimming, 
with only 16% left after Q35 trimming and 89% remaining after Q20 trimming. Longest read 
lengths were reduced in all trimmed data with the Q20 data having the longest read length at 778 
bps (1200 bps in raw), as trimming became stricter the longest read length was reduced. There 
was less impact on the average read length with the Q35 sample having an average read length of 
486 bps (vs. 528 bps in raw data). Again the average read length increased as trimming strictness 
decreased.  
Once the data was reference assembled the genome coverage of the Q35 sample was 
reduced compared to the raw data (78.23% vs. 98.49%). There was less impact on reference 
coverage in the other trimming parameters. The Q35 sample was assembled into a high number 
of contigs (>11x the raw data), with the average contig size dropping from 19514 in the raw data 
to 1443 in the Q35 data. Again these changes lessened as the trimming became less strict.  
After de novo assembly the proportion of the reference genome covered decreased as 
trimming became stricter, (94.57%, 92.87%, 88.05% and 33.62% for Q20. Q25, Q30 and Q35 
trimmed data respectively). The number of contigs in all trimmed datasets was fewer than in the 
raw dataset, again numbers decreased as trimming strictness decreased. The number of 
misassemblies was at its lowest in the Q20 trimmed data, with the Q35 trimmed data having 
more misassemblies than the raw dataset.  
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 Raw Q35 Q30 Q25 Q20 
No: Reads  150,144 26,783 83,110 112,229 149,589 
No: Bases  79,359,696 13,017,445 42,113,413 57,406,212 70,940,838 
Shortest read (bps) 48  51 51 51 51 
Longest read (bps)  1200 586 609 674 778 
Average read length 
(bps) 
528.5 486.03 506.72 511.51 516.91 
Reference assembly 
Ref coverage (%) 98.49 78.23 97.07 98.02 98.33 
No: Contigs 242  2769 617 367 271 
Average contig size 
(bps) 
19,514 1443 7458 12657 17079 
Largest contig size 
(bps) 
220,401 9755 54997 97404 142037 
De novo assembly 
Ref coverage (%) 94.12 33.62 88.05 92.87 94.57 
No: Contigs 1692 1473 1327 983 818 
N50 (bps) 4554 1277 5916 9081 13103 
Largest contig (bps) 32,639 6203 36642 52917 74191 
misassemblies 20 22 20 18 15 
Table 4-3 Output of average read quality trimming using Prinseq at four different cut offs. Including basic read 
information and results of reference and de novo assemblies 
 
 
  
200 
 
4.3.4. Combination Average and End Trimming-Prinseq 
The overall aim of trimming is to retain as much information as possible whilst improving the 
reliability of the assembly, and so a combination of end trimming and average read trimming was 
investigated. Q20 average read trimming had shown the best output and so this was used as the 
cut off for average trimming. Four different end trimming cut offs were investigated, Q30, Q28, 
Q25 and Q20. Q35 wasn’t included as previously it had shown to be very detrimental to the 
assemblies, Q28 was included to provide an extra data point for optimising the trimming 
parameters. As before the first stage was to remove the sequencing tags from the sequences, 
following this ends were trimmed to the varying cut offs. Once this was complete the reads were 
average quality trimmed to remove reads at less than Q20 average quality. Finally, all reads less 
than 99 bps were removed, as these complicate assemblies whilst providing little additional 
information. An additional data set was included which only had reads less than 99 bp removed 
Table 4-4. 
Once trimming was complete, more than 99% of reads remained in all  trimmed samples 
except in the Q20 end trimmed sample, which had 96% of the reads remaining. The number of 
bases removed from the data increased as the end trimming cut off increased, with 73% of bases 
remaining in the Q30 end trimmed sample and 88% remaining in the Q20 end trimmed sample. 
Both the longest and average read lengths increased as trimming became less strict.  
There was very little impact on the reference coverage after reference assembly of all the 
data sets, and more than 98% of the genome was covered in all samples. More contigs were 
produced in all the trimmed samples compared to the raw data. The highest number of contigs 
was found in the most strictly trimmed data set.  
After de novo assembly the number of contigs produced in all samples was lower. This 
included the sample with no error trimming but with reads less than 99 bp removed. The lowest 
number of contigs were formed in the Q20 data set with the highest being found in the Q30 
dataset. Again as contig number increased contig length decreased. Genome coverage was good 
in all samples with >93% covered in all samples, the highest genome coverage was found in the 
Q20 sample.   
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 Raw Min_99 Q30 Q28 Q25 Q20 
No: Reads  150,144 150,062 148,638 148,940 148,591 144,730 
No: Bases  79,359,696 78,743,117 58,043,544 60,571,470 64,594,719 69,689,814 
Shortest read (bps) 48  99 99 99 99 99 
Longest read (bps)  1200 1196 577 606 607 759 
Average read length 
(bps) 
528.5 524.74 390.5 406.68 434.71 481.52 
Reference assembly 
Ref coverage (%) 98.49 98.47 98.10  98.23 98.39  98.42 
No: Contigs 242  245 376 336  268 258 
Average contig size 
(bps) 
19,514 19345 12765 14183 17679 18253 
Largest contig size 
(bps) 
220,401 220385. 93890  93889 156112 163822 
De novo assembly 
Ref coverage (%) 94.12 94.91 93.30 93.78 94.49 94.73 
No: Contigs 1692 787 983  919 825 799 
N50 (bps) 4554 14744 10787  11306 12644 14347 
Largest contig (bps) 32,639 74191 60036  60038 71926 74189 
misassemblies 20 19 15  14 14 14 
Table 4-4 Output of end quality combined with Q20 average read quality trimming using Prinseq at four different 
cut offs . Including basic read information and results of reference and de novo assemblies Min_99 refers to raw data 
with reads shorter than 99 bases removed  
 
4.3.5. Final Trimming Algorithm 
The final trimming algorithm used in further work was using Prinseq, tag removal, Q20 end 
trimming, and Q20 overall quality trimming with a minimum of 99 base pairs read length.  
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4.4 Impact of Abundance Trimming in de novo assembly 
Digital normalisation was used to investigate potential improvements in de novo assembly 
due to lower data complexity, the first stage was to optimise the parameters for this particular 
dataset. As stated in  Brown et AL’s 107  paper there is a relationship between the accuracy of the 
approach and the read length. Maximum lengths of K can be calculated using the following 
formula where L is read length and K is Kmer size used.  
Equation 3 
       
If this formula is used a single substitution error will not affect the median kmer abundance, 
which the programme uses as a base for normalisation. The average read length for single cell 
two hour ɸ29 MDA reactions was 432, so according to the formula above 143 would be the 
maximum kmer size.  A range of kmer sizes were tested from 20 (suggested by manual, based on 
short read data sets) to 140. Normalisation was performed on both raw and error trimmed data. 
The resulting reads were then assembled using reference and de novo methods and assessed for 
quality. The aim was to reduce the coverage to a similar level of the none amplification control 
assembly results (peak depth of 60)  
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4.4.1 Abundance Trimming on Raw Reads  
Digital normalisation was applied to the sequencing results from the single cellɸ29 MDA two 
hours incubation with the highest peak depth (160).  
After abundance trimming using the K value 20 only 59.9% of reads remained, which was 
lower than K values 50-140 where 81.8-85.5% of reads remained Figure 4-6-A. After reference 
assembling the data genome coverage above 98.4% was achieved in all samples other than the 
K20 data which gave slightly lower genome coverage of 98.0%. Abundance trimming had very 
little impact on the number of contigs in the reference assembly, with a slight increase in number 
observed in the K20 sample. The peak depth of the assembly when K values 50-140 was used gave 
a range from 52-56, whereas the K20 assembly was reduced to 26 Figure 4-6-B. A similar pattern 
was observed in the average depth with abundance trimming using K50-140 giving an average 
depth the range of 14-14.6 and the K20 sample having an average depth of 9.7 (Figure 4-6-C). 
When investigating the de novo assembly the genome coverage was greater than 95% in all 
abundance trimmed samples. Contig numbers were higher in all abundance trimmed assemblies, 
with the highest number being produced in the K20 sample.  The largest contig size and N50 
values were reduced in all abundance trimmed assemblies. However the number of 
misassemblies was lower than the raw data set Table 4-5 and Figure 4-6-D.   
 
 raw k20  k50 k80 k110 k140 
No: Reads 181,058 108,474 152,805 154,035 154,854 148,009 
    59.91% 84.40% 85.07% 85.53% 81.75% 
No: Bases 81064083 46,422,541 68,195,117 69,394,995 70,237,617 67,356,833 
    57.27% 84.12% 85.61% 86.64% 83.09% 
Ref Assembly 
% Covered 98.46% 97.97% 98.45% 98.45% 98.46% 98.47% 
Contig Number 143.00 153 140 141 145 143 
Peak Depth  160 26 52 56 57 54 
Average Depth 16.5489 9.68678 14.2109 14.461 14.6325 14.0223 
De Novo Assembly 
% Covered 95.53% 95.156% 95.297% 95.269% 95.245% 95.256% 
Contig Number 538 614 567 558 567 559 
Largest Contig 
(bp) 
87216 72500 68435 68436 68436 80293 
N50 20471 18648 20346 20596 20470 20418 
Misassemblies 23 18 17 18 19 18 
Table 4-5 Results of abundance trimming of raw reads using varying K va lues, including read and base number, 
reference assembly and de novo assembly data including misassemblies. % of bases and reads compared to raw data  
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4.4.2 Abundance Trimming on Error Trimmed Reads  
The raw reads were error trimmed using the optimised parameters described in 4.3.5, the 
resulting reads were then abundance trimmed using K values from 20-140.   
The K20 data again removed more reads than the other values, only leaving 60.4%, with the 
other K values giving values 84.1-87.7% Figure 4-6-A. This had no impact on the proportion of the 
genome covered in the reference assembly with all assemblies covering more than 97.4% of the 
genome. The peak depths from K values 50-140 was 49-58, whereas the peak depth of the K20 
data was 26 Figure 4-6-B. The average depth of the K20 sample was also lower (9.7) compared 
with the other K values (14.0-14.6) Figure 4-6-C. After de novo assembly there was genome 
coverage greater than 95% in all samples. The number of contigs produced was equivalent to the 
raw data, with a slight increase in the K20 data. The number of misassemblies was lower in the 
abundance trimming samples, other than the K20 sample, with K150 abundance trimming giving 
the lowest number Figure 4-6-D.  
 
 
  trimmed trimmedk
20 
trimmed 
k50 
trimmed 
k80 
trimmed 
k110 
trimmed 
k140 
Total reads 177,737 107,312 151,596 154,273 155,900 149,382 
  98.17% 60.38% 85.29% 86.80% 87.71% 84.05% 
Total bases 79,427,727 46,076,860 67,428,717 68,670,284 69,598,188 66,912,909 
    58.01% 84.89% 86.46% 87.62% 84.24% 
Ref assembly 
% covered 98.42% 97.94% 98.43% 98.43% 98.46% 98.46% 
Contig 
number 
155 156 145 145 143 147 
Peak depth  155 26 53 56 58 49 
Average depth 16.3425 9.67412 14.1478 14.4025 14.5887 14.0126 
De novo assembly 
% covered 95.495% 95.179% 95.296% 95.266% 95.292% 95.286% 
Contig 
number 
557 607 576 572 574 566 
Misassemblies 14 14 13 12 13 11 
Table 4-6 Results of abundance trimming of error trimmed reads using varying K va lues, including read and base 
number, reference assembly and de novo assembly data including misassemblies   
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4.4.3 Abundance Followed by Error Trimming  
To investigate the impact of abundance trimming prior to error trimming the raw data was 
first abundance trimmed using K values 20-140 and then error trimmed using the previously 
optimised parameters.  
The K20 sample once again removed more bases than the other K values Figure 4-6-A; 
however this had no impact on the proportion of the genome covered after reference assembly. 
The number of contigs was lower in all the abundance trimmed samples. The peak depth of the 
K50-140 samples ranged from 51-57, whereas the peal depth of the K20 sample was once again 
26 (Figure 4-6-B). Genome coverage after de novo assembly was slightly lower in all abundance 
trimmed data compared to the error trimmed sample. However the number of misassemblies was 
lower, with the lowest number (9) being found in the K150 sample  Figure 4-6-D.  
 
  trimmed k20 
trimmed 
k50 
trimmed 
k80 
trimmed 
k110 
trimmed 
k140 
trimmed 
Total reads 177737 108296 152675 153955 154793 147959 
  98.17% 60.93% 85.90% 86.62% 87.09% 83.25% 
Total bases 79427727 45646768 67031069 68220160 69054559 66228323 
    56.31% 82.69% 84.16% 85.19% 81.70% 
 Ref assembly 
% covered 98.42% 97.97 98.43 98.43 98.45 98.46 
Contig number 155 150 137 137 140 140 
Peak depth  155 26 51 56 57 53 
Average depth 16.3425 9.5781 14.2769 14.3079 14.4782 13.8758 
 De novo assembly 
% covered 95.495 95.175 95.238 95.277 95.259 95.252 
Contig number 557 620 578 579 575 569 
Misassemblies 14 12 12 11 11 9 
Table 4-7 Results of abundance trimming of raw reads using varying K va lues followed by error trimming, including 
read and base number, reference assembly and de novo assembly data including misassemblies 
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Figure 4-6 Impact of abundance trimming using different K va lues on (A) read removal  compared to raw data , (B) 
peak reference assembly depth (C) average reference assembly depth  and (D) number of misassembl ies  
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4.5 Comparison of Genome Assembly quality using Varying De 
Novo Assemblers  
The performances of six different assemblers on sequenced single cell ɸ29 MDA samples were 
investigated. Four sequencing files, C. difficile, E. coli and A. naeslundii and Adenovirus 41, 
representing a range of GC contents as well as a viral genome were abundance and error trimmed 
as described previously before being used in each assembler Table 4-8.  
Initial assessment of the assembler was based on the ability of the assemblers to give good 
genome coverage. SSAKE performed poorly on all the genomes tested particularly at the GC 
extremes with only 12% of the A. naeslundii and 22% of the C. difficile genomes covered Figure 
4-7-A. Due to the low genome coverage the assembler gave misleadingly low numbers of contigs 
and misassemblies and so was excluded from all other analysis. The next stage was to consider 
the assemblers performances across the selected genomes, particularly across the GC range. The 
remaining five assemblers (Newbler, Abyss, SPAdes, Ray and MIRA) had comparable genome 
coverage for the two pathogens with GC at 48.5% and 50.38% (Adenovirus and E. coli) Figure 4-7-
B. However, Ray and Abyss were outliers in coverage of the two bacteria with extreme GC 
content. This was particularly obvious in the low GC pathogen C. difficile.  
Assembly accuracy was the next consideration, as interpretation of data is reliant on good 
quality assembly. Data assembled using MIRA had considerably more misassemblies in every data 
set and so was not selected as the assembler Figure 4-7-C. Newbler and Spades had comparably 
low numbers of misassemblies with no clear advantage to either.  
The final stage of selection was to consider the number of contigs the genome was assembled 
into, with a lower number desirable. In all cases Newbler produced more contigs than SPAdes, 
and so SPAdes was considered the most appropriate assembler for this dataset Figure 4-7-D.   
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  % cov contigs largest N50 misassemblies 
SSAKE 
Ad41 65.095 563 9543 908 5 
C. dif 21.908 729 3520 705 0 
E. coli 58.816 2195 11533 1503 8 
A. naes 11.838 547 1768 781 1 
Newbler 
Ad41 96.873 62 16453 6901 2 
C. dif 89.075 1046 27971 6348 11 
E. coli 95.252 569 78005 6074 9 
A. naes 65.59 1660 22726 4406 8 
Abyss 
Ad41 90.687 634 11007 1516 32 
C. dif 72.228 2651 6218 1366 59 
E. coli 88.567 1621 22949 4008 52 
A. naes 56.325 1780 20141 2283 42 
Spades 
Ad41 96.994 53 14532 4560.00 2 
C. dif 92.899 469 72426 8273.00 8 
E. coli 95.963 242 129944 12170.00 11 
A. naes 63.417 1300 36873 7437.00 5 
Ray 
Ad41 92.355 54 14671 1515 32 
C. dif 54.625 1685 13803 1811 31 
E. coli 89.232 1388 55257 5860 38 
A. naes 45.165 1049 17938 1918 21 
Mira 
Ad41 96.991 87 16978 1835 18 
C. dif 90.812 1385 33820 5517 35 
E. coli 97.226 954 79580 16280 20 
A. naes 68.579 1076 32784 3294 17 
 
Table 4-8 results of the de novo assembly of C. difficile, E. coli and A. naeslundii  single cell ɸ29 MDA data and ɸ29 
MDA of Adenovirus 40 us ing six different assemblers.  
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Figure 4-7 results of the de novo assembly of C. difficile, E. coli and A. naeslundii  s ingle cell ɸ29 MDA data and ɸ29 
MDA of Adenovirus 40 us ing six different assemblers on (A) genome coverage, (B) genome coverage at different GC 
contents, (C) number of misassemblies and (D) the number of contigs 
  
0 20 40 60 80 100
Ad41
C. dif
E. coli
A. naes
% genome coverage 
ssake
Newbler
Abyss
Spades
Ray
Mira
0
10
20
30
40
50
60
70
80
90
100
0 20 40 60 80
%
 G
e
n
o
m
e
 C
o
ve
ra
ge
 
% GC content 
newbler
Abyss
Spades
Ray
Mira
0
5
10
15
20
25
30
35
40
Ad41 C. dif E. coli A. naes
n
u
m
b
e
r 
o
f 
m
is
sa
se
m
b
lie
s Newbler
Spades
Mira
0
200
400
600
800
1000
1200
1400
1600
1800
Ad41 C. dif E. coli A. naes
co
n
ti
g 
n
u
m
b
e
r 
Newbler
Spades
A 
D 
C 
B 
210 
 
4.6 Characterisation of Pathogens using de novo Assembled 
Genome Data  
4.6.1 Annotation of the Genome 
To assess the potential for de novo assemblies to provide detailed genome data, annotations 
of completed reference genomes were compared to de novo assembled datasets.   De novo 
assemblies produced by none amplification controls and single cell ɸ29 MDA amplifications for C. 
difficile, E. coli and A. naeslundii were investigated alongside ɸ29 MDA amplification of 
adenovirus. Files for de novo assembly were error and abundance trimmed before assembly using 
Spades. The result assemblies and reference files were then annotated using Prokka115, which is a 
tool specifically designed for rapid annotation of prokaryotic genomes. After annotations were 
completed the number of hypothetical proteins was calculated before they were removed from 
analysis along with any repeated proteins, Table 4-9.  
Overall for all bacterial annotations the majority of predicted proteins were found i n all three 
annotations Figure 4-8. In the E. coli annotations, a similar number of proteins were predicted in 
all three annotations (3102, 3103 and 3094), with 2934 of these being identified in all three 
annotations. A small number of proteins (<1%) were found in only a single annotation, and a 
slightly larger proportion (2%) were found in only two annotations.  In the C. difficile annotations, 
the reference and single cell ɸ29 MDA annotations identified a similar number of proteins (2413 
and 2356), whereas fewer proteins were identified in the non-amplification control (2123). The 
non-amplification control also contained more hypothetical proteins than the other two 
annotations. Almost 5% of the genes predicted in the C. difficile non-amplification control 
annotations were only identified in that annotation, whereas 14% of proteins were identified in 
the reference and the ɸ29 MDA sample. In the A. naeslundii annotations a similar number of 
proteins were identified in the non-amplification control and ɸ29 MDA sample (1123 and 1121), 
however this was less than identified in the reference (1420). 30% of the genes identified in the 
reference annotation weren’t found in the non-amplification or ɸ29 MDA sample.  
After annotation of the adenovirus reference and ɸ29 MDA assembly a similar number of 
proteins were identified in both (22 and 28), but only one of these was identified in both. 
However when the two annotation results were arranged by transcription unit (supplementary 
Table 7-1) 13 out of 14 units were found in both annotations.  
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 Reference  Control  Single cell MDA  
E. coli 
Genes 4552 4735 4826 
Hypothetical  764 815 647 
Unique hits 3102 3103 3094 
C. difficile 
Genes 4113 3982 4745 
Hypothetical  877 1126 964 
Unique hits 2413 2123 2356 
A.naeslundii 
Genes 2520 2141 2028 
Hypothetical  852 915 615 
Unique hits 1420 1129 1121 
Adenovirus 
Genes 33  53 
Hypothetical  10  32 
Unique hits 22  28 
Table 4-9 genome annotations for reference genome, non-amplification control and single cell ɸ29 MDA de novo 
assemblies for E. coli, C. difficile and A. naeslundii alongside reference and ɸ29MDA de novo  assembly annotations of 
Adenovirus. 
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Figure 4-8 Venn diagrams for genome annotations results for unique hits  for reference genome, non-
amplification control and single cell de novo assemblies for (A) E. coli, (B)  C. difficile (C) A. naeslundii and (D) 
Adenovirus 
A 
C 
B 
D 
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4.6.2 Virulence Determinants 
4.6.2.1 Key Word Search  
To further investigate the Prokka outputs, a key word search was performed to identify 
potential virulence factors identified. A list of the virulence key words can be found in  2.4.10.1 
The annotated reference sequence for C. difficile predicted 15 virulence factors, 13 of which 
were found in all annotations and included six phage associated genes, three transposons and 
four toxins including toxin A and B associated with C. difficile virulence. Two additional genes 
were identified in the ɸ29 MDA and the reference annotations, a conjugative transposon and a 
pathogenicity locus.  In the non-amplification control a plasmid associated gene was identified, 
which was not found in the other two annotations. The overlapping virulence factors are  
summarised in Figure 4-9-B and the details of all factors identified are found in Table 4-11. 
After filtering for repetition the E. coli reference sequence contained 19 possible virulence 
determinants, 12 of which were phage associated, five were toxins, and two were virulence 
associated. In total the non-amplification control had 47 genes predicted and the single cell ɸ29 
MDA had 45 genes identified. 27 of these were not identified in the reference, Figure 4-9, of these 
24 were phage associated, one was a toxin, one was a plasmid element and one was a conjugative 
transposon. All factors identified are shown in Table 4-10 
In the reference annotation of A. naeslundii, four factors were identified, two plasmid genes, 
one toxin and one transposon. The control annotation included two factors, plasmid maintenance 
and a toxin. The ɸ29 MDA annotation contained four factors, two toxins, one plasmid factor and 
one transposon Table 4-12 
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Common elements All Common elements in E_coli_con E_coli_MDA : 
Phage antitermination protein Q Conjugative relaxosome accessory transposon 
phage exclusion protein Lit Phage portal protein, lambda family 
Phage Terminase Phage terminase large subunit (GpA) 
Phage portal protein Phage tail  fibre repeat 
Phage Tail  Collar Domain protein Phage NinH protein 
Phage shock protein A Phage minor tail  protein L 
Phage shock protein B Phage minor tail  protein 
Phage shock protein C Phage minor tail  protein U 
Phage shock protein D Phage Head-Tail Attachment 
Phage shock protein G Phage major capsid protein E 
phage T7 F exclusion suppressor FxsA Plasmid-derived single-stranded DNA-binding 
Toxin YkfI Toxin CcdB 
Toxin YoeB Transposon gamma-delta resolvase 
Toxin CptA Phage lysozyme 
Toxin YhaV Phage holin family (Lysis protein S) 
Toxin-antitoxin biofilm protein TabA Phage integrase family protein 
Virulence regulon transcriptional 
activator 
Lambda phage tail  tape-measure protein 
Virulence factors putative positive Bacteriophage CII protein 
 Bacteriophage Lambda NinG protein 
Common elements in E_coli_ref 
E_coli_con : 
Prophage tail  length tape measure protein 
Phage DNA packaging protein Nu1 Bacteriophage lambda minor tail  protein (GpG) 
 Prophage minor tail  protein Z (GPZ) 
 Bacteriophage lambda head decoration protein D 
Elements only in E_coli_con : Bacteriophage lambda Kil  protein 
Plasmid SOS inhibition protein (PsiB) Lambda Phage CIII  
 Bacteriophage replication protein O 
 Bacteriophage lambda tail  assembly protein I  
Table 4-10 -al l virulence factors identified in the E. coli genomes using Prokka output keyword search  
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Common elements in All : Common elements in C_dif_ref C_dif_MDA : 
"Phage terminase large subunit" "Conjugative transposon protein TcpC" 
"Phage portal protein, SPP1 Gp6-like" "Pathogenicity locus" 
"Phage minor structural protein GP20"  
"Phage tail  sheath protein"  
"Phage-like element PBSX protein XkdM" Elements only in C_dif_con : 
"Phage XkdN-like protein" "Plasmid maintenance system kil ler protein" 
"Toxin B"  
"Toxin A" Elements in C_dif_con and C_Dif_MDA :  
"Toxin-antitoxin biofilm protein TabA" “Phage tail  fibre repeat" 
"Transposon Tn10 TetD protein"  
"Transposon gamma-delta resolvase"  
"Transposon Tn3 resolvase"  
"Virulence protein"  
"Toxin HigB-1"  
Table 4-11 al l vi rulence factors identified in the C. difficile genomes using Prokka output keyword search  
 
 
Elements only in A_nae_ref : Common elements in A_nae_con A_nae_MDA : 
"Plasmid stabilisation system protein" "Plasmid maintenance system kil ler protein" 
"Plasmid encoded toxin Txe" "Toxin HigB-1" 
  
Common elements in A_nae_ref A_nae_MDA :  
"Toxin Doc"  
"Transposon Tn10 TetC protein"  
Table 4-12 al l vi rulence factors identified in the A. naeslundii genomes using Prokka output keyword search  
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Figure 4-9 Venn diagrams for vi rulence factors identified using Prokka output keyword 
search for reference genome, non-amplification control and s ingle cell de novo assemblies for 
(A) E. coli, (B) C. difficile and (C) A. naeslundii 
C 
B A 
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4.6.2.2 Database search 
The same files used in the Prokka annotations were used to predict virulence factors using the 
VFDB. The database identified 79 hits in the E. coli reference, and 82 in the non-amplification 
control and single cell ɸ29 MDA de novo assemblies.  Of these identified factors 28 were 
associated with the genes were E. coli CFT073 and 15 were associated with E. coli 536 
(uropathogenic strains). Additionally, seven factors were associated with E. coli 0157:H7 and three 
unspecified E. coli strains. There were also 25 hits against Shigella flexerni serotype 2a, four 
against Shigella dysenteraie.  When the proteins were grouped into classes, 43 were unknown, 
hypothetical or had unknown functions. 20 were involved in ferric export, 9 were fimbri ae 
associated, three were involved in efflux or export, and two were insertion elements found in all 
files, two additional insertion factors were found only in the ɸ29 MDA and control samples. Two 
phage proteins were also identified. A full list of the identified factors can be found in the 
supplementary material. 
When using the VFDB to predict resistance in C. difficile the reference, non-amplification 
control and ɸ29 MDA all had four hits identified, toxin A and B, along with cdtA and cdtB. Shown 
in Table 4-13 
No virulence determinants were identified in any A. naeslundii assemblies.  
 
Gene ID Bacterial origin 
tcdA toxin_A Clostridium_difficile_630 
tcdB toxin_B Clostridium_difficile_630 
cdtB CdtB Clostridium_difficile 
cdtA CdtA Clostridium_difficile 
Table 4-13 output of VFDB for C. difficile, the same output was achieved using completed reference and de novo 
assemblies of the non-amplification and ɸ29 MDA samples 
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4.6.3 Antibiotic Resistance Prediction  
4.6.3.1 Key Word Search  
An additional key word search was performed to investigate the potential of the Prokka 
annotation to provided antibiotic resistance prediction. A list of terms included can be found in 
2.4.10.1 
When the E. coli reference was investigated for the word resistance there were 33 hits, seven 
(21%) of which were environmental resistance factors, all other hits also contained another word 
in the search  the full list can been seen in the supplementary material Table 7-5.When the C. 
difficile was investigated for the work resistance 26 hits were found, si x of which were 
environmental resistance factors, all others but one contained other words in the search. One hit 
conferred resistance to phages which would have been detected in the previous search.  When A. 
naeslundii was investigated for the word resistance 13 hits were found, five (38%) of which were 
environment associated, all others had another searched for string.  
 
When the E. coli reference was investigated for efflux pumps, 24 were identified, 20 of which 
were housekeeping associated, all others were found to have other search terms in. When the C. 
difficile reference was searched for efflux there were 11 results seven of which were 
housekeeping, one had an unknown function and one was only identified as a putati ve 
component. Two were associated with resistance and had other search strings in their name. In 
the A. naeslundii reference four efflux pumps were identified, all of which were housekeeping 
efflux pumps.  
Searches were repeated without the words resistance or efflux. When the E. coli reference 
genome was investigated for resistance factors there were 53 identified, the control had 51 
identified proteins and the ɸ29 MDA sample had 53. 51 of these genes were associated will all 
three searches; two appeared only in the reference and the ɸ29 MDA. In all three datasets 27 
efflux pumps and export systems were identified associated with drug resistance, with an 
additional two found in the ɸ29 MDA and reference datasets Table 4-10. Seven penicillin binding 
proteins were identified, and two repressor or activator genes were detected. Six of the identified 
genes had an unknown or undefined role and five identified genes weren’t associated with 
antibiotic resistance.  
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When the C. difficile reference genome was investigated for resistance factors 39 genes were 
identified, Table 4-10 the control found 33 and the ɸ29 MDA identified 36. 28 of these genes 
were found in all three, seven were found only in the reference and ɸ29 MDA sample, four were 
found in the control and ɸ29 MDA and one gene was found in the control, and one found only in 
the ɸ29 MDA sample. Four beta-lactamases were identified in all datasets, 12 efflux or export 
systems were found in all samples, along with an additional two in the reference and ɸ29 MDA. 
One penicillin binding protein was found in the ɸ29 MDA and control and one in only the ɸ29 
MDA. Four activator or repressor were identified in all datasets, and an additional one was 
identified in the reference and the ɸ29 MDA. Two vancomycin specific resistance factors were 
found in the all samples and an additional one in the control sample. One tetracycline resistance 
associated gene was identified in all samples and two additional genes were found in the ɸ29 
MDA and reference. Three proteins had no defined function and four weren’t associated with 
antibiotic resistance.  
 
In the A. naeslundii reference 17 factors were identified in the search for antibiotic resistance 
Table 4-10, 14 factors were identified in the control and 18 were identified in the ɸ29 MDA 
sample. Ten of these factors were common to all, five export or efflux systems, three without 
defined function, one penicillin binding protein and one factor not associated with antibiotic 
resistance. Three factors were only found in the reference sequence, one with an unknown 
function and two penicillin binding proteins. Four factors were found in the ɸ29 MDA and 
reference sequence, two efflux pumps, one penicillin binding protein and a vancomycin resistance 
associated gene. Four genes were only identified in the ɸ29 MDA and control, two beta lactamase 
associated gens, a resistance operon repressor and an export protein.  
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4.6.3.2 Database Search  
When the ardbAnno script was used to detect resistance factors in E. coli none were 
identified any of the datasets. In all the C. difficile the ermB resistance gene was detected, which 
is associated with resistance to macrolides, Lincosamides and Streptogramin B.  No resistance 
factors were identified in the A. naeslundii genomes.  
When the Resfinder database was used to find resistance factors in A. naeslundii, no matches 
were found. In all the C. difficile   genomes ermB and tetM gens were identified. In the E. coli 
genomes, the oqxB gene and the blaCMY operon were identified.  
 Reference  Control MDA  
A. naeslundii None detected None detected None detected 
C. difficile erm(B)_10_U86375 
erm(B)_11_M19270 
erm(B)_12_U18931 
erm(B)_15_U48430 
erm(B)_18_X66468 
erm(B)_1_JN899585 
erm(B)_20_AF109075 
erm(B)_21_U35228 
erm(B)_6_AF242872 
erm(B)_7_AF368302 
erm(B)_9_AF299292 
tet(M)_10_EU182585 
tet(M)_11_JN846696 
erm(B)_10_U86375 
erm(B)_11_M19270 
erm(B)_12_U18931 
erm(B)_15_U48430 
 
erm(B)_1_JN899585 
erm(B)_20_AF109075 
erm(B)_21_U35228 
erm(B)_6_AF242872 
erm(B)_7_AF368302 
erm(B)_9_AF299292 
tet(M)_10_EU182585 
tet(M)_11_JN846696 
erm(B)_10_U86375 
erm(B)_11_M19270 
erm(B)_12_U18931 
erm(B)_15_U48430 
 
erm(B)_1_JN899585 
erm(B)_20_AF109075 
erm(B)_21_U35228 
erm(B)_6_AF242872 
erm(B)_7_AF368302 
erm(B)_9_AF299292 
tet(M)_10_EU182585 
tet(M)_11_JN846696 
E. coli blaCMY-12_1_Y16785 
blaCMY-15_1_AJ555823 
blaCMY-38_1_AM931008 
oqxB_1_EU370913 
blaCMY-12_1_Y16785 
blaCMY-15_1_AJ555823 
blaCMY-38_1_AM931008 
oqxB_1_EU370913 
blaCMY-12_1_Y16785 
blaCMY-15_1_AJ555823 
blaCMY-38_1_AM931008 
oqxB_1_EU370913 
Table 4-14 Results from Resfinder for predicting resistance in A. naeslundii, C. difficile and E. coli for completed 
references and  de novo assemblies of non-amplification control and ɸ29 MDA samples  
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Figure 4-10 Venn diagrams for resistance predictions for reference genome, non -amplification control 
and s ingle cell ɸ29 MDA de novo assemblies for E. coli, C. difficile and A. naeslundii 
A 
C 
B 
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4.7 Analysis of Mixed Cell Input Sequencing Data  
To investigate the impact of abundance trimming on mixed samples, the four samples 
consisting of mixed bacteria at different ratios (3.9) were error and abundance trimmed. The 
resulting reads were then identified using Blastn and LCA analysis, with reads belonging to 
each bacteria being extracted into separate fastq files. These fastq files were then de novo 
assembled using Spades, before being annotated using Prokka. 
After completion of the trimming stage the 1:1 reads had more reads remaining (54%) 
than the other ratio samples. As the ratio between the bacteria increased the proportion of 
reads remaining after trimming decreased Figure 4-11-A. The E. faecalis genome (3,218,030 
base pairs) is twice the size of the H. influenzae genome (1,830,140 base pairs), and so the 
proportion of reads mapping to the E. faecalis genome was halved to normalised the read 
proportion for genome size. After completion of trimming the proportion of reads identified 
as each bacterium was slightly closer to the original cell mix ratio Figure 4-11-B. As the ratio of 
E. faecalis reads decline the proportion of the genome covered dropped, with no genome 
coverage achieved in the 1:1000 ratio Figure 4-11-C. However, Enterococcus phages BE2 and 
EF62phi were identified in all samples.  Genome coverage of the H. influenzae remained high 
in all samples after abundance trimming (92-94%) Figure 4-11-D 
 
 
 1:1 1:10 1:100 1:1000 
 Before 
Pipeline 
After 
Pipeline 
Before 
Pipeline 
After 
Pipeline 
Before 
Pipeline 
After 
Pipeline 
Before 
Pipeline 
After 
Pipeline 
Total reads 133320 72583 167837 80562 148139 61361 152879 59208 
Reads 
Enterococcus 
83286 43710 30086 13293 3169 2002 0 0 
% reads 
Enterococcus 
62% 60% 13% 17% 2% 3% 0% 0% 
% reads 
Enterococcus 
normalised 
31% 30% 7% 8% 1% 1.6% 0% 0% 
%genome 
coverage 
Enterococcus 
93% 93% 64% 65% 15% 15% 0% 0% 
Reads 
Haemophilus 
33254 22098 195217 66866 122308 58331 145235 57211 
%reads 
Haemophilus 
25% 30% 85% 83% 83% 95% 95% 97% 
% genome 
coverage 
Haemophilus 
92% 92% 94% 94% 94% 93% 93% 92% 
Table 4-15 summary of results of sequencing of different s tarting ratios of E.  Faecalis and H. Influenzae before and 
after application of the developed analysis pipeline  
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Figure 4-11 Impact of abundance and error trimming on different mixed cell rations, (A) proportion of total reads 
remaining (B) normalised proportion of reads identified as each bacterium before and after abundance trimming (C) % 
genome coverage of E. faecalis at different mix ratios before and after abundance trimming (D) % genome coverage of 
H. influenzae at di fferent mix ratios before and after abundance trimming 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
1:1 1:10 1:100 1:1000
P
ro
p
o
rt
io
n
 o
f 
re
ad
s 
re
m
ai
n
if
 a
ft
e
r 
ab
u
n
d
ac
e
 a
n
d
 e
rr
o
r 
tr
im
m
in
g 
1:1 1:10 1:100 1:1000
p
ro
p
o
rt
io
n
 o
f 
re
ad
s 
id
e
n
ti
fi
e
d
 a
s 
e
ac
h
 
b
ac
te
ri
a 
b
e
fo
re
 a
n
d
 a
ft
e
r 
ab
u
n
d
an
ce
 
tr
im
m
in
g 
0% 20% 40% 60% 80% 100%
1:1
1:10
1:100
1:1000
% genome coverage 
E.faecalis after trimming
E.faecalis before trimming
0% 20% 40% 60% 80% 100%
1:1
1:10
1:100
1:1000
% genome coverage 
H.influenzae after trimming
H.influenzae before trimming
A 
B 
C D 
224 
 
4.7.1 Characterisation of Mixed Samples 
4.7.1.1 Mixed bacterial Input  
As the ratio of E. faecalis declined the number of predicted proteins also declined with 2476 
unique proteins predicted in the 1:10 ratio sample and only 716 predicted in the 1:100 ratio. A 
total of 650 of these products were identified in all ratios, 1232 were found in the 1:1 and 1:10 
ratio, and 571 were only found in the 1:1 ratio sample.  
When the H. influenzae samples were annotated the number of unique proteins identified 
was fairly constant (2392-2428)Figure 4-12-B. The total number of proteins predicted and the 
number of hypothetical proteins were lower in samples with a lower ratio of E. faecalis Figure 
4-12-A A total of 2290 of these products were identified in all ratios, with 62 being identified in 
three datasets, 104 were identified in two samples and 105 were identified in only a single 
sample.   
 The annotation data from the H. influenzae also gave an insight into the reproducibility of the 
amplification and annotation method Figure 4-13. Over 94% of predicted proteins were found in 
all four H. influenzae amplifications, 2.5% of proteins were found in three annotations, 4% in two 
annotations and 4% were identified only in one annotation.  
4.7.1.2 Mixed Viral Input 
When the sequencing results from the amplification of mixed HIV and Adenovirus (3.10.1.2) 
was annotated using Prokka, the adenovirus results were comparable with those found in 4.6.1, 
with a total of 52 genes predicted with 22 of these being hypothetical and 28 remained after 
filtering for repetition.  
The HIV de novo assembly covered 99.9% of the genome in three contigs, with two 
misassemblies. The output from the Prokka annotation was nine products, one of which was 
hypothetical and after filtering for repeats, four proteins remained. When the reference was 
annotated using Prokka, eight products were identified, three of which were hypothetical, and 
after filtering for repeats four remained. The four remaining gene annotations were the same in 
both the reference and de novo assembly which were Gag polyprotein, Gag-Pol polyprotein, 
Virion infectivity factor and Envelope glycoprotein gp160 precursor.  
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Figure 4-12 Results of Prokka annotation on different mixed call ratios of (A) E .faecalis and (B) H. influenzae 
showing total number of predicted genes, number of hypothetical genes and number of unique genes  
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Figure 4-13 Venn diagram of unique genes identified in the (A) E. faecalis and (B) H. influenzae in each mix ratio 
us ing Prokka  
A 
B 
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4.7.1.3 Resistance in Enterococcus 
The number of resistance genes predicted dropped as the ratio of E. faecalis declined. When 
the 1:1 enterococcus annotation was interrogated for resistance factors 47 genes were identified, 
12 were penicillin binding proteins and four weren’t associated with antibiotic resistance. 19 were 
efflux pumps associated with drug resistance, four were specifically tetracycline resistance genes, 
two were beta-lactamases, and two were associated with streptomycin resistance, one 
specifically with vancomycin/teicoplanin resistance and three with other antibiotic breakdown. 
When the 1:10 enterococcus annotation was investigated for resistance factors 39 genes were 
identified, nine were penicillin binding proteins and four weren’t associated with antibiotic 
resistance. 16 were efflux pumps associated with drug resistance, four were specifically 
tetracycline resistance genes, and two were beta-lactamases, one specifically with 
vancomycin/teicoplanin resistance and three with other antibiotic breakdown. In the 1:100 
annotation of the enterococcus genome, 14 resistance genes were identified, seven were 
penicillin binding proteins, one wasn’t associated with antibiotic resistance, five were drug efflux 
pumps and one was a beta-lactamase. This is summarised in Table 4-16       
                                
 All ratios  1:1 only 1:1 and 1:10 1:10 only 1:100 only  
None antibiotic resistance 1 1 2 1  
PBP 6 4 2 1 1 
Efflux 5 6 8 3  
Tetracycline resistance   4   
Beta-lactamase 1  1   
Streptomycin resistance  2    
Vanc/Teic resistance   1   
Other ABx breakdown   3   
Table 4-16 summary of antibiotic resistance factors identified in  E. faecalis in a mixed bacteria samples at different 
input ratios  
4.7.1.4 Haemophilus Resistance  
In the 1:1 and 1:10 sample 52 resistance genes were identified, 50 were identified in the 
1:100 and 52 were identified in the 1:1000. 47 genes were found in all samples, including 11 PBP 
and two not associated with antibiotic resistance. 21 drug efflux pumps were identified, five 
genes specifically associated with tetracycline were identified, two genes associated with 
streptothricin were identified, along with two genes associated with vancomycin and teicoplanin 
resistance, and four genes which broke down other antibiotics.  Three genes were found in three 
datasets, two efflux pumps and one PBP, three genes were  only found in two datasets, one efflux, 
one PBP and one gene not associated with antibiotic resistance. An additional PBP was only found 
in one dataset.  
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4.8 Final Assembly Pipeline 
A final analysis pipeline was designed using the methods optimist in this chapter to provide 
robust data analysis of sequencing produced from ɸ29 MDA on the 454 Junior, Figure 4-14.  
The first stages of the pipeline include removal of host and possible environmental and kit 
contamination using reads from negative amplification samples.  This is then followed by digital 
normalisation and error trimming. Read identification is then performed using Blastn and LCA 
analysis. At this point the results are visualised to allow assessment of mixed samples, and 
provide microbial species identification. Species specific reads are then extracted from the 
trimmed fastq, and de novo assembled. Finally, annotation is performed alongside use of 
database searches for virulence and resistance factors.  
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Figure 4-14 summary of bioinformatic analysis of sequencing produced using ɸ29 MDA on the 454 Junior 
 
•Newbler assembly against human genome 
•Custom script to move unmapped reads to a new file 
Remove host contamination 
•Newbler assembly against a compiled negative library 
•Custom script to move unmapped reads to a new fi le 
Removal of kit and environmental contamination 
•converstion to a fastq 
•normalisation my median to a coverage of 60, using kmer size of 140 
•abundance fi ltering to remove very low number kmers  
•normalisation by median to a coverage aim of 50, using kmer size of 140 
Digital normalisation  
•using prinseq 
•remove tags, trim ends to Q20, trim average to Q20 and remove reads shorter than  
99 base pairs  
Error trimming  
•Using blastn none redundant database 
Identify species 
•load blast results into MEGAN 
•view the results 
•extract reads in identified species in fasta format 
Visulise the results  
•extract the identified reads from the trimmed fastq fi le 
•assemble using Spades de novo  assembler 
assemble data 
•using PROKKA  
annoate the genome 
•extract key identifeid genes from the prokka genebank fi le 
•using ARDB , ardbAnno.pl and VFDB 
•assembly can also be loaded into specialist databases for identified organims.  
Extract resistance and virulence factors  
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4.9 Chapter Discussion 
4.9.1 Removal of Contaminants from Sequencing Data 
Host signals increase data size and make de novo assemblies more complex and so a simple 
mapping method was used to remove them. The adenovirus sequencing in 3.10  which had the 
highest level of host contamination was used to model the bioinformatic stage of the procedure 
to remove host signals.  After the human signals were removed from the file, the reads belonging 
to the adenovirus and Enterobacteriaceae were left intact; the only information removed was the 
host contamination. This method allows simple and rapid removal of host signals without 
affecting the pathogen signals, thereby lowering the overall complexity of the downstream 
assembly.  
 Kit and environmental contaminants are important factors to consider when using highly 
sensitive molecular methods 103. Throughout this study negative samples were amplified and 
sequenced. The sequencing was then investigated using LCA analysis to provide a way of 
monitoring possible contaminations. Within the negative samples in 4.1, the majority of the reads 
present were either classed as unmapped or unidentified. The possible source of these reads 
could be polymerisation and joining of very degraded DNA, which was introduced at some point 
in the sample processing. Also the ɸ29 could be randomly joining nucleotides together or could 
be using primers as sites of replication because of its high processivity. These reads make up a 
much smaller proportion in positive runs, suggesting ɸ29 will preferentially copy good quality 
DNA. 
   There was a significant presence of Mycobacterium sp which have previously been 
identified as a laboratory contaminant problem with the 16S sequencing service run in the same 
laboratory, with the most probable source being water. In this case the contamination appears to 
be post amplification; otherwise the Mycobacterium would be present in much higher numbers.  
Most Mycobacterium sp reads remained in the negative library which was later used to re move 
mapping reads. If these reads had remained they may lead to misassemblies and mis-annotations, 
appearing as gene variants or inserted genes. If there was a true infection with mycobacterium, 
there would be a higher coverage of the genome, and so this would still be identifiable. This 
highlights the need for manual visual monitoring of samples and contamination libraries side by 
side to monitor contaminants, false positives and true pathogen presence.  
Other contaminating species were present in very low numbers, again suggesting post 
amplification contamination. All of these were species that had previously be en sequenced in the 
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laboratory. The most likely source of these would be when loading the PTP, as the same loading 
apparatus is used for each sequencing run.  
In conclusion removing contaminants, amplification and sequencing artefacts improves the 
reliability of the data. It also lowers the overall size of the files which need to be analysed, 
speeding up processing. However negative libraries need to be manually monitored and not just 
added into a negative reference file. Negative extractions and amplification will allow monitoring 
of all processes in the laboratory. Other studies have begun to recognise the importance of 
monitoring results for contamination, when 57 sequencing runs (across six sites) from the 1000 
genome project were analysed reads classed as ‘contaminating sequences’ were present in all 
runs, representing a range of 0.000007% to 0.015% of all reads155. The main source to which these 
contaminants were attributed was an UltraPure water system, and a high level of Bradyrhizobium 
Spp was identified.  A whole genome sequencing study of a blood sample from a febrile patient 
identified Bradyrhizobium sp as the possible cause citing that this was the first known infection 
with this bacterial species,156 however this conclusion is quite possibly erroneous in light of the 
findings of Laurence et al  155. No negative samples or environmental testing were undertaken in 
this study identifying Bradyrhizobium sp as a pathogen, this highlights the need for caution and 
the use of negative controls.  
 
4.9.2 Quality Trimming of Raw Reads 
To improve reliability of assemblies and data interpretation, poor quality data needs to be 
removed from the raw reads. The trimming method needs to be balanced to improve data quality 
whilst retaining as much information as possible. Two different trimming algorithms were 
investigated, running sum and window based, with the specific programmes selected based on 
the ability to trim 454 data.   
There was no real difference observed after the control tags were removed ( 4.3.2), however 
Newbler is designed for 454 data and has inbuilt detection of these tags, other assemblers may 
not recognise these. No information is found in these tags and so they may as well be removed as 
part of the trimming process. 
Ends of reads often have the lowest quality bases, removing poor quality bases at the end of 
reads allows better overlaps with higher confidence. After end quality trimming there was very 
little impact on the number of reads using Prinseq; however strict trimming (Q35) using Cutadapt 
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reduced the read length so far that some reads were removed entirely. Most of the impact on 
data was through the removal of bases, leading to shorter reads.  
There was very little impact on the reference assembly after end error trimming with Prinseq, 
the main difference was more and shorter contigs, probably owing to the reduced read lengths, 
leading to less overlaps made. Both the Q30 and Q35 trimming using Cutadapt were actually 
detrimental to the reference assembly, lowering the reference coverage and increasing the 
number of contigs, as more information was removed with this trimming algorithm.  
Strict (Q35) end error trimming was detrimental to the de novo assemblies both Prinseq and 
Cutadapt trimmed samples. Reference coverage was lowered to 90.93% and 75.2% from 94.12%. 
However, the Prinseq assembly actually had fewer and longer contigs, with the N50 increasing 
155% and the longest contig increasing 127%, misassemblies dropped from 20 to 17. Cutadapt 
assembly had a shorter N50 (34%) and longest contig (65%), but the misassemblies did decrease 
to 18. Lower genome coverage is probably down to loss of information due to over trimming, 
especially using Cutadapt, which only left 40% of the bases.    
Less strict (Q20) end trimming improved the de novo, with the reference coverage increasing 
to 94.85% using Prinseq and 94.29% using Cutadapt. Contig number was reduced, and the N50 
length increased compared to the raw data to 222% using Prinseq and 220% using Cutadapt, and 
the largest contigs increased to 304% and 259%. Misassemblies dropped to 15 using Prinseq and 
17 using Cutadapt. Fewer contigs were produced because the overall quality of overlaps increases 
allowing more overlaps to be accepted by the assembler. This leads to longer contigs being 
constructed because there are more high quality overlaps. There is particular improvement in the 
Q20 trimmed assemblies, as these have maintained the longest read lengths.  
Cutadapt removes more bases in every quality cut off compared to Prinseq. Window based 
trimmers (Prinseq), make allowances for poor quality base that are surrounded by high quality 
bases, however running sum algorithms (Cutadapt) will take averages of sections of reads. Poor 
quality bases essentially lower the quality of the surrounding bases, and so high quality bases may 
be removed.  Removal of more bases predictably leads to shorter reads, lowering overlaps 
causing higher contig numbers and shorter lengths of the resulting contigs. This was apparent in 
both the reference and de novo assembly. Whilst there was no improvement in reference 
assembly results using Q20 Prinseq, there was improvements in the de novo assembly, showing 
there is an advantage to end trimming.   
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In addition to end quality trimming, Prinseq has the ability to trim reads based on overall read 
quality. As expected the higher the quality metric the more reads were removed. The longest and 
average read lengths were reduced in all metrics, due to poor quality bases at the end of long 
reads, which lower the overall read quality. Very strict average read trimming (Q35) led to a drop 
in the genome covered to 78.3% after reference assembly; there was also an increase in contig 
number and a decrease in contig size, with the average contig size being only 7% of the original. 
This is probably due to the large amount of data lost to trimming, coupled with the removal of 
long reads, Q20 trimming also lead to a poorer performance of the reference assembly, although 
to a lesser scale. The Q35 trimming reference assembly was able to still cover 78% of the genome 
using only 18% of the original reads, suggesting the occurrence of poor quality reads was random 
and spread across the genome.  
The de novo assembly of the strictly trimmed file only covered 34% of the genome, suggesting 
difficulty in matching and overlapping reads, probably due to the large data loss especially in read 
length. The de novo assembly of the Q20 average trimmed file was actually improved, with a 
slight increase in genome coverage (94.12% to 94.57%). The number of contigs was halved, and 
larger contigs were produced, both the average contig size and the N50 doubled in length.  The de 
novo assembly has benefited from removal of erroneous reads, allowing more high quality 
overlaps to be made.  
Overall there is very poor assembly of reads when very strict quality metrics are used, over 
trimming causes loss of data, particularly those reads with the longest length. Less strict error 
trimming had a slightly detrimental effect on the reference assembly, but actually improved the 
performance of the de novo assembly.  Reference assembly metrics are better adapted to 
interpret erroneous reads as they have a something to compare the reads to and allow be tter 
interpretation of reads.  De novo   metrics must rely completely on the read information given, 
and removing erroneous reads leads to a less complex data set with only high quality reads, 
improving the performance of de novo assemblers. For rapid genome coverage assessment where 
a similar reference is available untrimmed data can be used to reference assemble, saving time 
and processing power needed by trimmers, however the improvements in the de novo 
assemblers is such that error trimming should be performed.  
Very short reads (some as little as one base) left behind after error trimming contain little or 
no information, and increase the complexity of the assembly, and often will be ignored by 
assemblers. On its own it has negligible in its impact on assembly, but when combined with error 
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trimming parameters it will lower the number of reads the assemblers have to process without 
loss of information. 
The impact of preceding average read trimming with end read trimming was investigated with 
the reasoning that by removing the poor quality ends from reads before average quality trimming, 
more reads and therefore more data should remain. As very high quality trimming has proved 
detrimental to assembly, Q20 was chosen as the average quality cut off and combined with 
various end quality trimming varying from Q20 to Q30.  
Once again the reference assembly was slightly negatively impacted with all metrics, with the 
reads being assembled into more and shorter contigs, but there was no impact on the coverage of 
the genome. And in contrast the de novo assemblies were once again improved across all in terms 
of contig number and length, however the strictest end trimming did lead to a small decrease the 
reference coverage (94.12% to 93.3%), probably down to loss of data. The Q20 end trimming 
combined with Q20 average trimming led to the best performance with a small increase in 
reference coverage (94.73%), less than half the number of contigs, and the largest contig more 
than double in length compared to the raw data. Of particular note was the increase in the N50 
value which more than trebled. The number of misassemblies was only 14 compared to the 
original 20. Again this is most likely down to the removal of poor quality overlaps which interfere 
with the assembly algorithm, good quality overlaps allow more to be accepted and larger contigs 
to be built.  
Overall for rapid genome coverage assessment using a close reference, error trimming 
appears to be slightly detrimental and so may be contraindicated. However, for de novo assembly, 
the aim of this thesis, the quality of the output is improved. Additionally, in this data set window 
based trimming algorithms provide a better performance than running sum, allowing more data 
to be retained, whilst still improving the data quality. The combination of end quality trimming 
prior to average quality trimming allows a better outcome, by allowing more reads and therefore 
more data to be retained. Over trimming is detrimental to the assembly because a large amount 
of data is lost. The findings reported here are in line with those of a larger trimming study 
performed by Del Fabbro et al 104, who concluded that when trimming strictness was too high 
there was a significant reduction in the dataset lowering genome coverage, whereas too little 
trimming increased the data complexity and lowers overall data quality. By optimising the 
trimming parameters reliability of downstream analysis increases, Del Fabbro et al showed that 
the same quality cut-offs have different outcomes with different trimming algorithms. Ultimately 
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the data analysis pipeline has to reflect the biological question and the dataset being analysed, 
which has been achieved here.   
 
4.9.3 Impact of Abundance Trimming on de novo Assembly 
Data was digitally normalised to reduce the dynamic range of the coverage depth, using 
Khmer107. The aim of digital normalisation was to decrease the data size by discarding redundant 
reads, whist maintaining the information within the file.  This software also has the additional 
benefit of removing those reads that appear at very low numbers, which are most likely due to 
random sequencing errors. This approach has been used previously to aid in the assembly of 
metagenomes157, transcriptomes158, as well as genomes159. 
The programme uses a reference free algorithm to estimate the genome coverage of the data 
by looking at the abundance distribution of kmers on the assumption that kmers tend to have 
similar abundances within a read. (The more times a piece of DNA is copied the higher the kmer 
abundance will be in that region). In the absence of errors, the average kmer number can be used 
to estimate the depth of coverage. Additionally, any kmers that overlap errors will have low 
abundance, which is the basis for the additional error trimming.   
 
The initial stage focused on optimising the method for this data set by finding the value of K 
that gave the best assembly outcome. The overall aim was to reduce the peak depth to a depth 
similar to that achieved in the non-amplification assemblies (50), whilst not reducing the genome 
coverage achieved.   A Kmer size of 20 removed more reads than any other value of K, with only 
58% of reads remaining after normalisation of the raw data. The use of a short K value appears to 
have overestimated the read depth at each point, perhaps because more kmers will be present in 
each read. The peak depth was lowered to 26, much lower than the targeted peak depth, removal 
of so many reads also had a large impact on the average depth which was reduced to 9.6 from 
16.5. However, there was only a very small reduction in the genome coverage from 98.46% to 
97.97%, showing that the reads removed were from areas of high coverage, and so not losing 
much information.  
When larger values of K (50-140) were used, more accurate estimation of the depth was 
achieved, with the resulting peak depth being reduced to a range of 49-58 across these kmer 
values. These kmer values also predictably had less impact on the average depth of the reads, 
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ranging from 14-14.6. The proportion of reads retained varied between 84.2% and 87.6%. 
Reducing the peak depth had very little impact on assembly, both reference and de novo, with the 
only real difference being a reduction in the misassemblies from 23 to 17-19 across the kmer 
range, probably mostly attributable to the removal of erroneous kmers.   
The percentage reads removed from the post trimmed data was very similar to that from the 
non-trimmed dataset (84%-87%), lowering the peak depth by the same amounts. Again there was 
little impact on the assemblies, other than to lower the misassemblies, which were as low as 11 
when using a kmer value of 140. When performing abundance trimming prior to error trimming, 
the amount of reads removed was again similar. The main difference was the further lowing of 
the misassembly rates to 9 in the k140 sample. 
In conclusion, the removal of overrepresented reads lowers the amount of data to be 
processed without removal of information, and has very little impact on the assembly statistics. 
However, when combined with error trimming it does have a positive impact on the number of 
misassemblies present in the de novo assembly.  One of the factors to bear in mind is this 
algorithm will remove repetitive sequences, which in some cases may contain additional 
information and may be used for typing (e.g. MIRU typing), however in most cases the read length 
will be longer than the repetitive element which will prevent their removal. The removal of low 
abundance kmers is a good additional error check, removing errors that other trimmers may miss. 
The error trimming is also performed in the context of the depth at that point, a fact that other 
error trimmers cannot account for, leading to less data loss. The Newbler assembler used does 
not use a kmer based algorithm, and so the impact on the assembly time is negligible, however 
other assemblers will be trialled for this pipeline and so the impact there might be greater.  
4.9.4 Comparison of Genome Assembly quality using varying De 
Novo Assembler Algorithms  
Robust de novo assembly will allow the data to be interpreted dependably; the best assembly 
for a data set will depend on the type of nucleic acid sequenced, the amplification method used 
and the platform upon which the DNA was sequenced. Numerous assemblers are publically 
available, utilising a number of different algorithms, several of these were investigated for their 
suitability to assemble single cell data from three bacteria with differing GC contents, as well as 
viral sequencing.   
SSAKE (Greedy graph algorithm) was one of the very first assemblers to be designed for short 
read assemblers, for this data set the assembler performed poorly, with all the genomes having 
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low coverage, 21.9%, 58.8%, 11.8% and 65.1% for the C. difficile, E. coli, A. naeslundii and 
Adenovirus respectively. Short contigs and N50s suggest that the reads aren’t successfully being 
joined. The method was optimised for read lengths of 50-300 base pairs in lengths, which are 
shorter than the reads produced on the 454 Junior.  
Newbler (overlap consensus algorithm) is the recommended assembler for using with 454 
data and was specifically designed for data produced by this sequencing chemistry. The assembler 
performed well across all genomes, with coverage being 89.1%, 95.3%, 65.59% and 96.9%.  Contig 
numbers varied from 247 for the Adenovirus, and 569-1660 for the bacterial genome assemblies. 
Misassemblies were low across all of the assemblies, from 2-11, with the lowest being for the 
adenovirus, which is probably attributable to its small genome size. The highest was for the C. 
difficile, which may be down to the mosaic nature of the genome, with many insertion and 
repetitive elements which are difficult to assemble.  
Three De Bruijn Graph Algorithms were tested with the four datasets. The first of these types 
of assembly algorithms to be trialled was Abyss, which had the highest kmer setting of 96, a short 
size considering the reads lengths produced by 454 sequencing chemistry. There was a decent 
coverage of the pathogens, 72.2%, 88.6%, 62.8% and 90.7% for the Adenovirus. There was a high 
number of contigs produced by this assembler (1621-2651), and the number of misassemblies 
was also high, between 32 and 52. The poor performance was perhaps due to the short kmer 
sizes, and the loss of the advantage of long reads.  
The second of the de Bruijn graph algorithms to be tested was Spades; the algorithm is able to 
use several kmer sizes and the relationship between these to produce a distance histogram, 
allowing the route across the graph to be resolved using relative distances. This assembler 
provided very good coverage, 92.9%, 96.0% and 62.4% for the bacterial genomes and 97% for the 
adenovirus genome. This was the best resolution of the C. difficile genome using a de novo 
approach. The number of contigs produced was also the lowest; however, there was a still large 
number of contigs for the A. naeslundii genome, and the coverage was still lower than in the 
other bacteria.   
The final de Bruijn graph algorithm to be tested was Ray; here the maximum kmer size 
available was 140. The genome coverage was quite low, especially for the C. difficile genome, 
which only covered 54.6%, suggesting either the assembler struggles to adapt to GC content, or 
has difficulty resolving repetitive elements. There misassemblies across all genomes were high, 
21-38.  
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De Bruijn graph algorithms are increasing popular to assemble short read data sets, as they 
are rapid and fairly computationally light. It is important to note that the three De Bruijn 
assemblers didn’t perform equally and so optimisation of assembly parameters for individual 
datasets is important, as resolution of GC content and repetition in the genome may be handled 
differently. We hypothesise that the main cause for poor performance on this dataset is the 
limitations caused by small kmer sizes, which would suit other data types such as those produced 
on the Illumina system.  
Mira-4 is a Weighted Graph Algorithm assembler and produced good coverage of the 
genomes, 90.8%, 97.2%, 68.6% and 96.99%. This assembly shows good results across all the GC 
contents studied, however the contig numbers are still high, with C. difficile in 1385 contigs.  
Overall Spades showed the best assembly performance on the dataset, in terms of genome 
coverage across GC contents, it also had the lowest contig number and most importantly the 
lowest misassembly number. Other assemblies studied here mainly struggled because of the 
limitation in kmer sizes, which was poor for this data type. Spades is specifically designed to use a 
variety of kmer sizes, allowing a more dynamic de Bruijn graph approach. Newbler also performed 
well on this data set, which is unsurprising as it specifically designed for 454 data. The preferred 
data entry for Newbler is the original SFF produced by the sequencer, however the additional 
benefits of error and abundance filtering of this dataset outweighs any additional performance 
using the SFF file.  
4.9.5 Characterisation of Pathogens using de novo Assembled 
Genome Data  
Preliminary investigation was carried out to compare annotation outputs across three 
datasets, closed complete ‘reference’ genomes, and two draft genomes consisting of de novo 
assemblies of culture controls and single cell ɸ29 MDA sequencing.  
The published, annotated E. coli K-12160 was reported to have 4288 genes, with 1632 being 
hypothetical, leaving 2656 remaining with putative functions. Use of Prokka in this study 
identified 446 more genes than previously stated, perhaps attributable to improvements in 
databases since this publication in 1997, and improvements in open reading frame calling. This 
also demonstrates the importance of controls when implementing new techniques, and not 
relying solely on references. Both the ɸ29 MDA and non-amplification control annotations 
produced a higher number of gene predictions; however, the difference was greatly reduced 
when the genes were filtered for repetition, suggesting that the cause behind the higher number 
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was the same genome elements being assembled into multiple contigs. 95% of all the genes 
identified were found in all three annotations, showing high concordance suggesting that the 
annotation of ‘draft’ genomes is comparable to polished, closed genomes. Additionally, the 
control and single cell data were comparable showing no increase in potential false genes 
introduced from single cells, or missing genes. The small number of differences could be 
accounted for due to differences in naming nomenclature, or with very similar genes being 
identified, (redundancy in the database), which is a downside to comparing exact strings of data. 
The ɸ29 MDA and non-amplification control samples both had a number of additional genes 
which were associated with phages, either suggesting the phage is extra chromosomal, and 
therefore not present in the reference genome, or the phage has been acquired during sub 
culturing events since the publication of the reference. Overall the E. coli annotation showed that 
the data produced from the single cell reaction was equivalent to the non-amplification control 
and comparable to the polished control.  
This process was repeated with the C. difficile data. The publication associated with the 
reference genome136 for this strain stated that the genome had 3776 genes, with 250 having an 
unknown function and 370 being classed as conserved unknown, leaving 3156 predicted genes. 
After repeat filtering the reference was predicted to have 2413 genes, so either there are genes 
missing from the database, or there was no repeat filtering performed. Many repetitive elements 
were identified in the C. difficile genome, such as clustered regulatory interspersed palindromic 
repeats (CRISPRs) and insertion elements so if these weren’t filtered to singularity it woul d explain 
the disparity between results. This again highlights the need for controls when establishing new 
techniques for analysis.  
The non-amplification sample had fewer genes identified than both the ɸ29 MDA and the 
reference, this may relate to the lower coverage found in the control, possibly due to the poorer 
DNA quality that was input into the sequencer due to the extraction technique. Overall 80.5% of 
genes were found in all three annotations, and 95% were shared between the reference and the 
single cell ɸ29 MDA. With the small discrepancies again probably down to different naming, or 
multiple database entry for the same or similar gene products.  In this case the ɸ29 MDA from 
single cells actually outperformed the non-amplification and was comparable to the reference. 
For A. naeslundii the reference paper suggested that there were 2761 161 genes present in A. 
naeslundii, however there was no information regarding the number of hypothetical genes. The 
reference annotation in this studied gave 1420 genes after removal of hypothetical and repeat 
genes. 66% of the genes identified were found in all three annotations, with the non-amplification 
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and ɸ29 MDA sharing 92% of genes. The reference coverage of the A. naeslundii never exceeded 
68%, which is in line with the number of annotated genes shared with the reference. The possible 
explanations for this include that the reference and the bacteria sequence are not the same 
strain, most probably due sample mislabelling when the bacterium was archived. Alternatives 
could be that genes have been lost, or the reference could be incorrectly joined creating a larger 
genome, or there could be considerable diversity within A. naeslundii and the reference genome 
and the genome analysed here could be at opposite ends of that diversity. Alternatively, these 
missing sections could be down to the sequencing errors, and the inability of the platform to cope 
with very high GC regions. The most probable explanation is that the reference genome does not 
match the bacteria sequenced in this study, and a smaller genome is present in this strain. The 
non-amplification and the ɸ29 MDA matched, and so any errors will be down to either the 
reference mismatching or the sequencing platform, and not the amplification of the single cell to 
sequencing quantities of DNA.  
When the adenovirus sequencing was annotated, initial investigation suggested a poor 
outcome with only one gene found in both the reference and the ɸ29 MDA sample. However, 
upon closer inspection the discrepancies were resolved by comparison of function and in the 
context of viral expression. This was possible, although time consuming in this example where 
only 28 genes were identified in a single comparison, this however would be impractical at a 
larger scale. This highlights the problem of comparative genomics using a generic database, 
especially for viral genomes, where there are multiple naming nomenclatures and complex 
expression systems in viruses allowing multiple expression products from coding regions. Also the 
Adenovirus used here was grown in a tissue culture, but was originally isolated from a clinical 
isolate, and may have slight genome differences to the reference.  
Overall the annotation of single cell ɸ29 MDA reactions has been comparable or better than 
multicellular inputs. The use of de novo multi contig inputs have performed well and given 
comparable results to the polished reference genomes, but have highlighted the need for filtering 
of repeat genes which may appear on more than one contig. Limitations of using a reference set 
to annotate data includes, inconsistency of the database due to multiple strain entries, spelling 
errors in the database, different naming nomenclature for the same gene and the 
misrepresentation of the output ‘hypothetical protein’162 .  
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4.9.6 Virulence Prediction Using Genome Data 
Further investigation into characterisation of pathogens using genomic data was performed. 
Firstly, methods for prediction of virulence factors were tested.  
When using Prokka on the completed reference genome of E. coli K12 only 19 virulence 
factors were identified using Prokka, compared to 47 and 45 in the control and ɸ29 MDA sample. 
The majority of these were phage associated, suggesting phage acquisition since the reference 
was sequenced, or an extra chromosomal phage. There was also a conjugation factor identified, 
which is associated with the F plasmid. 
Using the VFDB a large number of factors were identified, mostly originating from Shigella  sp. 
E. coli and Shigella  are genetically similar, with many systems failing to differentiate them, 
including 16S studies, multi-locus enzyme electrophoresis (MLEE) and a housekeeping gene 
sequence study163 and so it is no surprise to find Shigella  associated genes in the E. coli strain 
studied. However, many of the genes identified actually have no known function, and only appear 
in the database as they were identified in pathogenic Shigella. This highlights a weakness in this 
database, particularly with the inclusion of genes without solid functional evidence of being a 
virulence gene. It also highlights issues of using genomic data for E. coli, and there is a huge 
genetic and disease type variation of this organism. This comparative method seems unsuitable 
for E. coli and highlights that careful choices of database are required for virulence prediction, and 
expert interpretation is still required.  
Using Prokka for the three C. difficile assemblies, overall 13 out of 16 factors were identified 
in all the samples, with 15 out of 16 being identified in both the ɸ29 MDA and the reference. 
Importantly toxin A and B were identified in all samples, and additional factors identified included 
transposons and phage elements. The pathogenicity island was identified in the reference and 
ɸ29 MDA but not culture control. Once again the ɸ29 MDA performed better than the control and 
equal to the reference in prediction of factors. Using VFDB, a very clear prediction of the toxin A 
and B was identified in all samples. This database worked well in the case of toxin detection for C. 
difficile, although no additional data was found, here selection of Prokka elements performed 
better. Use of databases compiled by others restricts what factors will be identified.  
When using Prokka for A. naeslundii only four factors were identified in the reference and ɸ29 
MDA, and only two were found in the control. The reference has phage elements not found in the 
other two sequence files, probably explained by previous mis-matches identified in the genomes.  
The VFDB produced no hits, these results either demonstrate the low pathogenicity of the isolate 
or the lack of study means there are few genes identified as causing virulence.  
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The use of databases to predict virulence has had mixed results on this dataset. In the case of 
E. coli use of VFDB gave a huge number of hits, with very little application to this strain of E. coli, 
over estimating the potential virulence of the bacteria. In the case of A. naeslundii, no factors 
were identified, despite evidence of its ability to cause infections164. However, A. naeslundii is 
considered an opportunistic pathogen, which is associated with less traditional virulence factors, 
and so more investigation of factors which cause this bacterium to become pathogenic would be 
required. Although there are demonstrable problems with using comparative genomics for 
prediction of virulence, for rapid de novo characterisation use of data bases is the best current 
option. Outputs need to be intelligently interpreted to prevent over estimation of virulence, such 
as in the case of E. coli in this study. In general, when using external databases, the quality of the 
output is dependant of the quality of the database including contributors and curators. As whole 
genome sequencing becomes more widely used, these databases will grow and their duration will 
become increasingly important, possibly too important to be left to purely voluntary curators. 
4.9.7  Resistance Prediction using Genome Data  
A significant proportion of the genes on bacterial genomes are responsible for environmental 
survival, which includes resistance to toxic substances. When searching for the word ‘resistance’ 
within the Prokka output files, all relevant genes that were identified were also identified using 
another term in the search, such as ‘drug’, making this search term redundant. Efflux pumps are 
increasingly being appreciated as important resistance mechanisms, especially where multi factor 
resistance is present; however, efflux pumps are also essential for bacterial survival. Similarly, to 
resistance, searching for the term efflux produces a large number of irrelevant results. When an 
efflux pump is associated with drug resistance they are mostly renamed accordingly and so the 
word efflux was removed. However, if a study was to look for difference between two similar 
strains, but one had an increased antibiotic resistance, the term could once again be incl uded, 
which would potentially prove useful in comparative studies.  
Using the Prokka output from E. coli, there was a large and complex output, which was 
difficult to interpret. Many drug efflux systems were identified, as well as many PBPs, which 
would need to be investigated to distinguish housekeeping genotypes from those which are 
associated with drug tolerance or resistance. Potentially a second database would need to be 
built to remove commonly found elements (such as housekeeping PBP), which don’t confer 
resistance. In total 51 out of 53 elements were found in all three datasets, showing good 
performance in draft genomes compared to the completed reference. Using ardbAnno.pl no 
resistance factors were identified, suggesting this strain has no acquired resistance factors. Using 
Resfinder the bacteria was identified as having the blaCMY genotype, which is an ampC that 
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confers resistance to ceftriaxone165. It also identified oqxB which is part of the oqxB efflux system 
that is a multidrug efflux pump166, however when oqxB is present on its own it has been shown 
that it is simply part of the membrane make-up. This shows that using more targeted tools, such 
as ResFinder, can provide improved results compared with general tools such as Prokka. However, 
it also emphasises the need for context and expert interpretation of results, as there is not always 
a simple relationship between genotype and phenotype when it comes to complex drug 
resistance. 
In the case of E. coli, the three databases all produced very different results, either an 
overwhelming number of results with difficult biological interpretation, no results, or a simple 
output with limitations. 
Using the Prokka output to predict resistance in C. difficile 39 factors were identified in the 
reference, 33 in the control and 36 in the ɸ29 MDA. Several resistances were identified in all, 
including beta-lactams, metallo-beta-lactamase, resistance to flouroquinolones including 
ciprofloxacin, resistance to tetracycline and streptomycin. VanB was also identified as being 
present, although only VanW was identified through similarity, which is only one gene in the 
seven gene operon, and isn’t even essential for production of resistance. ArdbAnno.pl identified 
ermB which induces resistances to erythromycin, clindamycin and macrolides. Resfinder identified 
ermB and tetM (tetracycline resistance). This demonstrates the current need to look at several 
sources to gain a full picture of the resistance factors that are present. It also highlights again the 
need to match prediction with the biological output, particularly when partial operons are shown. 
Overall the ɸ29 MDA showed good concordance with the reference.  
Most of the factors identified by Prokka as resistance factors in the A. naeslundii assemblies 
were efflux pumps and PBP, which are commonly found in all bacteria. This is probably 
attributable to the lack of studies focussing on the genome of this organism. In the culture control 
and ɸ29 MDA a beta-lactamase was identified that wasn’t present in the reference which has 
either been acquired since the reference sequence production, or is additional evidence to the 
sequenced strain being different to the reference. ArdbAnno.pl and Resfinder didn’t identify any 
resistance factors.  
It is beyond the scope of this thesis to write new databases for antibiotic resistance 
predictions, several new species specific databases are available to use, which are useful if one of 
these species is identified. However, this did demonstrate that the ɸ29 MDA sample is as reliable 
as the reference for prediction of antibiotic resistance from genome data. 
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It is also worth noting that through this study it is obvious that some bacteria such as E. coli 
have been extensively studied, and so the databases are almost overpopulated with predictions 
for genome function. Whereas other bacteria such as A. naeslundii have been almost neglected in 
studies making prediction from genomes very limited.  Prokka often outputs complex results 
which are hard to interpret on their own, making targeted tools like ResFinder more appropriate, 
however when comparing two similar bacteria comparison of the resistance output might prove 
valuable. 
4.9.8 Analysis of Mixed Cell input sequencing data  
Use of Blastn and LCA analysis allows the identification and separation of mixed bacterial 
species allowing de novo assembly. The limit of detection for mixed cells lies between the 1:100 
and 1:1000 dilution factor as in the 1:1000 sample no chromosomal Enterococcus genes are 
detected, however phages, which may be present at more than one per cell, were detected 
confirming the presence of the Enterococcus in the sample.  After abundance trimming the 
relative abundance of the two bacteria was closer to the original mix ratio. One possible 
explanation for this could be removal of repetitive genome elements, as some genomes will have 
a higher proportion of repetitive elements than other, and removing them will help normalise the 
data. This assay would not be able to exactly quantify the input cells, but it would be able to give 
an estimation of the relative abundance of the bacteria. When characterising the Enterococcus at 
lowering relative abundance, 77% of the gene products were identified in the 1:10 sample and 
29% were identified in the 1:100 sample. Demonstrating that even at very low numbers without 
whole genome coverage it is still possible to gain insight into the genome.  
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5. Application of ɸ29 MDA to Real and Modelled Clinical 
Samples 
In order to take advantage of the single cell amplification, sequencing and interpretation 
methods developed in this thesis, a process for isolating pathogens from clinical samples was 
developed. Initial development work focused on direct pathogen sequencing from blood. 
Bacteraemia is a major cause of morbidity and mortality, and is a particular problem in healthcare 
settings. Current methods for diagnosis of bacteraemia involves specialist equipment in the form 
of blood culture machines, which constantly monitor blood samples for possible bacterial growth. 
Once growth is detected these blood cultures must be sub cultured in order to isolate and identify 
the bacterial pathogen present. Applying whole genome sequencing to blood samples would 
allow rapid pathogen diagnosis, along with simultaneous pathogen typing. The application of 
unbiased pathogen detection would also allow a combined workflow for viral and bacterial 
pathogens.  
A bacteraemia model was developed, using defibrinated horse blood to model whole human 
blood infection additionally selective host cell lysis was explored using Saponin. Separation of 
RBCs from other cellular components in blood was investigated using both density gradients and 
specific RBC aggregation. HetaSep® induces aggregation of red blood cells through the formation 
of stacks of erythrocytes which leads to a rapid sedimentation rate. And has previously been used 
to isolate nucleated cells in the blood particularly granulocytes. 
Once a specific workflow for isolating pathogens from whole blood is developed it will then be 
applied to multiple sample types, both real and modelled. This will allow testing of the isolation 
and amplification of pathogens to multiple sample types. Additional bacteraemia models will be 
performed to evaluate the use of ɸ29 MDA to more challenging pathogens. Also tissue models 
will be investigated to investigate the potential for isolating and sequencing of pathogens from 
tissue infections. Various clinical samples were obtained from multiple sources and tested, 
including urines, CSF and STI swabs.  
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5.1 Blood Culture Model  
5.1.1 Survival of Bacterial in Horse Blood and 2% Saponin 
Initial investigations were undertaken to examine bacterial survival in horse blood and 
saponin. A panel of 27 bacterial isolates were collected from the Royal Free Hospital Hampstead, 
from clinical cases, with the details Table 2-2. These bacteria represented a variety of cell wall  
types, morphology and growth requirements. For these 27 isolates approximately 500 bacterial 
cells were spiked into 1 ml of horse blood, 2% saponin, PBS or 1ml of 2% saponin in horse blood. 
The samples were then incubated at room temperature for 2 hours, and the number of bacterial 
cells was calculated by culturing three sets of 100 µl in each condition and counting the CFU, 
survival percentage was calculated using the PBS as the control. Survival of isolates in all 
conditions is shown in Table 5-1 and Figure 5-1. All of the isolates showed better that 95% 
survival in 2% saponin, except Paenibacillus anaericanus (87.2%) and Streptococcus pneumoniae 
(94%). 20 of the isolates showed greater than 95% survival in horse blood . Seven of the isolates 
had poorer survival in the horse blood, Staphylococcus epidermidis (73%), Streptococcus 
pneumoniae (6%), Proteus vulgaris (60.9%), Streptococcus agalactiae (45%), Listeria 
monocytogenes (50.3%), Proprionibacterium acnes (23.4%) and Shigella sonnei had a 33.3% 
survival rate. Nine of the isolates showed altered colony morphology after incubation in horse 
blood, with the colonies appearing smaller and with a lobate margin, marked with a * in  Table 
5-1(Escherichia coli, Staphylococcus aureus two isolates, Klebsiella pneumoniae, Pseudomonas 
aurginosa one isolate, Enterobacter cloacae, Salmonella Typhimurium, Serratia marcescens and 
Listeria monocytogenes).  
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Table 5-1  surviva l rates of 27 cl inically i solated bacteria in PBS, horse blood and saponin, numbers represent 
average CFU of each bacterium ca lculated from three replicates  
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5.1.2 Bacterial Isolation using Density Gradients 
To assess the applicability of using density gradients to isolate bacteria from whole blood, E. 
coli and S. aureus were spiked into two separate 1:1 mixture of horse blood and PBS. This was 
then slowly added to a Percoll density gradient, described in 2.6.2.  After centrifuging for 25 
minutes there were three visible bands, the top segment being a pale red colour of about 3 ml in 
volume.  The middle layer was very dense and red, being about 2.5 ml in volume. The bottom 
layer was clear and about 500 µl in volume.   
The positive control (same inoculum cultured) indicted that the starting numbers of bacteria 
cells were 150 CFU for E. coli and 123 CFU for S. aureus. After the spiked blood was centrifuged 
with the Percoll to create a gradient, culture was performed at several points down the gradient 
(Table 5-2). Each bacterial spiking experiment was performed in triplicate and averages re ported. 
When the E. coli spiked sample was investigated, bacterial cells were recovered at most points in 
the gradient. The three samples from the top segment gave average results of 1, 35 and 40 CFU. 
The middle segment gave average results of 20, 30, 26 and 4 CFU at the four sampling points. No 
E. coli cells were recovered from the bottom segment. When S. aureus spiked blood was 
centrifuged into a Percoll gradient no S. aureus was recovered from the top segment. From the 
middle segment 30, 35, 41 and 12 CFU of S. aureus was recovered on average at each of the four 
sampling points.  Four addition CFUs of S. aureus were recovered from the very bottom segment 
of the gradient. The number of CFUs of each bacteria recovered is shown in  Table 5-2  alongside 
the volume of sample cultured at each point, the sedimentation of E. coli and S. aureus compared 
to RBCs is visualised in Figure 5-2.  
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Figure 5-2  graphical representation of the sedimentation of E. coli and S. aureus compared to RBCs in a Percoll 
gradient (RBCs numbers for i llustration purposes only, to demonstrate RBC sedimentation position in the Percoll 
gradient)   
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Distance from top of the gradient 
E. coli
S. aureus
RBC
Layer  Volume  E. coli (CFU) S. aureus (CFU) 
Top 1ml 1 0 
Top 1ml 35 0 
Top 1ml 40 0 
RBC 500µl 20 30 
RBC 500µl 30 35 
RBC 200 µl 26 41 
RBC 100 µl 4 12 
Clear  500 µl 0 4 
Table 5-2 sample volumes and CFU recovery of sampling points in a  Percoll gradient to show sedimentation of E. 
coli and S. aureus in whole horse blood 
Top  
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5.1.3 Erythrocyte Depletion using HetaSep®  
5.1.3.1 Centrifugation vs. Gravity Sedimentation 
HetaSep® can either be incubated at 37oC to allow sedimentation of RBCs, or can be 
centrifuged to facilitate sedimentation.  Bacterial cells (E. coli and S. aureus) were spiked into 
either neat blood or blood diluted 1:1 in PBS. HetaSep was added and the samples either 
centrifuged or incubated at 37oC. Three replicates for each condition were performed and 
averages calculated. After both centrifugation and incubation at 37oC there was separation of the 
sample with RBCs pelleted at the bottom of the tube and a red coloured clear liquid at the top of 
the tube. There was also a small joining phase was visible between the two sections.  
The control samples (bacterial cells incubated in PBS) contained on average 18 CFUs S. aureus 
and 27 CFUs E. coli. In the centrifuged sample with E. coli the top segment contained and average 
of 20 CFUs, the middle segment contained 5 CFUs and the bottom contained no bacterial cells. 
When the blood was dilution 1:1 in PBS the top segment contained 15 CFU, the middle segment 
had 2 CFUs and the bottom contained 10 CFUs. In the centrifuged sample with S. aureus 12 CFUs 
were found in the top segment 1 CFU was isolated from the middle segment and 4 CFU in the 
bottom segment. With the added PBS 15 CFU were found in the top segment, 1 CFU in the middle 
segment and 2 CFUs were found in the bottom segment Table 5-3.  
In the gravity sedimented samples, no bacterial cells were found in the bottom segment of 
any samples. In the E. coli sample 21 CFUs were found in the top and 2 CFU in the middle 
segment. When samples were diluted with PBS 25 CFUs was recovered from the top segment and 
5 CFUs were recovered from the middle segment. In the S. aureus sample 18 CFU were found in 
the top segment and 1 CFU was found in the middle segment. With the additional PBS 15 CFUs 
were found in the top segment and 2 CFUS were recovered from the middle segment.  
 Upper Segment 
(CFU) 
Middle segment 
(CFU) 
Lower Segment 
(CFU) 
 Centrifuge 
E. coli 20 5 0 
E. coli with PBS 15 2 8 
S. aureus 12 1 4 
S. aureus with PBS  15 1 2 
 Gravity sedimentation 
E. coli 21 2 0 
E. coli with PBS 25 5 0 
S. aureus 18 1 0 
S. aureus with PBS  15 2 0 
Table 5-3 average number of bacterial CFU (E. coli and S. aureus) recovered from the three different HetaSep 
segments after centrifugation or incubation at 37oC with and without PBS dilution.  
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5.1.3.2 Single vs. Double Incubation with HetaSep 
In order to remove more of the RBCs from the middle segment an additional incubation stage 
with HetaSep was investigated. The single incubation was performed as before with the samples 
being incubated at 37oC for 20 minutes and culture performed from each segment. For samples 
having a double incubation, after 10 minutes’ incubation at 37oC the top and middle segment was 
removed and more HetaSep was added and the sample was again incubated at 37oC for 15 
minutes.  
From the S. aureus control 89 CFU were isolated and from the E. coli control 125 CFU were 
isolated. The one step separation showed a clear separation with a top clear (red coloured) 
segment and a dark bottom layer, with a small visible stage in between. With the single 
incubation samples, no bacteria cells were isolated from the bottom segment. The majority of 
bacterial cells were isolated from the top layer, 115 CFUs of E. coli and 75 CFUS of S. aureus. The 
middle segment also contained some bacterial cells, 12 CFUs of E. coli and 6 CFU of S. aureus 
(Table 5-4) 
The separation after the second incubation seemed to be less defined that previously. The top 
segment still had the majority of bacterial cells, 103 CFUs and 70 CFUs for E. coli and S. aureus 
respectively. The middle segments had slightly higher numbers than in the single incubation 
sample 26 CFUs for E. coli and 14 CFUs S. aureus. The bottom segment of the E. coli sample had 
no bacterial cells, but 2 CFUs were found in the S. aureus sample. No bacteria were isolated from 
the pellet left after the initial incubation of 10 minutes (Table 5-4). 
  
 Upper Segment 
(CFU) 
Middle segment 
(CFU) 
Bottom segment  
(CFU) 
 
Single Incubation  
E. coli 115 12 0  
S. aureus 75 6 0  
Double Incubation Bottom segment  
(first  incubation) 
E. coli 103 26  0 0 
S. aureus 70 14 2 0 
Table 5-4 number of bacterial CFUs present at each point in the HetaSep gradient. Comparing recovery after either 
a  s ingle or double incubation with HetaSep  
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5.1.4 Low Level Bacterial Isolation from Horse blood 
Approximately ten bacterial cells of either E. coli or S. aureus were spiked into 1 ml of horse 
blood and processed as described in 2.6.4.  After the completion of each stage of the process, the 
sample was cultured to identify bacterial survival Figure 5-3 and Table 5-5.  
The initial starting CFUs were obtained by culturing the same volume of spiking material as 
was used to spike the blood samples. This yielded 9 CFUs of S. aureus and 12 CFUs for E. coli. After 
incubating the sample with HetaSep to pellet the RBCs, the 500 µl supernatant contained 8 CFUs 
for the S. aureus sample with 1 CFU isolated from the pellet. A similar pattern was observed in the 
E. coli sample with 9 CFUs isolated from the supernatant and 2 CFUs from the pellet. Once the 
saponin treatment was completed 12 CFUs of S. aureus and 10 CFUs of E. coli were recovered. 
Water shock treatment didn’t affect the S. aureus recovery (9 CFUs) but had an impact on E. coli 
CFU numbers which decreased to 5 CFU. Post-salt restoration samples showed similar numbers to 
those recovered from the water shock samples (8 CFUs for S. aureus and 5 CFUs for E. coli).  All E. 
coli cells pelleted during the centrifugation step at 3000xg whereas only 2 CFUs of S. aureus were 
recovered from the pellet. For all washes at 6000xg both bacteria were only recovered from the 
pellet. When the DNA in the final supernatant was quantified, 0.35 ng/ µl was detected from the 
S. aureus sample and 0.76 ng/ µl was detected in the E. coli sample.  
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Figure 5-3 I l lustration of the process for bacterial isolation from whole blood using HetaSep and selective lysis with 
Saponin. Numbers refer to sampling points where bacterial recovery was investigated.  
 
 
Stage   S. aureus E. coli 
1 Spiked cells  9 12 
2 RBC separation-bottom 1 2 
3 RBC separation-top 8 9 
4 Addition of Saponin 12 10 
5 Water shock  9 5 
6 Salt restoration  8 5 
7 Cell pelleting-top 
Cell pelleting-bottom 
2 
11 
0 
5 
8 Wash 1-top 
Wash 1-bottom 
0 
8 
0 
 4 
9 Wash 2-top 
Wash 2–bottom 
0 
9 
0 
5 
10 Final pellet  10 5 
Table 5-5  the  number of CFU isolated at each processing s tage for bacterial isolation from whole blood using 
HetaSep and selective lysis with Saponin. Numbers refer to sampling points where bacterial recovery was investigated 
as  i llustrated in Figure 5-3. 
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5.1.4.1 Assessment of DNase inactivation 
To remove host DNA in the supernatant following cell lysis a DNase treatment was used, 
however heat inactivation of the enzyme caused remaining RBCs and other blood components to 
coagulate. Therefore, the removal of the DNase activity through chelation and multiple washes 
was investigated. DNase was added to either PBS or horse blood post RBC aggregation and 
saponin treatment. Positive controls were set up alongside, to which DNA was added to a 
concentration of 50 ng /µl. The samples were then incubated at 37oC for 15 minutes, after 
incubation the concentration of DNA in the positive controls were 0.06 ng / µl in the PBS and 0.08 
ng / µl in the processed horse blood sample. For the test samples after incubation with DNase 
EDTA was added and the samples were washed three times with PBS. DNA to a final 
concentration of 50 ng / µl was added to both and the samples incubated at 37oC for one hour. 
DNA concentrations after incubation were 49.2 ng / µl in the PBS sample and 50.3 ng / µl in the 
processed horse blood.  
5.1.4.2 Improvements to Work Flow 
Based on the results from 5.1.4 several improvements were made to the work flow. This 
included increasing the volume of supernatant kept after RBC pelleting, reducing the water shock 
treatment time and increasing the centrifugation speed from 3000xg to 4000xg. Additionally, a 
DNase stage was included and an extra pellet wash was added. The full details of the improved 
work flow are described in 2.6.4.1.  
The number of cells initially spiked into the blood was quantified as 10 CFU for S. aureus and 
11 CFU for E. coli.  Similarly, to the previous work flow samples were cultured at several points 
along the process to ascertain bacterial survival rates. After aggregation of the RBC using HetaSep 
no bacteria were isolated from the RBC pellet. (10 CFU S. aureus and 9 CFU E. coli was cultured 
from the supernatant).  Incubation with saponin caused no decrease in the number of CFU 
recovered for either bacterium. The decreased water shock improved the recovery of E. coli with 
12 CFU cultured from this stage. After initial pelleting of the bacterial cells at the higher speed of 
4000xg no bacterium were found in the supernatant (9 CFU S. aureus and 9 CFU E. coli was 
cultured from the pellet.) DNase treatment and inactivation had no impact on bacterial survival 
and all three wash stages only recovered bacteria in the pellets. The final number of bacteria 
recovered on completion of the process was 11 CFU for S. aureus and 9 CFU for E. coli.  
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Figure 5-4 I l lustration of the process for bacterial isolation from whole blood using HetaSep and selective lysis with 
Saponin after workflow improvements. Numbers refer to sampling points where bacterial recovery was investigated.  
 
Stage   S. aureus E. coli 
1 Spiked cells  10 11 
2 RBC separation-bottom 0 0 
3 RBC separation-top 10 9 
4 Addition of Saponin 12 9 
5 Water shock  12 12 
6 Salt restoration  10 10 
7 Cell pelleting-top 
Cell pelleting-bottom 
0 
9 
0 
9 
8 DNAse treatment 11 12 
9 EDTA and PBS 10 12 
10 Wash 1-top 
Wash 1-bottom 
0 
9 
0 
11 
11 Wash 2-top 
Wash 2–bottom 
0 
10 
0 
10 
12 Wash 3-top 
Wash 3–bottom 
0 
8 
0 
9 
13 Final pellet  11 9 
Table 5-6  the number of CFU isolated at each processing s tage for bacterial isolation from whole blood using 
HetaSep and selective lysis with Saponin after workflow improvements. Numbers refer to sampling points where 
bacterial recovery was investigated as illustrated in Figure 5-4 
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5.1.5   Sequencing from Low Levels in Blood  
Single cells of E. coli and S. aureus were spiked into 1ml of horse blood to simulate low level 
bacteraemia. This was then processed as shown in Figure 5-4, with the exception of the final 
pellet being suspended in 4 µl PBS. The resulting sample was then extracted and amplified for two 
hours. The resulting DNA was then sequenced on the 454 Junior and the resulting file analysed 
using the pipeline described in section 2.7.3 
 
5.1.5.1 S. aureus 
After processing and sequencing the horse blood spiked with S. aureus the number of reads 
passing filter was 128500.Once the processing pipeline described in 2.4.13 was complete, 124,145 
reads remained.  Using Blastn and Megan, 77131 (62.1%) reads were identified as S. aureus.  
8,395 (6.76%) of the reads were identified as the genus Equus, and 2,138 (1.72%) were identified 
as Parascaris equorum. When examining the S. aureus reads closer 4254 reads were identified the 
subspecies level, (Staphylococcus aureus subsp. aureus HO 5096 0412), this subspecies has a 
complete genome available, and so the fasta file was downloaded from NCBI and used as a 
reference for reference mapping. The reference mapped reads were assembled into 451 contigs 
and covered 92% of the reference genome. When the reads identified as Staphylococcus using the 
LCA analysis were extracted and the reads de  novo assembled 1212 contigs were produced.  
When this was compared to the same reference as the reference assembly 83% of the genome 
was covered with 10 misassemblies and a N50 of 3882. The de novo assembly was then 
investigated using a programme specifically written to predict resistance in S. aureus, Mykrobe-
predictor 167. Using Mykrobe a genotypic result was produced for 12 antibiotics, which were 
compared to the phenotypic results (produced using the BD Phoenix™).  The genotypic and 
phenotypic results matched in 11 of the 12 antibiotics with the output of both methods shown in 
Figure 5-5. The results for ciprofloxacin were inconclusive in genotypic tests, but resistant by 
phenotypic methods. Additionally, Mykrobe ruled out the presence of the PVL gene in this isolate.  
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5.1.5.2  E. coli 
After completion of the sequencing 173597 reads passed the initial filter, once the analysis 
pipeline was complete 170243 reads remained. 69538 of these were identified by LCA as 
Enterobacteriaceae, 2529 as Escherichia, and 51479 were identified to the species level as E. coli. 
Overall 73% of all reads remaining after the analysis pipeline were identified as E. coli. 5661 reads 
were identified as the genus Equus and 1927 were identified as Equorum.  31959 (18%) reads had 
no identity. Unlike S. aureus it was not possible to sub-type the E. coli, 150 reads were assigned to 
O7:K1 and 211 reads were assigned to JJ1886, Figure 5-6. Reads which were identified as 
Enterobacteriaceae, Escherichia and E. coli were extracted from the fastq produced after pipeline 
completion.  The genome of JJ1886 was available on Integrated Microbial Genomes (ID 
2558309052), and the chromosomal sequence was used as the reference against which the 
extracted reads were assembled. After reference assembly 93.5% of the genome was covered in 
548 contigs. When the reads were de novo assembled, 89% of the same reference was covered in 
1334 contigs. The number of misassemblies was 23. The de novo assembly was used to identify 
several resistance markers using a combination of ardbAnno and ResFinder (Table 5-7). The 
resistance markers included dfrA, conferring trimethoprim resistance, gyrA conferring resistance 
to fluoroquinolones. mdtK an efflux pump conferring resistance to norfloxacin and blaCMY-2 
which is an AmpC, conferring resistance to beta-lactams including cephalosporins. Additionally, 
eight drug efflux systems were identified. These results are comparable to the phenotypic data 
(supplementary Figure 7-1) 
 
Figure 5-6 LCA analysis of E. coli i solated from blood showing reads identified as Enterobacteriaceae or higher, with 
the ci rcle size being proportional to the number of reads identified at each taxonomic point, demonstrating that i t was 
not possible to identify a  single sub-species   
 
  
260 
 
 
Gene 
name 
Gene  Gene function  
dfrA D-arabinitol 4-
dehydrogenase 
dfrA The DHFRs in this family are 64–88% 
identical in amino acids and mediate high-level 
resistance to trimethoprim 
mdtB multidrug efflux system, 
subunit B 
MdtB is a transporter that forms a 
heteromultimer complex with MdtC to form a 
multidrug transporter. MdtBC is part of the 
MdtABC-TolC efflux complex. 
gyrA DNA gyrase (type II 
topoisomerase), subunit 
A.  
Point mutation of Escherichia coli gyrA resulted 
in the lowered affinity between 
fluoroquinolones and gyrA. Thus, conferring 
resistance 
emrB multidrug resistance 
protein B 
 
emrB is a translocase in the emrB -TolC efflux 
protein in E. coli. It recognizes substrates 
including carbonyl cyanide m-
chlorophenylhydrazone (CCCP), nalidixic acid, 
and thioloactomycin. 
emrY putative multidrug efflux 
system 
emrY is a multidrug transport that moves 
substrates across the inner membrane of the 
Gram-negative E. coli. It is a homolog of emrB. 
tolC Multi-drug efflux pump TolC is a protein subunit of many multidrug 
efflux complexes in Gram negative bacteria. It is 
an outer membrane efflux protein and is 
constitutively open. Regulation of efflux activity 
is often at its periplasmic entrance by other 
components of the efflux complex 
mdtK multidrug efflux system 
transporter 
A multidrug and toxic compound extrusions 
(MATE) transporter conferring resistance to 
norfloxacin, doxorubicin and acriflavine 
mdtG drug efflux system Efflux protien mdtG 
emrA multidrug efflux system EmrA is a membrane fusion protein, providing 
an efflux pathway with EmrB and TolC between 
the inner and outer membranes of E. coli, a 
Gram-negative bacterium. 
CMY-
2 
blaCMY-2 protein CMY-2 is an AmpC type beta-lactamase 
(resistance to  amoxicillin, amoxicillin plus 
clavulanic acid, cephalothin, cefoxitin, 
ceftazidime and cefotaxime, but susceptible to 
cefepime and imipenem) 
mdtE multidrug resistance 
efflux transporter 
MdtE is the membrane fusion protein of the 
MdtEF multidrug efflux complex. It shares 70% 
sequence similarity with AcrA 
Table 5-7 Res istance indicators predicted using of ardbAnno and ResFinder on de novo assembly of s ingle cell 
sequencing of E. coli i solated from blood. Including the gene ID, gene name and gene function according to UniProt
168
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5.1.6 Final Sample Processing for Isolation of Pathogens from 
Human Samples 
Using the methods developed previously in 2.5.3 for viral concentration and extraction 
alongside those methods for isolating bacteria from whole blood in this chapter a sample 
processing workflow was developed to allow detection of pathogens from multiple clinical sample 
types. This sample process was then combined with the amplification and data analysis developed 
in previous chapters. An overview of the work flow is shown in Figure 5-7 with full processing 
details shown in Figure 2-4. 
  
Viral 
Concentration 
Pellet  
Eukaryotic Cell Lysis    
Cell pellet    
DNAse Treatment    
Cell pellet and wash    
Bacterial Extraction     
Viral Extraction    
Reverse 
Transcription     
ɸ29 MDA Reaction  
SAMPLE 
Red blood cell 
depletion  
Cell 
Concentration   Supernatant  
Figure 5-7 overview of sample processing for isolation and amplification of low level 
pathogens from clinical samples 
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5.2 Application to Multiple Sample Types 
Several sample types were extracted, amplified and sequenced (on Illumina HiSeq platform) 
in parallel to test the method for suitability for application across sterile site infections. 
Summaries of the output from all sample types are shown in Figure 5-15 and Table 5-11.  
5.2.1 Negative Amplifications 
Two negative controls were amplified and sequenced, the first was a negative extract starting 
with 1ml of sterile PBS and following the full extraction process. The second was a negative 
amplification sample, which was sterile PBS which underwent the reverse transcription and ɸ29 
MDA amplification. After amplification the negative extract had a DNA concentration of 126 ng/µl 
and in the negative amplification the DNA concentration was 68 ng/µl. The number of raw reads 
and number of reads remaining after each pipeline element is shown in Table 5-11 and Table 
5-11. The number of reads that were removed using the existing contamination database was 127 
for read one and 157 for read two in the negative extraction and 108 for read one and 144 for 
read two in the negative amplification.  
After completion of the Blastn and LCA analysis, 99.55% of the negative extract reads and 
99.61% of the negative amplification reads had no hits Table 5-8. Of the reads identified a similar 
pattern was observed for both samples. 29.66% and 27.26% of the identified reads for the 
negative extract and negative amplification respectively were identified as bacteria (Figure 5-8). 
Within these reads the two major Phylums were Firmicutes (2.24% and 4.30%) and Proteobacteria 
(27.34% and 22.41%). When looking closer at the Firmiculates the major genus identified was 
Alicyclobacilli, with 2.28% and 3.57% of the identified reads for each sample. Within the 
Proteobacteria, those which were assigned a higher level fell within the class 
Alphaproteobacteria. With the majority of these falling the in Bradyrhizobium genus, with 17.91% 
of the identified reads in the negative extract sample being identified within this genus, and 
12.77% of the negative amplification. Other genera represented in this class were Nitrobacter and 
Rhodopseudomonas, which were identified in both samples.  
Within the Eukaryotes, the reads were identified as fungal, with 59.78% of the identified 
reads from the negative extraction, and 71.90% of the reads from the negative amplification 
being identified as fungal. Two division of the fungal phylum were identified in both samples the 
Ascomycota and Basidiomycota. Within the Ascomycota phylum the main represented class was 
the Leotiomycetes, with 4.25% of the negative extract reads and 3.83% of the negative 
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amplification reads.  Within the Basidiomycota phylum (which represented 28.27% and 34.60% of 
the two samples), the main class represented was the  Agaricostilbales, which had 9.76% and 
12.49% of the identified reads. No reads within the fungal family were identified beyond the class 
level. Additionally, reads identified as Horduem vulgare were only identified in the negative 
extract, which represented 10.93 % of all identified reads. This information is summarised in 
Figure 5-8 and Table 5-8 
All reads from the negative runs were added to the contamination library, and this updated 
contamination library was used in the pipeline for all other sequencing runs.  
 Negative extract Negative amplification 
 reads % all 
reads 
%identified 
reads  
reads % all 
reads 
%identified 
reads  
Bacteria  3010 0.13% 29.66% 2382 0.10% 27.26% 
P:Firmicutes 227 0.01% 2.24% 376 0.02% 4.30% 
G:Alicyclobacilli 231 0.01% 2.28% 312 0.01% 3.57% 
P:Proteobacteria 2775 0.12% 27.34% 1958 0.09% 22.41% 
G:bradyrhizobium 1818 0.08% 17.91% 1116 0.05% 12.77% 
G:Nitrobacter 67 0.00% 0.66% 20 0.00% 0.23% 
G:Rhodopseudomonas 308 0.01% 3.03% 194 0.01% 2.22% 
       
Fungi 6067 0.27% 59.78% 6283 0.28% 71.90% 
P:Ascomycota 622 0.03% 6.13% 629 0.03% 7.20% 
C:Leotiomyces 431 0.02% 4.25% 335 0.01% 3.83% 
P:Basidiomycota 2869 0.13% 28.27% 3023 0.13% 34.60% 
C:Agaricostilbales 991 0.04% 9.76% 1091 0.05% 12.49% 
       
Horduem vulgare 1109 0.05% 10.93%  0.00% 0.00% 
       
total 2280503 100.00%  2269242 100.00%  
no hits/not assigned 2270354 99.55%  2260504 99.61%  
total identified  10149 0.45%  8738 0.39%  
Table 5-8read identification in the two negative samples using Illumina sequencing , including read number and 
proportion of all reads. 
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5.2.2 Blood Model  
Further spiked blood models were used to test more challenging scenarios, one sample 
consisted of a mixed bacteria and virus spike. The second was spiked with Shigella sonnei to test 
the ability to differentiate   E. coli and Shigella directly from sample. The third was a clinically 
invasive non typhoidal Salmonella, which had previously been whole genome sequenced, allowing 
comparison of direct from sample to culture workflows. The final spike was a carbapenem 
resistant Pseudomonas. One ml aliquots of horse blood were spiked with bacteria and or viruses 
and processed for isolation of bacteria and viruses as described in 2.6.5.  
5.2.2.1 Mixed Bacterial and Viral 
Quantification of DNA after amplification using ɸ29 MDA gave a concentration of 139 ng/µl 
and after abundance trimming, removal of orphan reads and error trimming was complete 
1436158 reads remained. 
 Investigation of the LCA analysis allowed identification of both Influenza and  S. Pyogenes.  
When the reads identified as influenza were examined, 45,897 reads were identified as Influenza, 
and 997 were identified as H3N2. De novo assembly of these reads covered 91% of the genome in 
51 contigs.  
When investigating the reads using LCA analysis, 959,760 reads were identified as 
Streptococcus or higher, 544,384 reads were identified to species level as S. pyogenes and 4135 
reads were identified as type M2, (MGAS10270). When these reads were extracted from the file, 
converted to a fastq and mapped against the MGAS10270 reference 93.4% of the reference was 
covered in 432 contigs, using 96.2% of the reads. The  de novo assembly covered 89.7% of the 
genome and when this assembly was uploaded to the online tool ‘Multilocus Sequence Typing of 
Total Genome Sequenced Bacterial’ 169, it was able to give a serotype of ST150, with all the 
targeted regions covered Figure 5-9. When the de novo assembly was annotated, 1581 proteins 
were identified, 313 of these were hypothetical, and when repeats were removed 1203 remained. 
When the reference was annotated 1781 proteins were identified, 461 of these were 
hypothetical. When repeated proteins were removed 1206 proteins remained.   When these two 
annotations were compared there was an overlap of 1174 proteins (98%), with 29 only identified 
in the de novo assembly, and 32 only identified in the reference genome.   
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Figure 5-9 output from online MLST analysis of de  novo  assembly of S.Pyogenes reads showing good coverage of 
a l l genes used for MLST analysis.   
 
5.2.2.2 Shigella  
Quantification of DNA after amplification using ɸ29 MDA gave a concentration of 143 ng/µl. 
After abundance trimming, removal of orphan reads and error trimming 242940 reads remained.  
When inspecting the LCA output, 800,165 reads were assigned to the family 
Enterobacteriaceae or above (Figure 5-10) with 131,799 of these assigned to the species E. coli. 
57,266 reads were assigned to the genus Shigella or higher, 55,374 to the species Shigella sonnei, 
and 16,229 reads were identified to the strain level as Ss046.  When the reads were mapped 
against the IpaH gene (gene for invasive toxin), 100% of the gene was covered.  
When the reads were extracted and assembled against the reference Ss046 92.4% of the 
genome was covered in 212 contigs. When the reads were de novo assembled 85.5% of the same 
reference was covered in 1134 contigs.  The de novo assembly was used to predict resistance to 
antibiotics using Resfinder71 one resistance gene was  identified, dfrA1 which confers resistance to 
trimethoprim. According to the phenotypic data (supplementary Figure 7-2), the only antibiotic to 
which the isolate was phenotypically resistant was trimethoprim. There were additional 
antibiotics changed to resistant based on clinically ineffectiveness of the antibiotics for treatment 
of Shigella (first and second generation cephalosporins and primary aminoglycosides). When the 
de novo assembly was used for MLST typing the result was ST-152 with full coverage of all genes 
used for typing. 
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Figure 5-10 LCA analysis of Shigella sonnei isolated from horse blood, showing reads identified to 
Enterobacteriaceae or higher. 
5.2.2.3 Salmonella 
 The Salmonella reference laboratory routinely uses whole genome sequence analysis (from 
cultured bacteria) to characterise and investigate Salmonella sp. In the hospital lab the isolate was 
identified as Salmonella sp. Via API20E, (2704542) but VI negative ruling out Typhi. Sensitivities by 
disc diffusion found no resistance markers.  
When the DNA produced by ɸ29 MDA was quantified the concentration was 239 ng/µl. After 
sequencing 17732898 reads were produced, after completion of the trimming pipeline 2117443 
reads remained. When the Megan LCA analysis was investigated 1,922,946 reads were identified 
as the family Enterobacteriaceae or higher. 1,870,222 reads were identified as the genus 
Salmonella or above. 1,815,371 reads were identified to the species level as Salmonella enterica, 
and 1,698,669 to the subspecies level as Salmonella enterica subsp. Enterica.  And 12,975 of these 
reads were identified to the serovar level of Typhimurium. After de novo assembly when 
comparing the assembly to a closely related Salmonella whole genome sequence 95.4% of the 
genome was covered in 389 contigs, when this assembly was used to sequence type, the result 
was ST19 with full coverage of all the required genes. This matched the reference laboratory ID of 
Salmonella enterica serovar Typhimurium ST19. No resistance markers were detected using the 
de novo assembly file which was consistent with the phenotypic results (supplementary Figure 7-3 
). 
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5.2.2.4 Highly Resistant P. aeruginosa  
When the Megan LCA analysis was investigated 1,142,554 reads were identified as the family 
Pseudomonadaceae or higher and 1,099,834 reads were identified as the genus Pseudomonas or 
above. 1,091,384 reads were identified to the species level as P. aeruginosa, and 298,669 to the 
strain level of MTB-1. Additionally, two phages were identified, Pseudomonas phage PAJU2 and 
Pseudomonas phage vB_Paes_PGM1.  
When interpreting resistance markers for P. aeruginosa it is important to remember the high 
number of antibiotics that P. aeruginosa are intrinsically resistant to. (Glucose none fermenting 
Gram-negative bacteria are intrinsically resistant to penicillin, cefoxitin, cefamandole, cefuroxime, 
glycopeptides, fusidic acid, macrolides, Lincosamides, Streptogramin, rifampicin, daptomycin and 
linezolid. P. aeruginosa is intrinsically resistant to ampicillin, Augmentin, cefazolin, cefotaxime, 
ertapenem, chloramphenicol, trimethoprim, trimethoprim-sulfamethoxazole, tetracyclines and 
tigeclyine. Additionally, nitrofurantoin is not clinically effective for the treatment of Glucose none 
fermenting Gram-negative bacteria.) In addition to the intrinsic resistances phenotypic methods 
also identified resistance to cefepime, ciprofloxacin, Gentamicin, Levofloxacin, meropenem, 
piperacillin, piperacillin-tazobactam and tobramycin. The isolate was also found to have an 
intermediate MIC for aztreonam (supplementary Figure 7-4).  These phenotypic resistances were 
confirmed at the reference laboratory.  
When ResFinder was used on the de novo assembly of the P. aeruginosa four resistance genes 
were identified. The resistance markers were blaOXA-50 (carbapenemase-hydrolysing 
oxacillinase), blaPAO (ampC), fosA and aph (3’)-IIb (aminoglycoside phosphotransferase) Table 
5-9. The presence of both an ampC and a carbapenase would confer resistance to all beta-lactam 
antibiotics. Presence of an aminoglycoside phosphotransferase would confer resistance to 
gentamicin and tobramycin; fosA would confer resistance to fosfomycin 
The reference laboratory for this isolate reported the presence of blaVIM metallo-
carbapenemase gene, which was not identified in the chromosomal de novo assembly. P. 
aeruginosa has been reported to carry resistance markers on plasmids, which may not have been 
assigned to P. aeruginosa using LCA analysis. The unassigned reads were extracted from the 
trimmed fastq file and de novo assembled and this was then used in ResFinder. This identified the 
blaVIM-7 gene.  
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Resistance 
gene 
%Identity Query/HSP 
length 
Predicted phenotype Accession number 
Chromosomally encoded 
Beta-lactam 
blaOXA-50 100.00 789 / 789 Beta-lactam resistance AY306132 
blaPAO 99.25 1194 / 1194 Beta-lactam resistance AY083592 
Fosfomycin 
fosA 99.26 408 / 408 Fosfomycin resistance NZ_ACWU01000146 
Aminoglycoside 
aph(3’)-IIb 99.01 807 / 807 
Aminoglycoside 
resistance 
X90856 
Probable Plasmid Encoded 
blaVIM-7 100.00 798 / 798 Beta-lactam resistance AJ536835 
Table 5-9 Res istance genes detected using ResFinder on a de novo assembly of P. aeruginosa i solated from blood 
HSP=High-scoring Segment Pairs 
5.2.3 Tissue Model  
Four tissue infection models were created and testing using rhesus macaque tissue. The four 
models were bacterial endocarditis, viral hepatitis, mixed bacterial brain abscess and viral 
pyelonephritis. 
5.2.3.1 Endocarditis Model 
When the DNA from the ɸ29 MDA was quantified a concentration of 846 ng/µl was found. 
After sequencing 1709690 reads were produced and after trimming pipeline completion 868754 
reads remained, with the average read lengths being 93.02 and 85.64 bases for the first and 
second read. The majority of the reads (794,782) were removed during the abundance trimming 
stage. 3161 reads were assigned to Gammaproteobacteria, 8911 reads were assigned to 
Pasteurellacaeae, 29,870 were assigned to Haemophilus and 786252 reads were assigned to H. 
influenzae.  Further identification based on LCA analysis showed six possible sub-types, 2019 
(1366 reads), 86-028NP (2,459 reads), CGShiCZ412602 (2,554 reads), KR494 (3,781 reads), pittEE 
(7.733 reads) and R2846 (5,236 reads) Figure 5-11. The result of the MLST typing was ST-165 with 
all required genes fully covered. When the Resfinder data base was used to detect resistance 
markers one gene was identified, blaTEM-1B (100% gene identity, 861/861 bases) which confers 
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resistance to beta-lactam antibiotics. The phenotypic results for this isolate can be found in the 
supplementary material (Figure 7-5) 
 
Figure 5-11 LCA analysis of Haemophilus influenzae sub-types after isolation from horse blood and sequencing  
5.2.3.2 Hepatitis Model 
 The ɸ29 MDA produced a DNA concentration of 63ng/µl and produced 2365815 sequencing 
reads. After completion of the trimming pipeline 2,048,841 reads remained. The average read 
lengths for read one and read two were 94.4 and 86.8 bp. When examining the Megan LCA output 
1,389,982 reads mapped to H. influenzae, suggesting a pre amplification contamination. 
Additionally, 354,389 reads mapped to Macaca mulatta (rhesus macaque), suggesting less 
efficient removal of host.  There were 112,987 reads which mapped to HAV, which when de novo 
assembled covered 98.1% of the genome in 8 contigs  
5.2.3.3 Mixed Brain Abscess Model  
After ɸ29 MDA amplification the DNA concentration was 63 ng/µl, and after completion of 
sequencing there were 1,493,664 raw reads. After completion of trimming and host removal 
1,326,822 reads remained. 
587248 reads were identified using LCA as Bacteroides sp or higher, with 385,825 of these 
identified as B. vulgatus, with 298,498 reads further identified as ATCC 8482.  When the reads 
were extracted from the fastq and mapped against the ATCC 8482 genome, 92.45% of the 
genome was covered in 589 contigs. When the de novo assembly was compared to the reference 
81.0% of the genome was covered in 1128 contigs with 32 misassemblies. No resistance markers 
were found using ResFinder.   
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In total 757450 reads were identified as Streptococcus sp or higher Figure 5-12. The number 
of reads identified as S. anginosa was 228,770, with 98,710 reads identified as the subspecies 
‘C1050’, when the extracted reads were mapped against this reference 87.65% of the genome 
was covered. When the de novo assembly was compared to the reference 79.65% of the 
reference was covered.  No resistance markers were identified using ResFinder. The number of 
reads assigned to S. mitis was 19,633, and 5487 reads were further identified as strain ‘B6’, when 
this was used to reference assembly 85.89% of the reference was covered, and 74.87% was 
covered in the de novo assembly. ResFinder identified resistance markers conferring resistance to 
aminoglycosides and tetracycline Table 5-10. The number of reads identified as S. oralis was 
153,093, with 3009 reads further identified as ‘Uo5’ strain. When Uo5 strain was used to 
reference assemble the extracted reads 93.3% of the genome was covered, and 81.4% was 
covered using de novo assembled reads. ResFinder identified resistance markers for macrolide 
and tetracycline resistance.  
 
Figure 5-12  Bacterial read identification using LCA analysis on mixed brain abscess model 
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Resistance 
gene 
%Identity Query/HSP 
length 
Predicted phenotype Accession 
number 
B. vulgatus-No resistance markers found 
S. anginosa-No resistance markers found 
S. mitis 
Aminoglycoside 
aac(6')-aph(2'') 100.00 1440 / 1440 
Aminoglycoside 
resistance 
M13771 
aph(3')-III 99.75 795 / 795 
Aminoglycoside 
resistance 
M26832 
Tetracycline 
tet(M) 99.48 1920 / 1920 Tetracycline resistance FN433596 
S. oralis 
MLS - Macrolide, Lincosamide and Streptogramin B 
erm(B) 
100.0
0 
738 / 738 Macrolide resistance U86375 
Tetracycline 
tet(M) 98.75 1920 / 1920 Tetracycline resistance FN433596 
Table 5-10Res istance markers identified in bacteria used in mixed brain abscess model  
  
5.2.3.4 Viral Pyelonephritis Model  
After ɸ29 MDA amplification no DNA was detectable when using the Qubit, and so the sample 
was concentrated using an isopropanol clean up and the DNA reconstituted in 10 µl and 
submitted for sequencing. Sequencing produced 858,248 raw reads. 67.6% of these reads 
mapped to the human genome and so were removed during the trimming pipeline. After 
completion of the trimming pipeline 262,038 reads remained.  Most of these reads (213,819) had 
no hits. The remaining reads were identified as Macaca mulatta. No reads were assigned to CMV.  
5.2.4 Pathogen Detection in Urine 
Culture negative urines from symptomatic patients were sent as part of another molecular 
study, 50 µl aliquots of these were blinded and tested using methods developed in this study.  
After amplification using ɸ29 MDA the amount of DNA present was 768, 156, 791 and 293 ng/µl 
for the four samples.  
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Two of the samples (1 and 3) had a large presence of vaginal flora including predominantly 
Lactobacillus sp (including Lactobacillus acidophilus, Lactobacillus amylolyticus, Lactobacillus 
crispatus, Lactobacillus gallinarium, Lactobacillus gasseri, Lactobacillus iners, and Lactobacillus 
johnsoni) suggesting female patients with poor quality sampling. In one of these samples, (3) it 
was possible to identify JC virus amongst the vaginal flora.  
A large proportion of the reads in samples 2 and 4 were unidentified however it was possible 
to identify BK polyomavirus within these samples. No further identification of the BK virus was 
possible.    
5.2.5 Pathogen Detection in CSF  
After amplification the concentration of DNA for the four CSFs was 2, 142, 491 and 484 ng/µl. 
the number of raw reads produced after sequencing was 3085267, 1773960, 544302 and 
2,113,620. The percentage of reads that mapped to the human genome was 94.1%, 93.9%, 61.2% 
and 99.2%.  In CSF samples 1, 2 and 4 there was no pathogen identified with remaining reads 
being unassigned. In CSF there was 1.1% of reads which were identified as Onchocerca volvulus, 
when mapped against the genome 0.95% of the genome was covered. The remaining reads from 
CSF three were unassigned.  
5.2.6 Sexually Transmitted Disease Detection  
Four blinded samples were supplied by the sexually transmitted bacteria reference unit 
(STBRU) at PHE Colindale. 
 After amplification the concentration of the two samples in BD viper buffer were 1ng /µl for 
each sample, the two samples in COBAS buffer produced 361 and 251 ng/µl. After completion of 
sequencing for the first STI swab the percentage of reads mapping to host was 1.4%. When 
examining the LCA analysis, the majority of reads (1,254,897, 69.1%) mapped within the 
Gammaproteobacteria class, or the class Clostridia (324,946 reads, 17.9%). Other reads were 
either unidentified or represented other classes expected in the gut. It was not possible to detect 
C. trachomatis within this sample.  
After completion of sequencing of STI sample two 2.6% of read mapped to the host. Within 
STI sample two 7.83% of reads mapped to the Bacteroides genus, with the main species within 
this was Bacteroides uniformis with 5.35% of all reads. Also identified in this sample was 
Runinococcus torques which represented 8.88% of all the reads. The largest species represented 
in this sample was Sneathia sanguinegens which represented 61.03% of all reads. Chlamydia 
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trachomatis was identified in this sample with 3.29% of reads. No further identification of the C. 
trachomatis was possible. 
The number of raw reads produced after sequencing STI sample 3 was 2,104,335, with 
408,962 mapping the human genome. After completion of the trimming pipeline 1,282,026 reads 
remained. When examining the LCA, it was possible to see a large variety of bacterial species 
represented. Mobiluncus curtisii represented 12.10% of all reads; Corynebacterium sp acounted 
4.10% of reads, there was also a large presence of Staphylococcus epidermidis representing 4.44% 
of the reads. Streptococcus species were also heavily represented with a total read percentage of 
10.85%; the genus Peptoniphilus sp was a highly represented with 31.85% of the reads. Within 
this family Finegoldia magna was present at the highest proportion with 12.16% of all reads. It 
was possible to identify Neisseria gonorrhoeae in the sample, with 3.54% of reads identified as 
this species. It was not possible to further subtype the N. gonorrhoeae. Also detected within this 
sample was Mycoplasma genitalium, which represented 3.83% of the overall reads, along with 
1.38% of reads which were identified as Trichomonas vaginalis. A list of all genus and species 
detected in this sample at a level of greater than 0.2% of all reads can be seen in supplementary 
Table 7-10.  
In the fourth STI swab sample the number of raw reads produced was 1778454 with 437691 
of these mapping to human. After completion of the trimming pipeline, 889337 reads remained. 
When inspecting the LCA analysis, 89.32% of the reads were identified as Gardnerlla vaginalis, 
0.67% of reads mapped to Alpha papillomavirus 8. Additionally, 9.08% of the reads were 
identified as Neisseria gonorrhoeae. A subtype was identified using LCA as MU_NG4, when this 
was used as a reference 38.3% of the genome was covered after reference assembly and 25.9% 
was covered using the de novo assembly. The MLST tool was unable to identify the sequence type 
as only two of the required genes had sufficient coverage Figure 5-13, ResFinder was unable to 
identify any resistance genes.  
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Figure 5-13  MLST output of N. gonorrhoeae reads identifed by LCA and de novo  assembled 
Five additional STI samples delivered from St Mary’s hospital, three blood samples and two 
ulcer samples. After amplification using ɸ29 MDA the amount of DNA produced was 107, 53 and 
184 ng/µl for the blood samples and 193 and 1 ng/µl for the ulcer samples. After sequencing the 
blood samples produced 2,470,807, 2,181,750 and 2,694,688 reads. Of these reads 85.1%, 98.9% 
and 97.6% mapped to the human genome. When examining the LCA analysis samples two and 
three all remaining reads were either mammalian or not assigned. In sample one, Torque teno 
virus accounted for 5% of the remaining reads, with other reads identified as mammalian or 
unassigned.  
The ulcer samples produced raw 2,087,616 and 869 reads. From the first ulcer sample 2.5% 
reads mapped to the human genome. There was a large number of reads which mapped to the 
genus Staphylococcus, (54.9%) with S. epidermidis (43.0%) the majority species of this genus. 
Other genera heavily represented were Corynebacterium, Acinetobacter and Streptococcus. 
Treponema Pallidum was detected at a level of 0.05% of all the reads.   
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Figure 5-14 bacterial identification using LCA analysis: percentage of reads identified in three vagina swabs (reads 
>0.05% of a l l reads) 
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Sample 
type 
DNA Quant 
post 
amplification 
(ng/µl) 
No: Raw 
Reads 
No: 
reads 
Mapped 
to host 
No: reads 
Mapped to 
contaminat
ion 
No: reads 
after 
abundance 
trimming 
No: Reads 
after 
pipeline 
read length 
(bp) 
1 
Negative 
extraction 
126 2779602 
59100 127 2280519 2254737 93.39 
53486 157 2280519 2254737 86.5 
2 
Negative 
amplificatio
n 
68 2861044 
57307 108 2269259 2251228 93.43 
62505 144 2269259 2251228 
87.14 
3 
Spiked 
blood 
139 1524710 
22633 3191 1444806 1436158 95.13 
21286 2706 1444806 1436158 88.03 
4 
Spiked 
blood 
143 1444641 
4867 467 255457 1242940 92.72 
4335 412 255457 1242940 80.1 
5 
Spiked 
blood 
239 17732898 
33574 10027 2132469 2117443 92.27 
31562 9403 2132469 2117443 85.4 
6 
Spiked 
blood 
394 1648391 
36134 61 1435310 1410913 94.25 
32345 100 1435310 1410913 86.37 
7 
Spiked 
heart 
846 1709690 
11699 15016 888193 868754 93.02 
10573 13427 888193 868754 85.64 
8 Spiked liver 973 2365815 
34980 12562 2073516 2048841 94.4 
31376 11898 2073516 2048841 86.8 
9 
Spiked 
brain 
63 1493664 
12259 1949 1332533 1326822 92.21 
11509 1805 1332533 1326822 86.34 
10 
Spiked 
kidney 
<  858248 
579875 682 264676 262038 98.68 
559886 855 264676 262038 99.7 
11 Urine 768 2428095 
43015 111 2169474 2149803 93.71 
39354 138 2169474 2149803 86.91 
12 Urine 156 2161570 
39214 158 1936518 1920385 93.82 
35532 169 1936518 1920385 87.1 
13 Urine 791 1913768 
32772 59 1772817 1744528 94.12 
29133 101 1772817 1744528 86.03 
14 Urine 293 2100457 
36441 247 1909599 1893709 94 
33440 251 1909599 1893709 87.2 
15 CSF 2 3085267 
2902191 19 79991 79257 89.55 
2863550 297 79991 79257 84.4 
16 CSF 142 1773960 
1665264 2 32290 30909 88.38 
1618340 4060 32290 30909 80.29 
17 CSF 491 544302 
333062 3 126419 114083 92.06 
324408 3 126419 114083 76.23 
18 CSF 484 2113620 
2097739 2 3472 3286 80.32 
2065525 5 3472 3286 76.69 
19 STI swab 1 1938864 
27826 4239 1827346 1816884 95.07 
26338 3861 1827346 1816884 
87.97 
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20 STI swab 1 1270294 
33891 1978 1224811 1220567 95.13 
32655 1770 1224811 1220567 87.96 
21 STI swab 361 2104335 
408962 5616 1292173 1282026 94.81 
402582 5161 1292173 1282026 87.99 
22 STI swab 251 1778454 
437691 3966 902435 889337 98.58 
428113 3361 902435 889337 86.88 
23 STI Blood 107 2470807 
2103620 27 355004 350672 95.01 
2071314 33 355004 350672 87.06 
24 STI Blood 53 2181750 
2157065 1 14265 13930 92.59 
2115394 12 14265 13930 85.41 
25 STI Blood 184 2694688 
2630702 3 52915 51426 93.9 
2544864 14 52915 51426 84.69 
26 SnosStrip 193 2087616 
40199 52 1788958 1769905 94.17 
37114 99 1788958 1769905 87.04 
27 SnosStrip 1 869 
15 2 831 715 93.72 
23 1 831 715 79.8 
Table 5-11 DNA concentrations, sequencing outputs and pipeline outputs for modelled and clinical samples  
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Figure 5-15 Results of amplification and sequencing of real and modelled clinical samples along with negative 
controls, grouped by sample type (A):DNA concentrations produced by ɸ29 MDA (B): number of raw reads (dark bar) 
and read number after completion of trimming (light bar), X i llustrates the number of reads identified as human in each 
sample.  
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5.3 Chapter Discussion 
 
5.3.1  Blood Culture Model-Development 
Fresh horse blood was used to model bacteraemia, as whole blood was readily available. The 
initial experiments focused on bacterial survival in horse blood and the use of saponin to 
selectively lyse host cells. The aim of the isolation method was to keep bacterial cells whole so 
that the alkali extraction method could be used in order to prevent DNA shearing. Saponin has 
previously been used to lyse human cells 170. Lysing human cells will release any intracellular 
pathogens and release host genetic material allowing removal using nucleases.  Incubation of most 
bacterial cells in saponin showed no impact on the number of CFU recovered across the different 
bacterial species studied.  Paenibacillus anaericanus showed the lowest survival rates (87.2%), 
however if the saponin was toxic to the bacteria a lower survival would be expected. The slight 
drop in survival could be accounted for by the bacteria’s need to adapt to the aerobic conditions 
or some of the slow growing colonies not being visible and so not counted. Several bacteria did 
show poor survival in horse blood, particularly S. pneumoniae, L. monocytogenes, S. sonnei and 
Paenobacterium.   This suggests that the horse blood is toxic to these bacteria, either due to 
specific antibodies, innate immune response or general toxicity of the blood. Other bacteria 
developed altered colony morphology after incubation with horse blood, suggesting some 
inhibition of growth, although not cell death.  Knowledge that most of these bacteria survived 
well in horse blood allowed the isolation model to be developed, knowing to what degree the 
bacteria survived allowed informed decisions about which bacteria were spiked into the model 
and at what number.  Two bacteria were selected to develop the isolation method , E. coli and S. 
aureus, representing both a Gram negative and Gram positive cell wall type, and different cell 
shapes and densities.  
Red blood cells (RBCs) represent the largest proportion of the cellular makeup of blood (up to 
96%171) and so the first stage was to remove them. By keeping the RBCs whole, it was hoped to 
not release cell contents which might be toxic to pathogens, or which may inhibit extraction or 
amplification. Originally isolation of bacteria in a density gradient using Percoll was investigated. 
The results showed poor separation of bacterial cells and RBCs, with E. coli cells being found at 
almost all points in the density gradient (Figure 5-2). The density of E. coli most likely varies 
greatly as the cell elongates before division, with short rod shaped bacteria being produced after 
cell division. Additionally, S. aureus was only found co-located with RBCs, suggesting that whilst 
they have a more constant cell density, it is in the same range as the RBCs.  Density was shown to 
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be a poor method for isolating bacteria from RBCs, additionally, density of bacterial cells will vary 
among species, and even between bacteria of the same species at different life cycle stage s. 
HetaSep was then investigated as a method of isolating and removing RBCS from whole 
blood, this product causes the RBCs to form stacks, which increases the weight, allowing easy 
pelleting of the RBCs.  The first stage of investigation was whether the bacteria and RBCs still co-
pelleted, and also ensure that the use of HetaSep wasn’t toxic to the bacterial cells. The 
manufacturer documented two methods for separating the stacked-RBCs from other blood 
components, either with centrifugation or by incubating at 37oC, both were investigated. When 
the sample was centrifuged there was co-sedimentation of the E. coli and S. aureus with the RBCs, 
probably through the action of centrifugation. Gravity sedimentation at 37oC, prevented co-
sedimentation of bacterial cells and RBCs (Table 5-3).  
Low numbers of bacterial cells (ten) were spiked into horse blood to investigate the process of 
bacterial isolation from whole blood. The process trialled included removal of RBCs using se lective 
aggregation and lysis of other host cells. Lysis was achieved through the use of saponin coupled 
with an osmotic shock treatment, which was added to aid in host cell destruction, with the aim of 
improving intracellular pathogen recovery and increasing host cell breakdown. Once the host 
genetic material was released from the cells the aim was to remove it through the use of 
centrifugation and washing. At several points along the process bacterial cells were cultured to 
check bacterial viability and isolation. The water shock treatment proved detrimental to E. coli 
survival due to too much osmotic stress on the bacterial  cell wall, and so the time the cells were 
exposed to the stress was reduced. The host cells would be selectively damaged by the sapon in 
and so a short treatment should cause more damage to these cells than bacterial cells. The initial 
centrifugation speed of 3000 x g failed to pellet all cells of S. aureus, and so was increased to 4000 
xg, a low speed was required so as to leave as much host DNA and cell debris in the supernatant 
as possible.  After completion of the process the pellet was suspended in PBS and the free DNA 
quantified, showing that there was still host DNA present (the E. coli sample had a higher 
concentration possibly due to release of bacterial DNA due to osmotic cell lysis). The large 
genome size and complex structure of the host genome along with accompanying proteins and 
cellular debris may have caused the DNA to pellet alongside the bacteria. A DNAse stage was 
added to the process, aiming to avoid use of heat to deactivate the enzyme to prevent sample 
coagulation and release of potentially toxic cellular components. The combination of Mg + 
chelation with EDTA and several centrifuge and washing stages successfully removed DNAse 
activity without damage to the bacteria. Any small traces of DNAse would be inactivated during 
bacterial DNA extraction.  
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 When the improvements were trialled they showed good results for both E. coli and S. 
aureus. Once the isolation method was optimised, the method was tested by spiking single 
bacterial cells into 1ml horse blood, to represent a low level bacteraemia. The bacterial DNA was 
then extracted and sequenced, with the reads being input into the pipeline previously developed. 
After sequencing of the S. aureus isolated from blood, 6.76% of reads were identified as 
Equus, and 62.1% of the reads were identified as Staphylococcus. The remaining Equus reads 
were most likely due to remaining free DNA as whole host cells would produce  more reads than 
the S. aureus due to a larger starting genome. Additionally, LCA analysis identified the presence of 
a horse tapeworm, suggesting the horse had a current or previous infection with Parascaris 
equorum. The LCA analysis provided subspecies identification of the S. aureus, 5.5% of the S. 
aureus reads were identified as a single subspecies, which most likely represented a S. aureus 
lineage that was very closely related to the clinical isolate.  The de novo assembly was then used 
to predict the antibiogram using a tool specifically designed for S. aureus, Mykrobe. The 
antibiogram matched for 11/12 of the antibiotics available in the genotypic and phenotypic 
methods.  The genotypic results for Ciprofloxacin were inconclusive, suggesting either poor 
coverage of the targets, or insufficient information in the database to call the isolate resistant. 
With 92% of the resistance markers being called correctly, data quality is unlikely to be the cause 
of the Ciprofloxacin resistance mismatch. The de novo assembly only covered 83% of the genome, 
suggesting that the gene might be missing, however 13% of the S. aureus genome has been 
shown to be repetitive172, and so most of the absent  genome could be accounted for if these 
repeated elements were misplaced during assembly. Three mechanisms of fluoroquinolone 
resistance have been proposed in S. aureus, Topoisomerase IV gene mutations, DNA gyrase gene 
mutations and an active efflux pump (NorA)173. The complexity of predicting ciprofloxacin 
resistance suggests that the database may be lacking in i ts ability to predict ciprofloxacin 
resistance, and so this is the most likely cause of the inconclusive result for ciprofloxacin 
resistance. Additionally the creators of Mykrobe (Bradley et al 167) found a false negativity rate of 
4.6% for ciprofloxacin resistance. Overall there was good concordance of phenotypic and 
genotypic results show the potential for rapid genotypic prediction of antibiotic resistance from a 
single cell in 1 ml of host blood, however the inconclusive ciprofloxacin results demonstrate the 
need for improved understanding of the mechanisms of resistance. The fact equine tapeworm 
DNA was identified in the blood of this animal highlights the ability of this method to discover 
pathogens in a non-targeted manner. 
283 
 
 There were fewer antibiotic non-susceptibilities predicted using the genomic data compared 
with phenotypic testing, but this is most likely a reflection that the BD phoenix is a generic tool, 
with the same panel of antibiotics being tested for all Gram positive bacteria, and Mykrobe being 
a specific tool for S. aureus. In addition to identifying the isolates resistance to beta-lactams the 
database was able to identify the blaZ gene and MecA gene. Genotypic testing will never entirely 
replace phenotypic susceptibility testing, due to its inability to identify novel resistance 
determinants and the comprehensive nature of phenotypic testing. However, in this scenario, of 
invasive sepsis, the gain in speed provided by not having to culture the organism to determine 
susceptibility could be life-saving. When Prokka was used to annotate the resulting genomes 
more CDS were predicted than in the reference used, which may reflect the fact that the clinical 
isolate was not an exact match to the reference sequence used, or the fact that only 92% of the 
genome was covered when the reference mapping was used.   
When the LCA analysis from E. coli spiked blood was analysed it was not possible to assign a 
single genotype, with a small proportion of reads being assigned to two different subtypes. This 
could be that both of these named genotypes are actually the same strain but with different 
names, or that the clinical isolate is not an exact match for any genome in the database. 
Additionally, there is the chance that there was low genome coverage at the points where 
genotypes differ. However, when using one of the genotypes identified good genome coverage 
was achieved (93.5%) when the data was reference assembled, and the de novo assembly also 
performed well covering 89% of the genome. Multiple antibiotic resistance factors were 
identified, which gave good concordance with the phenotypic data. Using the genotypic data, it 
was possible to rapidly identify the beta-lactamase present as BlaCMY-2. The rapid identification 
of the specific resistance genes in bacteria could help identify outbreaks by providing more 
information than a simple antibiogram. Additionally, it could help monitor novel resistance genes, 
or genes that are becoming increasingly common. Large amounts of horizontal genome transfer 
amongst Gram negative bacteria has the potential to cause outbreaks of resistance bacteria 
through gene or plasmid outbreaks174, which would be more complex to track. Rapid 
identification of genes causing the resistance in isolates could help inform epidemiological and 
outbreak studies which could involve several species of bacteria.  The output for the resistance 
prediction was quite difficult to interpret with several genes identified which didn’t always have 
specific drug resistance associated. This highlights a down side of generic databases, as they are 
often time-consuming to interpret. A study of NGS sequencing data from bacteraemia isolates of 
E. coli have shown resistance prediction specificity of 97%6, if this was coupled with direct from 
sample sequencing genotypic prediction could inform treatment more rapidly than phenotypic 
test.  
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When using whole genome sequencing on NGS platforms the biggest limitation is the data 
output of the platform use, which for the 454 junior is 0.04 GB/run175. This means that when pure 
bacteria are investigated it is possible to get good depth of coverage, allowing robust prediction 
and good genome coverage. However, when host and environmental DNA is also sequenced there 
is an impact on the number of reads assigned to the pathogen, potentially lowering coverage and 
decreasing depth. At several points during library preparation only a small portion of the DNA is 
carried forward to the next stage. For example, after completion of ɸ29 MDA there is often >100 
ng/µl DNA in a 50 µl reaction. Only 500 ng of this is needed for the library preparation. There are 
also additional points during library preparation when small amounts of DNA are needed. These 
multiple stages will mean that at every point random pieces of DNA will be lost, which may lead to 
technical variation in the method. This phenomenon will be exacerbated when looking a 
pathogen signals that originated in clinical material if host DNA is present. However, despite these 
limitations, we have shown that this method of isolation, amplification and sequence 
interpretation produces good data is produced allowing pathogens to be identified, even on a 
sequencing platform which is showing its age, the 454 Junior. Good quality antibiotic resistance 
predication has also been possible using unbiased amplification and de novo data analysis 
methods.  
There are several limitations to the model created for bacteraemia, firstly by using a model 
several things are controlled for which may not be possible in real samples. This includes the t ime 
from inoculation to isolation of the bacteria, the temperature of the blood, and the inoculum 
itself. Additionally, bacteria spiked into horse blood may differ in their behaviour compared to 
bacteria causing disease in humans. Horse blood may also differ from human blood in several 
ways including cellular make up, and human blood which is reacting to infection may contain 
additionally components which are toxic to bacteria and make isolating whole bacterial cells more 
challenging. However, the main limiting factor for this model is the estimation of a single cell 
based on dilution studies, which may be incorrect and mean that more than a single cell was 
added due to human error or aggregation of bacteria leading to more cells being added. To 
overcome all these limitations would require a large study and ethical approval for using an 
unbiased amplification method on real human samples, which would be challenging to achieve. 
However, some limitations could be more easily over come, such as the use of human blood in 
place of horse blood, which would require volunteers donating blood. Additionally, to ensure 
accurate single cell inoculum microfluidics could be used to isolate single cells to be spiked into 
the samples.  
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The process developed and tested for the bacteraemia model was used to inform a single 
sample process which could be applied to multiple sample types.  This also included to viral 
sample preparation, the two processes were kept separate due to the small size of viruses, and 
not wanting to exposure enveloped viruses to saponin. The two halves were joined at the ɸ29 
MDA stage which allowed one amplification and sequencing per sample. The aim of the work flow 
was to be able to identify pathogens without need for any prior knowledge other than the sample 
type. The success of this approach was highlighted by the discovery of a parasite in horse blood, a 
pathogen type for which no explicit optimisation was carried out. The intention was to remove as 
much host as possible using laboratory methods without compromising the pathogen integrity.  
5.3.2 Application to Multiple Sample Types 
Several different samples including both real and modelled clinical samples were processed in 
parallel to test the applicability of the method. The sequencing was performed using the Illumina 
HiSeq, which allowed all samples to be tested on a single run as the data output is higher than 
that of the 454 Junior. By switching to an alternative platform the applicability of the method to 
multiple platforms was demonstrated. The first samples to be analysed were two negative 
samples, an extraction and amplification control. Using two controls allowed monitoring of the 
processing, and if contamination was identified as a problem it would be possible to i dentify 
potential sources.  DNA was produced by both negative samples, with the extraction negative 
producing more, which would be expected as there were more opportunities to pick up 
contaminants. However, both had very few reads that were assigned an identity (0.45% and 
0.39%) showing very low level contamination, which were most likely introduced after 
amplification. With such low numbers it could be that the reads that were assigned weren’t the 
true identity, and were actually random DNA that happened to be similar to organism signals, 
however as the reads were similar in both would seem to suggest that these were true identities. 
The most likely source would be sequencing preparation kits the low numbers suggest the source 
was degraded DNA.  A very low number of reads from the new negative samples mapped to the 
original negative library previously prepared, several factors could account for this, a new ɸ29 
MDA kit was used to perform the final set of samples, a different laboratory was used and 
additional reagents were used. Furthermore, the change to a new sequencing platform and 
library preparation methods alter the process which may have selected for different 
contamination points.  
Monitoring of kit, environmental and instrument contamination is vital to prevent false 
association of microorganisms with disease. Strong et al compared RNAseq data from two 
different studies on the same, presumed bacterial free, cell lines176, with bacterial reads being 
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identified in all samples at a level of up to 10,0000 reads per million human mapped reads 
(RPMH). Interestingly the two studies identified different taxa, suggesting bacterial reads didn’t 
originate in the samples. They presented further evidence by sequencing the same EBV-positive 
lymphoma at six different quality controlled study laboratories. Again bacterial reads were 
identified in all samples, but the number of reads identified varied by up to 30-fold in number, 
with distinct taxa identified at each site. Additionally, when sample sequencing was repeated at 
the same laboratory data showed taxa clustering with the original sequencing data.  This study 
put doubt on another study which reported an association of Fusobacterium nucleatum with 
human colorectal cancer177, which found a level of 861 RPMH.  This evidence from multiple study 
sites highlights a need for care when drawing conclusions of association, especially when entire 
study sets are batched into single sequencing runs. Negative controls at multiple sample 
preparation points will increase the confidence with which conclusions can be drawn by providing 
evidence that pathogen reads originated in the sample and are not derived during sample 
processing.  
Further blood spiking experiments were undertaken to explore the potential of  the method 
for more challenging situations. Most clinical diagnostics separate the viral and bacterial elements 
of infectious disease diagnosis, however there situations where the two can be linked, for 
example bacterial pneumonia following influenza infection178. The first model was a mix of 
bacteria and virus in the blood. An enveloped RNA virus was used as it is the most challenging 
pathogen type as the enveloped nature of the virus means it is fragile during sample processing 
and the RNA needs additional conversion before amplification.  The method allowed identification 
of both the influenza and S. pyogenes in the sample showing it is possible to merge investigation 
of viruses and bacteria.  For future applications this could be important to look at disease 
associations, when looking at the 2009 influenza pandemic S. pyogenes re-emerged as a bacterial 
superinfection179. Using methods developed in this thesis, both infections could be diagnosed 
simultaneously, which could aid in the appropriate treatment of this co-infection which has a very 
high associated morbidity180.  
When spiking the horse blood, a higher inoculum of Shigella sonnei was used than with other 
bacteria, this was to compensate for the poor survival of the bacteria in horse blood. Diagnostic 
identification of E. coli and Shigella can be challenging with some methods not being able to 
differentiate them (e.g. MALDI-TOF) as the two are very closely related. The difference is 
historically based on disease profile, toxin production and serological differences. As genomic 
methods are being increasingly adopted separation of Shigella and E. coli is becoming less 
fundamental, as genomic data shows how related they are. In this sample most reads were 
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identified as Escherichia, with reads being speciated as both E. coli and Shigella sonnei, which is to 
be expected with how closely related they are. Very few genes differentiate the two species, the 
IpaH gene is the main method of separating enteroinvasive E. coli (EIEC) and Shigella sp from 
other E. coli181. This method was adopted bioinformatically, with good mapping results. The 
challenge of this sample was to see if it was possible to differentiate E. coli and Shigella in a 
clinical sample. Because of their mostly shared genome it would always be expected to never 
separate the two completely, but if the LCA analysis from the Shigella (Figure 5-10) and the E. coli 
(Figure 5-6) are compared they show some difference, with Shigella only identified in the Shigella 
sample. By double checking for the presence of the IpaH gene the Shigella in this case can be 
confidently call Shigella. sonnei above the E. coli however if the two were mixed (e.g. in faeces) it 
would be a more complex picture with the Shigella representing a much lower proportion and the 
identification may not be so clear cut.  It was possible to sequence type using an E. coli database, 
and the trimethoprim resistance was predicted from the genome. The other resistances reported 
on the phenotypic report were either intrinsic resistances or cases where antibiotics were not 
clinically applicable. These were not reported using database resistance reporting, as the 
database was written to be pan-pathogen applicable and so species specific interpretation is not 
reported. If bioinformatic tools are to be used to predict antibiograms in bacteria it is important 
to build in a database of species specific intrinsic resistances and report thi s alongside any 
acquired resistance genes. Distinguishing between different pathogenic subtypes of E. coli and 
Shigella can be important due to the potentially serious nature of infection.  These challenges 
have previously been described66, and the ability to on some level differentiate this in a sterile site  
shows the potential of this method for use in future outbreaks.  
The genotypic method applied to the Salmonella gave better results than the phenotypic test 
undertaken at the hospital laboratory which was unable to speciate the isolate using biochemical 
methods. The genotypic method was able to identify, sequence type and provide accurate 
resistance information directly from the sample, which would have been more rapid in real -time 
than the current method which required the reference laboratory to assign a species to this 
isolate. The application of real-time typing using sequencing data has been shown during a 
Salmonella hospital outbreak 182, using methods developed in this thesis genomic data could be 
obtained without the need for culture, speeding up time to results.  
When investigating the clinical isolate of P. aeruginosa several resistance markers were 
initially identified using the de novo assembly on the reads identified as P. aeruginosa using Blastn 
and LCA analysis. However, the beta-lactamase identified using PCR at the reference laboratory 
was not found. When the unassigned reads were investigated the blaVIM-7 gene was identified, 
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which demonstrates the need for not discarding these, as they may contain reads that are 
plasmid, not obviously belonging to a specific species or be of poor quality. This may be more of a 
problem with very short read technologies as the reads won ’t span whole genes and therefore are 
less likely to span genus/species specific elements.  It also demonstrates this method is poor at 
plasmid classification and might suggest that further pipeline development is needed in order to 
reliably identify plasmid presence. However, this de novo method did allow an additional beta-
lactamase to be identified, Oxa-50, which is not one of the targets amplified in the reference 
laboratory PCR. This demonstrates a weakness in targeted processes for resistance identification. 
Interestingly although Oxa-50 is a fairly narrow spectrum oxacillinase, it has been reported to 
have low level capacity to hydrolyse imipenem183.   Evolution of resistance in bacteria can be 
rapid, especially in Gram negative species, and so using targeted methods may miss newly 
evolved genes or SNPs conferring novel or adapted resistance mechanisms. One emerging area 
that this technique could be applied is for plasmid outbreaks, which have recently been reported 
in Klebsiella spp174. This is particularly important as Klebsiella spp are the 5th most common cause 
of bacteraemia in the UK93. Using the methods developed in this thesis the exact isolate causing a 
bacteraemia could be sequenced, rapidly and without need for culture, and be used to inform 
further epidemiological study where an outbreak is suspected. The method has been shown to be 
able to sequence plasmids, although further bioinformatic work may need to be done to increase 
detection of plasmids.   
 
The value of the developed method for host DNA depletion from samples can be seen when 
the results of this study are compared to those found by Grumaz et al 184. When they used NGS to 
investigate bacteraemia an average of 96% of their reads mapped to the human genome. This is 
in stark contrast to the average 1.5% of Illumina reads mapping to host from the spiked blood 
samples in this thesis. Grumaz et al relied only on centrifugation without a selective lysis step 
before extraction and amplification of the DNA.  In order to identify bacteria species in the sample 
they relied on very high depth sequencing (average of 26 million reads per sample) , which was an 
order of magnitude higher than the number of reads achieved in this thesis (average1.8 million 
reads). This level of sequencing output wouldn’t be practical in a clinical setting due to the 
prohibitive cost associated, additionally time to bioinformatic analysis completion would also 
increase.  The results achieved using the selective lysis presented in this thesis also compare 
favourably to those achieved using ɸ29 amplification to investigate HPV from cervical swabs185, 
which had 64.5% reads identified as human.  
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Four tissue models were investigated to test the suitability of the sample processing 
procedure to solid cellular samples, which is potentially the biggest challenge to this method as 
there are high levels of host in a difficult to extract form. The first sample was H. influenzae spiked 
into heart tissue. We were able to recover H. influenzae reads, showing that the sample 
processing worked for this tissue type. The LCA analysis was unable to sub-type the bacterium 
which probably reflects the lack of similar sequence available in the database. It was possible to 
use the MLST database using the de novo assembly, showing this is a more suitable method for 
sub-typing pathogens.  
The hepatitis model showed high level contamination with H. influenzae indicating pre-
amplification contamination, probably during sample preparation.  This problem highlights the 
downside of very sensitive methods, in that they are very open to contamination events, as even 
a single cell can be amplified. However, it was still possible to detect HAV in the sample with good 
genome coverage. The brain model showed good isolation of all four bacteria and good 
separation of the three Streptococcus species, which is often time consuming where using 
biochemical test. An identical resistance marker was identified in both the S. oralis and the S. mitis 
isolate, which could either mean that the gene is conserved, rapidly spread through the 
Streptococcus genus, or that the LCA analysis mistakenly placed the gene in both bacterial 
species. Separation of S. mitis and S. oralis is important due to their differing antibiotic 
susceptibilities186.  Differentiation can be difficult, for example  the sequence homology of the 16S 
gene is greater than 99%187 and routine MALDI-TOF techniques also often struggle188. There have 
been developments, with Friedrichs et al 186showing that using a bioinformatic approach known 
as support vector machine (SVM) analysis of MALDI-TOF spectrum they can confidently 
differentiate the two species, however this analysis is beyond the scope of clinical laboratories.  
 The kidney model sample had undetectable levels of DNA after ɸ29 MDA suggesting that no 
amplification occurred.  This could be because of a technical error (e.g. no enzyme was added), 
the ɸ29 was inhibited or the DNA was lost during treatment with S1 nuclease. All identifiable 
reads mapped the Macaca, the host species and the pathogen of interest was not detectable.   
These tissue models were only designed to test the suitability of the isolation method and 
DNA amplification from tissues, and do not truly reflect a deep tissue infection.  When applied to 
real samples it might be necessary to increase the depth of sequencing and isolating the pathogen 
may be more challenging.  
Four clinical urine samples were tested to investigate the potential for whole genome 
pathogen analysis from urine. Two of these urines were of poor quality, with high levels of vaginal 
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flora present, suggesting female patients and poor sample collecting. Female urines are often 
problematic to take due to the high floral content, when using traditional methods selective agar 
and purity plates can be used to help isolate the pathogens above regional flora. In the two 
samples with less bacterial contamination there was a large number of unassigned reads, 
suggesting that this was random background contamination. Additionally, the urines were old and 
had been freeze thawed several times. There is also evidence that urine is an inhibitory sample for 
molecular methods 189, and so this combination of factors suggests that this method is not 
suitable for diagnostics from urine.  
When examining the CSF data there was very little pathogen recovery. There are several 
possible explanations for this, firstly the samples came from a collection of patients which had 
neurological symptoms but no proven infection, and so there is the possibility of a non-infectious 
cause of the symptoms. Additionally these were old samples that may have been freeze thawed 
causing pathogen degradation, which may have particular impact on pathogens present at low 
levels in the sample190. There is also the factor that there were high levels of human signals, which 
may have masked smaller pathogen signals present at low levels. The decision to not treat these 
samples with nucleases was taken as the integrity of the sample was unknown and there was 
potential that lysed pathogen signals would have been destroyed. This high level of host even in a 
fairly low cellular sample shows how important laboratory host depletion is. One of the CSFs had 
1.1% of reads assigned to Onchocerca volvulus covering less than 1% of the genome , a nematode 
that is a causative agent of river blindness. The nematode has been associated with a neurological 
condition known as ‘nodding syndrome’ through an  epidemiological and IgG study 191 in Uganda.   
There was no clinical data available alongside these samples and so it is difficult to comment on 
the possibility of this being a true cause of the neurological syndrome. There was very low 
genome coverage of the pathogen, so no strong evidence that it was a true positive. However 
other studies have inferred clinical significance from the presence of as l ittle as two viral reads, 
from a total read number of 15 million reads192. In this case for further conclusions to be drawn 
patient information on syndrome and geographical exposure would be needed. This pathogen 
would not have been tested for when investigating neurological symptoms in the UK.  
Four STI eluents were provided from the Sexually Transmitted Bacteria Reference Unit at PHE 
Colindale after they had completed routine testing. The samples in BD viper buffer produced very 
little DNA in the ɸ29 MDA amplification. DNA quantified in these first two STI swabs could have 
been the original DNA extracted from the samples and not amplified the ɸ29 MDA reaction. The 
first sample was a rectal swab which had previously been shown to be positive for C. trachomatis.  
Using ɸ29 MDA amplification is was not possible to detect the C. trachomatis above rectal flora, 
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however this may have been possible if the sample was deep sequenced. The second STI swab 
was a vaginal swab and it was possible to find the C. trachomatis in the ɸ29 MDA sample; 
however, it was not possible to further identify the pathogen. There was a high level of anaerobic 
bacteria present in line with those found in culture based investigations193 . Additionally Sneathia 
sanguinegens was identified in this sample, which has previously been suggested as a pathogen194 
. Sneathia spp have only recently been associated with a variety of female reproductive orders, 
due to its fastidious nature194. The ability of the methods developed to identify a putative 
pathogen, shows the potential value in pathogen discovery and characterisation. Additionally, the 
GC content of Sneathia spp being as low was 28% provides further evidence that this method is 
robust to extremes of GC content.  In the third STI swab sample N. gonorrhoeae was identified 
concurring with the reference laboratory. Additionally, the pathogen T. vaginalis was identified; 
there was no clinical information available so it was not possible to tell if this was a known T. 
vaginalis infection. T. vaginalis  is a poorly diagnosed pathogen with most diagnostics dependant 
on wet mount microscopy or culture, and visual identification of the pathogen, both of which 
need viable parasites and have sensitivity ranging from 35% to 60% 195. Mycoplasma genitalium 
was also identified, which has increasingly been considered a pathogen of the genital tract196, M. 
genitalium can be difficult to identify with traditional means as it is an intracellular pathogen and 
no commercial PCR systems are available. The fourth STI swab had a single species (Gardnerlla 
vaginalis) which represented 89.32% of identified reads, which shows a difference in floral 
composition from the mixed one seen in the other samples, suggesting a disease state that has 
altered the flora state. As well as identifying the expected N. gonorrhoeae a human papilloma 
virus (HPV8) was also identified, which although not know to be pathogenic itself, showed that 
the method would be suitable for detection of viral STIs.  
The female genital tract is a complex interaction of colonising bacteria197 which are in dynamic 
response to hormonal changes, sexual exposure and disease state of the host. In the three vaginal 
samples sequenced a large number of different species were found Figure 5-14. Increasingly, the 
line between ‘pathogen’ and ‘commensal’ is becoming blurred, especially in this site, as what 
constitutes a pathogen depends not only on the virulence of the bacteria itself but also with its 
interaction with the complex flora present, as well as the host state193.  The samples sequenced 
here represented samples that are referred to the reference laboratory because they show a 
more complex infection, perhaps due to treatment failure or unusual or severe symptoms, which 
might explain why multiple pathogens were present in each vaginal sample. Sequencing analysis 
of complex presentations of infections will allow insight into causes of symptoms moving on from 
the single-pathogen diagnostic system currently used to a more dynamic, ecological 
understanding of the disease state198. This will bring many challenges in interpretation, and a high 
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level of training will need to be provided to take full advantage of the potential benefits o f this 
technology.  
The three STI blood samples appeared to be lysed when they were received, most likely due 
to freeze thawing action. This process would also affect the integrity of pathogens present. The 
method was developed to be applied to whole fresh blood, and so it wasn’t possible to remove 
the RBCs from the blood samples as intended. T. pallidum was not identified in any of these 
samples, however even if the sample integrity wasn’t compromised, T. pallidum only shows 
transient blood infections.  In one of the samples the Torque teno virus was identified, which has 
previously been described as a ‘ubiquitous virus’ 199, with no evidence of pathogenicity. The ulcer 
samples also showed poor amplification, possibly because the transport media had high salt 
levels. It was possible to identify skin flora bacteria. In one of the samples 0.05% of reads were 
identified as T. pallidum.  
Overall the methods developed in this thesis have been shown to be suitable for fresh whole 
blood, providing sensitive genome amplification directly from sample. When looking at isolates 
sequenced directly from blood there was consistently comparable results to the phenotypic 
results. In some cases, (Salmonella and P. aeruginosa) additional identification was achieved 
through genomic analysis compared to phenotypic results. The methods developed also 
performed well in clinical STI samples, a clinical CSF and spiked tissue samples. Previous work 
done with similar techniques have focussed on a targeted pathogen such as HPV200 or single 
sample type such as viruses from skin swabs201.  Another approach to overcome human 
background is to use a capture array technique such as SureSelect (Agilent Technologies), this has 
been used successfully to sequence TB in smear positive samples202. However, an approach such 
as this would not have been able to identify Onchocerca volvulus in the CSF.  
The urines in this study produced poor results, because of contamination and probably 
sample freeze-thawing. Use of nuclease treatment to remove host signals is an important stage in 
the laboratory process and this process is most suited to samples with low host cell number. 
Sample quality is important for good quality pathogen isolation and sequencing directly from 
samples.  It is possible to use this method to look at changes in the microbiome of samples and to 
simultaneously identify bacterial and viral pathogens present in blood 
The failure of the method to work in some sample types highlights the challenges of applying 
modern molecular biology techniques to samples collected for traditional processes. What we can 
learn from this failure is that this technique may be most effectively deployed close to the patient, 
by teams who appreciate the need for specialised sample handling.  
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Overall there was a noticeable poorer performance of real clinical samples when compared to 
prepared models in this thesis. There are several reasons for this, firstly the basis for the sample 
processing was entirely based on the creation of freshly spiked horse blood. Real samples may 
differ from the horse blood in several important ways such as cellular make up, volume and 
presence of inhibitory molecules. Sample and pathogen volumes were tightly controlled in the 
models, which would not be possible in real samples. Additionally, the calculated inoculums of 
bacteria and viruses were estimated based on dilution studies, and so there may have been more 
bacteria present than estimated. Problems with the tested clinical samples mainly stem from the 
acquisition of samples which had been submitted to the reference l aboratory, after all reference 
work had ben completed. This means that all samples had been processed, stored and 
transported lowering sample integrity. Additionally, low volumes were often available and storage 
of samples would normally involve at least one freeze thaw.  To overcome the issue of sample 
integrity a clinical trial would need to be undertaken to allow additionally samples to be taken 
from patients in order to compare the traditional diagnostics and direct from sample next 
generation sequencing to be compared. Ethics would need to be sort, and a plan in place for the 
potential public health outcomes of new and novel pathogen discovery. This would involve large 
planning over a long period of time and would be an expensive study, possibly involvi ng several 
staff including patient interactions. This kind of study is beyond the bounds of this PhD thesis, and 
would take a long time to plan, be commissioned and run.  
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6.  General Conclusions 
Currently, laboratory techniques for infectious disease diagnosis are based on culture and PCR 
amplicon detection. These techniques have inherent biases towards known aetiologies of 
infection, and would be slow in responding to novel outbreaks. In depth characterisation and 
epidemiological investigation is often time and labour intensive. The rapid improvements in 
technology and data outputs of next generation sequencers, offers the potential for improved 
diagnosis and scientific understanding of infectious diseases. Currently the application of NGS to 
microbiology is often limited to whole genome sequencing of cultured bacteria or DNA amplicons.  
The use of an unbiased method for direct from sample amplification alongside a robust data 
analysis pipeline could provide improved identification, characterisation and understanding of 
infections.  
Primer free amplification was investigated by attempting to initiate DNA replication at DNA 
nicking points. Although this had previously been successful using other enzymes capabl e of 
displacement amplification, it was not successful when ɸ29 was trialled. This failure was most 
likely down to the low working temperatures of ɸ29 meaning little DNA dissociation. Additionally, 
as discovered in this thesis, the enzymes requires of at least 5 bases of single stranded DNA in 
order to initiate replication. Combination with other displacement enzymes was also unsuccessful 
most likely due to different enzymatic working conditions. 
Attachment of a DNA tag to DNA as initiation points for DNA replication was successful when 
more than five bases was available, but lost efficiency when 15 single stranded bases were 
present.  However, it was not possible to initiate reverse transcription using this method. 
Amplification from tagging lowered the efficiency with which the DNA was produced, due to less 
DNA replication initiation points. For these reasons and the need for fragmented DNA this was 
not deemed suitable for rapid sensitive amplification of pathogen nucleic acid. It did however 
show potential, and could be used to produce ‘bar-coded’ DNA so exact initial abundance of 
samples could be established after sequencing in situations where rapid amplification is less 
important.  
The use of ɸ29 MDA with random primers allows rapid production of DNA for sequencing 
without the need of prior target knowledge. It was proven to be successful at amplifying single 
cells, with results being comparable to whole colony input (estimated 1x106 cells) and even non-
amplification culture based sequencing. It was also shown that reduction of amplification time to 
just two hours still allowed sufficient amplification for whole genome sequencing without 
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impacting on genome coverage.  The method also proved to be applicable to a range of bacterial 
genome GC contents and to low number mixed bacterial cells. The extraction method was 
successful at extracting nucleic acid from a variety of cell wall types and encapsulated viruses. Use 
of the alkali extraction method rapidly produced single stranded DNA with limited shearing, which 
improved the quality of the assemblies compared to column based extraction methods.   
Bioinformatic removal of host signals through reference mapping is a rapid and effective way 
of lowering data complexity and should be performed on all sequencing samples as the first stage 
of analysis. Likewise, it is important to monitor presence of contamination of environment and 
kits through the use of negative amplification. This allows a contamination library to be created 
which allows mapping based methods to be used to rapidly remove known contaminants, 
therefore simplifying the data set and removing the chance of false incorporation in de novo 
assemblies. Use of very strict error trimming is detrimental to the dataset as too much 
information is lost; the best combination for this dataset is a contamination of average reads and 
end trimming at a cut off of Q20. Use of abundance trimming lowers the size and complexity of 
the dataset without losing information and allows better quantification of input, most likely due 
to removing repetitive genome elements. There is a need to test and optimise the de novo 
assembler for datasets based on input, DNA preparation method and sequencing platform. For 
this dataset the best performing assembler was SPAdes which combines a de Bruijn algorithm 
with read distance relationships, allowing advantage to be taken of long reads. It also has the 
advantage of using several kmer lengths, allowing the optimal kmer length to be found by the 
programme for each dataset and doesn’t need to be set by the user. Characterisation using de 
novo assembled data in multiple contigs is comparable to results produced from whole polished 
reference genomes. Virulence and antibiotic resistance prediction is mostly database dependant 
and so attention should be used when interpreting the outputs.  
It is possible to have a processing pathway that allows a single amplification reaction and 
sequencing run to be performed on both viral and bacterial  pathogens. There is however a need 
to separate the isolation processes due to differences in size, particle stability and nucleic acid 
makeup. The sample processing pipeline developed in this thesis allows both sets to be 
performed simultaneously.  When the process was performed on fresh whole blood it was 
possible to produce accurate information on pathogen identification, sequence type and 
antibiotic resistances. This is included an example of both a bacteria and enveloped RNA virus.  
As we approach the dawn of the era of genomic diagnostics it is important to re-evaluate how 
pathogens are classified, such as our current system of defining Shigella sp and E. coli as different 
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species despite their close genetic relationship. Use of untargeted resistance detection allowed an 
additional resistance gene to be identified in the P. aeruginosa. Resistance in Gram negative 
pathogens evolves quickly, and targeted methods will limit those detected to those looked for. 
This also highlights the presence of multiple resistance genes in single isolates, which may not 
always be investigated.  This sample also highlighted that LCA analysis is not suitable for plasmid 
detection, and so additional plasmid-specific analysis may be required.  
Contamination can have serious impact on the detection of low level pathogens, and so extra 
care and vigilance should be taken during sample processing and data analysis. Removing host 
signals is important so that pathogens signals can be detected above them. Sample and pathogen 
integrity are hugely important when using amplification methods, especially when they are used 
in combination with nuclease methods for removal of host signals.  
Looking at the microbiome of samples, especially when symptom presentation is complex, 
will allow more insight into the disease state of the patient. By increasing data production, it is 
hoped that more understanding of the microbial environment can be achieved. potentially 
leading to a re-evaluation of how a pathogen is defined, accounting for not just the virulence of a 
single bacterium but also its impact and interaction with the microbiome. Overall the sample 
processing, amplification and data interpretation techniques are most suited to sterile site 
infections, and can allow identification of pathogens from the presence of a single copy of the 
genome.  
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6.1 Future Developments and Applications 
Microfluidics allows highly precise manipulation of small particles in small volumes, and they 
has been increasingly  used for concentration and isolation of bacteria from fluid samples203,204. 
This has been shown to be successful in environmental studies205, with magnetic  beads used to 
selectively isolate E. coli to a sensitivity of 100 cfu/ml in milk and food samples using a 3D printed 
microfluidic device. Microfluidic isolation has also been coupled with nucleic acid techniques206 
and used to isolate bacteria from blood170. With the increased availability of 3D printing, and the 
development of more sophisticated yet affordable microfluidic systems, coupling this isolation 
system with ɸ29 MDA could produce rapid, accurate sequencing, and more importantly lead to a 
higher throughput system with less hands on time for isolation of low numbers of bacterial cells 
from clinical samples. 
Other capture methods for pathogens could involve using magnetic beads in combination 
with a pan-pathogen binding molecular. One candidate is mucin, which is produced by epithelial 
cells, which is the site of most pathogen binding. It has previously proven affective as a capture 
method for Norovirus207,208, in house (unpublished) work has also shown that this methods is 
affective for capture of a number of Enteroviruses including Ev-D68  which is a respiratory 
pathogen. Additionally it has been shown that mucins are the first molecule that enteric bacteria 
interact with209 suggesting potential for pan-pathogen capture. Magnetic capture allows 
simultaneous selection and concentration of pathogens, but would have to be as broad as 
possible to take advantage of the un-targeted nature of the approach developed here.   
An alternative approach to capturing pathogen would be the use ɸ29 MDA with semi-specific 
primers which would allow whole genome capture without knowing the whole genome sequence. 
For example, these primers could be developed for species specific targets, but because of the 
long amplicons produced and the displacement activity of the enzyme whole genomes could be 
amplified including novel genome elements such as insertions or mutations.  
Additional work would need to be performed on the bioinformatic processes, to allow the 
results to be more reliable and easier to interpret. Current pipeline outputs are complex to 
interpret due to them using pan-pathogen databases (such as Prokka, ResFinder), species specific 
databases which are created and curated by experts in the field and would allow genomic 
predictions to be more accurate and reliable. 
Although short read technologies are the most used techniques for producing bacterial 
sequence data, difficulty in placing repetitive elements and fully mapping chromosomes means 
that it is not always possible to fully identify novel resistance and virulence islands in pathogens. 
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Long read technologies such as the MinION nanopore have been used to fully characterise these 
gene structures 61. One novel finding of this work was that DNA produced by ɸ29 MDA gave 
better results in bioinformatic analysis than traditional culture extraction. As there is no apparent, 
fundamental limit on the read lengths that can be produced with the MinION, one exciting 
possibility is coupling the method here with MinION sequencing. The long reads would be ideal 
for the MinION library prep, where DNA shearing is a problem. DNA production using ɸ29 MDA 
would lead to large numbers of long reads being sequenced, which could improve the efficiency 
of MinION sequencing. It would also be interesting to apply this method to low biomass 
microbiomes, as the DNA produced by ɸ29 MDA shows impressive abundance correlation with 
the input DNA.  
Additionally, short read technologies often have a long run time with no access to data before 
the completion of the run, they also require samples to be processed in bulk to provide economic 
data acquisition. The MinION allows real-time data collection and analysis, when this technology 
was applied to a hospital outbreak of Salmonella174, the species was identified within 20 minutes 
of sample loading. Furthermore, it was possible to assign an individual isolate to outbreak cluster 
or non-outbreak within 100 minutes, allowing informed infection control measures to be 
implemented. MinION data was also used during the Ebola outbreak in Guinea in 2015175, 
allowing real-time phylogenetic analysis to be performed. When optimum processing was 
achieved results were available with 24 hours of sample receipt.  One advantage was the ability to 
performed remote bioinformatic analysis, minimising the amount of equipment and staff needed 
at the site of the outbreak. However, data uploading did have the disadvantage of requiring 
internet connection, which is not always predicable in remote locations. However, this work relied 
on amplification of pathogen signals which was reliant on prior knowledge of the aetiology. The 
long DNA strands produced by the untargeted methods developed in this thesis would allow 
direct from sample real-time identification, characterisation and possibly phylogenetic analysis of 
infections for real-time field epidemiology of novel outbreaks. 
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7. Supplementary Material 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7-1 al l the genes identified by Prokka in Adenovirus reference and MDA amplified adenovirus, arranged by 
transcript 
 Elements only in adeno_mda : Elements only in adeno_ref : 
E1A  "Early E1A 27 kDa protein"  "Early E1A protein" 
E1B  "E1B protein, large T-antigen"  "Adenovirus EB1 55K protein / large t-antigen" 
IX  "Hexon-interlacing protein"  "Adenovirus hexon-associated protein (IX)" 
E2A  "DNA-binding protein"  "Vira l DNA-binding protein, zinc binding domain" 
  "Early E2A DNA-binding protein"  
E2B  "Preterminal protein"  
E3  "Early 3 14.7 kDa protein"  "Adenovirus 15.3kD protein in E3 region" 
  "Pre-early 3 receptor internalization and  "Adenovirus E3B protein" 
U  "U exon protein"  
E4  "Spl icing factor"  "Mastadenovirus E4 ORF3 protein" 
  "putative early E4 11 kDa protein"  "Mastadenovirus early E4 13 kDa protein" 
  "Early 4 ORF4 protein"  
  "Early 4 ORF6 protein"  
L1  "Pre-capsid vertex protein"  "Adenoviral protein L1 52/55-kDa" 
L2  "Core-capsid bridging protein"  "Adenovirus minor core protein PV" 
  "Late L2 mu core protein precursor"  "Adenovirus late L2 mu core protein (Protein X)" 
  "Pre-histone-like nucleoprotein"  "Adenoviral core protein VII" 
  "Penton protein"  "Adenovirus penton base protein" 
    "Minor capsid protein VI" 
L3  "Hexon protein"  "Adenoviral DNA terminal protein" 
  "Protease"  "Adenovirus endoprotease" 
L4  "Shutoff protein"  "Late 100kD protein" 
  "Pre-hexon-linking protein"  "Hexon-associated protein (IIIa)" 
    "Adenovirus hexon associated protein, protein 
L5  "Fiber protein 1"  "Adenoviral fibre protein (repeat/shaft region)" 
  "Fiber protein 2"  
  "Packaging protein 3"  "Adenovirus IVa2 protein" 
IVa2  "Packaging protein 1"  
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 Phage associated genes Plasmid associated 
genes 
Putative genes 
1 "Phage lysozyme" "Plasmid SOS inhibition 
protein (PsiB)" 
"putative acyl transferase" 
2 "Phage holin family (Lysis 
protein S)" 
"Plasmid-derived single-
stranded DNA-binding 
"putative ATP-dependent helicase Lhr" 
3 "Phage integrase family 
protein" 
"Conjugative relaxosome 
accessory transposon 
"putative signal peptide" 
4 "Lambda phage tail  tape-
measure protein 
"Type-F conjugative 
transfer system pilin 
"putative deoxyribonuclease RhsA" 
5 "Bacteriophage CII 
protein" 
"Conjugal transfer 
protein TrbE" 
"putative deoxyribonuclease RhsB" 
6 Bacteriophage Lambda 
NinG protein" 
"conjugal transfer 
mating pair stabilization 
"putative zinc-type alcohol 
dehydrogenase-like 
7 "Phage portal protein, 
lambda family" 
"Type-F conjugative 
transfer system protein 
"Putative dimethyl sulfoxide reductase 
chain YnfE 
8 "Phage terminase large 
subunit (GpA)" 
"F pilus assembly Type-
IV secretion system for 
"putative dimethyl sulfoxide reductase 
chain YnfF 
9 "Phage minor tail  protein L "Bacterial conjugation 
TrbI-l ike protein" 
"putative nucleotide-binding protein 
containing 
10 "Phage minor tail  protein"  "putative oxidoreductase YciK" 
11 "Prophage tail  length tape 
measure protein" 
 "Putative metal chaperone YciC" 
12 "Bacteriophage lambda 
minor tail  protein (GpG)" 
 "putative fimbrial -l ike protein YcbV 
precursor" 
13 "Phage minor tail  protein 
U" 
 "putative dehydratase" 
14 "Prophage minor tail  
protein Z (GPZ)" 
 "putative Nudix hydrolase NudL" 
15 "Phage Head-Tail 
Attachment" 
  
16 "Phage major capsid 
protein E" 
  
17 "Bacteriophage lambda 
head decoration protein 
D" 
  
18 "Bacteriophage lambda Kil  
protein" 
  
19 "Lambda Phage CIII"   
20 "Bacteriophage replication 
protein O" 
  
21 "Phage NinH protein"   
22 "Phage portal protein, 
lambda family" 
  
23 "Bacteriophage lambda 
tail  assembly protein I" 
  
24 "Phage minor tail  protein 
L" 
  
Table 7-2 Al l  genes found in MDA and Control K12 but not in the reference 
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E. coli C.  difficile  A. naeslundii 
"6-N-hydroxylaminopurine resistance 
protein" 
"Aluminium resistance protein" "6-N-hydroxylaminopurine 
resistance protein" 
"Arsenical resistance operon repressor" "Bicyclomycin resistance protein" "Antiseptic resistance protein" 
"Bicyclomycin resistance protein" "Daunorubicin/doxorubicin resistance 
ABC 
"Copper resistance protein A 
precursor" 
"Bifunctional polymyxin resistance protein 
ArnA" 
"Fusaric acid resistance protein family 
protein" 
"Daunorubicin/doxorubicin 
res istance ABC 
"Copper resistance protein C precursor" "Mercuric resistance operon 
regulatory protein" 
"Daunorubicin/doxorubicin 
res istance ATP-binding 
"Daunorubicin/doxorubicin resistance 
ATP-binding 
"Methicillin resistance mecR1 protein" "Mercuric resistance operon 
regulatory protein" 
"Fosmidomycin resistance protein" "Methicillin resistance regulatory 
protein MecI" 
"Multidrug resistance protein 3" 
"Multidrug resistance-like ATP-binding 
protein 
"Multidrug resistance operon 
repressor" 
"Multidrug resistance protein 
EbrB" 
"Multidrug resistance outer membrane 
protein MdtP 
"Multidrug resistance protein 3" "Multidrug resistance protein 
MdtA" 
"Multidrug resistance protein D" "Multidrug resistance protein MdtA" "Multidrug resistance protein 
MdtK" 
"Multidrug resistance protein MdtA 
precursor" 
"Multidrug resistance protein MdtG"                  "Multidrug resistance protein 
s tp" 
"Multidrug resistance protein MdtC" "Multidrug resistance protein MdtK" "tellurite resistance protein 
TehB" 
"Multidrug resistance protein MdtE 
precursor" 
"Multidrug resistance protein NorM" "Vancomycin B-type resistance 
protein VanW" 
"Multidrug resistance protein MdtF" "Multidrug resistance protein s tp"  
"Multidrug resistance protein MdtH" "Multiple antibiotic resistance protein 
MarA" 
 
"Multidrug resistance protein MdtK" "Non-motile and phage-resistance 
protein" 
 
"Multidrug resistance protein MdtL" "Organic hydroperoxide resistance 
transcriptional 
 
"Multidrug resistance protein MdtM" "putative multidrug resistance ABC 
transporter 
 
"Multidrug resistance protein MdtN" "putative multidrug resistance protein 
EmrY" 
 
"Multidrug resistance protein MdtO" "Quaternary ammonium compound-
resistance protein 
 
"Multidrug resistance protein stp" "tellurite resistance protein TehB"  
"Multiple antibiotic resistance protein 
MarA" 
"Tellurium resistance protein"  
"Multiple antibiotic resistance protein 
MarR" 
"Tetracycl ine resistance protein TetM"  
"Multiple stress resistance protein BhsA "Tetracycl ine resistance protein TetO"  
"putative multidrug resistance ABC 
transporter 
"Vancomycin B-type resistance protein 
VanB" 
 
"putative multidrug resistance protein 
EmrK" 
"Vancomycin B-type resistance protein 
VanW" 
 
"putative multidrug resistance protein 
EmrK" 
  
"putative multidrug resistance protein 
EmrY" 
  
"Putative multidrug resistance protein 
MdtD" 
  
"Tel lurite resistance protein TehA"   
"tel lurite resistance protein TehB"   
"Tetracycline resistance protein, class B"   
"Zinc resistance-associated protein 
precursor" 
  
Table 7-3 output of initial resistance prediction using Prokka output word search  
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E. coli C.  difficile  A. naeslundii 
"bicyclomycin/multidrug 
efflux system" 
"Ferrous-iron efflux pump FieF" "Ferrous-iron efflux pump 
FieF" 
"Cation efflux system protein 
CusA" 
"Glutathione-regulated 
potassium-efflux system 
"Glutathione-regulated 
potassium-efflux system 
"Cation efflux system protein 
CusC precursor" 
"Magnesium and cobalt efflux 
protein CorC" 
"Magnesium and cobalt 
efflux protein CorC" 
"Cation efflux system protein 
CusF precursor" 
"manganese efflux pump MntP" "Vacuole effluxer Atg22 
like protein" 
"Cysteine/O-acetylserine 
efflux protein" 
"multidrug efflux protein"  
"Ferrous-iron efflux pump 
FieF" 
"Multidrug-efflux transporter 1 
regulator" 
 
"Glutathione-regulated 
potassium-efflux system 
"Outer membrane efflux protein"  
"Homoserine/homoserine 
lactone efflux protein" 
"Purine efflux pump PbuE"  
"Leucine efflux protein" "putative cation efflux system 
proteinc/MT2084" 
 
"Magnesium and cobalt efflux 
protein CorC" 
"Putative efflux system 
component YknX" 
 
"Multidrug efflux pump 
accessory protein AcrZ" 
"Vacuole effluxer Atg22 like 
protein" 
 
"Multidrug efflux pump 
subunit AcrA precursor" 
  
"Multidrug efflux pump 
subunit AcrB" 
"Glutathione-regulated 
potassium-efflux system 
 
"Multidrug efflux pump 
subunit AcrB" 
"Magnesium and cobalt efflux 
protein CorC" 
 
"Nickel/cobalt efflux system 
RcnA" 
"manganese efflux pump MntP"  
"p-hydroxybenzoic acid efflux 
pump subunit AaeA" 
"multidrug efflux protein"  
"p-hydroxybenzoic acid efflux 
pump subunit AaeB" 
"Multidrug-efflux transporter 1 
regulator" 
 
"Purine ribonucleoside efflux 
pump NepI" 
"Outer membrane efflux protein"  
"putative amino-acid 
metabolite efflux pump" 
"Purine efflux pump PbuE"  
"Sugar efflux transporter" "putative cation efflux system 
proteinc/MT2084" 
 
"Sugar efflux transporter A" "Putative efflux system 
component YknX" 
 
"Sugar efflux transporter B" "Vacuole effluxer Atg22 like 
protein" 
 
"Sugar efflux transporter C" "Ferrous-iron efflux pump FieF"  
"Threonine efflux protein" "Glutathione-regulated 
potassium-efflux system 
 
Table 7-4 output of all efflux pumps in using Prokka annotations  
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Common elements in E_coli_ref E_coli_con 
E_coli_MDA : 
 
"Beta-lactamase precursor"  
"bicyclomycin/multidrug efflux system" Bicyclomycin antibiotic with unique structure, transmembrane 
transporter activity "Bicyclomycin resistance protein" 
"Colicin I receptor precursor" Colicin i s  a  type of bacteriocin produced by and toxic to some 
stra ins of Escherichia coli. 
"Colicin V production protein" 
"Daunorubicin/doxorubicin resistance ATP-binding Daunorubicin: a synthetic antibiotic that interferes with DNA 
synthesis  
"Fosmidomycin resistance protein" Fosmidomycin i s  an antibiotic that was originally i solated from 
culture broths of bacteria of the genus Streptomyces 
"Modulator of drug activity B"  
"Multidrug efflux pump accessory protein AcrZ" AcrB and its homologues are the principal multidrug 
transporters in Gram-negative bacteria and are important in 
antibiotic drug tolerance210 
 
"Multidrug efflux pump subunit AcrA precursor" 
"Multidrug efflux pump subunit AcrB" 
"Multidrug export protein AcrE precursor" 
"Multidrug export protein AcrF" 
"Multidrug export protein EmrA" efflux system EmrAB-TolC, which confers resistance to 
antibiotics such as CCCP, FCCP, 2,4-dinitrophenol and nalidixic 
acid211 
"Multidrug export protein EmrB" 
"Multidrug transporter EmrE" Multidrug transporter that expels positively charged 
hydrophobic drugs across the inner membrane of E. coli. 
thereby conferring resistance to a wide range of toxic 
compounds. The drug efflux i s coupled to an influx of protons. 
Is  involved in the resistance of E. coli cel ls to methyl viologen, 
ethidium bromide and acriflavine. Is also able to transport 
tetraphenylphosphonium (TPP+) and benzalkonium212 
"putative multidrug resistance protein EmrK" Part of the tripartite efflux system EmrYK-TolC, which confers 
res istance to various drugs 
"putative multidrug resistance protein EmrY" 
"Multidrug resistance protein MdtA precursor" The MdtABC tripartite complex confers resistance against 
novobiocin and deoxycholate213 "Multidrug transporter MdtB" 
"Multidrug resistance protein MdtC" 
"Putative multidrug resistance protein MdtD" Putative transmembrane protein 
"Multidrug resistance protein MdtE precursor" Part of the tripartite efflux system MdtEF-TolC, which confers 
res istance to compounds such as rhodamine 6G, erythromycin, 
doxorubicin, ethidium bromide, TPP, SDS, deoxycholate, crystal 
violet and benzalkonium214 
"Multidrug resistance protein MdtF" 
 
"Multidrug resistance protein MdtH" Confers  resistance to norfloxacin and enoxacin 214 
"Multidrug resistance protein MdtK" Multidrug efflux pump that functions probably as a  Na
+
/drug 
antiporter. Confers resistance to many drugs such as 
fluoroquinolones (norfloxacin, ciprofloxacin, enoxacin), 
tetraphenylphosphonium ion (TPP), deoxycholate, doxorubicin, 
trimethoprim, chloramphenicol, fosfomycin, acriflavine, 
ethidium bromide and benzalkonium214 
"Multidrug resistance protein MdtL" Confers  resistance to norfloxacin and enoxacin 214 
"Multidrug resistance protein MdtM" Confers  resistance to acriflavine, chloramphenicol, norfloxacin, 
ethidium bromide and TPP214 
"Multidrug resistance protein MdtN" Operon: mdtNOP: Could be involved in resistance to 
puromycin, acriflavine and tetraphenylarsonium chloride 
"Multidrug resistance protein MdtO" 
"Multidrug resistance outer membrane protein 
MdtP 
"Multidrug resistance protein stp" Contributes to spectinomycin and tetracycl ine resistance215 
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(common in mycobacterium) 
 
"Multiple antibiotic resistance protein MarA" May be a  transcriptional activator of genes involved in the 
multiple antibiotic resistance (Mar) phenotype216 
"Multiple antibiotic resistance protein MarR" Repressor of the marRAB operon which is involved in the 
activation of both antibiotic resistance and oxidative stress 
genes216 
"Penicillin-binding protein 1A" AKA mrcA and mrcB 
Cel l  wall formation. Synthesis of cross-linked peptidoglycan 
from the l ipid intermediates. The enzyme has a  penicillin-
insensitive transglycosylase N-terminal domain (formation of 
l inear glycan s trands) and a penicillin-sensitive transpeptidase 
C-terminal domain (cross-linking of the peptide subunits)
217
 
 
"Penicillin-binding protein 1B" 
"Penicillin-binding protein 1C" AKA pbpC  
Cel l  wall formation.217 
"Penicillin-binding protein 2D" Involved in the polymerization and cross-linking of spore 
peptidoglycan. May be required for synthesis of the spore germ 
cel l  wall, the first layer of peptidoglycan synthesized on the 
surface of the inner forespore membrane 
"Penicillin-binding protein activator LpoA Regulator of peptidoglycan synthesis that is essential for the 
function of penicillin-binding protein 1A/1B Stimulates 
transpeptidase activi ty of PBP1a/PBP1b in vi tro
218
 
 
"Penicillin-binding protein activator LpoB 
"Penicillin-insensitive murein endopeptidase Aka mepA  
Murein is a another name for  peptidoglycan 
Involved in the removal of murein from the sacculus.219 
"Peptide antibiotic transporter SbmA" Uptake of antimicrobial peptides. Required for the transport of 
microcin B17 (MccB17), microcin 25 (Mcc25) and proline-rich 
antimicrobial peptides into the cell220 
"putative antibiotic transporter"  
"Putative beta-lactamase HcpD precursor" May hydrolyze 6-aminopenicillinic acid and 7-
aminocephalosporanic acid (ACA) derivatives (By s imilarity). 
Binds to penicillin. (UniProt) 
"putative multidrug resistance ABC transporter  
"Putative phosphinothricin acetyltransferase  
"Ribosome-recycling factor"  
"RNA-splicing ligase RtcB"  
"vancomycin high temperature exclusion protein" AKA sanA Participates in the barrier function of the cell 
envelope. 
Common elements in E_coli_ref E_coli_MDA : 
 
 
Multidrug resistance protein D" 
 
AKA emrD Multidrug resistance pump that participates in a low 
energy shock adaptive response 
Tetracycline resistance protein, class B" AKA tetA: Res istance to tetracycline by an active tetracycline 
efflux. This is an energy-dependent process that decreases the 
accumulation of the antibiotic in whole cells. This protein 
functions as a metal-tetracycline/H+ antiporter 
Table 7-5 al l resistance factors identified using Prokka in E. coli 
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Gene identified Function 
Common elements in C_diff_ref C_dif_con C_dif_MDA : 
Beta-lactamase  
Beta-lactamase HcpA precursor Slowly hydrolyzes 6-aminopenicillinic acid and 7-
aminocephalosporanic acid (ACA) derivatives. May be 
involved in the synthesis of the cell  wall peptidoglycan (By 
similarity). 
Beta-lactamase precursor  
Bicyclomycin resistance protein  
Daunorubicin/doxorubicin resistance 
ABC 
Part of the ABC transporter complex DrrAB involved in 
daunorubicin and doxorubicin resistance. Probably 
responsible for the translocation of the substrate across the 
membrane. 
Daunorubicin/doxorubicin resistance 
ATP-binding 
Part of the ABC transporter complex DrrAB involved in 
daunorubicin and doxorubicin resistance. Responsible for 
energy coupling to the transport system. Binds ATP or GTP 
Metallo-beta-lactamase superfamily 
protein 
Functionally predicted beta-lactamase 
Methicil l in resistance regulatory 
protein MecI 
Transcriptional repressor that constitutively blocks the 
transcription of the gene for the penicil l in-binding protein 
MecA. Binds palindromic DNA with the sequence 5'-TACA-
[AT]-N-TGTA-3'. Regulates genes involved in antibiotic 
resistance. Binds DNA as a dimer. (In S.aureus) 
Multidrug-efflux transporter 1 
regulator 
MerR family transcriptional regulator 
Multidrug export protein EmrB Drug resistance transporter, EmrB/QacA subfamily 
Multidrug export protein MepA Multidrug resistance efflux protein involved in transporting 
several clinically relevant monovalent and divalent biocides 
and the fluoroquinolone antimicrobial agents norfloxacin and 
ciprofloxacin 
Multidrug resistance operon 
repressor 
 
Multidrug resistance protein 3  
Multidrug resistance protein MdtA The MdtABC tripartite complex confers resistance against 
novobiocin and deoxycholate 
Multidrug resistance protein MdtG Confers resistance to fosfomycin and deoxycholate 
Multidrug resistance protein MdtK 
Multidrug resistance protein NorM Multidrug efflux pump that functions as a Na
+
/drug 
antiporter. Confers resistance to several drugs, such as 
norfloxacin, ciprofloxacin, ethidium, kanamycin and 
streptomycin 
Multidrug resistance protein stp Contributes to spectinomycin and tetracycline resistance
215
 
(common in mycobacterium) 
 
Multiple antibiotic resistance protein 
MarA 
May be a transcriptional activator of genes involved in the 
multiple antibiotic resistance (Mar) phenotype. 
Penicil linase repressor Transcriptional repressor that constitutively blocks 
expression of beta-lactamase. Regulates genes involved in 
antibiotic resistance. Binds DNA as a dimer 
Penicil lin-binding protein 1A AKA mrcA Cell wall formation. Synthesis of cross -linked 
peptidoglycan from the lipid intermediates. The enzyme has a 
penicil l in-insensitive transglycosylase N-terminal domain 
(formation of l inear glycan strands) and a penicillin-sensitive 
transpeptidase C-terminal domain (cross-linking of the 
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peptide subunits)
217
 
 
Putative multidrug export ATP-
binding/permease 
May be involved in multidrug export. Transmembrane 
domains (TMD) form a pore in the cell  membrane and the 
ATP-binding domain (NBD) is responsible for energy 
generation 
putative multidrug resistance 
protein EmrY 
Part of the tripartite efflux system EmrYK-TolC, which confers 
resistance to various drugs  
Putative small multi -drug export 
protein 
 
RNA-splicing l igase RtcB  
Tetracycline resistance protein TetM  Abolishes the inhibitory effect of tetracyclin on protein 
synthesis by a non-covalent modification of the ribosomes. 
Vancomycin B-type resistance 
protein VanB 
D-alanine-- l igase,  This protein is involved in the pathway 
peptidoglycan biosynthesis , which is part of Cell  wall 
biogenesis 
Vancomycin B-type resistance 
protein VanW 
Homology based 
Common elements in C_diff_ref C_dif_con 
Demethylrebeccamycin-D-glucose Glycosyl O-methyltransferase that catalyses the final step in 
the biosynthesis of rebeccamycin, an indolocarbazole alkaloid 
that inhibits topoisomerase 1. Has broad substrate specificity 
and functions as glycosyl O-methyltransferase on a number 
of rebeccamycin analogs  
Penicil lin-binding protein 1A/1B Cell wall formation. Synthesis of cross -linked peptidoglycan 
from the lipid intermediates. The enzyme has a penicil lin-
insensitive transglycosylase N-terminal domain (formation of 
l inear glycan strands) and a penicil lin-sensitive transpeptidase 
C-terminal domain (cross-linking of the peptide subunits)
217
 
 
Ribosome-recycling factor Responsible for the release of ribosomes from messenger 
RNA at the termination of protein biosynthesis  
Streptothricin hydrolase  
Elements only in C_dif_con : 
vancomycin high temperature 
exclusion protein 
Participates in the barrier function of the cell  envelope. 
Common elements in C_diff_ref C_dif_MDA : 
Methicil l in resistance mecR1 protein Penicil lin-interactive protein and potential antirepressor  
multidrug efflux protein  
Oleandomycin glycosyltransferase Oleandomycin macrolide antibiotic Specifically inactivates 
oleandomycin via 2'-O-glycosylation using UDP-glucose. 
putative multidrug resistance ABC 
transporter 
 
Tetracycline resistance protein TetM Abolishes the inhibitory effect of tetracycline on protein 
synthesis by a non-covalent modification of the ribosomes Tetracycline resistance protein TetO 
Elements only in C_dif_MDA : 
Penicil lin binding protein 
transpeptidase domain 
AKA penicil l in binding protein 1B 
Table 7-6 al l resistance factors identified using Prokka in C. difficile 
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Common elements in A_naes_ref A_naes_con A_naes_MDA : 
Daunorubicin/doxorubicin resistance ABC Part of the ABC transporter complex DrrAB 
involved in daunorubicin and doxorubicin 
resistance. Probably responsible for the 
translocation of the substrate across the 
membrane. 
Daunorubicin/doxorubicin resistance ATP-binding Part of the ABC transporter complex DrrAB 
involved in daunorubicin and doxorubicin 
resistance. Responsible for energy coupling to 
the transport system. Binds ATP or GTP 
Multidrug export protein EmrB art of the tripartite efflux system EmrAB-TolC, 
which confers resistance to antibiotics such as 
CCCP, FCCP, 2,4-dinitrophenol and nalidixic 
acid 
Multidrug resistance protein 3  
Multidrug resistance protein MdtA The MdtABC tripartite complex confers 
resistance against novobiocin and 
deoxycholate 
Multidrug resistance protein stp Contributes to spectinomycin and tetracycline 
resistance 
Penicillin-binding protein 1A Cell wall formation. Synthesis of cross-linked 
peptidoglycan from the lipid intermediates. 
The enzyme has a penicil l in-insensitive 
transglycosylase N-terminal domain 
(formation of l inear glycan strands) and a 
penicil l in-sensitive transpeptidase C-terminal 
domain (cross-linking of the peptide subunits) 
(By similarity). 
Putative multidrug export ATP-binding/permease May be involved in multidrug export. 
Transmembrane domains (TMD) form a pore 
in the cell  membrane and the ATP-binding 
domain (NBD) is responsible for energy 
generation 
Ribosome-recycling factor Responsible for the release of ribosomes 
from messenger RNA at the termination of 
protein biosynthesis. May increase the 
efficiency of translation by recycling 
ribosomes from one round of translation to 
another. 
vancomycin high temperature exclusion protein Participates in the barrier function of the cell  
envelope. 
Elements only in A_naes_ref : 
Maf-like protein YceF Unknown: maf Involved in septum formation. 
Penicillin-binding protein 2D Involved in the polymerization and cross-
linking of spore peptidoglycan. May be 
required for synthesis of the spore germ cell  
wall, the first layer of peptidoglycan 
synthesized on the surface of the inner 
forespore membrane 
Penicillin-binding protein PbpB Penicil lin-binding proteins (PBPs) function in 
the late steps of murein biosynthesis. PBP-2B 
is required for vegetative cell  division and 
sporulation septation. Beta-lactamase 
inactivates the PBPs by acylating an essential 
serine residue in the active site of these 
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proteins, thereby interrupting normal cell  
wall synthesis. 
Common elements in A_naes_ref A_naes_MDA : 
Multidrug resistance protein EbrB Part of a multidrug efflux pump. Confers 
resistance to cationic l ipophilic dyes such as 
ethidium bromide, acriflavine, pyronine Y and 
safranin O. The efflux is probably coupled to 
an influx of protons 
Multidrug resistance protein MdtK Multidrug efflux pump that functions 
probably as a Na
+
/drug antiporter. Confers 
resistance to many drugs such as 
fluoroquinolones (norfloxacin, ciprofloxacin, 
enoxacin), tetraphenylphosphonium ion 
(TPP), deoxycholate, doxorubicin, 
trimethoprim, chloramphenicol, fosfomycin, 
acriflavine, ethidium bromide and 
benzalkonium 
Penicillin-binding protein A Cell  wall formation. Synthesis of cross -linked 
peptidoglycan from the lipid intermediates. 
The enzyme has a penicil l in-insensitive 
transglycosylase N-terminal domain 
(formation of l inear glycan strands) and a 
penicil l in-sensitive transpeptidase C-terminal 
domain (cross-linking of the peptide subunits) 
(By similarity). 
Vancomycin B-type resistance protein VanW By similarity  
Common elements in A_naes_con A_naes_MDA : 
Beta-lactamase  
Beta-lactamase precursor  
Bicyclomycin resistance protein Involved in sulfonamide (sulfathiazole) and 
bicyclomycin resistance. Probable membrane 
translocase 
Multidrug resistance operon repressor  
Table 7-7 al l resistance factors identified using Prokka in A. naeslundii 
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gene Identification  origin 
entF Enterobactin_synthetase_component_F Escherichia_coli_CFT073 
fimD Outer_membrane_usher_protein_fimD_precursor Escherichia_coli_CFT073 
ecpC putative_enzyme Escherichia_coli_O157:H7 
sap Sap_kinase  Shigella _flexneri_(serotype_2a) 
fepA Ferrienterobactin_receptor_precursor Escherichia_coli_CFT073 
ibeC membrane_protein_YijP Escherichia_coli_CFT073 
ecpD putative_receptor Escherichia_coli_O157:H7 
entE Enterobactin_synthetase_component_E Escherichia_coli_CFT073 
orf conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
fecA FecA Shigella _flexneri_(serotype_2a) 
orf49 hypothetical_protein Escherichia_coli_536 
orf48 hypothetical_protein Escherichia_coli_536 
ibeB IbeB Escherichia_coli 
aslA putative_arylsulfatase Escherichia_coli 
entC Isochorismate_synthase_entC Escherichia_coli_CFT073 
orf conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
intB bacteriophage_P4_integrase Escherichia_coli_536 
orf30 unknown Shigella _flexneri_(serotype_2a) 
ompA outer_membrane_protein_A Escherichia_coli 
fecC FecC Shigella _flexneri_(serotype_2a) 
fecR FecR Shigella _flexneri_(serotype_2a) 
fepE Ferric_enterobactin_transport_protein_fepE Escherichia_coli_CFT073 
fecD FecD Shigella _flexneri_(serotype_2a) 
yi22_ orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
yi22 orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
fepD Ferric_enterobactin_transport_system_permease_p
rotein_fepD 
Escherichia_coli_CFT073 
fecB FecB Shigella _flexneri_(serotype_2a) 
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fepB Ferrienterobactin-
binding_periplasmic_protein_precursor 
Escherichia_coli_CFT073 
yjgX hypothetical_protein Escherichia_coli_536 
fimH FimH_protein_precursor Escherichia_coli_CFT073 
orf50 hypothetical_protein Escherichia_coli_536 
fepG Ferric_enterobactin_transport_system_permease_p
rotein_fepG 
Escherichia_coli_CFT073 
entB Isochorismatase Escherichia_coli_CFT073 
gspL putative_general_secretion_pathway_for_protein_e
xport 
Shigella _dysenteriae_Sd197 
rpoS sigma_S_(sigma_38)_factor_of_RNA_polymerase,_
major_sigmafactor_during_stationary_phase 
Salmonella_enterica_(serovar_typh
imurium)_LT2 
yi22g5 orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
fecE ATP-binding_protein_FecE_ Shigella _flexneri_(serotype_2a) 
fepC Ferric_enterobactin_transport_ATP-
binding_protein_fepC 
Escherichia_coli_CFT073 
c3559 Hypothetical_protein Escherichia_coli_CFT073 
gspC putative_general_secretion_protein_GspC Shigella _dysenteriae_Sd197 
fimC Chaperone_protein_fimC_precursor Escherichia_coli_CFT073 
fecE ATP-binding_protein_FecE Shigella _flexneri_(serotype_2a) 
fepC Ferric_enterobactin_transport_ATP-
binding_protein_fepC 
Escherichia_coli_CFT073 
c3559 Hypothetical_protein Escherichia_coli_CFT073 
gspC putative_general_secretion_protein_GspC Shigella _dysenteriae_Sd197 
fimC Chaperone_protein_fimC_precursor Escherichia_coli_CFT073 
ecpE hypothetical_protein Escherichia_coli_O157:H7 
entD 4'-phosphopantetheinyl_transferase_entD Escherichia_coli_CFT073 
entA 2,3-dihydro-2,3-dihydroxybenzoate_dehydrogenase Escherichia_coli_CFT073 
ecpB hypothetical_protein Escherichia_coli_O157:H7 
ecpA hypothetical_protein Escherichia_coli_O157:H7 
fimE Type_1_fimbriae_Regulatory_protein_fimE Escherichia_coli_CFT073 
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fimB Type_1_fimbriae_Regulatory_protein_fimB Escherichia_coli_CFT073 
ecpR putative_regulator Escherichia_coli_O157:H7 
fecI FecI Shigella _flexneri_(serotype_2a) 
fimI Fimbrin-like_protein_fimI_precursor Escherichia_coli_CFT073 
orf46 unknown Shigella _flexneri_(serotype_2a) 
fimF FimF_protein_precursor Escherichia_coli_CFT073 
fimG FimG_protein_precursor Escherichia_coli_CFT073 
tnpH orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
fimA Type-1_fimbrial_protein,_A_chain_precursor Escherichia_coli_CFT073 
z1217 Z1217_protein Escherichia_coli_536 
SF2976 orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
orf83 hypothetical_protein Escherichia_coli_536 
orf50 unknown Shigella _flexneri_(serotype_2a) 
yi21 g2_-_orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
gspM putative_secretion_pathway_protein Shigella _dysenteriae_Sd197 
yi21 g2_-_orf,_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
insG transposase_InsG_of_insertion_element_IS4 Escherichia_coli_536 
orf25 unknown Shigella _flexneri_(serotype_2a) 
orf58 hypothetical_protein Escherichia_coli_536 
yeeU hypothetical_protein Escherichia_coli_536 
z5091 Z5091_protein Escherichia_coli_536 
Z5091 unknown_protein_encoded_within_prophage_CP-
933L 
Escherichia_coli_O157:H7 
c3576 Unknown_in_IS Escherichia_coli_CFT07 
l7045 L7045 Escherichia_coli_536 
SF2977 orf,_partial_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
yeeT YeeT_protein Escherichia_coli_536 
SF3713 orf,_partial_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
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c3614 Hypothetical_protein Escherichia_coli_CFT073 
z5092 Z5092_protein Escherichia_coli_536 
orf88 hypothetical_protein Escherichia_coli_536 
SF3720 orf,_partial_conserved_hypothetical_protein Shigella _flexneri_(serotype_2a) 
Only found in MDA and control 
c3611 Transposase_insD_for_insertion_element_IS2A/D/F/
H/I/K 
Escherichia_coli_CFT073 
c3612 Transposase_insC_for_insertion_element_IS2A/D/F/
H/I/K 
Escherichia_coli_CFT073 
pB171O
RF51 
ORF51_protein_of_pB171 Escherichia_coli_536 
Table 7-8 al l vi rulence factors identified by VFDB in E. coli K12 
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Elements only in de_novo : Elements only in reference : 
Phosphoribosylformylglycinamidine synthase 1 putative amino acid permease YhdG 
Type II secretion system protein E Peptidoglycan DL-endopeptidase CwlO 
precursor 
Glycine betaine/carnitine transport binding Phosphoribosylformylglycinamidine synthase 
Phosphoadenosine phosphosulfate reductase 
family 
tRNA-Trp 
RNA-binding protein tRNA-His 
Iron-uptake system permease protein FeuC Tyrosine--tRNA ligase 
Phosphoglycerate transporter protein Putative type II secretion system protein E 
Heparin-sulfate lyase precursor Type II secretion system protein G precursor 
PTS system N-acetylgalactosamine-specific Deoxyguanosine kinase 
Sorbose-specific phosphotransferase enzyme IIB Collagen adhesin precursor 
Bacterial SH3 domain protein Cna protein B-type domain protein 
glutathionine S-transferase Bone sialoprotein-binding protein precursor 
Autoinducer 2 import system permease protein Glycine betaine/carnitine transport permease 
Cardiolipin synthase chromosome segregation protein 
NADH oxidase Oligopeptide transport ATP-binding protein 
OppF 
SkfA peptide export ATP-binding protein SkfE RNA-binding protein YhbY 
Melibiose carrier protein Regulatory protein MgsR 
DNA polymerase III subunits gamma and tau Lactate 2-monooxygenase 
GDSL-like Lipase/Acylhydrolase putative oxidoreductase YdgJ 
Type IV leader peptidase family protein Glycerol-3-phosphate transporter 
Arabinose operon regulatory protein Putative metallo-hydrolase YycJ 
CRISPR-associated protein Cas4/endonuclease Cas1 Ribonuclease 3 
HTH-type transcriptional regulator CynR Xylose isomerase-like TIM barrel 
3-oxoadipate CoA-transferase subunit A Putative bacilysin exporter BacE 
Sulfate/thiosulfate import ATP-binding protein Heparinase II/III-like protein 
Alpha/beta hydrolase family protein Fructose-specific phosphotransferase enzyme 
IIB 
M protein, serotype 2 precursor DNA-invertase hin 
Arginine/agmatine antiporter Methyltransferase domain protein 
Multidrug resistance protein MdtH Modification methylase HindIII 
 D12 class N6 adenine-specific DNA 
 Phage terminase, small subunit 
 L-serine dehydratase, beta chain 
Table 7-9 list of genes present in either the de novo or reference assembly of S.Pyogenes isolated from horse 
blood 
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Figure 7-1 phenotypic results of clinical E. coli 
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Figure 7-2 results of phenotypic resistance testing for cl inical Shigella sonnei 
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Figure 7-3 Phenotypic resistance testing for clinical Salmonella sp 
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Figure 7-4 phenotypic results of resistance testing of P.aeruginosa 
 
Figure 7-5 phenotypic resistance of H.influenzae 
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Genus/Species % reads identified using LCA analysis 
 Sample 2 Sample 3 Sample 4 
Mobiluncus curtisii   12.10%  
Corynebacterium sp  4.10%  
Corynebacterium aurimucosum  0.47%  
Corynebacterium riegelii  0.48%  
Corynebacterium sp ATCC 6931  0.34%  
Corynebacterium ureicelerivorans  0.23%  
Propionibacterium sp  0.20%  
Bifidobacteriaceae adolescentis   0.52%  
Gardnerlla vaginalis   0.61% 89.32% 
Atopobium vaginae   0.11% 
Eggerthella lenta   0.26%  
Bacteroides sp 7.83% 0.36%  
Bacteroides uniformis 5.35%   
Bacteroides dorei 2.32%   
Bacteroides xymanisolvens 1.08%   
Odoribacter splanchnicus 1.54%   
Prevotella melsninogenica 1.79%   
Chlamydia trachomatis 3.29%   
Staphylococcus epidermidis   4.44%  
Aerococcus sp   0.18%  
Enterococcus sp   0.80%  
Lactobacillus 0.28%  0.82% 
Streptococcus sp  10.85%  
Streptococcus agalactiae  0.60%  
Streptococcus anginosa   1.04%  
Streptococcus constellatus  0.52%  
Streptococcus dysgalactiae  0.52%  
Runinococcus torques 8.88% 0.00%  
Rosburia 1.37% 0.00%  
Peptoniphilus sp  31.85%  
Anaerococcus prevotii  4.71%  
Finegoldia magna  12.16%  
Parvimonas micra   0.46%  
Peptoniphilus asaccharolyticus  0.35%  
Filifactor alocis   1.89%  
Clostridiales genomosp 5.23% 0.86%  
Fusobacterium nucleatum   0.22%  
Sneathia sanguinegens 61.03% 0.20%  
Neisseria gonorrhoeae  3.54% 9.08% 
Mycoplasma genitalium  3.83%  
Trichomonas vaginalis   1.31%  
Alpha papillomavirus 8   0.67% 
Table 7-10 al l species representing > 0.2% of reads in the three vaginal STI samples 
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10. Abbreviation list 
  
ABC transporter ATP-Binding Cassette Transporters 
AIDS Acquired Immune Deficiency Syndrome 
CDC  Centre For Disease Control And Prevention 
CPE Cytopathic Effects 
CFU Colony-Forming Unit 
CMV Cytomegalovirus 
CNS Central Nervous System 
CSF Cerebrospinal Fluid 
ELISA Enzyme-Linked Immunosorbent Assay 
ESBL Extended Spectrum Beta Lactamases 
HACEK Haemophilus, Aggregatibacter (Previously 
Actinobacillus), Cardiobacterium, Eikenella 
Corrodens, Kingella 
HBV Hepatitis B Virus  
HCV Hepatitis C Virus 
HIV Human Immunodeficiency Virus 
HUS Haemolytic Uremic Syndrome 
LAMP Loop Mediated Isothermal Amplification 
MALDI-TOF Matrix-Assisted Laser Desorption/Ionization 
Time Of Flight 
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MDA Multiple Displacement Amplification  
MDR TB Multi-Drug Resistant Tuberculosis 
MIC Minimum Inhibitory Concentration 
MLST Multi-Locus Sequence Type 
MRSA Meticillin Resistant Staphylococcus aureus 
NDM-1 New Delhi Metallo-Beta-Lactamase-1 
NGS Next Generation Sequencing 
PCR Polymerase Chain Reaction 
PGM Personal Genome Machine 
PSGE Pulsed-Field Gel Electrophoresis 
SFF Standard flowgram format 
SNP Single Nucleotide Polymorphisms 
TB Tuberculosis 
TDR TB Totally Drug-Resistant Tuberculosis 
VNTR Variable Number Tandem Repeat 
WGS Whole Genome Sequencing 
XDR TB Extensively Drug-Resistant Tuberculosis 
 
 
